Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABHD14A-ACY1		ENSG00000114786	"ABHD14A-ACY1 readthrough"		3	51974706-51989183	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 4.8;Collecting duct cells: 5.5;Distal tubular cells: 3.9;Proximal tubular cells: 16.8;Theca cells: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											"HPA036174, HPA036175, HPA038153"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"			"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA036174: AB_2674988, HPA036175: AB_2674989, HPA038153: AB_2675868"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.90e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.11e-4)"	0.5	0.8	0.1	0.1	0.1	0.0	0.4	0.6	0.4	0.2	0.2	0.2	0.0	0.6	0.0	0.2	0.5	0.1	0.2	0.1	0.2	0.3	0.3	0.2	0.0	0.2	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.7	0.2	0.2	0.0	0.2	0.2	0.4	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.4	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.4	0.5	1.2	0.9	0.8	0.6	0.7	1.1	1.0	0.5	0.7	1.0	0.0	1.1	0.6	0.6	1.0	0.5	0.1	0.1	0.6	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.2	1.4	0.0	4.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.2	3.2	0.0	0.0	1.8	5.5	0.0	0.0	0.9	0.1	3.9	1.5	0.0	0.4	1.4	0.6	0.0	0.8	1.0	1.2	0.0	1.0	2.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.5	1.2	2.0	0.0	0.0	0.0	0.0	0.2	16.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	6.3	0.0	0.0
AC011455.2		ENSG00000269547	"Novel protein"		19	38915404-38949855	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"A549: 1.0"									"HPA052730, HPA056957"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA					"Cluster 6: T47d - Mammary gland"		"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"										"unprognostic (6.10e-2)"			"unprognostic (3.79e-2)"					0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 770.4;liver: 1319.0;skeletal muscle: 731.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 355.8;Hepatocytes: 1170.0;Late spermatids: 456.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"neutrophil: 475.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 475.2"	"Cell line enhanced"	"Detected in all"		"ASC diff: 1124.0;ASC TERT1: 275.2;HSkMC: 609.5;RPTEC TERT1: 358.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011317, HPA011964"	Enhanced		Uncertain	Vesicles		NA	NA		44000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA011316: AB_1844536, HPA011317: , HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	770.4	43.3	32.5	94.8	43.9	337.9	316.7	45.2	70.2	62.1	60.7	34.0	32.4	41.6	78.2	66.0	50.6	36.2	172.7	34.4	39.1	218.7	1319.0	173.7	20.7	63.2	44.4	15.5	49.3	57.0	39.6	30.0	56.2	91.3	16.3	28.4	84.2	30.1	731.8	173.0	34.5	42.8	45.2	132.8	54.2	41.9	63.2	12.2	51.3	442.0	24.7	73.2	57.7	70.8	51.6	15.9	9.7	24.6	1124.0	275.2	8.3	29.1	13.8	16.1	11.2	3.9	14.0	22.2	3.0	32.8	38.4	29.7	43.1	17.8	13.3	107.1	17.7	16.6	13.1	40.5	183.4	41.9	37.2	609.5	140.7	13.6	67.1	27.6	21.1	3.6	7.5	59.4	77.0	26.9	3.1	55.1	2.0	32.5	23.3	8.0	8.6	27.0	358.4	135.9	36.3	35.1	25.4	70.8	86.5	3.9	26.9	39.8	25.1	13.8	16.8	34.5	8.7	24.5	13.5	8.9	45.6	56.3	22.4	16.5	54.7	17.7	3.3	30.9	2.8	3.3	2.3	1.5	13.1	3.4	2.5	2.2	475.2	4.4	23.0	2.4	4.9	20.8	32.5	43.9	45.2	70.2	34.4	39.1	63.2	44.4	56.2	45.2	63.2	70.8	7.5	25.6	121.0	6.5	15.7	21.0	16.0	14.0	5.2	6.6	49.7	10.3	119.1	25.8	33.5	31.3	18.8	10.2	7.1	4.3	93.9	4.6	355.8	9.8	25.0	9.8	0.0	34.1	15.2	12.8	2.2	19.4	36.2	24.6	24.1	1.5	18.2	1170.0	41.8	3.3	22.8	4.7	85.5	140.7	14.6	456.6	19.3	170.1	32.0	6.5	40.5	3.1	1.0	8.5	89.8	8.6	1.6	16.6	8.6	51.3	1.5	111.1	26.8	11.4	13.1	11.1	12.4	10.5	16.7	26.4	41.1	3.4	10.6	1.8	3.2	23.1
ACSM5	FLJ20581	ENSG00000183549	"Acyl-CoA synthetase medium chain family member 5"	Q6NUN0	16	20409534-20441336	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 276.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 237.8"	"Group enriched"	"Detected in some"	7	"liver cancer: 20.5;renal cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 5.3;ASC TERT1: 11.5;HSkMC: 13.8;U-87 MG: 8.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041435	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA041435: AB_10961121"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.57e-1)"	25.5	2.5	7.1	0.6	5.2	0.6	10.7	4.7	5.0	2.8	3.0	3.7	0.8	1.2	7.1	1.0	1.7	2.3	3.3	5.5	7.9	25.4	276.6	2.1	1.9	6.3	6.8	0.8	0.6	1.0	0.5	1.4	6.8	0.6	1.2	0.5	0.9	0.9	13.9	2.3	1.9	1.0	6.7	4.6	3.4	0.9	8.2	0.7	4.2	1.7	0.7	1.1	2.2	8.2	0.0	0.0	0.1	0.1	5.3	11.5	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	13.8	0.0	0.8	0.1	0.2	0.0	0.0	0.1	0.5	1.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	8.5	0.1	0.0	0.1	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	7.1	5.2	4.7	5.0	5.5	7.9	6.3	6.8	6.8	6.7	8.2	8.2	0.4	0.0	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.8	0.4	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.5	0.5	0.0	0.3	1.2	0.0	13.5	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	6.1	237.8	3.7	0.0	0.2	0.0	0.0	11.7	1.5	0.8	9.3	3.5	0.0	7.5	1.3	0.9	0.0	1.5	0.1	0.0	0.0	6.0	0.0	0.2	0.0	52.1	0.0	0.1	0.0	11.3	0.3	0.2	0.3	0.1	0.6	0.0	0.7	0.9	0.1	0.2
ADAM15	MDC15	ENSG00000143537	"ADAM metallopeptidase domain 15"	Q13444	1	155050566-155062775	"Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.5;Extravillous trophoblasts: 172.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 39.1;intermediate monocyte: 26.5;myeloid DC: 64.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 64.0;monocytes: 39.1"	"Cell line enhanced"	"Detected in many"		"PC-3: 329.5;RPMI-8226: 361.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011633, HPA072878"	Uncertain		Uncertain	Vesicles		NA	NA		640000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA011633: AB_1844574, HPA072878: "	"unprognostic (6.35e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (5.83e-5)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.64e-9)"	"unprognostic (3.35e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.40e-2)"	70.1	18.5	12.5	21.4	16.0	34.1	64.7	16.9	13.9	40.3	7.1	38.3	16.4	42.5	7.6	79.1	41.5	21.6	63.1	10.5	13.8	32.4	15.1	50.0	10.0	20.2	15.1	25.5	25.5	30.0	14.1	39.1	16.8	40.0	23.8	3.4	45.3	16.7	22.7	107.9	31.3	38.6	17.3	28.8	44.2	4.9	17.1	7.3	31.6	32.4	13.6	38.9	57.3	18.0	112.0	35.0	7.0	153.2	54.9	45.6	66.3	48.2	60.9	60.1	40.5	25.9	63.3	30.9	210.7	63.5	26.7	135.9	34.5	147.9	15.8	14.3	44.9	7.6	63.1	25.3	95.5	63.4	7.9	48.7	153.8	60.5	86.6	82.6	274.7	9.3	11.9	124.8	45.2	64.7	0.5	47.1	21.6	193.4	329.5	10.0	20.5	361.8	43.7	29.7	20.8	44.7	105.2	131.2	41.8	10.7	194.8	38.9	205.1	58.6	24.6	58.9	54.1	13.9	11.7	13.7	42.7	47.6	65.4	0.0	39.1	0.8	9.5	26.5	6.5	2.0	4.7	5.6	64.0	2.1	2.0	2.5	1.4	1.6	6.2	5.3	8.9	22.8	12.5	16.0	16.9	13.9	10.5	13.8	20.2	15.1	16.8	17.3	17.1	18.0	164.5	3.2	6.7	8.8	6.6	48.9	30.4	81.6	47.8	9.7	34.6	20.7	11.5	35.8	38.3	9.2	29.2	13.0	8.1	100.4	0.0	33.4	1.7	13.3	9.2	120.8	12.7	4.6	8.1	25.5	172.4	19.8	85.6	15.4	1.3	8.5	62.2	19.9	31.7	6.7	9.8	80.7	18.3	65.0	43.6	1.3	17.4	27.2	14.2	15.9	28.8	8.8	13.4	9.0	16.8	42.1	50.9	18.0	8.0	55.2	47.4	2.6	22.9	17.0	13.1	15.7	14.5	0.8	6.4	91.2	57.1	17.8	8.6	2.7	76.9	40.0
ADAMTSL3	"KIAA1233, punctin-2"	ENSG00000156218	"ADAMTS like 3"	P82987	15	83654088-84039842	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 141.1;Alveolar cells type 2: 111.8;Astrocytes: 86.5;Club cells: 61.7;granulocytes: 63.1;Inhibitory neurons: 91.6;Oligodendrocytes: 75.2;Respiratory ciliated cells: 56.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 12.1;hTERT-RPE1: 3.6;RPTEC TERT1: 14.0;TIME: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034773, HPA034774"	Uncertain		Uncertain	Vesicles	"Secreted in other tissues"	NA	NA		270000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA034773: AB_10601965, HPA034774: AB_2674326"	"unprognostic (2.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (5.92e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.00e-3)"	"unprognostic (4.62e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.95e-5)"	6.3	4.2	1.1	1.0	1.7	0.0	1.7	1.4	1.0	3.1	4.4	10.6	1.4	6.9	1.5	3.3	4.4	1.1	10.7	1.1	1.1	3.3	10.4	7.4	1.1	1.4	1.5	1.2	7.3	0.8	1.4	10.4	1.7	6.6	3.2	0.3	2.4	7.1	2.6	1.4	1.8	4.7	1.5	1.9	4.6	2.7	1.1	1.0	2.6	4.8	0.5	5.2	2.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.9	0.0	14.0	0.0	0.0	0.0	0.2	0.2	0.0	1.3	0.0	0.0	13.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.4	1.0	1.1	1.1	1.4	1.5	1.7	1.5	1.1	3.0	8.7	141.1	111.8	86.5	0.1	7.0	5.2	1.7	0.6	0.2	0.2	0.3	9.4	0.0	61.7	1.8	0.0	0.1	0.8	0.0	0.0	0.5	14.9	0.6	0.4	10.6	0.0	0.0	31.3	2.4	0.2	29.0	1.5	1.2	63.1	0.1	1.1	10.2	0.2	6.7	91.6	0.0	0.0	0.6	0.5	16.9	49.4	5.9	0.0	5.6	0.0	0.1	1.0	4.5	75.2	1.0	0.0	17.0	0.4	2.4	0.0	0.6	56.4	0.2	26.3	13.0	8.3	2.1	2.8	0.6	1.1	0.1	5.0	0.4	0.0	2.3
ADGRE2	"CD312, EMR2"	ENSG00000127507	"Adhesion G protein-coupled receptor E2"	Q9UHX3	19	14732392-14778560	"CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Cell adhesion, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 19.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 47.9;Kupffer cells: 69.4;Macrophages: 73.2;monocytes: 49.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 70.0;eosinophil: 74.7;intermediate monocyte: 46.9;neutrophil: 55.7;non-classical monocyte: 89.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 74.7;monocytes: 89.9"	"Cell line enhanced"	"Detected in many"		"HEL: 11.8;HMC-1: 18.3;NB-4: 11.5;RPMI-8226: 8.4;U-937: 14.9"					"Low region specificity"	"Detected in many"			HPA055200			Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	Cytosol	"HPA055200: "	"unprognostic (2.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.35e-6)"	"unprognostic (1.46e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.01e-1)"	4.9	1.5	1.0	19.4	1.3	6.9	1.8	1.2	2.1	0.9	1.3	1.4	1.9	0.7	0.7	0.9	0.9	2.5	0.5	1.0	1.5	2.1	2.0	4.2	3.0	2.5	1.6	0.1	0.8	1.1	0.5	1.6	2.2	1.1	1.9	0.6	1.0	2.8	0.6	2.0	2.3	1.6	1.1	15.6	1.5	0.4	1.8	2.4	0.6	0.9	2.2	5.4	0.9	2.4	0.3	1.2	0.1	0.2	0.0	0.3	1.2	0.9	1.3	0.0	0.0	0.2	0.2	0.1	0.1	0.7	2.3	1.9	0.3	0.1	0.0	0.2	0.2	11.8	3.8	0.2	0.5	4.3	18.3	0.9	1.6	4.1	0.6	0.1	0.1	1.0	2.7	0.4	1.3	0.5	1.5	11.5	0.4	0.8	0.2	0.1	1.5	8.4	0.0	0.3	0.0	0.2	2.4	2.0	0.4	0.2	0.3	5.4	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.2	1.1	14.9	0.6	70.0	13.9	74.7	0.2	46.9	0.2	0.2	0.2	0.1	9.3	0.3	0.1	0.2	55.7	3.3	89.9	1.9	0.1	7.3	1.0	1.3	1.2	2.1	1.0	1.5	2.5	1.6	2.2	1.1	1.8	2.4	0.6	3.2	7.7	0.7	1.9	0.0	4.8	0.0	0.6	0.8	1.6	1.5	0.8	0.0	2.5	0.0	0.0	0.2	12.8	0.0	0.0	0.0	2.0	0.7	3.5	1.8	1.2	3.8	0.9	0.0	0.5	1.9	1.1	0.9	47.9	0.1	0.7	0.5	12.8	0.0	1.2	0.1	0.0	69.4	0.0	2.5	0.0	73.2	0.0	0.0	49.2	0.0	2.1	0.5	12.0	0.0	0.2	0.4	2.1	2.4	0.1	0.1	2.2	0.9	0.0	2.0	1.5	0.3	0.5	0.6	0.0	0.4	3.0	0.1	0.1	3.0
ADRA1A	"ADRA1C, ADRA1L1"	ENSG00000120907	"Adrenoceptor alpha 1A"	P35348	8	26748150-26867278	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.6;liver: 60.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 105.4;Early spermatids: 51.3;Inhibitory neurons: 123.2;Late spermatids: 28.3;Oligodendrocyte precursor cells: 114.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.9;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029678, HPA029679, HPA076693"	Approved	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 15: Liver - Metabolism"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Vesicles"	"HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: "	"unprognostic (1.27e-1)"		"unprognostic (1.68e-2)"		"unprognostic (1.99e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.04e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.30e-1)"	21.8	0.5	13.3	1.1	11.1	0.0	3.6	3.0	22.6	0.7	0.0	1.4	0.9	1.4	0.6	0.8	0.2	0.3	7.6	42.6	20.8	0.7	60.1	3.9	1.7	9.3	4.9	0.9	0.0	0.0	0.1	0.0	9.5	12.4	0.5	0.3	6.2	13.5	0.2	0.6	1.1	2.9	1.5	9.2	0.9	0.1	4.2	0.1	0.1	1.4	0.4	0.4	0.3	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	11.1	3.0	22.6	42.6	20.8	9.3	4.9	9.5	1.5	4.2	6.9	0.0	0.0	0.0	105.4	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.3	0.0	0.0	0.1	0.0	0.0	15.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	16.2	0.0	0.0	123.2	0.0	0.0	0.0	0.5	28.3	0.6	0.0	0.0	9.4	0.0	0.0	0.0	114.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
AGMO	"FLJ16237, TMEM195"	ENSG00000187546	"Alkylglycerol monooxygenase"	Q6ZNB7	7	15200317-15562015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 122.5"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 83.0;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 38.5;Proximal enterocytes: 30.5;Proximal tubular cells: 16.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 15.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.5;Karpas-707: 7.7;NTERA-2: 3.5;SCLC-21H: 3.2;TIME: 4.0;WM-115: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057900			Uncertain	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA057900: "	"unprognostic (2.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	2.8	0.1	0.9	0.6	2.4	0.1	1.8	0.7	1.9	0.1	0.1	1.2	9.7	0.1	14.5	0.1	0.1	3.6	0.4	0.7	1.4	8.9	122.5	0.2	0.5	1.5	1.4	0.1	0.1	0.0	0.4	0.8	1.5	0.0	0.6	0.1	0.2	0.1	0.3	0.2	14.9	0.1	0.9	0.0	0.3	3.0	1.8	0.2	0.4	0.4	0.1	1.2	0.1	4.1	0.0	2.2	0.0	1.9	0.2	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	1.2	0.0	0.7	3.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.0	1.3	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	15.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.9	2.4	0.7	1.9	0.7	1.4	1.5	1.4	1.5	0.9	1.8	4.1	10.0	0.0	0.0	6.8	0.3	0.1	0.1	0.7	0.0	0.0	0.2	0.3	0.1	11.5	0.4	3.7	0.0	0.1	0.1	0.5	0.0	0.0	1.3	0.3	0.1	1.2	1.8	2.7	1.3	0.0	0.2	1.2	0.0	0.0	0.0	0.0	1.1	83.0	0.1	0.0	1.7	0.4	0.0	1.6	0.5	1.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	33.7	38.5	0.9	0.1	0.0	0.0	0.0	30.5	16.9	0.3	0.0	6.6	0.4	2.4	1.7	6.4	0.1	0.0	0.1	0.2	0.1	0.6	0.0
AGTR1	"AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R"	ENSG00000144891	"Angiotensin II receptor type 1"	P30556	3	148697784-148743008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 96.6;placenta: 141.6"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 53.1;Hepatocytes: 30.9;Leydig cells: 145.1;Sertoli cells: 144.7;Smooth muscle cells: 71.2"	"Group enriched"	"Detected in many"	8	"breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8"	"Region enhanced"	"Detected in some"		"midbrain: 8.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 176.8;ASC TERT1: 24.4;BJ hTERT+ SV40 Large T+: 34.8;HBF TERT88: 53.9;HSkMC: 32.2"					"Low region specificity"	"Detected in all"			HPA003596	Enhanced		Uncertain	Vesicles		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA003596: AB_1845163"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.48e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.41e-3)"	65.9	38.2	0.3	1.8	0.7	0.0	39.9	0.2	0.4	3.4	0.4	21.1	0.8	3.5	2.7	2.8	9.8	6.2	10.9	0.4	1.4	18.4	96.6	10.4	0.7	2.1	8.1	3.8	3.5	2.8	3.8	141.6	0.9	5.3	4.4	0.9	4.7	4.2	11.6	15.8	4.3	4.6	0.2	9.1	6.5	2.2	0.7	3.0	14.2	13.8	0.2	14.6	6.1	0.2	0.0	1.0	0.8	0.0	176.8	24.4	0.0	0.2	3.9	34.8	20.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0	53.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	32.2	0.0	3.4	1.8	1.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.2	0.4	0.4	1.4	2.1	8.1	0.9	0.2	0.7	0.2	20.5	0.0	0.6	0.0	0.0	3.4	0.2	0.0	0.0	0.0	1.3	0.9	6.3	2.8	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.1	0.8	0.0	0.3	3.8	23.5	0.0	0.1	7.6	0.3	53.1	0.5	0.0	0.0	0.0	17.5	30.9	0.7	0.0	0.0	0.2	0.0	0.3	3.5	1.7	145.1	0.5	1.8	2.8	0.0	5.7	0.0	0.0	0.1	0.5	0.0	7.5	0.4	1.1	0.0	0.1	0.0	0.1	144.7	7.6	71.2	0.0	1.8	0.3	1.7	0.3	0.5	0.3	0.0	0.1
AL049629.2		ENSG00000284969	"Novel protein"		11	33698261-33722467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Ductal cells: 9.1;Exocrine glandular cells: 14.4;Pancreatic endocrine cells: 44.8"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 42.8;HUVEC TERT2: 55.1;TIME: 66.2;U-2197: 57.6"									HPA026494	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"		"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Vesicles"		"HPA026494: AB_1846321"																		2.5	0.7	1.5	2.3	1.4	1.5	1.1	1.5	1.6	0.5	2.5	0.7	1.4	1.3	1.8	1.2	0.6	2.1	1.1	1.4	1.7	1.6	0.8	1.7	0.3	1.8	2.0	0.6	0.7	1.0		1.5	1.8	0.5	0.7	0.6	2.4	0.7	3.5	0.3	0.3	0.6	1.8	0.5	2.9	1.1	1.8	0.2	0.8	1.1	1.4	2.3		2.1	1.3	3.3	0.2	2.4	3.4	7.9	0.1	18.5	8.4	2.3	2.2	0.1	9.6	0.0	2.3	12.5	1.1	2.2	0.3	42.8	4.0	2.0	0.4	0.3	7.1	0.8	0.8	0.4	1.2	3.0	2.7	1.0	14.7	1.9	55.1	0.3	0.5	7.4	15.4	1.0	1.8	0.8	0.5	1.3	24.8	0.4	1.5	1.3	4.9	2.2	0.0	0.3	2.0	3.4	7.3	0.2	1.0	0.0	66.2	7.0	2.7	57.6	7.4	3.8	3.7	0.3	16.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	1.4	1.5	1.6	1.4	1.7	1.8	2.0	1.8	1.8	1.8	2.1	0.5	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.7	0.2	2.1	0.0	0.0	0.0	14.4	0.0	0.2	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Cell adhesion, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 438.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 737.2;Oligodendrocyte precursor cells: 680.1;Oligodendrocytes: 981.1;Respiratory ciliated cells: 318.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 29.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 29.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 393.4;U-138 MG: 473.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced		Uncertain	Vesicles	"Secreted to blood"	NA	NA		1600000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.15e-4)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (7.76e-2)"	7.7	32.7	31.3	12.2	48.1	10.5	81.0	42.4	47.2	28.0	14.4	16.6	17.0	15.5	35.4	8.2	49.1	23.3	9.6	32.4	70.6	22.2	47.9	74.1	9.9	50.7	54.9	57.6	32.7	438.9	19.2	12.1	51.7	32.7	14.5	3.6	33.8	39.6	0.8	11.0	17.4	16.2	44.9	6.3	33.4	4.5	45.7	14.2	62.4	5.0	14.5	25.6	6.4	85.0	248.4	93.7	65.9	33.7	97.6	42.7	0.6	197.7	115.1	124.9	173.8	0.8	50.5	17.3	80.3	280.6	68.8	186.5	10.6	157.4	366.1	16.6	16.6	2.4	65.8	4.6	109.6	101.3	0.8	76.0	114.9	159.9	393.4	346.8	139.3	17.9	0.3	28.6	165.9	16.9	14.5	37.0	13.7	79.3	104.8	9.4	5.9	1.0	188.9	27.2	47.5	131.9	20.6	19.6	12.9	25.9	37.7	66.3	291.6	473.7	162.3	20.9	237.2	0.3	0.6	1.8	108.0	21.1	207.4	0.0	4.7	3.5	0.6	2.1	1.9	4.7	1.5	0.9	29.6	3.0	0.3	0.2	5.3	0.6	1.2	10.5	2.4	3.2	31.3	48.1	42.4	47.2	32.4	70.6	50.7	54.9	51.7	44.9	45.7	85.0	4.5	737.2	143.6	238.6	17.9	12.1	22.8	65.8	12.0	3.0	112.4	47.9	10.1	62.9	255.3	16.5	2.1	0.7	19.5	9.1	1.9	18.5	66.5	108.6	20.1	11.9	16.8	6.3	143.0	43.0	0.7	37.0	23.4	158.1	11.4	29.5	3.6	44.1	57.5	1.7	287.0	16.3	46.8	51.0	162.6	60.1	3.7	86.4	24.9	40.3	93.4	1.3	1.0	680.1	981.1	55.2	8.5	6.4	21.8	117.5	9.6	24.2	318.3	0.8	0.0	7.9	21.8	8.1	5.5	30.1	20.2	0.8	8.9	22.8	10.4	105.4
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.9"	"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HEK 293: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Uncertain	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA					"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANO10	"FLJ10375, MGC47890, SCAR10, TMEM16K"	ENSG00000160746	"Anoctamin 10"	Q9NW15	3	43354859-43691594	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 123.3;Excitatory neurons: 77.4;Inhibitory neurons: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016624, HPA051569"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA016624: , HPA051569: AB_2681537"	"unprognostic (1.51e-3)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.70e-4)"	"prognostic favorable (1.11e-4)"	"unprognostic (4.23e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (7.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.41e-6)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (5.71e-2)"	26.6	14.1	17.6	15.1	18.6	33.0	21.8	23.9	20.9	22.3	18.4	39.4	61.1	21.6	13.6	25.3	13.9	19.4	12.7	18.1	21.1	29.9	14.1	16.9	7.6	22.7	22.9	13.9	15.2	23.7	13.9	18.1	23.2	14.2	33.7	10.1	28.6	20.2	15.5	32.0	54.7	28.0	19.6	9.1	13.5	13.0	19.8	7.1	24.5	11.6	9.7	18.1	21.5	24.1	30.6	23.6	26.1	27.4	101.1	53.5	31.2	87.7	141.1	42.0	54.4	16.2	27.5	3.1	27.4	114.8	43.1	16.3	20.6	47.0	52.6	33.6	14.2	39.4	28.7	17.7	43.9	7.2	31.1	50.5	36.3	53.6	71.8	79.4	100.3	18.7	30.8	24.9	95.2	20.8	7.8	5.2	31.3	23.7	28.6	6.3	18.7	10.2	85.5	31.4	6.4	19.4	34.4	27.0	19.8	45.3	59.5	14.5	84.7	66.2	24.4	70.2	40.7	15.7	22.9	1.1	60.2	14.6	44.2	7.4	19.0	1.4	6.7	11.1	3.8	2.7	4.6	4.5	13.1	2.5	3.9	6.0	32.8	9.7	12.7	2.3	5.4	7.0	17.6	18.6	23.9	20.9	18.1	21.1	22.7	22.9	23.2	19.6	19.8	24.1	24.3	6.4	3.2	70.2	4.1	5.6	5.8	6.9	8.0	8.0	18.2	8.4	5.2	8.6	13.2	14.7	0.0	14.4	3.7	38.5	123.3	21.6	2.9	11.8	23.6	17.8	9.6	11.8	77.4	17.8	19.5	10.6	10.2	31.2	2.5	6.8	23.6	10.7	11.6	10.1	97.9	23.8	10.2	9.6	5.3	5.2	5.6	9.1	14.2	69.3	9.2	17.1	5.2	71.4	46.4	11.7	22.1	10.1	2.6	4.4	58.4	19.0	4.0	3.6	6.6	19.1	15.7	17.1	23.6	8.7	6.1	17.1	5.8	6.2	26.9	4.8
ANTXR1	"ATR, FLJ10601, FLJ21776, TEM8"	ENSG00000169604	"ANTXR cell adhesion molecule 1"	Q9H6X2	2	69013176-69249327	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	Hypotrichosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 130.6;Endometrial stromal cells: 78.1;Oligodendrocyte precursor cells: 141.8;Skeletal myocytes: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 367.9;TIME: 240.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054785			Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		11000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA054785: "	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.26e-3)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.09e-2)"	38.7	63.1	25.7	20.3	24.1	0.2	32.7	26.6	16.1	77.8	70.2	32.7	12.9	81.4	25.2	33.9	44.1	114.6	39.9	27.9	69.2	11.0	8.2	44.8	12.1	42.5	49.5	107.2	6.7	35.4	14.6	78.8	45.6	47.9	21.4	9.5	28.6	55.4	11.3	39.3	20.2	62.1	36.5	28.3	14.5	11.7	38.3	10.5	43.3	24.0	13.0	52.3	42.4	36.6	36.8	39.5	36.4	33.9	162.7	78.8	0.6	57.1	115.6	63.2	51.5	0.4	3.0	0.0	31.6	147.4	41.7	31.7	30.7	33.8	59.9	0.1	24.4	9.5	90.5	11.9	71.1	7.6	5.1	129.7	13.4	55.5	36.4	140.9	17.3	19.4	6.7	0.1	367.9	15.2	22.1	0.5	35.8	0.0	26.5	0.1	186.3	0.6	13.8	27.9	21.1	91.0	104.3	0.5	37.5	23.7	11.0	2.3	240.4	71.3	61.6	72.1	59.6	0.2	0.1	0.2	37.3	6.7	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.7	24.1	26.6	16.1	27.9	69.2	42.5	49.5	45.6	36.5	38.3	36.6	4.7	6.4	20.0	130.6	0.0	49.5	21.1	15.4	17.6	1.7	7.9	13.8	6.8	0.0	8.3	0.0	0.0	0.7	0.1	0.0	0.0	1.5	37.9	5.5	78.1	4.3	0.0	0.0	61.9	2.6	1.9	68.2	0.0	11.7	1.3	22.1	3.3	0.1	4.0	0.0	64.3	0.0	4.1	0.8	19.8	33.9	42.6	2.9	24.9	40.3	0.6	13.6	0.0	141.8	1.3	1.1	0.0	67.7	1.2	10.1	0.0	0.1	9.9	0.8	19.7	111.7	59.6	5.2	2.7	4.6	23.4	1.4	1.7	26.4	0.0	8.9
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512941-36724549	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 77.9;Kupffer cells: 119.7;Macrophages: 77.1;Microglial cells: 233.3;monocytes: 67.5;NK-cells: 90.6;T-cells: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 298.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.8;NB-4: 26.5;THP-1: 20.2;U-937: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA021666, HPA026716"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"	7.5	5.1	2.4	33.7	2.2	43.3	3.8	2.1	3.1	5.7	4.7	10.4	9.5	2.8	1.5	3.3	3.5	15.6	2.0	2.1	3.6	1.9	13.2	12.7	35.1	6.6	5.1	2.6	1.5	1.5	0.9	11.2	5.7	2.5	13.3	0.8	3.7	2.8	0.5	0.8	12.1	9.3	4.0	64.9	7.0	1.3	5.1	13.9	1.8	0.9	15.1	13.9	1.3	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.6	0.0	0.0	0.0	3.8	0.0	0.3	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	26.5	0.1	0.0	0.0	0.5	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	8.9	0.0	1.8	298.5	97.8	43.6	251.9	9.0	2.6	2.2	30.7	183.1	0.3	4.8	37.3	97.9	106.8	113.2	2.7	0.7	207.3	2.4	2.2	2.1	3.1	2.1	3.6	6.6	5.1	5.7	4.0	5.1	8.6	1.3	0.0	9.6	1.3	3.6	0.8	0.1	0.0	0.0	1.1	0.6	1.7	0.5	1.5	2.5	0.0	0.0	0.2	77.9	9.2	1.9	0.3	0.6	0.4	0.3	1.4	15.5	16.0	12.4	0.0	0.2	3.1	2.6	0.4	5.1	0.7	2.5	0.9	32.8	0.0	8.1	0.3	0.0	119.7	20.3	1.2	0.0	77.1	0.0	233.3	67.5	2.8	90.6	12.1	38.6	0.0	3.8	0.4	13.6	0.1	0.3	0.5	0.7	0.3	0.0	0.3	0.5	0.0	0.1	0.4	0.3	0.1	54.1	0.6	0.9	0.2
ARHGAP11B	"B'-T, FAM7B1"	ENSG00000285077	"Rho GTPase activating protein 11B"	Q3KRB8	15	30624494-30649529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.6;lymphoid tissue: 1.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.6;Erythroid cells: 37.4;Late spermatids: 21.7;Muller glia cells: 17.3"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 8.9;Karpas-707: 7.1"									HPA064479	Uncertain		Uncertain	Vesicles		NA	NA					"Cluster 20: HeLa - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles		"HPA064479: AB_2685272"																		0.2	0.0	0.0	0.8	0.2	2.6	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.2	0.2	0.0	0.0	0.1		0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.1	0.2	0.2	0.3	0.1	1.4	0.1	0.0	0.8	0.1		0.1	1.2	1.0	2.8	1.3	0.0	0.4	0.8	3.2	0.9	1.6	1.8	0.6	1.8	1.5	0.1	0.2	0.9	1.4	1.6	0.6	1.3	3.0	3.9	3.1	8.9	0.2	0.0	2.8	1.8	0.1	0.0	0.4	0.2	0.5	0.9	1.9	0.8	7.1	1.7	1.0	1.0	2.8	0.8	0.7	1.2	1.9	3.2	0.8	0.7	1.3	1.5	0.8	1.9	0.7	0.4	0.7	1.5	1.4	1.0	2.6	1.7	0.5	0.8	1.4	0.5	3.1	0.4	3.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.3	0.0	1.5	1.0	6.1	2.0	1.0	2.8	1.8	3.2	0.6	0.3	0.7	0.0	0.6	1.8	6.2	0.0	5.1	7.0	0.0	0.4	22.6	0.4	1.3	1.1	0.0	37.4	0.4	0.6	0.0	2.3	15.3	0.7	1.3	6.9	4.2	0.8	0.0	3.3	0.2	8.3	2.0	7.9	3.1	21.7	2.1	3.3	0.0	1.0	4.8	17.3	4.1	0.0	0.7	0.4	2.5	1.2	12.6	1.0	1.6	0.6	1.2	2.3	0.0	1.3	1.5	15.5	12.9	6.9	1.4	0.0	5.8	1.2	12.1	0.9
ARHGAP15	BM046	ENSG00000075884	"Rho GTPase activating protein 15"	Q53QZ3	2	143091362-143768352	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 79.8;lymphoid tissue: 75.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 126.3;Early spermatids: 132.3;granulocytes: 88.5;Microglial cells: 250.1;NK-cells: 89.6;T-cells: 149.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 59.4;HEL: 75.8;HL-60: 124.3;MOLT-4: 82.0;NB-4: 100.4;THP-1: 131.0;U-698: 89.5;U-937: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032125			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA		38000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA032125: AB_10671370"	"unprognostic (1.59e-2)"	"unprognostic (2.40e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.62e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.95e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.94e-2)"	6.9	5.9	1.4	27.1	1.3	79.8	7.6	2.3	2.3	4.1	1.9	7.3	6.8	2.6	9.7	4.0	2.8	11.4	5.6	1.2	2.2	4.4	10.2	9.8	59.3	3.0	1.9	1.8	1.3	1.7	1.0	4.0	2.7	4.3	7.7	1.3	4.2	5.1	1.2	2.0	15.1	3.9	1.9	44.9	7.5	7.4	2.1	75.2	4.5	2.2	46.3	11.4	4.3	4.0	0.3	0.1	4.9	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	59.4	0.2	0.1	0.1	0.1	0.2	0.1	0.3	14.6	0.0	75.8	0.5	0.1	0.0	124.3	1.2	0.0	0.0	0.2	0.2	0.1	0.0	47.0	0.3	4.4	0.0	0.1	82.0	100.4	0.3	0.0	0.1	44.7	0.6	22.7	0.0	0.1	0.2	0.4	0.3	0.2	1.0	0.1	4.5	131.0	0.6	0.4	1.2	0.1	0.2	1.0	0.3	89.5	0.7	63.9	3.9	181.8	32.0	140.1	97.7	34.3	161.6	94.3	172.8	125.7	56.3	86.2	119.0	101.7	207.2	121.4	40.5	54.3	147.7	99.9	1.4	1.3	2.3	2.3	1.2	2.2	3.0	1.9	2.7	1.9	2.1	4.0	8.2	0.0	9.6	2.0	126.3	5.6	0.1	0.0	0.0	0.3	1.8	2.0	3.9	1.5	2.5	0.0	0.0	0.2	78.9	0.3	0.0	0.1	132.3	1.8	2.3	4.3	0.0	26.3	12.2	0.0	0.3	9.7	8.6	3.5	88.5	0.0	8.6	0.8	21.3	1.7	6.8	0.0	0.0	39.9	30.9	17.5	14.9	43.0	8.8	250.1	34.9	0.4	89.6	20.6	3.2	0.0	0.0	3.4	65.8	0.2	0.0	0.7	2.2	0.3	46.0	2.7	31.6	68.4	1.2	0.4	4.5	0.3	149.2	0.1	0.2	0.2
ARMC8	"DKFZP434A043, GID5, HSPC056, VID28"	ENSG00000114098	"Armadillo repeat containing 8"	Q8IUR7	3	138187248-138298384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036996, HPA044869"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA036996: AB_10672786, HPA044869: AB_2679123"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (3.51e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.18e-1)"	20.8	14.3	14.6	18.0	16.6	60.6	16.4	41.2	18.5	14.7	25.6	16.8	12.0	17.6	12.2	21.0	15.7	15.3	17.4	13.3	16.9	18.9	16.9	16.3	21.2	16.0	15.8	16.0	14.2	21.3	12.3	19.8	17.5	16.5	18.3	26.2	12.5	17.5	38.7	12.8	13.5	24.4	15.9	15.9	15.4	18.4	16.7	22.2	21.3	34.8	22.9	22.2	13.4	19.4	46.2	22.0	28.5	23.2	35.2	30.7	37.9	34.8	33.4	46.7	45.3	34.3	23.7	43.2	35.0	30.2	54.6	23.5	37.1	33.9	57.4	29.3	25.7	77.2	14.3	23.9	44.3	60.6	82.5	46.2	21.2	30.0	42.9	25.4	37.0	37.0	29.3	23.8	58.6	40.5	42.7	28.6	39.2	34.8	19.1	33.0	45.7	34.6	30.7	42.3	33.0	24.0	50.0	17.2	29.1	36.8	33.8	31.6	40.4	24.8	20.2	33.1	25.9	45.0	37.5	65.2	22.4	28.4	25.2	79.7	39.7	74.8	38.6	43.5	44.6	48.8	35.2	41.1	45.9	43.3	41.1	40.6	27.9	48.8	46.0	20.3	50.4	37.4	14.6	16.6	41.2	18.5	13.3	16.9	16.0	15.8	17.5	15.9	16.7	19.4	25.0	28.9	14.1	56.2	38.2	31.0	31.9	29.0	25.0	34.9	17.7	14.9	23.1	24.3	27.2	12.9	33.3	29.9	35.6	25.1	11.7	20.2	7.3	16.2	22.3	23.4	23.4	59.6	101.9	14.6	27.6	23.4	31.1	19.5	35.4	24.1	24.3	24.6	22.5	43.7	93.6	16.9	30.5	32.7	39.2	7.3	30.4	35.2	19.6	70.3	27.2	25.0	39.1	128.2	120.8	14.8	17.2	22.2	26.8	28.1	17.0	26.1	17.4	47.0	13.1	30.2	31.5	43.4	32.2	22.3	28.4	34.1	30.9	19.6	17.4	28.3
ARNTL	"bHLHe5, BMAL1, JAP3, MOP3, PASD3"	ENSG00000133794	"Aryl hydrocarbon receptor nuclear translocator like"	O00327	11	13276652-13387266	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 63.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 11.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045962, HPA050938"	Supported		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"CAB045962: AB_11124144, HPA050938: AB_2681282"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.08e-2)"	15.0	13.3	3.2	5.1	4.8	7.4	14.1	4.8	8.3	10.5	3.2	12.4	5.2	11.6	1.6	10.5	11.5	4.0	9.5	5.5	1.9	7.2	19.4	15.0	5.8	1.6	2.6	19.7	10.3	1.5	12.3	4.4	2.2	8.5	4.1	23.4	12.7	3.4	27.0	17.6	12.4	5.6	1.9	11.6	10.9	10.9	4.4	14.1	18.9	8.2	6.4	9.3	11.5	7.4	8.2	9.0	7.5	4.0	15.0	9.0	5.7	9.5	8.1	8.6	9.7	3.7	10.9	0.1	2.6	5.2	10.4	3.4	5.3	10.3	7.7	13.6	6.3	3.9	6.6	1.8	23.7	1.8	16.2	10.1	21.3	3.7	14.1	5.9	6.2	12.6	2.5	14.9	6.9	4.7	4.7	0.9	1.6	5.4	4.3	5.1	11.4	3.4	5.7	1.8	1.2	12.2	6.1	0.7	7.6	7.1	5.7	7.0	11.5	6.2	6.8	20.3	5.5	4.1	12.0	0.0	6.4	4.1	8.3	4.3	8.3	17.9	18.1	9.0	25.2	2.6	16.8	15.6	8.4	3.1	9.4	11.1	24.5	14.1	8.9	1.1	11.1	10.7	3.2	4.8	4.8	8.3	5.5	1.9	1.6	2.6	2.2	1.9	4.4	7.4	4.9	25.6	21.0	49.9	9.0	30.8	13.4	7.3	10.2	28.3	6.1	5.0	8.8	10.0	11.1	1.8	16.7	17.6	34.8	8.6	17.6	6.8	1.5	6.1	14.2	6.6	1.2	3.0	63.6	6.4	2.2	10.3	11.7	12.9	2.5	6.9	10.8	22.9	8.2	30.3	30.5	4.6	4.1	14.0	12.3	4.2	12.8	11.9	3.6	18.7	13.1	18.8	32.0	34.2	11.9	8.3	9.3	19.9	11.5	8.0	13.5	11.3	5.3	30.9	13.1	6.6	10.7	4.7	5.4	9.4	32.4	6.3	33.0	4.7	4.5	12.0
ARV1		ENSG00000173409	"ARV1 homolog, fatty acid homeostasis modulator"	Q9H2C2	1	230978981-231000733	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035709	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA035709: AB_2674744"	"unprognostic (2.32e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.95e-2)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.27e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.82e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-3)"	10.6	18.4	23.4	10.2	24.5	13.9	19.0	26.2	32.8	12.2	25.7	24.6	16.4	9.7	22.9	15.7	14.3	16.4	30.1	24.5	25.6	25.2	26.2	15.0	14.8	25.2	24.1	11.2	17.5	33.3	20.1	11.7	25.0	16.2	25.9	29.0	22.0	15.2	21.7	17.8	17.3	13.1	25.7	13.5	17.1	31.3	25.2	15.0	21.9	24.8	15.3	15.2	11.2	27.7	40.8	43.6	20.8	25.1	29.6	26.4	20.1	19.0	34.0	33.5	38.3	16.3	31.4	11.4	22.7	21.3	20.5	32.3	40.6	25.5	39.2	30.4	55.7	36.8	28.9	22.1	30.5	53.6	27.9	28.0	25.8	18.1	20.9	21.9	22.5	34.7	53.7	30.7	22.2	14.3	22.3	16.4	27.1	43.0	27.1	25.2	32.1	33.1	47.1	33.0	21.2	32.6	22.6	26.6	57.9	5.3	46.6	46.6	13.9	13.4	8.7	23.6	45.9	47.4	44.6	28.9	36.8	45.9	36.7	9.1	8.1	8.5	10.0	12.2	13.9	18.1	11.2	12.4	10.1	11.2	13.7	13.0	2.0	12.7	21.2	14.9	15.4	9.0	23.4	24.5	26.2	32.8	24.5	25.6	25.2	24.1	25.0	25.7	25.2	27.7	13.6	16.0	31.7	10.7	12.6	12.9	22.0	75.8	11.4	18.9	14.8	15.6	32.2	21.5	38.9	29.5	2.1	37.9	12.7	15.8	60.7	24.1	52.6	12.7	10.9	12.7	7.7	58.1	20.2	40.8	14.5	14.5	11.7	9.7	17.1	14.4	15.0	17.3	24.9	38.7	25.6	18.5	34.6	13.3	5.5	22.9	9.3	13.5	24.9	8.4	9.8	33.6	7.2	8.5	19.3	21.5	11.5	16.6	14.7	11.6	17.9	32.5	27.3	20.0	0.0	11.4	15.6	116.7	21.0	20.3	15.2	15.6	11.4	22.0	26.4	20.9
ATP6V0A2	"a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1"	ENSG00000185344	"ATPase H+ transporting V0 subunit a2"	Q9Y487	12	123712353-123761755	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044279	Approved		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"HPA044279: AB_10961274"	"unprognostic (2.60e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.58e-1)"	6.6	4.4	5.6	7.0	6.2	10.4	5.7	7.4	6.5	4.7	6.9	5.5	8.7	6.0	3.9	4.3	4.8	3.8	4.7	6.0	6.0	3.8	4.2	6.3	8.3	6.6	5.8	4.1	5.7	3.7	4.9	3.7	6.5	4.7	5.8	6.7	7.6	4.0	6.5	9.4	7.0	5.1	5.6	6.6	8.8	4.9	6.2	7.5	4.8	3.5	8.2	5.3	4.5	7.9	4.8	10.3	12.0	17.8	9.2	7.0	6.7	6.2	6.2	5.4	5.8	6.9	2.7	18.0	4.2	7.6	5.5	9.0	16.1	6.2	4.5	11.4	10.2	27.9	9.2	5.4	10.2	16.8	51.0	6.7	4.4	5.9	7.4	9.0	5.0	15.0	14.5	3.4	8.1	8.4	15.4	24.8	11.5	6.6	6.5	15.7	9.9	6.4	8.3	10.4	7.2	13.6	9.3	6.9	9.4	6.6	5.9	14.4	8.3	8.0	3.1	10.8	9.1	10.8	12.8	14.9	9.4	12.1	6.5	6.3	0.7	13.7	1.7	0.9	1.0	0.9	1.7	1.5	0.8	3.7	1.6	1.8	2.0	1.7	1.5	2.8	1.0	0.8	5.6	6.2	7.4	6.5	6.0	6.0	6.6	5.8	6.5	5.6	6.2	7.9	13.0	6.4	11.0	3.9	20.4	10.1	10.8	4.6	11.4	20.5	7.9	5.3	8.8	12.8	8.3	9.2	12.5	5.2	27.9	17.9	0.0	8.1	10.2	11.0	11.9	10.6	13.2	50.3	21.2	10.9	5.7	11.3	18.3	12.3	75.3	8.7	18.2	11.4	8.4	11.8	19.3	9.8	2.0	9.4	17.2	4.5	8.7	11.3	1.8	7.5	13.2	9.0	25.7	10.6	17.1	9.2	9.0	9.4	19.7	15.7	11.1	4.0	13.5	28.8	6.6	12.4	10.9	23.6	12.6	9.6	14.2	6.8	21.8	5.7	11.4	11.4
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"bone marrow: 78.1"	"Cell type enriched"	"Detected in many"	6	"Microglial cells: 248.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 15.2;NK-cell: 11.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.2;NK-cells: 11.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 40.2;NB-4: 19.2;THP-1: 26.7;U-937: 103.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040254	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	Cytosol	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	2.3	2.5	2.4	78.1	0.7	3.5	6.5	1.5	3.0	1.1	0.7	6.4	4.2	0.5	3.1	2.2	0.4	4.5	2.9	1.2	1.6	1.1	1.0	2.5	2.6	0.4	0.5	0.2	0.3	3.5	2.8	0.6	1.7	0.1	0.5	0.8	0.1	0.3	1.3	3.1	3.1	2.6	0.6	0.4	2.4	0.5	0.1	0.1	1.0	1.4	0.4	4.9	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.5	0.5	0.2	0.0	0.2	12.2	0.0	7.3	1.7	0.1	0.0	13.6	40.2	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	19.2	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.1	1.2	0.0	0.0	0.1	0.0	26.7	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	1.3	103.7	0.0	15.2	2.0	3.8	0.4	1.2	0.1	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.8	11.0	0.4	0.0	0.0	0.9	2.3	2.4	3.5	6.5	4.5	2.9	2.5	2.6	2.8	3.1	2.4	4.9	1.7	0.0	1.9	1.6	0.8	1.5	0.1	0.2	0.6	0.6	0.2	0.6	1.3	0.0	0.1	0.0	0.0	5.4	12.5	0.3	0.0	0.0	27.6	0.3	1.7	1.0	0.0	12.2	20.3	0.0	1.8	8.1	3.1	0.2	19.7	0.0	1.1	3.7	16.4	0.0	17.5	0.3	2.0	37.0	17.7	25.3	1.8	27.0	1.8	248.3	6.3	0.5	15.5	1.0	2.1	0.0	0.1	0.7	4.8	2.3	0.7	1.2	0.7	0.2	0.0	1.0	7.0	0.5	0.6	0.6	0.3	2.9	13.4	1.1	0.2	0.3
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219223-41261766	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 147.2;Kupffer cells: 187.5;Langerhans cells: 185.5;Prostatic glandular cells: 123.4;Sertoli cells: 210.4;Smooth muscle cells: 171.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 11.1;plasmacytoid DC: 25.7"	"Group enriched"	"Detected in many"	12	"dendritic cells: 25.7;NK-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 501.2;U-251 MG: 540.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	Yes	12100000	72000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: "	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (1.16e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.83e-3)"	43.6	18.8	17.5	15.5	22.6	1.7	26.6	19.7	17.7	36.1	12.4	42.5	11.7	34.4	8.7	17.6	25.4	22.4	26.7	16.6	18.8	9.8	15.0	25.9	6.2	26.8	20.6	24.7	6.3	10.7	7.3	34.2	22.1	19.2	12.6	5.8	10.6	24.6	9.4	20.0	19.0	37.1	20.9	37.7	21.4	18.6	24.0	7.2	16.6	11.3	5.0	32.5	25.2	21.9	408.0	160.0	9.7	1.3	34.6	34.7	0.5	314.5	280.2	450.9	278.2	8.5	185.5	0.2	124.7	501.2	235.3	33.3	0.4	211.8	384.8	0.7	0.3	0.0	100.4	6.3	125.0	0.3	0.3	26.4	3.8	266.7	409.5	254.8	169.8	0.1	15.8	0.5	284.6	0.5	0.2	0.4	4.1	1.0	76.3	0.2	165.3	0.3	202.3	0.2	0.1	0.1	81.5	0.6	1.8	57.4	0.9	7.2	351.8	317.8	214.6	307.7	540.8	0.5	0.9	1.0	211.5	0.5	241.8	1.5	0.3	0.2	0.1	0.4	0.2	0.1	0.3	0.1	6.0	0.1	0.3	0.3	0.3	11.1	0.2	25.7	0.4	0.3	17.5	22.6	19.7	17.7	16.6	18.8	26.8	20.6	22.1	20.9	24.0	21.9	13.5	9.6	3.6	35.9	1.9	41.7	88.3	10.3	3.4	0.5	2.3	14.2	8.6	1.5	4.4	5.5	0.0	4.2	0.8	0.1	0.0	6.9	8.7	6.0	45.8	17.7	0.0	0.0	0.8	0.2	2.1	147.2	1.5	5.4	0.0	17.3	11.0	1.2	28.8	1.7	1.1	0.1	2.0	187.5	185.5	5.5	61.5	61.4	26.6	30.9	3.1	26.8	0.0	11.1	0.5	14.5	0.1	79.7	0.8	123.4	0.3	0.1	2.8	1.2	210.4	38.1	171.1	1.9	2.0	1.2	29.1	11.5	3.6	2.5	0.1	28.0
B4GALNT4	"FLJ25045, NGalNAc-T1"	ENSG00000182272	"Beta-1,4-N-acetyl-galactosaminyltransferase 4"	Q76KP1	11	369499-382117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3;ovary: 27.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.2;Bipolar cells: 23.8;Excitatory neurons: 31.2;Horizontal cells: 33.7;Inhibitory neurons: 32.3;Muller glia cells: 45.6;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 35.4;NTERA-2: 32.0;SCLC-21H: 39.5;SH-SY5Y: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043276, HPA053126"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	No				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cytosol"	Vesicles	"HPA043276: , HPA053126: AB_2682049"	"unprognostic (6.11e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.92e-3)"	"unprognostic (5.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-10)"	"unprognostic (9.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-4)"	"unprognostic (1.25e-1)"	0.9	0.6	23.1	0.9	17.2	0.0	3.3	5.1	33.3	17.2	0.0	5.9	0.6	14.1	0.6	2.3	11.9	0.5	1.6	23.8	12.9	1.0	0.3	0.5	0.3	19.3	20.7	27.8	1.1	2.6	17.9	0.0	14.9	6.3	0.2	5.3	2.0	1.2	0.0	2.1	2.9	1.0	8.4	0.3	2.1	1.5	15.1	0.3	0.5	0.0	0.3	1.8	6.3	13.4	0.0	4.8	35.4	20.4	0.0	0.1	8.4	6.5	1.7	2.9	0.8	3.7	0.0	0.0	4.8	0.7	5.6	1.4	4.8	8.5	0.8	0.0	12.3	0.0	13.4	11.4	0.4	0.0	8.7	0.6	5.0	0.2	3.8	12.7	0.4	1.9	11.5	0.0	0.0	10.8	0.4	0.0	32.0	0.6	14.0	0.0	0.0	4.9	0.4	0.0	39.5	47.6	2.4	1.7	0.5	3.7	14.0	0.0	9.0	2.0	11.1	3.5	0.4	0.1	1.7	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	17.2	5.1	33.3	23.8	12.9	19.3	20.7	14.9	8.4	15.1	13.4	0.1	0.0	0.0	133.2	0.2	0.8	1.5	1.4	0.6	23.8	6.5	8.9	12.5	0.0	0.1	1.8	4.2	0.1	0.3	0.1	0.0	1.3	0.0	0.6	7.1	0.6	1.8	0.0	31.2	0.0	0.0	2.4	0.0	1.1	0.0	6.9	0.0	0.0	0.2	33.7	32.3	0.1	2.0	0.0	0.0	0.0	3.1	0.1	3.6	2.8	0.2	45.6	0.0	28.1	32.5	0.2	0.0	1.2	0.0	2.6	0.0	0.0	0.1	8.6	0.0	0.0	3.3	0.1	0.2	0.1	0.3	0.3	0.1	0.6	0.5	0.4
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101354182-101385400	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"liver: 721.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 996.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.4;CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		520000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.1	0.0	0.5	0.0	0.5	1.2	0.0	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	17.4	0.1	0.5	0.4	0.3	721.0	0.4	0.0	0.4	0.3	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.4	0.8	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	1.0	0.5	0.4	0.4	0.3	0.5	0.1	0.3	0.8	0.3	0.0	0.0	0.7	2.4	0.0	0.1	0.0	0.0	1.1	0.3	0.1	0.7	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.1	0.7	0.0	16.0	9.7	0.2	0.0	0.1	0.0	0.1	0.0	0.0	12.1	996.7	0.0	0.0	7.2	0.0	0.0	18.2	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	3.0	0.9	1.8	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.4	0.0
BBOX1	"BBH, BBOX, G-BBH, gamma-BBH"	ENSG00000129151	"Gamma-butyrobetaine hydroxylase 1"	O75936	11	27040725-27127809	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 467.9;liver: 131.9"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 1623.0"	"Group enriched"	"Detected in many"	6	"glioma: 23.7;renal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTCEpi: 13.7;RPTEC TERT1: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007600, HPA027823"	Enhanced	Approved	Uncertain	"Vesicles,Actin filaments"		NA	NA		35000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Actin filaments"	"HPA007600: AB_1845284, HPA027823: AB_10602394"	"unprognostic (9.96e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (7.03e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.73e-3)"	1.4	0.0	24.3	0.0	23.4	0.0	25.1	28.8	34.0	5.1	17.3	0.2	0.0	0.1	8.1	17.5	9.0	9.6	0.0	22.8	25.6	467.9	131.9	0.3	0.1	27.2	33.1	0.0	0.8	0.0	6.9	0.3	35.0	0.5	0.0	0.4	6.1	4.1	0.9	51.8	0.0	0.0	28.8	0.0	0.2	0.1	25.2	1.1	9.6	0.0	0.6	0.1	11.3	27.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	13.7	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.2	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	23.4	28.8	34.0	22.8	25.6	27.2	33.1	35.0	28.8	25.2	27.0	0.1	0.0	0.6	66.3	5.3	8.2	9.0	80.9	0.6	0.0	16.3	11.0	0.0	15.7	18.1	46.0	0.0	0.3	0.2	0.0	223.0	0.7	1.1	10.3	0.1	0.3	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.4	27.9	0.0	0.0	0.8	0.0	12.2	0.6	1.1	1.1	0.0	7.1	1.8	4.7	0.0	13.8	0.0	2.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	1623.0	9.4	0.4	0.0	0.0	1.4	0.0	0.6	16.9	35.8	0.3	5.0	0.0	0.0	2.6
BDKRB2	BK-2	ENSG00000168398	"Bradykinin receptor B2"	P30411	14	96204679-96244166	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 41.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.3;Endothelial cells: 18.2;Fibroblasts: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 49.2;BJ hTERT+: 94.5;U-87 MG: 39.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA003551, HPA050841"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA003551: , HPA050841: AB_2681254"	"unprognostic (1.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.11e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.49e-2)"	14.0	1.4	0.8	5.5	1.0	0.0	5.8	3.8	1.1	15.6	0.9	12.4	7.9	6.7	2.4	17.2	7.2	20.8	1.2	0.9	0.8	13.4	0.7	2.5	0.3	4.9	1.3	1.0	9.4	0.9	0.8	1.3	5.0	4.8	12.2	0.0	3.5	6.2	0.9	5.4	9.7	10.2	1.0	0.1	4.9	0.2	1.5	0.9	3.6	1.8	1.7	41.1	15.4	1.2	1.7	6.1	0.1	11.0	16.2	49.2	0.0	5.5	94.5	3.2	3.7	0.3	10.4	0.0	0.2	8.7	3.7	14.8	0.0	2.4	2.8	1.2	0.1	0.0	1.1	0.0	7.8	0.0	0.0	15.1	7.5	9.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.1	20.4	0.0	0.0	2.2	0.0	3.2	0.0	3.4	1.1	1.8	15.6	0.1	2.1	1.0	0.0	0.0	0.3	0.3	3.3	0.1	0.2	0.0	0.0	39.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.0	3.8	1.1	0.9	0.8	4.9	1.3	5.0	1.0	1.5	1.2	8.2	3.2	3.1	0.0	0.0	9.2	0.7	5.3	6.8	0.0	0.2	0.5	0.6	10.0	11.6	9.2	0.0	1.2	0.0	19.3	7.9	11.5	0.0	7.5	16.1	18.2	7.1	0.0	1.8	3.8	3.6	25.8	1.1	4.6	0.0	0.0	3.3	0.2	0.2	0.0	0.4	7.2	8.2	0.0	15.2	0.0	0.9	0.4	5.4	0.0	0.0	0.0	0.0	1.0	1.9	6.9	6.2	1.2	0.0	1.0	10.6	0.2	12.5	0.0	0.0	4.5	1.2	0.0	0.0	15.3	5.8	4.0	0.3	0.1	0.9	2.9
BICD1		ENSG00000151746	"BICD cargo adaptor 1"	Q96G01	12	32106835-32383633	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 198.8;Excitatory neurons: 267.2;Inhibitory neurons: 331.5;Microglial cells: 96.5;Oligodendrocyte precursor cells: 167.4;Oligodendrocytes: 131.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041309	Approved		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA041309: AB_10804000"	"unprognostic (1.40e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-6)"	"unprognostic (5.93e-2)"	"unprognostic (4.57e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.36e-1)"	5.8	3.8	7.8	6.0	6.2	3.2	4.5	29.8	10.3	13.7	0.0	4.0	2.1	9.8	4.9	2.0	9.8	4.7	5.3	6.7	7.0	6.0	1.2	6.0	6.8	4.4	6.0	20.6	1.8	6.1	6.9	8.7	7.3	5.2	2.8	7.9	2.7	2.6	3.8	2.3	3.8	5.4	2.6	8.0	2.8	3.1	6.0	7.4	6.2	3.4	5.3	4.6	4.1	8.5	14.5	9.9	7.1	4.3	6.9	9.3	8.1	16.4	6.7	16.5	11.6	12.8	9.6	21.0	13.3	14.5	18.8	6.7	36.2	13.8	25.7	14.9	10.6	28.3	9.9	6.2	7.7	22.8	16.8	5.5	6.8	19.4	15.9	25.4	16.8	22.8	13.0	41.7	6.5	5.8	22.3	8.7	73.7	6.2	11.0	16.7	23.9	15.7	21.7	8.3	31.7	17.4	12.5	0.9	12.8	48.7	8.3	5.0	16.6	25.1	24.0	18.6	23.7	13.7	20.9	44.3	16.8	10.0	27.3	0.0	0.5	0.0	1.5	0.2	2.3	2.4	1.4	0.9	0.8	2.0	1.8	1.5	0.1	1.9	0.0	1.9	2.4	0.8	7.8	6.2	29.8	10.3	6.7	7.0	4.4	6.0	7.3	2.6	6.0	8.5	15.1	16.0	1.1	198.8	22.0	0.4	8.2	13.6	6.8	30.5	5.4	6.3	8.3	1.5	9.1	9.2	37.5	0.4	10.7	0.7	1.9	9.1	0.6	11.7	26.2	17.0	6.6	9.2	267.2	4.7	0.5	12.6	1.1	34.2	0.0	35.1	13.2	0.5	6.5	23.5	331.5	1.2	16.2	1.3	4.2	1.2	4.1	5.1	8.8	96.5	4.2	39.2	4.1	167.4	131.7	8.3	0.5	4.5	34.5	7.0	0.6	2.7	2.6	19.3	0.0	18.1	12.3	6.9	9.2	3.9	2.4	0.3	10.7	28.1	2.6	3.7
BTAF1	"MOT1, TAF-172, TAF(II)170, TAF172, TAFII170"	ENSG00000095564	"B-TFIID TATA-box binding protein associated factor 1"	O14981	10	91923770-92030325	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070682			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"HPA070682: AB_2686294"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (2.72e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	20.4	13.2	5.2	20.1	7.3	32.1	19.2	8.5	8.6	18.4	5.9	20.4	16.2	20.7	21.1	17.2	23.4	15.2	14.4	6.1	5.5	11.8	15.4	19.1	32.0	6.1	5.3	25.4	18.1	14.7	13.3	13.7	6.0	16.8	15.9	34.3	19.2	12.7	14.8	50.4	22.0	14.0	5.9	22.0	18.4	17.9	5.8	21.7	17.3	9.2	25.5	20.1	19.9	10.4	28.9	13.8	31.7	38.7	16.5	25.8	15.8	16.5	19.6	16.0	23.7	19.1	17.2	30.8	10.3	16.3	9.9	30.4	21.5	14.6	23.8	21.2	23.2	21.9	35.7	20.0	16.8	33.3	22.0	18.4	18.5	24.3	35.1	34.3	15.6	25.9	18.2	34.5	16.6	12.6	25.8	21.0	14.4	8.3	10.8	20.6	19.7	14.5	14.9	17.5	12.2	14.3	15.8	8.0	20.3	20.8	16.2	21.9	16.9	14.3	11.4	19.5	23.7	39.7	19.6	24.9	22.4	30.1	3.8	4.4	2.7	1.5	2.5	1.9	2.2	2.5	1.9	1.8	2.1	3.1	2.3	1.8	1.9	2.2	3.6	4.9	1.6	1.4	5.2	7.3	8.5	8.6	6.1	5.5	6.1	5.3	6.0	5.9	5.8	10.4	18.3	19.2	31.5	58.4	29.5	21.7	12.1	7.3	21.6	26.7	16.2	11.9	13.6	7.2	14.6	20.2	45.9	6.6	34.8	7.9	1.9	6.8	12.9	33.3	28.0	15.6	16.2	13.9	78.5	6.6	9.8	17.3	35.2	46.6	24.1	22.4	8.9	8.7	7.1	18.5	66.4	7.1	6.1	9.7	19.8	5.1	11.8	27.1	5.4	67.5	16.4	13.9	14.4	68.3	91.5	6.7	6.3	11.7	52.1	15.7	9.6	3.3	24.9	35.5	6.6	25.7	22.8	24.7	12.2	20.4	29.8	14.6	24.7	11.4	9.3	16.4
BTN3A1	"BT3.1, BTF5, BTN3.1, CD277"	ENSG00000026950	"Butyrophilin subfamily 3 member A1"	O00481	6	26402237-26415208	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 59.1;NK-cells: 73.2;Plasma cells: 47.6;T-cells: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA012565	Approved		Uncertain	Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA012565: AB_1845494"	"unprognostic (2.82e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.72e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (2.45e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (4.81e-4)"	19.2	20.7	10.2	44.8	11.1	29.6	20.1	9.8	10.5	21.2	10.3	24.8	28.5	28.0	16.0	11.9	22.5	30.5	12.1	9.1	12.1	12.8	18.9	41.4	63.4	16.4	10.9	35.1	13.1	13.1	13.7	19.2	12.5	16.5	28.8	3.6	23.9	13.5	12.8	24.9	35.1	21.3	12.2	84.0	31.3	5.0	11.4	33.1	11.5	14.5	52.6	20.0	17.4	12.0	7.4	6.2	9.3	9.5	25.9	27.5	1.2	6.2	24.1	13.5	39.4	0.3	16.7	19.7	20.4	11.2	20.9	5.1	3.0	9.7	8.2	19.5	6.4	10.4	8.5	4.7	11.8	9.5	9.3	15.0	5.6	11.8	5.4	20.4	19.3	31.0	2.5	25.3	5.5	0.6	17.6	6.6	1.0	3.3	2.1	24.2	4.0	45.2	8.3	9.4	4.9	9.8	3.4	7.1	13.5	1.4	6.5	4.0	4.8	10.3	2.6	3.1	5.9	41.8	45.9	7.3	15.6	21.4	8.4	53.8	11.1	28.8	44.7	11.7	40.4	18.8	27.8	42.3	9.1	10.5	24.1	32.0	23.9	40.5	12.9	4.3	36.0	28.0	10.2	11.1	9.8	10.5	9.1	12.1	16.4	10.9	12.5	12.2	11.4	12.0	24.8	16.0	6.5	0.0	27.1	4.2	3.9	3.5	2.2	4.3	8.6	8.1	4.2	11.5	8.5	5.5	0.0	5.5	59.1	8.2	0.0	7.4	0.1	5.5	10.4	18.0	4.8	13.3	0.0	3.2	4.3	9.9	9.2	10.3	25.9	14.0	11.7	3.9	7.2	0.0	0.0	17.3	2.0	19.2	6.1	0.8	3.7	15.4	1.8	0.0	13.7	1.9	73.2	0.0	0.0	2.2	6.3	2.6	47.6	5.4	15.9	1.3	6.7	0.4	0.0	6.7	5.5	0.0	0.1	3.6	3.3	1.5	50.1	8.4	7.4	5.0
C11orf16		ENSG00000176029	"Chromosome 11 open reading frame 16"	Q9NQ32	11	8920076-8933006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 6.2;fallopian tube: 12.9;lymphoid tissue: 6.2"	"Group enriched"	"Detected in some"	8	"Endometrial ciliated cells: 40.8;Ionocytes: 28.5;Respiratory ciliated cells: 110.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA040644			Uncertain	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"	"Endoplasmic reticulum"	Vesicles	"HPA040644: "	"unprognostic (5.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.09e-3)"	"prognostic favorable (3.32e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.94e-5)"	"unprognostic (6.40e-4)"	"unprognostic (1.58e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.13e-3)"	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.3	0.1	1.0	6.2	0.0	0.0	0.3	0.0	0.0	12.9	0.0	0.0	0.3	0.7	0.3	0.0	2.6	0.0	1.3	2.3	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	2.2	0.6	6.2	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.1	0.3	0.7	1.3	2.3	0.8	1.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.3	0.1	0.0	0.0	7.1	5.5	0.0	0.1	0.0	0.0	0.0	0.0	1.6	40.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	28.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	110.8	0.0	0.0	0.0	1.5	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
C1QTNF4	"CTRP4, ZACRP4"	ENSG00000172247	"C1q and TNF related 4"	Q9BXJ3	11	47589667-47594411	"Predicted secreted proteins"		Cytokine	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.0;pituitary gland: 17.1"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 51.7;Leydig cells: 46.0;Muller glia cells: 54.5;Peritubular cells: 38.4;Spermatogonia: 44.5;Theca cells: 39.0"	"Group enriched"	"Detected in some"	4	"glioma: 1.7;ovarian cancer: 2.5;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"REH: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041032	Approved		Uncertain	"Golgi apparatus,Vesicles"	"Secreted in brain"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus, Vesicles"		"HPA041032: AB_10671170"	"unprognostic (1.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.98e-4)"	"unprognostic (8.19e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-3)"	"unprognostic (6.78e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.22e-1)"	"unprognostic (8.22e-6)"	"unprognostic (6.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.28e-2)"	1.7	1.5	7.9	0.0	33.0	1.1	2.2	13.2	17.6	5.3	0.0	3.9	0.1	5.8	0.0	0.5	4.2	0.0	1.0	7.5	1.1	1.4	0.9	0.7	0.0	6.0	4.9	12.0	0.4	0.7	17.1	0.0	2.1	2.8	0.0	0.1	1.1	0.1	0.9	1.8	1.5	0.1	1.0	1.0	1.5	5.8	6.7	0.0	1.5	0.0	0.0	1.3	2.0	3.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	33.0	13.2	17.6	7.5	1.1	6.0	4.9	2.1	1.0	6.7	3.4	2.4	0.0	0.0	18.9	0.0	2.4	6.5	0.2	0.0	15.8	1.3	25.8	0.7	1.5	0.3	3.7	16.7	1.3	0.1	0.2	3.9	0.1	11.3	0.8	21.2	4.5	0.0	2.5	15.5	0.2	2.7	20.7	0.5	0.6	0.0	31.3	2.5	0.2	3.3	5.0	17.8	0.1	0.0	0.3	3.0	51.7	46.0	0.7	10.6	4.7	0.0	54.5	0.0	5.0	8.0	0.1	0.1	38.4	0.0	4.3	0.1	0.6	0.6	24.7	26.3	12.8	8.5	13.5	44.5	0.3	1.8	3.6	0.6	39.0	0.2	2.4
C20orf173	dJ477O4.4	ENSG00000125975	"Chromosome 20 open reading frame 173"	Q96LM9	20	35523186-35529652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"testis: 35.5"	"Group enriched"	"Detected in some"	76	"Early spermatids: 473.3;Late spermatids: 156.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA076859			Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA076859: "										"unprognostic (1.90e-1)"				"unprognostic (1.03e-1)"				0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	473.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	156.5	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C4orf47	LOC441054	ENSG00000205129	"Chromosome 4 open reading frame 47"	A7E2U8	4	185426249-185449826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 24.3;fallopian tube: 13.6;retina: 15.1;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 191.3;Endometrial ciliated cells: 50.0;Excitatory neurons: 36.6;Respiratory ciliated cells: 106.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 2.4;hTERT-RPE1: 4.9;U-87 MG: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043662, HPA063485"	Enhanced		Uncertain	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA043662: AB_10964715, HPA063485: "	"unprognostic (3.38e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.82e-5)"	"unprognostic (3.72e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.50e-1)"	0.5	0.3	3.2	0.2	4.4	0.3	2.1	3.8	2.9	1.0	24.3	0.3	0.1	1.2	3.8	0.3	13.6	0.9	0.9	3.3	3.6	2.7	0.4	2.0	0.1	7.2	8.2	0.7	0.7	0.6	2.9	0.2	5.5	0.6	0.2	15.1	0.5	0.6	0.1	1.0	0.2	0.3	7.1	0.2	0.3	13.3	3.9	0.2	4.6	0.1	0.2	0.3	0.3	3.9	2.4	0.0	0.2	1.2	0.4	2.3	0.7	0.0	0.1	0.2	0.3	0.3	1.4	0.1	0.4	0.1	0.2	0.2	0.3	0.4	0.5	0.5	0.4	0.0	0.1	0.3	0.5	0.0	0.1	0.5	0.5	0.5	0.2	4.9	0.0	0.5	0.3	0.1	1.8	0.3	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.2	0.7	0.0	1.3	0.6	0.4	0.0	1.5	0.5	0.1	0.4	0.7	0.4	0.1	0.0	0.0	1.0	0.0	0.0	5.9	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.2	0.0	0.0	3.2	4.4	3.8	2.9	3.3	3.6	7.2	8.2	5.5	7.1	3.9	3.9	0.6	3.2	1.5	21.5	2.0	0.6	0.9	8.7	4.6	0.9	2.2	3.9	0.6	1.5	13.2	3.7	10.4	0.1	0.4	0.4	1.9	2.8	191.3	50.0	1.5	1.3	0.0	0.0	36.6	0.6	1.5	2.4	6.6	3.4	0.0	0.3	1.1	0.1	0.2	1.7	26.3	0.0	2.0	0.6	0.4	20.9	0.6	0.7	1.8	4.7	0.1	3.6	0.0	18.6	13.4	1.0	0.0	0.7	9.6	0.6	0.0	3.7	106.6	14.8	0.0	3.0	3.1	12.6	5.0	2.6	0.6	0.3	1.5	0.5	0.0	0.3
C8orf44-SGK3		ENSG00000288602	"C8orf44-SGK3 readthrough"		8	66667596-66860472	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Astrocytes: 17.3;Excitatory neurons: 23.5;Inhibitory neurons: 17.5;Microglial cells: 11.2;Oligodendrocyte precursor cells: 15.6;Oligodendrocytes: 18.0"					"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006699, HPA027146"	Approved		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"		"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"																		4.1	3.1	5.2	3.1	5.5	6.1	6.3	5.3	7.2	4.5	3.5	3.5	2.8	5.6	11.5	2.1	7.3	3.7	4.4	5.1	6.3	4.2	3.1	3.4	5.7	4.6	4.8	7.9	2.2	2.9		3.8	4.7	5.1	5.8	9.1	4.2	6.1	4.1	6.9	2.6	4.9	3.9	5.1	4.3	6.6	4.8	5.7	7.6	3.7	5.4	2.6		7.5	6.9	2.4	3.5	2.6	5.8	7.0	1.7	2.3	4.3	5.2	5.8	2.8	8.7	9.8	1.3	5.3	4.1	4.4	5.5	3.1	8.2	8.5	8.3	9.3	7.2	5.5	4.6	5.3	6.0	9.2	9.1	3.3	7.3	9.0	5.3	10.7	9.7	5.6	4.8	2.1	4.6	3.7	3.5	6.6	3.8	3.7	2.4	2.4	5.0	2.0	3.4	3.8	2.9	1.3	3.9	5.3	7.0	3.5	5.1	2.6	2.5	2.2	2.2	5.7	3.8	4.8	4.7	6.0	1.4	31.0	9.8	6.2	4.0	4.1	4.9	7.6	4.5	5.1	7.2	6.1	7.0	5.0	6.9	5.2	2.7	6.9	7.0	4.2	5.2	5.5	5.3	7.2	5.1	6.3	4.6	4.8	4.7	3.9	4.8	7.5	0.0	0.0	0.0	17.3	0.9	0.0	0.0	0.1	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	23.5	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	11.2	0.1	0.5	0.0	15.6	18.0	0.0	1.1	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	1.4	0.1	0.0	0.6	0.0	0.0	0.0
CA4	"CAIV, Car4, RP17"	ENSG00000167434	"Carbonic anhydrase 4"	P22748	17	60149942-60170899	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"Disease variant, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 263.6"	"Group enriched"	"Detected in many"	16	"Adipocytes: 704.2;Distal enterocytes: 1289.3;Paneth cells: 2368.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 99.5"	"Lineage enriched"	"Detected in single"	995	"granulocytes: 99.5"	"Cell line enhanced"	"Detected in single"		"OE19: 1.1"	"Region enriched"	"Detected in all"	5	"cerebellum: 300.3"	"Low region specificity"	"Detected in all"			"HPA011089, HPA017258"	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA		190000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA011089: AB_1845996, HPA017258: AB_1845997"	"unprognostic (2.07e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.76e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-2)"	83.0	2.3	17.8	3.1	18.8	19.5	80.9	86.8	34.2	12.7	13.9	263.6	3.8	6.0	51.9	1.0	5.0	38.3	55.2	22.8	13.9	47.6	0.7	87.2	0.6	13.4	17.8	6.2	31.8	16.9	15.7	8.6	22.8	8.2	172.6	0.1	10.4	36.9	30.5	3.8	11.2	2.7	12.7	16.0	10.0	1.3	15.1	1.6	74.6	42.3	0.1	6.2	5.6	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.3	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.5	0.0	0.0	0.0	0.0	0.1	17.8	18.8	86.8	34.2	22.8	13.9	13.4	17.8	22.8	12.7	15.1	14.9	704.2	0.0	2.4	1.3	1.5	1.5	0.3	0.0	2.2	0.0	2.3	2.5	9.1	0.0	0.6	14.7	0.0	0.0	1.2	1289.3	33.2	11.7	0.5	0.6	13.0	88.3	19.3	0.0	3.8	0.2	0.0	4.4	0.0	0.2	11.4	23.2	1.4	0.0	0.6	0.0	1.4	24.6	0.0	0.0	1.2	0.1	0.6	1.1	0.0	23.4	0.0	0.1	0.0	1.0	0.4	0.1	2368.3	0.0	1.2	0.1	14.9	72.4	0.7	0.0	6.6	5.0	23.4	0.1	0.0	0.1	1.1	0.0	2.4	0.4	41.7	0.3
CALN1	CABP8	ENSG00000183166	"Calneuron 1"	Q9BXU9	7	71779491-72447151	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 11.3;brain: 44.3;lymphoid tissue: 24.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 88.8;Excitatory neurons: 130.6;Inhibitory neurons: 212.7;Oligodendrocyte precursor cells: 44.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Karpas-707: 44.5"	"Low region specificity"	"Detected in all"							"HPA036278, HPA036708"	Approved		Uncertain	"Vesicles,Plasma membrane"		No	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Plasma membrane"	"HPA036278: AB_10673125, HPA036708: "	"unprognostic (6.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.67e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.72e-4)"	"unprognostic (2.99e-1)"	0.1	11.3	12.2	0.0	18.5	0.6	0.2	44.3	15.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	25.4	40.6	0.0	0.2	0.0	0.0	27.9	17.0	0.1	1.0	0.0	0.5	0.0	30.2	0.2	0.1	1.9	0.0	1.1	0.0	3.5	0.0	0.0	15.2	0.0	0.0	3.2	8.3	24.7	0.1	0.0	0.0	0.0	3.2	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	44.5	0.0	0.0	0.1	0.0	6.0	0.0	0.0	7.1	0.0	0.8	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	7.2	0.1	0.0	7.0	7.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	18.5	44.3	15.0	25.4	40.6	27.9	17.0	30.2	15.2	8.3	26.5	0.0	0.0	0.0	88.8	0.0	2.3	0.4	0.0	0.0	3.8	0.0	0.6	5.6	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	0.1	0.1	0.3	0.0	2.1	130.6	0.0	0.0	0.2	0.0	0.4	0.0	0.0	1.4	0.4	0.1	0.0	212.7	1.5	0.0	0.3	0.7	7.0	0.0	0.1	0.0	14.0	0.0	0.2	1.0	44.7	15.7	0.0	0.1	0.7	0.0	0.2	0.0	0.1	0.0	0.8	0.0	6.1	0.2	8.8	12.8	0.0	9.8	0.1	0.2	0.2	0.1	0.1
CAMTA2	KIAA0909	ENSG00000108509	"Calmodulin binding transcription activator 2"	O94983	17	4967992-4987675	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027835, HPA051147"			Supported	"Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Vesicles, Actin filaments, Mitochondria, Cytosol"	"HPA027835: , HPA051147: AB_2681362"	"unprognostic (2.82e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.08e-2)"	"prognostic favorable (6.00e-8)"	"unprognostic (3.42e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.19e-1)"	15.8	15.6	10.7	13.6	15.9	10.3	15.0	5.2	36.7	14.8	0.0	19.6	10.3	17.0	4.4	14.4	14.4	8.7	17.7	24.2	3.4	16.0	12.9	18.4	9.7	10.0	4.4	14.8	17.5	19.2	26.0	7.4	8.5	15.1	10.8	10.7	13.9	11.6	38.0	17.4	19.0	14.2	0.5	21.6	18.6	14.5	7.3	10.4	17.0	27.5	9.5	16.0	13.0	18.4	13.2	23.2	4.2	6.1	27.8	19.0	8.6	12.4	13.8	11.6	10.1	5.9	3.6	15.5	11.9	19.7	9.8	13.1	16.2	19.5	6.6	21.8	20.7	9.8	13.3	6.6	15.9	5.8	40.4	13.4	24.0	10.8	17.1	14.0	19.6	11.8	16.2	13.9	11.0	8.8	10.3	3.7	0.6	15.6	9.5	8.9	4.8	6.1	13.1	13.8	5.8	5.1	7.8	14.1	3.8	7.2	12.6	5.6	25.6	9.1	5.3	9.8	20.6	6.8	8.0	5.6	22.4	11.5	9.2	0.5	1.2	0.9	1.3	1.6	1.0	0.6	0.6	1.2	0.7	0.4	0.8	1.0	3.0	0.6	4.9	1.1	0.5	1.4	10.7	15.9	5.2	36.7	24.2	3.4	10.0	4.4	8.5	0.5	7.3	18.4	15.2	3.2	11.3	11.4	9.2	6.9	3.7	11.6	8.6	14.7	11.9	8.9	8.0	12.8	6.9	11.0	10.4	5.9	9.0	16.1	1.9	7.9	30.1	5.9	12.6	10.0	11.4	7.4	17.9	11.2	9.6	12.3	20.4	11.6	13.3	14.7	16.8	15.3	8.5	35.3	15.7	13.9	20.3	16.7	10.2	54.3	10.2	13.1	3.6	4.7	14.9	6.5	12.3	9.0	9.5	10.6	13.9	9.4	9.0	6.3	20.1	15.4	6.1	11.2	13.1	7.9	14.8	7.2	6.9	8.8	10.4	12.4	11.4	14.4	12.2	4.1
CATSPERB	"C14orf161, FLJ14298"	ENSG00000133962	"Cation channel sperm associated auxiliary subunit beta"	Q9H7T0	14	91580696-91780707	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 10.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 22.9;Exocrine glandular cells: 10.9;Gastric mucus-secreting cells: 11.7;Glandular and luminal cells: 6.2;Pancreatic endocrine cells: 7.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;OE19: 1.3;U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035134			Uncertain	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA035134: AB_10671510"	"unprognostic (2.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.04e-3)"	"unprognostic (2.72e-5)"	"unprognostic (1.81e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.85e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.71e-3)"	0.5	0.2	0.5	0.6	0.5	0.3	0.8	1.0	0.5	0.4	0.1	0.6	0.4	0.2	0.4	0.5	0.4	0.8	0.4	0.3	0.2	0.2	0.1	0.6	0.9	0.3	0.1	0.3	10.7	0.3	0.2	0.2	0.3	0.6	0.5	0.8	2.5	0.2	1.2	2.3	0.9	0.2	0.1	0.6	1.4	1.1	0.2	0.3	0.5	0.0	0.5	0.2	0.2	0.8	0.2	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.7	1.2	0.4	0.3	0.0	0.0	0.2	0.0	0.1	0.2	0.4	0.6	0.1	0.4	0.7	0.0	0.5	0.2	0.1	0.2	0.1	0.1	0.5	0.0	0.3	0.1	0.0	0.1	0.7	0.2	0.2	0.0	1.3	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.2	0.5	0.5	0.1	0.7	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.0	1.2	0.3	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	1.0	0.5	0.3	0.2	0.3	0.1	0.3	0.1	0.2	0.8	0.1	3.2	1.5	0.3	0.1	0.1	0.3	0.2	0.0	0.0	3.3	1.0	0.2	0.0	2.1	0.0	0.0	0.1	0.3	2.2	0.0	2.7	22.9	1.6	0.9	0.6	0.0	0.0	4.9	10.9	0.1	0.6	11.7	6.2	0.0	0.1	0.0	0.1	0.0	0.0	1.3	3.0	0.0	0.3	0.3	3.2	0.6	0.1	0.0	1.9	0.6	0.0	1.0	0.5	1.8	7.5	2.5	0.0	0.4	0.9	0.1	0.5	1.5	0.0	0.0	0.9	0.3	4.5	0.2	0.8	0.0	0.3	0.7	0.1	1.4	0.8
CCDC169-SOHLH2	C13orf38-SOHLH2	ENSG00000250709	"CCDC169-SOHLH2 readthrough"		13	36168794-36297842	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	22	"testis: 10.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Inhibitory neurons: 1.2;Late spermatids: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;HL-60: 2.6;NB-4: 1.5;U-937: 2.0"									HPA029182			Uncertain	Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA029182: AB_10602409"					"unprognostic (5.56e-2)"			"unprognostic (3.93e-1)"		"unprognostic (3.60e-2)"		"unprognostic (4.66e-1)"	"unprognostic (2.17e-1)"		"unprognostic (1.84e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.43e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	10.2	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.4	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC74A	FLJ40345	ENSG00000163040	"Coiled-coil domain containing 74A"	Q96AQ1	2	131527675-131533666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 73.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 424.4;Late spermatids: 274.9;Respiratory ciliated cells: 166.1;Spermatocytes: 154.2;Theca cells: 211.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 28.6;SCLC-21H: 23.2"									HPA060727			Uncertain	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA060727: "	"prognostic favorable (5.11e-4)"	"unprognostic (2.89e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.70e-7)"	"unprognostic (7.28e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.53e-2)"	3.3	32.7	10.6	1.2	9.6	0.1	9.6	7.3	11.3	17.6	29.3	6.9	1.1	12.8	8.9	3.0	34.5	7.0	3.5	11.1	12.2	8.9	1.2	6.2	1.3	12.1	12.8	14.8	2.6	20.4	34.7	1.1	10.5	15.8	1.7	2.0	3.1	6.3	0.5	4.9	2.5	3.0	10.5	1.2	3.2	73.5	15.1	5.3	7.3	0.8	0.8	14.5	8.0	8.0	0.0	5.9	6.0	0.3	8.4	20.2	0.5	5.1	8.4	4.6	3.4	0.2	8.9	2.3	3.1	7.9	7.7	4.6	2.6	1.5	1.9	6.1	11.1	0.0	6.2	0.2	1.0	0.2	0.5	6.6	0.6	4.5	0.0	9.0	1.8	12.7	3.4	6.5	4.2	3.8	13.3	3.6	28.6	2.3	3.8	6.4	0.0	2.7	11.8	0.1	23.2	16.9	0.6	0.8	0.9	2.3	8.2	1.3	1.9	1.4	4.3	18.0	3.9	1.3	1.2	0.8	19.0	0.6	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	9.6	7.3	11.3	11.1	12.2	12.1	12.8	10.5	10.5	15.1	8.0	0.8	0.0	0.5	1.6	0.3	5.1	12.2	21.6	14.2	1.0	34.8	28.4	0.5	4.3	15.8	7.3	0.0	0.5	1.1	0.8	7.9	9.4	424.4	88.2	7.6	1.4	7.7	0.0	3.7	0.7	0.4	11.1	1.1	4.7	0.0	30.4	1.4	0.1	0.3	0.0	2.4	0.6	16.2	0.0	5.9	274.9	37.0	0.8	1.8	1.0	0.0	14.2	0.0	1.0	0.5	2.7	0.5	68.4	0.9	7.4	0.1	2.6	166.1	1.1	0.0	2.5	14.2	154.2	18.8	7.2	6.0	0.3	1.2	211.1	2.4	7.2
CCDC74B	DKFZp434E2321	ENSG00000152076	"Coiled-coil domain containing 74B"	Q96LY2	2	130139287-130145134	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 55.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 322.3;Late spermatids: 129.6;Respiratory ciliated cells: 70.3;Spermatocytes: 142.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.2;SH-SY5Y: 14.8"									HPA060727			Uncertain	Vesicles		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA060727: "	"prognostic favorable (4.46e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.76e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.43e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-4)"	"unprognostic (8.31e-3)"	"unprognostic (9.94e-3)"	1.5	1.9	3.5	0.3	3.6	0.0	2.4	2.6	4.3	17.0	7.6	1.6	0.2	8.9	0.8	0.4	14.1	1.4	1.5	4.1	5.4	3.8	0.1	2.8	0.3	6.2	7.2	5.0	0.8	11.1	19.7	0.2	5.1	7.1	0.1	0.6	0.6	2.8	0.2	1.0	0.7	1.2	5.7	0.4	1.5	55.4	6.1	0.6	7.0	0.0	0.2	2.4	3.6	3.9	0.0	1.9	2.8	0.1	2.5	5.4	0.6	2.2	1.1	0.3	0.5	0.9	0.7	0.1	3.5	2.0	3.2	1.0	0.2	0.3	0.4	2.0	5.5	0.0	7.0	0.1	0.3	0.1	0.2	1.1	0.0	0.9	0.0	3.4	0.1	1.3	0.1	1.7	0.8	2.1	0.0	0.0	5.7	0.5	5.9	4.6	0.0	3.2	1.7	0.0	10.2	14.8	1.6	0.1	0.2	0.6	5.9	0.7	0.4	1.1	4.8	5.9	0.5	0.1	0.3	0.0	6.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	2.6	4.3	4.1	5.4	6.2	7.2	5.1	5.7	6.1	3.9	0.2	3.2	0.5	1.6	0.1	0.5	3.0	6.3	1.2	0.5	6.1	9.5	0.4	1.5	4.3	5.5	0.0	0.2	0.2	0.1	3.9	1.5	322.3	42.8	9.9	0.2	11.4	0.0	1.6	0.2	0.8	3.6	0.0	2.2	0.0	7.8	0.0	0.0	0.3	3.3	1.1	0.1	2.0	0.0	0.2	129.6	10.2	0.6	0.0	1.0	0.0	6.2	0.0	0.5	0.3	0.0	0.1	12.4	0.1	3.9	0.0	1.2	70.3	0.1	0.0	0.9	3.2	142.7	16.4	0.7	1.1	0.1	0.3	28.8	0.1	0.7
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541073-74546115	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.7;lung: 8.4;lymphoid tissue: 7.3"	"Group enriched"	"Detected in some"	5	"granulocytes: 15.2;Hofbauer cells: 32.1;Kupffer cells: 26.3;Langerhans cells: 15.3;Macrophages: 36.1;monocytes: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 228.3;non-classical monocyte: 242.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.1;HMC-1: 33.1;THP-1: 6.5;U-937: 16.2"					"Low region specificity"	"Detected in some"			"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (1.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	4.0	1.3	0.7	6.8	1.1	9.7	0.8	0.8	5.5	0.6	1.1	1.3	1.1	0.6	0.1	0.6	0.7	2.0	0.9	0.7	1.4	0.7	1.5	8.4	2.1	1.7	1.8	0.3	0.6	0.4	0.4	2.9	2.1	0.5	1.3	0.0	0.7	0.5	0.3	0.4	1.2	3.1	1.4	7.3	0.7	0.3	2.7	1.0	1.0	0.2	1.1	3.8	0.4	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	3.3	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	16.2	0.0	51.8	142.1	7.0	0.7	228.3	0.4	2.7	0.3	0.3	158.8	2.4	0.2	0.2	5.2	43.9	242.7	10.5	0.2	64.6	0.7	1.1	0.8	5.5	0.7	1.4	1.7	1.8	2.1	1.4	2.7	2.2	0.1	0.0	1.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.3	0.1	0.0	0.0	15.2	0.0	0.0	0.2	32.1	0.0	0.0	0.0	0.0	26.3	15.3	0.1	0.0	36.1	1.8	1.0	19.6	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	1.3	0.0	0.0	0.0
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736479	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1445.2;Prostatic glandular cells: 1678.0;Urothelial cells: 1531.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 3747.5;U-2197: 3049.9"									"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		58000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.66e-2)"	"prognostic favorable (1.39e-10)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.09e-1)"	517.4	248.3	284.5	209.6	310.8	198.8	555.9	329.0	365.1	305.5	542.2	255.1	120.7	290.7	971.7	478.9	368.1	475.3	608.3	288.2	359.7	577.4	339.8	553.5	148.8	327.9	340.2	228.5	353.6	706.1	250.3	485.6	340.9	256.8	271.4	130.7	693.6	443.2	529.3	282.8	167.9	380.0	330.5	131.8	422.7	127.7	337.0	167.7	308.1	915.0	288.6	550.5	325.5	315.6	297.2	278.4	77.6	212.0	1697.1	1314.9	46.8	1765.7	1778.5	408.9	451.9	129.7	822.1	23.9	291.5	1802.5	475.5	314.0	141.0	1589.9	561.1	475.5	218.2	31.3	846.7	193.1	483.2	183.4	94.8	631.8	387.2	343.3	1550.6	1104.9	2475.5	109.3	207.9	585.9	2575.4	282.7	79.9	70.3	43.5	541.8	1421.8	30.1	232.1	227.8	1304.4	510.0	54.3	79.5	576.2	243.7	298.2	218.0	187.5	18.1	3747.5	838.6	235.5	3049.9	595.9	273.8	558.8	30.4	734.2	1.3	1556.9	164.9	22.3	209.6	50.9	7.9	64.8	63.9	104.9	56.6	95.4	59.6	68.2	41.4	134.3	92.5	4.8	49.9	298.2	53.5	284.5	310.8	329.0	365.1	288.2	359.7	327.9	340.2	340.9	330.5	337.0	315.6	728.0	272.4	247.2	32.3	39.1	286.0	1103.2	951.4	82.0	51.3	434.9	270.0	315.5	444.7	569.7	242.8	33.3	553.5	29.2	344.6	164.4	1445.2	129.4	94.3	91.6	792.6	166.6	206.0	25.1	618.3	407.2	303.5	109.6	115.6	139.4	88.2	585.0	185.7	486.7	47.1	29.9	112.8	722.2	139.4	374.2	61.6	237.3	88.2	1270.0	54.4	161.7	198.3	26.8	32.6	22.2	1195.7	392.2	204.7	149.7	1678.0	41.7	208.2	1042.5	56.2	276.1	159.1	410.7	130.6	31.2	83.7	284.4	836.6	52.4	139.5	104.9	1531.0
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 7.2;NK-cells: 18.1;T-cells: 28.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Uncertain	"Vesicles,Mitotic spindle"		Yes	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Mitotic spindle"	"HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	29.2	15.6	30.5	28.8	32.4	29.4	25.1	39.2	33.2	41.7	23.2	37.6	14.4	35.0	9.4	27.1	31.5	17.9	16.3	27.6	32.5	31.3	24.8	78.4	47.6	31.3	29.9	37.4	12.8	3.8	45.7	31.1	30.2	25.4	11.3	7.8	16.7	8.9	10.5	21.8	41.2	14.2	27.4	56.1	30.1	12.4	30.9	44.7	41.8	6.3	32.8	35.8	30.2	35.8	129.6	273.2	36.5	60.0	43.8	43.0	19.3	63.3	95.3	103.1	75.9	49.2	182.9	91.3	27.5	65.4	253.5	183.5	50.6	105.8	50.2	36.2	54.4	49.4	88.5	59.6	178.4	38.6	25.0	41.1	85.0	95.4	115.7	35.6	58.4	44.2	33.3	232.7	63.1	105.5	119.0	57.7	27.3	90.9	116.9	62.0	102.6	67.5	73.2	12.2	25.8	56.9	148.6	140.8	78.1	31.7	48.1	20.4	48.6	55.1	66.2	101.5	85.0	57.8	97.8	36.8	28.1	38.0	54.6	3.9	2.4	0.0	22.7	3.4	21.3	5.8	22.6	23.3	2.4	7.2	18.6	21.6	0.3	18.1	1.7	1.3	28.2	11.2	30.5	32.4	39.2	33.2	27.6	32.5	31.3	29.9	30.2	27.4	30.9	35.8	14.0	9.6	21.7	18.6	21.7	11.2	6.0	10.9	7.4	14.4	4.8	5.5	8.6	8.6	4.5	7.3	2.1	11.9	30.6	5.8	0.0	9.9	0.7	2.7	20.6	27.1	7.8	32.6	39.2	4.8	17.7	15.7	17.3	5.4	1.3	11.5	14.3	13.7	30.4	3.3	38.0	10.4	12.2	14.8	9.4	1.1	7.2	12.4	17.8	6.5	8.8	8.3	44.3	22.6	13.2	15.0	4.3	9.1	49.6	6.0	5.5	11.1	3.7	2.6	0.0	26.5	14.0	2.3	12.3	10.3	11.2	3.6	36.4	7.1	10.9	4.4
CDH12	"Br-cadherin, CDHB"	ENSG00000154162	"Cadherin 12"	P55289	5	21750673-22853344	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6;retina: 11.6"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 859.5;Inhibitory neurons: 887.7"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basal ganglia: 6.6;cerebral cortex: 3.8;hippocampal formation: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 2.2;SCLC-21H: 3.1;U-2 OS: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029325	Uncertain		Uncertain	Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA029325: AB_2672998"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-1)"		"unprognostic (4.95e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.31e-2)"		"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.25e-4)"	"unprognostic (7.35e-2)"	"unprognostic (3.48e-2)"		"unprognostic (5.19e-2)"	0.0	2.0	0.8	0.0	6.6	0.0	0.5	0.2	3.8	3.0	2.1	0.0	0.0	0.3	0.2	0.0	2.2	0.0	0.0	2.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.1	0.8	0.0	0.1	11.6	1.4	0.2	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.6	0.2	3.8	2.0	0.0	0.5	0.0	0.8	0.0	0.0	0.7	0.4	0.0	0.0	41.4	0.0	0.1	0.0	0.0	0.0	25.1	0.4	0.6	0.9	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	2.1	0.0	0.0	859.5	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	20.2	887.7	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	15.9	0.0	2.2	0.0	31.2	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.1	0.0	0.2	0.0	2.6	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
CDK5R1	"Nck5a, p35, p35nck5a"	ENSG00000176749	"Cyclin dependent kinase 5 regulatory subunit 1"	Q15078	17	32486993-32491253	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 63.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Early spermatids: 21.2;Excitatory neurons: 36.6;Inhibitory neurons: 31.6;Late spermatids: 18.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"SCLC-21H: 58.1;SH-SY5Y: 15.6;SK-MEL-30: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000252			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"HPA000252: AB_2665953"	"unprognostic (1.08e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.74e-5)"	"unprognostic (1.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.03e-1)"	0.8	2.8	37.8	7.1	50.8	5.4	1.2	11.0	63.5	1.5	0.0	0.9	1.4	0.9	0.2	7.5	0.7	0.9	1.1	53.4	21.1	0.8	1.0	0.8	13.9	3.2	10.5	2.6	1.4	0.7	6.9	0.6	4.5	0.6	0.8	10.4	1.1	0.5	2.3	1.9	3.6	0.6	3.5	12.1	1.6	7.2	21.7	4.2	0.5	0.8	14.1	0.8	3.1	34.2	3.9	2.2	9.8	3.1	1.1	1.8	1.1	2.4	1.4	2.9	3.7	5.7	0.9	1.9	2.2	2.0	2.4	1.8	3.8	2.4	3.8	0.7	7.3	0.7	1.1	2.3	0.5	1.3	1.9	1.1	5.8	2.9	2.4	1.1	2.1	6.9	3.9	2.2	6.2	1.6	3.4	1.5	6.2	1.4	2.1	2.9	5.9	7.1	1.4	1.7	58.1	15.6	2.3	1.3	43.8	1.4	2.5	4.4	2.2	4.0	5.9	1.6	6.3	1.1	1.5	1.9	3.4	5.6	9.7	0.0	0.3	0.4	0.8	0.3	0.6	0.2	1.1	0.4	0.0	0.1	1.5	0.9	1.2	0.2	0.1	0.6	0.1	0.6	37.8	50.8	11.0	63.5	53.4	21.1	3.2	10.5	4.5	3.5	21.7	34.2	1.7	0.0	1.5	6.5	13.1	1.5	0.5	1.0	7.4	15.9	3.7	2.3	3.6	0.0	0.8	0.0	45.9	0.6	10.1	0.3	0.0	0.2	21.2	1.1	1.3	1.2	0.0	0.0	36.6	0.6	0.3	1.2	0.5	1.5	0.0	1.6	0.7	0.7	0.9	1.7	31.6	1.4	2.0	3.5	0.5	18.9	0.0	1.3	3.6	2.8	2.0	18.4	10.3	9.5	11.9	1.2	1.2	0.7	0.9	1.2	0.4	1.5	1.0	6.3	0.0	2.9	3.1	6.7	4.3	8.8	1.3	1.1	7.1	1.9	1.1	0.5
CDKL3	NKIAMRE	ENSG00000006837	"Cyclin dependent kinase like 3"	Q8IVW4	5	134286350-134371047	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 342.0;Late spermatids: 295.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027751			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Vesicles"		"HPA027751: AB_10601256"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.47e-4)"	"unprognostic (2.82e-1)"	"unprognostic (9.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.43e-3)"	0.7	0.8	2.5	0.5	2.8	0.2	0.6	2.5	4.4	0.8	1.3	0.8	0.5	1.1	0.6	0.6	1.2	0.6	2.7	2.4	2.7	1.5	0.8	0.5	0.7	2.9	2.6	0.7	0.5	1.0	0.6	0.4	3.0	0.7	0.6	4.2	0.4	0.8	3.4	0.6	0.6	1.5	3.1	0.7	0.5	16.2	2.8	0.9	1.2	3.3	0.9	0.6	0.5	5.0	0.5	1.3	1.7	1.2	2.7	2.4	0.7	1.7	1.4	0.7	1.7	1.2	0.8	1.3	1.0	1.1	3.3	0.5	1.5	1.0	1.2	1.6	1.0	0.8	1.7	1.9	1.7	0.3	0.5	1.1	2.5	2.2	0.6	1.2	0.7	3.4	1.1	0.7	1.9	0.6	1.2	4.6	1.2	0.3	0.5	1.9	0.6	0.4	0.9	0.5	2.5	0.8	1.8	0.1	2.1	1.8	1.0	0.9	0.5	1.4	0.3	1.9	0.5	1.8	2.5	2.9	2.1	1.4	1.1	0.0	0.3	0.3	0.3	0.4	1.4	0.5	0.4	0.9	1.0	0.3	1.3	1.3	0.0	0.6	0.1	0.5	0.9	0.4	2.5	2.8	2.5	4.4	2.4	2.7	2.9	2.6	3.0	3.1	2.8	5.0	4.1	0.0	3.7	50.6	2.0	10.8	6.4	18.8	4.0	13.3	4.5	5.8	2.2	2.8	9.9	5.5	4.2	3.1	3.2	0.5	9.8	3.5	342.0	7.5	6.4	4.6	3.0	4.8	41.6	5.1	1.8	6.2	1.5	3.7	3.8	7.0	3.6	2.3	3.6	6.7	52.0	1.5	18.3	2.1	19.4	295.3	5.0	2.8	10.6	16.9	2.4	10.8	3.1	32.6	50.7	1.5	1.6	9.1	1.4	4.3	1.3	9.5	12.9	9.7	0.0	6.3	7.9	35.3	17.2	1.7	11.1	4.5	3.4	6.2	0.9	3.8
CFAP410	"A2, C21orf2, LRRC76, YF5"	ENSG00000160226	"Cilia and flagella associated protein 410"	O43822	21	44328944-44339402	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, DNA damage"		"Ciliopathy, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 30.8;Extravillous trophoblasts: 15.7;Hofbauer cells: 35.5;Syncytiotrophoblasts: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030283, HPA030284, CAB034126, CAB034128"	Supported		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Vesicles, Cytosol"	"CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700"	"unprognostic (1.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (2.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.06e-1)"	19.8	22.2	14.5	5.1	14.6	11.4	19.5	13.8	18.6	22.9	12.7	21.1	6.5	23.4	2.3	12.5	26.3	3.8	19.9	14.9	14.5	26.0	26.8	18.5	6.6	16.5	16.8	22.3	24.0	7.5	34.4	3.3	14.5	26.3	1.4	10.0	18.6	5.0	16.1	17.9	19.2	2.4	13.9	20.9	20.7	30.9	18.5	4.2	32.8	4.9	2.3	19.2	14.8	16.2	12.9	5.2	4.9	6.3	3.2	2.0	19.3	6.4	3.7	2.5	1.3	9.4	3.7	9.1	12.5	2.2	5.1	6.0	0.9	1.2	0.6	14.2	12.9	9.5	4.3	11.2	4.1	10.2	9.8	2.9	2.2	1.0	2.2	4.4	1.6	6.7	11.6	15.1	1.6	15.5	11.2	25.0	12.2	6.4	7.8	28.6	6.3	20.3	2.9	18.0	12.9	12.2	8.9	2.1	11.0	2.9	9.3	22.0	7.5	5.4	6.9	5.8	4.9	25.1	14.2	6.4	13.2	20.4	9.9	1.7	10.2	1.6	9.4	12.6	11.3	16.6	10.0	13.2	10.5	11.6	11.3	11.1	1.3	17.3	9.5	31.3	6.1	7.6	14.5	14.6	13.8	18.6	14.9	14.5	16.5	16.8	14.5	13.9	18.5	16.2	5.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	30.8	6.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	15.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	32.7	1.1	0.0	0.0	0.0
CFDP1	"BCNT, CENP-29, CP27, p97, SWC5, Yeti"	ENSG00000153774	"Craniofacial development protein 1"	Q9UEE9	16	75293698-75433503	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 493.3;Paneth cells: 745.2;Proximal enterocytes: 612.2;Proximal tubular cells: 637.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041316, HPA048242"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA041316: AB_10794371, HPA048242: AB_2680327"	"unprognostic (1.45e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (9.63e-5)"	"unprognostic (5.81e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.25e-1)"	45.0	51.0	57.4	24.0	58.0	35.0	45.2	60.8	75.3	69.1	57.9	47.5	30.4	58.6	62.3	41.2	55.6	29.7	36.8	57.1	61.7	64.5	43.1	37.3	27.1	58.8	59.3	83.1	41.2	30.8	57.1	63.1	58.8	39.9	40.2	49.6	39.4	38.1	35.7	42.4	36.4	51.0	56.7	30.2	34.7	59.5	59.6	57.0	45.0	34.9	35.8	44.8	50.7	60.8	65.0	47.6	158.9	59.2	141.2	156.3	47.2	63.2	74.1	83.0	119.1	82.5	86.6	61.3	91.1	79.3	92.7	71.5	123.3	101.9	164.9	26.4	58.6	63.0	46.6	177.2	97.3	69.2	51.6	98.4	85.5	100.2	121.4	144.6	91.5	114.0	91.3	28.3	93.9	149.0	102.2	152.6	77.1	110.0	24.8	182.7	64.3	108.5	93.1	35.5	94.5	79.4	105.7	22.3	92.5	136.4	91.8	121.6	53.8	59.2	63.1	63.2	40.8	54.4	89.2	228.6	59.3	89.9	53.3	61.3	45.5	60.8	31.2	47.8	44.5	33.6	42.7	34.7	48.8	35.4	38.7	36.5	38.1	28.5	46.2	48.7	68.5	25.8	57.4	58.0	60.8	75.3	57.1	61.7	58.8	59.3	58.8	56.7	59.6	60.8	87.4	38.5	57.5	37.5	45.5	57.9	116.3	135.9	47.3	87.2	89.5	103.4	34.7	91.5	111.2	115.8	116.7	119.0	50.5	493.3	197.6	79.1	133.7	197.7	118.5	97.6	82.2	78.9	49.5	94.9	114.0	82.9	61.2	121.3	28.5	194.5	62.8	153.9	77.1	62.2	50.5	219.2	59.0	53.1	44.5	69.7	125.2	51.1	33.8	45.9	64.8	60.8	84.5	49.8	75.6	92.4	745.2	112.5	42.3	116.9	612.2	637.6	205.3	112.5	98.6	55.3	88.2	311.2	178.0	49.5	65.6	154.9	51.6	103.5	120.0	130.4
CGRRF1	"CGR19, RNF197"	ENSG00000100532	"Cell growth regulator with ring finger domain 1"	Q99675	14	54509812-54539292	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.4;Spermatocytes: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002930	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA002930: AB_1078507"	"unprognostic (1.81e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (2.57e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.74e-1)"	9.9	9.2	20.5	3.9	21.1	7.9	11.9	22.2	25.8	9.6	21.2	11.7	5.3	11.0	13.8	5.9	11.2	5.9	12.3	20.2	21.2	14.5	7.8	7.5	6.0	21.2	21.4	10.0	13.1	12.8	12.7	7.0	21.2	11.3	6.9	13.6	8.5	10.9	19.3	4.2	8.5	8.6	22.1	8.5	9.7	22.3	20.9	5.6	12.7	12.5	5.3	10.1	7.5	22.3	10.4	8.6	9.7	8.6	16.7	10.6	7.3	9.5	10.2	14.6	15.2	8.7	11.7	5.9	11.9	8.2	15.8	9.1	10.8	8.4	18.5	11.9	8.7	8.3	1.7	10.6	20.1	4.6	4.4	10.9	16.7	11.0	18.1	9.6	10.6	9.3	3.3	7.6	13.6	19.0	4.9	7.2	6.0	9.5	15.3	10.8	12.3	2.9	11.8	13.3	6.4	6.3	8.3	3.9	16.1	8.7	11.3	4.2	9.3	18.2	14.3	7.2	8.7	5.0	6.4	8.5	10.0	5.6	12.0	61.9	12.4	22.6	19.1	15.4	18.7	18.2	19.9	20.2	10.4	19.4	20.0	18.6	12.5	20.3	19.0	9.0	22.3	19.7	20.5	21.1	22.2	25.8	20.2	21.2	21.2	21.4	21.2	22.1	20.9	22.3	20.3	9.6	11.5	21.5	22.6	7.6	17.4	26.7	16.5	18.6	18.3	18.7	22.1	14.3	17.3	16.5	10.4	14.7	21.8	17.5	23.5	21.6	145.4	13.7	15.1	20.3	10.7	4.2	14.2	16.9	11.5	22.3	5.6	13.1	29.2	12.7	18.9	10.6	17.0	11.8	13.8	9.1	28.5	14.8	10.3	41.5	16.8	24.8	16.0	12.2	15.5	29.4	16.5	17.1	24.3	17.7	13.1	22.6	11.5	16.8	15.6	27.3	22.6	15.9	19.7	17.0	25.0	112.2	36.0	10.0	3.4	12.0	24.0	12.3	11.0	14.0
CLDN14	DFNB29	ENSG00000159261	"Claudin 14"	O95500	21	36460621-36576569	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"kidney: 13.8;liver: 39.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Distal tubular cells: 19.6;Ductal cells: 11.8;Exocrine glandular cells: 8.2;Hepatocytes: 22.2;Pancreatic endocrine cells: 21.3"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 7.9"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"HDLM-2: 224.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA054707			Uncertain	Vesicles		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA054707: "	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.43e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.54e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (3.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.87e-1)"	"unprognostic (7.44e-4)"	"unprognostic (2.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.71e-2)"	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.3	0.1	0.1	0.0	13.8	39.5	0.1	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.2	0.1	0.0	0.1	0.3	0.2	0.0	0.4	0.4	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	224.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.7	2.1	0.1	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	2.5	15.8	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.1	7.4	4.2	0.1	0.7	0.4	6.7	15.7	0.0	1.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.4	1.0	0.6	0.0	0.0	0.8	0.4	0.7	7.2	0.1	1.8	0.0	0.1	0.0	0.7	19.6	11.8	0.6	0.3	0.2	3.6	0.0	0.0	0.6	8.2	1.3	0.1	0.0	3.4	0.0	0.0	0.4	22.2	0.1	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.2	3.6	0.0	0.6	0.0	0.0	1.5	1.0	21.3	0.0	0.4	6.9	0.6	0.0	0.7	0.0	0.0	0.0	0.0	2.0	1.2	0.0	0.0	0.3	0.8	1.4	0.0	0.3	2.3
CLN6	"FLJ20561, HsT18960, nclf"	ENSG00000128973	"CLN6 transmembrane ER protein"	Q9NWW5	15	68206992-68257211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 181.8;Hofbauer cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066046, HPA066759"	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Endoplasmic reticulum"	"Nucleoli, Vesicles"	"HPA066046: AB_2685604, HPA066759: "	"unprognostic (1.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.78e-2)"	11.6	17.6	12.7	14.8	13.0	29.9	11.5	13.3	14.9	11.0	13.2	17.5	14.6	9.8	6.8	16.9	9.8	9.6	9.3	12.1	12.6	20.0	22.7	13.2	16.2	13.3	13.1	6.8	19.1	10.4	10.1	11.6	13.8	12.4	14.9	11.8	14.8	9.2	17.0	14.7	14.6	10.4	12.8	20.7	13.3	10.9	13.0	11.6	12.9	7.3	16.7	10.7	9.6	14.5	38.2	93.1	23.9	33.9	14.5	11.8	57.1	35.3	17.0	42.8	34.9	72.1	60.5	57.6	17.2	21.4	31.7	69.5	69.8	34.5	17.0	38.5	82.3	84.3	66.1	54.3	29.7	95.6	58.1	20.8	11.4	34.7	23.7	9.0	29.1	33.1	56.9	116.0	33.6	103.8	44.0	69.4	57.1	67.3	38.3	42.1	71.8	80.6	36.2	97.0	48.2	20.0	39.5	61.7	34.3	18.0	33.1	95.5	19.3	48.1	55.7	35.8	127.2	81.3	97.3	47.4	30.0	115.4	47.6	0.0	8.8	0.6	3.0	13.0	4.0	2.9	2.2	4.3	5.2	2.3	2.8	1.3	10.5	2.0	16.1	4.4	2.3	3.5	12.7	13.0	13.3	14.9	12.1	12.6	13.3	13.1	13.8	12.8	13.0	14.5	1.4	9.6	6.9	7.2	13.4	20.1	22.0	13.9	14.8	181.8	2.0	1.9	27.4	10.0	9.6	5.5	16.7	42.8	7.1	22.7	0.0	3.3	0.4	1.0	4.8	9.7	15.1	32.8	8.9	1.8	58.4	9.1	8.2	1.4	8.9	5.6	11.0	21.9	88.4	21.9	8.1	20.5	16.2	24.2	14.0	1.4	9.0	11.3	19.6	8.4	12.9	16.9	11.3	5.0	10.2	3.6	26.0	8.2	33.4	23.7	15.6	2.1	3.3	32.7	6.6	7.5	5.6	1.0	19.5	21.1	14.1	21.8	9.5	5.3	35.6	16.3
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 6.2"	"Cell type enriched"	"Detected in many"	5	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HDLM-2: 4.1;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.3	0.2	0.5	0.9	0.4	0.4	0.6	1.5	0.7	0.2	0.5	0.3	0.6	0.4	1.2	0.4	0.2	0.5	0.2	0.5	0.5	6.2	0.9	0.6	3.0	0.4	0.2	0.4	0.1	0.1	1.3	1.0	0.5	0.4	0.4	0.3	0.5	0.3	0.2	0.8	0.9	0.1	0.1	1.5	1.1	0.8	0.5	1.4	0.3	0.0	2.0	0.3	0.0	0.9	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.2	0.1	0.5	0.1	0.2	0.2	0.1	0.1	1.4	0.4	0.1	2.6	1.1	0.1	0.1	0.4	2.0	0.0	0.6	1.8	0.2	0.5	0.4	1.5	0.7	0.5	0.5	0.4	0.2	0.5	0.1	0.5	0.9	0.1	3.2	3.0	1.0	12.9	0.8	0.8	0.0	0.0	1.3	0.3	0.3	0.7	0.0	0.9	0.0	2.1	0.3	4.6	0.1	13.7	0.0	5.3	0.7	0.2	0.4	0.0	5.3	1.7	0.0	2.2	0.5	0.5	0.9	11.4	0.2	0.7	0.3	0.3	0.0	1.6	0.2	73.2	1.9	5.5	5.4	0.3	3.5	1.8	1.9	0.5	0.4	0.0	1.0	0.7	0.1	0.0	2.2	1.1	0.7	0.0	0.2	0.2	1.0	0.0	1.1	0.5	1.9	0.8	0.0	0.4	0.1	6.0	1.3	0.0	0.7
CLSTN2	"CDHR13, CS2, CSTN2, FLJ39113"	ENSG00000158258	"Calsyntenin 2"	Q9H4D0	3	139935185-140577397	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 18.2;brain: 26.7;ovary: 64.7"	"Cell type enriched"	"Detected in many"	4	"Excitatory neurons: 552.2"	"Cancer enriched"	"Detected in many"	7	"breast cancer: 15.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 32.7;SCLC-21H: 14.5;SuSa: 42.7;THP-1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031342, HPA061800"	Approved		Uncertain	"Vesicles,Cytokinetic bridge"		Yes	No		130000		"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Cytokinetic bridge"	"HPA031342: AB_10602800, HPA061800: AB_2684615"	"unprognostic (7.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.63e-5)"	"unprognostic (7.22e-5)"	18.2	4.8	17.3	0.3	15.3	0.0	8.8	0.0	26.7	4.2	0.0	1.4	0.5	5.1	0.7	1.0	4.7	2.1	6.1	23.4	0.0	4.3	0.8	1.1	2.7	13.3	3.1	64.7	1.6	0.8	0.9	0.9	9.1	5.3	0.8	2.7	1.3	1.1	1.6	2.0	1.3	6.8	0.0	0.1	1.0	0.6	0.0	0.7	2.8	2.2	0.2	1.6	3.2	15.6	0.0	0.0	5.1	0.0	2.2	0.6	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.1	0.0	32.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	2.1	0.0	0.0	0.0	42.7	2.2	9.4	0.0	1.0	0.5	1.4	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	15.3	0.0	26.7	23.4	0.0	13.3	3.1	9.1	0.0	0.0	15.6	2.1	0.0	0.0	18.3	0.0	0.5	0.3	0.0	8.6	1.8	10.9	2.2	8.0	0.0	0.6	3.7	0.0	0.2	0.1	0.0	1.9	0.2	39.8	0.5	8.9	0.8	0.0	0.0	552.2	0.2	0.0	9.1	0.0	0.2	0.0	25.0	2.2	0.0	0.1	0.0	111.5	0.0	0.0	0.3	1.5	31.1	28.0	0.8	0.0	5.6	0.0	0.8	0.0	108.6	29.4	0.0	0.0	0.7	0.0	5.0	0.0	32.3	3.0	3.8	0.0	28.3	13.7	0.8	0.8	0.4	0.0	0.0	0.7	0.5	0.0	0.3
CNIH1	"CNIH, CNIL, TGAM77"	ENSG00000100528	"Cornichon family AMPA receptor auxiliary protein 1"	O95406	14	54423561-54441391	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002544	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA002544: AB_2081856"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.09e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.71e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (8.95e-4)"	73.2	61.7	40.2	50.9	42.1	37.2	73.6	45.2	49.5	59.8	58.5	86.9	99.4	49.6	50.8	72.5	67.0	74.4	84.6	42.8	47.2	79.9	232.9	46.7	61.2	44.3	43.4	44.0	41.8	59.8	41.2	58.4	44.8	57.2	95.1	60.3	49.7	57.1	58.9	36.0	85.4	68.2	49.1	33.8	45.4	37.1	41.3	56.2	65.0	95.5	79.0	95.1	39.4	50.7	233.4	141.3	113.8	129.2	301.0	380.9	107.8	276.8	348.6	232.0	264.4	86.5	316.4	289.7	180.2	209.2	141.6	226.5	208.3	200.3	287.5	111.9	124.5	112.1	80.9	152.8	303.6	136.5	90.2	314.4	244.3	217.1	304.0	236.8	221.3	117.7	111.5	95.5	262.4	138.4	151.5	102.9	84.2	266.3	281.3	114.8	191.8	97.3	264.2	171.4	95.5	106.3	163.4	127.8	316.7	104.8	197.5	144.9	143.7	194.7	192.9	165.4	167.8	59.7	138.8	141.2	235.9	115.3	176.5	5.3	84.6	10.7	32.5	66.8	54.8	64.3	57.3	47.0	86.0	55.2	75.1	52.1	20.9	44.0	53.7	48.4	65.1	96.6	40.2	42.1	45.2	49.5	42.8	47.2	44.3	43.4	44.8	49.1	41.3	50.7	41.1	35.3	60.6	14.7	64.9	105.7	86.2	186.1	141.7	41.9	69.2	64.0	85.6	50.1	79.8	46.0	20.9	95.7	48.1	98.8	90.1	89.3	44.4	54.8	57.9	72.3	104.4	65.0	26.9	62.3	123.4	90.3	52.5	32.8	197.3	32.4	70.3	140.0	115.5	67.3	34.8	91.5	99.7	102.8	80.0	17.0	60.0	73.5	83.6	9.4	110.3	59.9	35.0	17.6	22.5	65.6	96.6	65.8	84.0	92.0	149.9	164.7	79.9	45.1	46.0	60.5	68.1	68.7	64.1	144.9	110.0	70.9	69.3	68.4	123.0	91.4
COMMD4	FLJ20452	ENSG00000140365	"COMM domain containing 4"	Q9H0A8	15	75336020-75343224	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039935, HPA066957"	Uncertain		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Vesicles, Plasma membrane"	"HPA039935: , HPA066957: AB_2685754"	"unprognostic (7.77e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.57e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.07e-2)"	36.2	72.3	38.8	33.5	39.4	52.9	36.8	40.5	50.4	31.1	43.7	41.6	48.3	30.3	30.2	39.9	34.6	37.3	38.9	36.9	39.7	54.6	51.0	34.6	44.7	39.5	38.1	24.4	33.8	48.9	33.9	31.2	38.6	34.2	33.8	13.4	43.4	34.0	30.3	35.0	42.2	24.7	40.8	41.3	42.5	81.2	42.4	53.3	38.8	15.3	36.7	33.6	31.8	42.0	138.2	222.5	97.5	124.8	42.3	64.9	98.5	98.8	106.2	191.2	196.6	133.8	184.0	88.8	100.2	79.5	168.8	144.8	175.2	116.5	82.7	70.1	242.4	104.8	169.8	151.0	76.4	79.4	111.0	74.3	63.6	116.2	21.9	48.4	96.5	103.6	108.2	128.1	147.1	179.7	71.0	117.4	140.9	75.2	127.9	127.5	137.4	127.8	98.6	127.8	79.2	114.8	131.2	105.1	169.8	63.8	164.7	160.9	78.6	135.3	119.2	125.8	184.8	93.4	218.7	101.4	138.9	181.9	125.4	27.0	44.1	40.7	84.7	61.8	52.8	47.5	51.7	63.2	50.0	46.4	31.9	47.4	9.5	76.8	55.6	70.6	87.6	39.4	38.8	39.4	40.5	50.4	36.9	39.7	39.5	38.1	38.6	40.8	42.4	42.0	43.7	28.9	52.4	15.0	26.2	27.0	44.8	58.5	28.5	40.7	44.3	50.3	18.7	38.6	46.2	35.0	31.3	80.9	34.8	59.6	58.7	72.6	12.2	37.1	44.9	42.7	30.5	60.8	9.0	78.7	107.0	43.4	33.1	45.7	41.8	91.1	37.5	41.9	127.5	16.8	8.8	72.8	44.7	35.8	27.0	17.6	49.0	41.3	37.4	11.2	28.5	78.1	53.5	7.1	17.6	72.4	61.7	34.3	43.0	26.6	71.2	98.1	39.8	49.4	46.0	36.1	59.3	152.9	63.5	34.3	30.7	50.8	32.2	53.4	58.7	48.7
CPLX1	CPX-I	ENSG00000168993	"Complexin 1"	O14810	4	784957-826129	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 273.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.5;Bipolar cells: 33.4;Endothelial cells: 29.6;Excitatory neurons: 44.2;Inhibitory neurons: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 84.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA071191: , HPA074390: "	"unprognostic (9.21e-3)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.26e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.77e-2)"	17.2	13.4	26.1	1.2	43.0	0.1	18.2	59.7	273.5	16.9	0.0	5.0	1.0	10.8	0.1	5.7	16.4	0.4	11.5	18.5	72.8	10.9	8.3	9.4	0.8	135.5	25.1	9.4	3.2	1.4	12.8	0.3	128.2	13.8	0.2	5.7	9.6	0.7	4.1	3.4	5.1	0.4	13.9	27.2	4.9	8.6	124.2	3.6	7.5	0.2	0.2	8.3	12.9	89.9	5.7	0.5	0.1	0.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	16.3	1.7	4.2	1.9	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.4	0.0	1.8	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.3	2.0	0.3	0.0	2.5	2.3	0.0	2.6	4.4	2.6	0.1	0.0	1.6	0.0	0.4	84.3	11.8	0.4	5.5	0.0	0.2	8.5	0.3	0.1	0.0	0.5	0.1	0.1	0.2	4.7	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	26.1	43.0	59.7	273.5	18.5	72.8	135.5	25.1	128.2	13.9	124.2	89.9	45.5	0.0	0.0	5.9	0.4	1.0	3.2	0.4	1.8	33.4	7.8	8.1	3.6	0.0	1.9	0.0	4.2	0.1	2.8	2.5	1.9	1.2	1.4	1.1	5.4	29.6	21.5	0.0	44.2	0.8	3.2	1.8	2.6	1.4	0.0	0.3	14.3	4.8	0.2	18.5	90.7	2.1	0.0	0.3	1.9	2.3	1.8	0.5	1.8	8.4	0.0	16.8	0.0	8.0	4.7	0.8	5.2	0.0	0.6	2.6	0.3	1.2	0.0	21.7	0.0	0.4	2.3	4.3	9.8	0.2	1.1	1.0	1.6	0.8	2.7	1.3
CPLX2	"CPX-2, DKFZp547D155"	ENSG00000145920	"Complexin 2"	Q6PUV4	5	175796310-175884021	"Predicted intracellular proteins"	"Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 308.9;epididymis: 128.6;pituitary gland: 65.6"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 36.6;Excitatory neurons: 44.7;Horizontal cells: 95.9;Inhibitory neurons: 35.9;Late spermatids: 32.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"A549: 496.4;Hep G2: 323.4;SCLC-21H: 201.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA071191: , HPA074390: "	"unprognostic (1.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"		"unprognostic (6.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.90e-5)"	"unprognostic (6.88e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	0.7	28.3	239.7	1.0	136.0	0.0	0.1	78.2	291.5	0.0	0.0	3.5	2.1	0.0	128.6	0.1	0.0	0.0	0.2	308.9	62.3	0.1	0.2	1.3	0.0	62.2	98.8	0.2	9.0	0.1	65.6	0.0	50.2	0.2	1.4	19.4	0.1	0.0	0.2	0.1	1.6	0.3	0.0	0.0	5.0	3.0	19.6	0.1	0.2	0.0	0.0	0.1	0.5	157.7	0.0	496.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	323.4	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.3	2.1	15.2	0.1	0.0	0.0	0.6	0.0	0.2	201.3	16.3	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.7	136.0	78.2	291.5	308.9	62.3	62.2	98.8	50.2	0.0	19.6	157.7	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.2	36.6	0.0	44.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	35.9	1.0	0.0	0.0	0.0	32.9	0.9	0.0	0.0	4.7	0.0	1.1	0.0	5.5	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPM		ENSG00000135678	"Carboxypeptidase M"	P14384	12	68842197-68971570	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 156.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 359.0;Alveolar cells type 2: 362.2;Kupffer cells: 368.5;Sertoli cells: 762.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 21.0;intermediate monocyte: 14.5;myeloid DC: 16.6;non-classical monocyte: 7.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 16.6;monocytes: 21.0"	"Group enriched"	"Detected in many"	4	"ASC diff: 71.1;ASC TERT1: 50.0;HSkMC: 91.2;SiHa: 68.9;THP-1: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002657, HPA077243"	Enhanced		Uncertain	Vesicles		NA	NA		7100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA002657: AB_1078398, HPA077243: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.06e-1)"	156.1	11.5	6.4	14.4	13.3	3.5	40.2	10.1	10.5	14.4	3.8	33.5	4.4	23.9	0.9	10.1	16.2	16.1	4.6	7.6	10.2	41.3	26.5	59.3	16.1	19.3	11.5	18.0	13.0	12.0	1.0	70.1	11.9	14.7	26.6	6.7	4.1	2.8	5.8	21.7	5.9	6.4	7.5	19.4	15.3	5.4	28.0	4.3	7.5	9.7	10.5	9.3	5.7	23.5	0.1	4.0	0.1	0.0	71.1	50.0	0.7	9.8	1.1	1.7	2.3	3.2	4.1	0.5	9.6	1.4	4.1	0.0	1.4	2.7	4.1	0.1	2.7	0.0	15.1	0.3	0.4	1.2	1.9	91.2	0.6	1.0	2.0	8.6	0.0	0.3	0.0	0.1	7.3	1.7	0.0	0.7	1.7	0.0	5.2	3.1	0.6	0.0	7.2	5.9	0.4	0.2	68.9	10.7	7.9	5.5	1.2	26.5	0.2	1.2	7.5	0.5	0.2	0.4	0.5	13.1	4.3	13.1	5.9	0.6	21.0	0.1	0.2	14.5	0.0	1.8	1.5	0.1	16.6	3.5	0.9	0.2	1.6	0.5	7.4	1.1	1.9	7.3	6.4	13.3	10.1	10.5	7.6	10.2	19.3	11.5	11.9	7.5	28.0	23.5	83.3	359.0	362.2	34.6	4.9	12.4	3.5	6.1	0.6	3.3	7.8	8.9	2.6	135.8	70.1	51.5	0.0	32.3	1.1	97.5	29.4	57.9	16.6	100.9	8.3	29.0	10.8	3.6	1.2	212.5	59.9	14.1	4.6	237.1	112.5	6.7	73.9	36.6	134.6	0.0	1.3	28.7	0.0	368.5	36.3	17.5	105.0	202.2	10.6	19.7	23.3	68.9	1.0	23.1	161.8	68.0	65.9	79.0	2.4	38.7	1.9	63.7	16.4	5.7	762.6	7.2	126.9	0.6	3.9	2.4	9.9	172.4	14.5	46.3	32.7	2.8
CPSF4	"CPSF30, NAR"	ENSG00000160917	"Cleavage and polyadenylation specific factor 4"	O95639	7	99438922-99457373	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049094, HPA066470"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Vesicles	"HPA049094: AB_2680626, HPA066470: AB_2685672"	"unprognostic (4.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.23e-2)"	20.4	19.0	31.4	13.8	30.8	20.1	19.2	29.9	35.1	18.7	23.6	16.7	14.0	16.8	11.7	20.4	15.7	11.3	17.4	30.1	30.4	17.3	20.2	15.4	23.7	35.5	31.6	18.8	29.9	8.3	18.4	16.7	32.1	19.1	10.7	7.2	19.8	12.3	36.1	20.4	16.1	11.1	30.4	22.0	20.0	32.0	32.3	16.1	13.9	18.0	19.9	16.0	17.4	30.4	40.0	33.9	55.4	44.9	22.4	25.5	66.8	25.8	31.5	38.8	50.5	56.0	52.0	56.4	34.2	25.2	48.2	34.0	39.1	40.5	35.4	41.9	41.6	27.0	41.4	54.4	117.2	49.4	33.3	46.8	34.0	40.7	60.4	28.1	35.8	40.1	70.8	64.8	36.2	95.6	99.6	88.9	51.3	53.0	47.7	40.8	37.0	66.8	24.2	36.1	43.3	50.6	29.4	60.9	61.6	58.2	25.3	51.8	20.0	36.5	50.1	64.3	50.0	59.9	68.6	83.3	28.1	48.1	44.1	1.2	3.4	2.6	3.3	3.0	4.4	8.2	5.0	6.1	4.1	8.4	6.3	5.6	1.3	4.4	2.1	5.4	8.2	3.0	31.4	30.8	29.9	35.1	30.1	30.4	35.5	31.6	32.1	30.4	32.3	30.4	11.6	6.4	8.9	6.2	11.2	8.8	16.4	10.6	9.6	4.6	11.9	10.3	10.4	14.3	8.6	1.8	10.4	55.9	17.7	8.7	15.6	15.6	3.0	4.9	9.3	11.0	7.7	15.6	10.7	17.1	33.1	12.7	5.1	5.3	12.7	27.0	8.2	8.2	21.5	6.7	14.7	10.6	14.2	10.1	13.5	7.8	27.4	8.7	8.8	5.6	18.5	10.7	14.4	6.0	8.1	13.9	6.0	17.3	14.7	28.6	10.1	20.2	4.3	6.9	19.7	23.7	16.4	20.9	19.8	9.3	9.2	45.4	10.7	25.1	12.6	14.9
CRB1	"LCA8, RP12"	ENSG00000134376	"Crumbs cell polarity complex component 1"	P82279	1	197268204-197478455	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Disease variant, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.3;retina: 74.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 469.5;Cone photoreceptor cells: 164.7;Inhibitory neurons: 130.1;Muller glia cells: 79.7;Oligodendrocyte precursor cells: 280.0;Oligodendrocytes: 105.6;Rod photoreceptor cells: 149.3"	"Cancer enriched"	"Detected in single"	12	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 7.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 7.7"	"Cell line enriched"	"Detected in some"	8	"HeLa: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA061250, HPA063127"	Approved		Uncertain	Vesicles	"Secreted in brain"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA061250: AB_2684458, HPA063127: AB_2684944"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-3)"		"unprognostic (2.92e-3)"	"unprognostic (1.50e-2)"	"unprognostic (5.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.96e-1)"	0.1	0.1	15.7	0.0	17.6	0.4	0.1	19.8	20.5	0.0	9.6	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.2	15.8	14.2	0.1	0.0	0.1	0.1	18.7	18.4	0.7	0.4	0.0	2.2	0.0	17.5	0.0	0.0	74.7	0.0	0.0	0.7	0.0	0.0	0.0	18.9	0.0	0.2	2.9	16.1	0.0	0.2	0.5	0.0	0.0	0.0	21.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	15.7	17.6	19.8	20.5	15.8	14.2	18.7	18.4	17.5	18.9	16.1	21.3	0.0	0.0	0.0	469.5	0.0	0.3	0.2	0.3	0.0	15.0	0.2	0.1	1.1	0.0	0.2	0.0	164.7	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.7	0.0	11.6	53.2	0.0	0.0	0.2	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.7	130.1	0.0	2.0	0.0	0.5	1.6	1.8	0.0	0.0	24.4	0.0	79.7	0.0	280.0	105.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.9	149.3	0.0	0.2	0.1	1.8	0.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0
CRYGA	"CRY-g-A, CRYG1, CRYG5"	ENSG00000168582	"Crystallin gamma A"	P11844	2	208160740-208163589	"Predicted intracellular proteins"		"Eye lens protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA043386	Supported		Uncertain	Vesicles,Cytosol		NA	NA						"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"		"HPA043386: "					"unprognostic (1.49e-1)"													0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.2	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.7	0.6	0.3	0.2	0.3	0.2	0.3	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683729-94736190	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 102.8;liver: 197.0;stomach 1: 67.2"	"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 68.8;Hepatocytes: 124.0;Proximal enterocytes: 62.5;Squamous epithelial cells: 22.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;OE19: 1.9"	"Not detected"	"Not detected"							HPA074424			Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"HPA074424: "	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.3	0.0	0.0	1.6	0.1	0.0	0.3	0.2	0.1	5.3	0.0	5.9	102.8	0.1	0.0	30.9	0.0	16.3	0.0	0.1	0.0	0.3	197.0	0.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	2.5	0.0	5.4	0.0	0.0	4.4	83.1	0.1	0.1	0.0	67.2	0.1	0.1	0.3	0.0	0.0	7.1	0.2	9.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.0	3.3	0.0	0.3	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.1	17.2	3.2	0.0	0.0	0.1	0.0	6.7	0.0	1.5	0.0	0.6	0.1	0.0	0.0	2.7	0.5	6.9	0.2	0.1	68.8	1.3	0.0	0.0	1.8	124.0	0.0	0.0	0.8	2.1	2.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	9.1	3.9	0.0	0.3	0.0	62.5	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.3	22.8	1.7	1.5	0.1	0.1	5.7	0.0
CYP2C19	"CPCJ, CYP2C, P450IIC19"	ENSG00000165841	"Cytochrome P450 family 2 subfamily C member 19"	P33261	10	94762681-94855547	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 190.2"	"Group enriched"	"Detected in some"	11	"Gastric mucus-secreting cells: 3.1;Hepatocytes: 9.5;Proximal enterocytes: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015066, HPA074424"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA015066: AB_1847433, HPA074424: "			"unprognostic (3.15e-2)"			"unprognostic (2.13e-1)"	"unprognostic (2.48e-1)"				"unprognostic (1.83e-2)"			"unprognostic (1.53e-1)"				0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.2	0.2	0.1	0.2	32.4	0.0	0.1	1.6	0.0	1.7	0.0	0.1	0.0	0.0	190.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.6	13.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	3.1	0.0	0.0	0.0	0.4	9.5	0.0	0.0	0.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	359	"liver: 2156.6"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 1834.2"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA013547, HPA013970, HPA015066, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.3	1.8	1.7	0.0	1.9	0.2	0.3	1.4	2.1	0.3	1.4	0.4	0.2	0.1	0.3	0.1	1.1	4.6	0.3	1.8	2.2	1.4	2156.6	0.4	0.1	1.7	2.2	0.1	1.7	0.5	3.1	0.1	1.8	0.6	0.0	3.1	0.2	0.3	0.2	0.1	1.1	0.0	1.4	1.0	6.0	4.0	2.1	0.2	0.9	0.0	0.1	0.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.9	1.4	2.1	1.8	2.2	1.7	2.2	1.8	1.4	2.1	1.8	0.0	0.0	0.0	1.6	8.9	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.2	147.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	7.3	0.9	0.1	2.0	1.8	57.5	4.5	0.2	0.0	0.1	0.0	0.2	0.0	0.6	52.8	1834.2	0.0	5.0	3.7	0.1	0.0	70.9	0.0	7.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	1.2	0.5	1.2	0.0	0.0	0.1	1.0	0.8	0.9	1.7	0.0	0.0	0.3	2.1	0.6	0.0	0.0	0.0	3.3	0.0	0.2	0.2
CYP2C9	"CYP2C10, P450IIC9"	ENSG00000138109	"Cytochrome P450 family 2 subfamily C member 9"	P11712	10	94938658-94990091	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 1719.9"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 1704.9"	"Cancer enriched"	"Detected in some"	41	"liver cancer: 118.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015066, CAB016123, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"CAB016123: AB_629363, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.37e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.16e-2)"		"unprognostic (1.83e-2)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-2)"		"unprognostic (4.93e-2)"		"unprognostic (1.26e-4)"	"unprognostic (7.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.24e-2)"	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.0	1.2	0.0	2.7	87.8	0.0	0.0	7.7	0.0	7.9	0.0	0.0	0.0	4.3	1719.9	0.2	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	2.3	46.2	0.1	0.0	0.5	18.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.6	0.2	1.8	0.0	0.0	0.0	1.5	0.0	7.6	0.0	0.8	0.7	1.1	0.0	16.0	0.0	0.7	0.0	0.2	44.4	7.4	0.0	0.0	26.7	1704.9	0.0	0.0	0.1	1.4	0.0	34.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.6	0.0	0.1	0.0	65.3	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.1	1.9	0.0	2.7	0.0
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784248	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 3796.2"	"Group enriched"	"Detected in some"	40	"Hepatocytes: 2612.9;Proximal enterocytes: 1685.2"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;NB-4: 2.2;RPMI-8226: 3.4;SCLC-21H: 1.3;SH-SY5Y: 2.0"					"Low region specificity"	"Detected in all"			"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.3	3.8	0.1	1.1	0.3	0.0	0.3	0.0	0.8	0.1	0.0	4.6	797.6	0.6	0.2	0.4	0.1	0.6	0.1	0.1	0.0	4.9	3796.2	0.1	0.9	0.0	0.0	0.1	43.4	0.0	1.0	0.0	0.0	0.2	2.2	0.4	0.3	0.0	2.4	1.9	853.0	0.0	0.0	0.1	1.1	1.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.8	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.2	0.2	0.0	0.0	0.0	0.8	3.4	0.0	0.1	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	2.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.4	32.9	0.0	0.0	0.0	0.3	0.0	5.6	0.0	0.1	0.4	0.0	0.0	1.4	0.0	26.7	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	30.0	2612.9	0.0	0.0	0.6	29.6	2.0	52.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	38.9	0.0	0.0	0.6	1685.2	3.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.9	0.1	2.3	0.5	16.1	1.1
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 44.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Early spermatids: 7.5;Excitatory neurons: 3.9;granulocytes: 2.5;Hepatocytes: 6.4;Late spermatids: 3.3;Spermatocytes: 2.4"	"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA066463, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Vesicles	"HPA066463: AB_2685670, HPA072245: , HPA075539: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	44.7	0.1	0.1	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.2	0.1	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.8	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.0	0.3	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.2	0.0	0.0	3.9	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	6.4	0.1	1.7	1.9	0.0	0.0	0.6	1.9	3.3	0.0	0.2	0.0	1.0	0.0	0.2	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.7	0.1	2.4	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.2
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99679998	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 177.7;liver: 276.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 377.4;Distal enterocytes: 382.7;Gastric mucus-secreting cells: 506.6;Hepatocytes: 454.5;Paneth cells: 451.6;Proximal enterocytes: 1074.6;Urothelial cells: 380.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.7;Hep G2: 7.9;OE19: 28.3"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	3.3	14.4	0.1	3.8	0.4	0.6	6.5	0.8	0.9	5.1	0.4	28.4	127.3	3.1	3.0	22.1	3.1	32.7	1.0	0.3	0.0	10.6	276.1	9.2	1.4	0.6	0.0	0.8	47.0	0.0	0.9	0.4	0.4	21.6	21.0	0.7	2.9	5.7	0.9	20.5	177.7	1.1	0.0	0.8	86.5	0.4	0.0	2.1	1.0	0.0	3.2	10.4	13.1	0.5	1.6	3.3	1.6	1.9	0.4	0.6	0.5	1.5	0.0	0.0	0.0	9.7	7.4	1.0	1.5	0.0	1.2	1.2	0.0	0.0	0.0	1.8	1.2	1.2	0.7	7.9	0.1	2.0	0.6	0.0	2.1	0.0	0.0	1.4	0.0	0.9	3.3	2.0	0.0	0.3	2.6	3.8	0.4	28.3	0.8	0.6	1.6	2.2	0.4	1.5	1.2	1.7	0.9	0.8	3.2	1.6	0.5	0.7	1.2	1.8	1.6	1.6	1.2	1.0	2.6	1.7	1.6	2.6	1.5	0.4	0.3	0.4	0.4	0.3	0.9	0.2	0.6	0.6	0.2	0.1	0.4	0.5	0.5	0.4	0.2	0.3	0.5	0.2	0.1	0.4	0.8	0.9	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.5	0.9	12.8	14.8	1.3	4.8	46.1	112.7	31.0	59.7	13.7	1.1	0.4	1.3	377.4	27.3	3.7	12.5	1.7	1.7	382.7	0.0	63.4	2.0	3.1	2.2	6.3	54.6	21.7	8.6	50.7	1.2	8.5	506.6	10.3	10.1	1.8	8.2	454.5	0.6	8.4	11.0	140.5	6.1	9.5	4.5	0.5	2.5	4.1	3.6	2.8	4.9	4.0	10.3	7.1	6.5	80.1	451.6	2.6	6.4	156.3	1074.6	10.8	12.1	21.6	0.0	2.5	3.4	15.1	6.4	107.3	59.0	1.5	7.5	3.1	139.8	380.4
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99705036-99735196	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 304.9"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 85.8;Hepatocytes: 60.5"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.3;Hep G2: 2.5;HHSteC: 1.4"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"	0.2	0.9	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.2	0.5	0.3	0.3	0.1	0.0	6.5	0.0	0.0	0.1	8.5	304.9	2.4	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.1	0.0	0.2	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.1	85.8	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.3	60.5	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	3.8	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	1.3	0.0	0.2
CYP3A7-CYP3A51P		ENSG00000282301	"CYP3A7-CYP3A51P readthrough"		7	99684957-99735102	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	8	"liver: 12.7"	"Group enriched"	"Detected in some"	10	"Cholangiocytes: 4.3;Hepatocytes: 2.2"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Vesicles	"HPA072245: , HPA075539: "																		0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	1.1	0.1	0.0	0.0	1.5	12.7	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DBF4B	"ASKL1, chifb, DRF1, FLJ13087, ZDBF1B"	ENSG00000161692	"DBF4 zinc finger B"	Q8NFT6	17	44708608-44752264	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Horizontal cells: 30.3;Oligodendrocytes: 30.9;Spermatocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA048465, HPA077959"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA048465: AB_2680405, HPA077959: "	"unprognostic (2.44e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.53e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.39e-1)"	0.9	0.7	1.1	1.2	1.1	2.0	1.3	1.2	1.8	1.5	0.5	1.9	0.6	1.9	3.5	1.4	1.8	0.7	0.8	1.1	1.0	1.6	0.6	0.8	1.5	1.1	1.0	1.7	0.9	0.8	1.7	0.9	1.1	2.3	1.2	2.9	1.1	1.3	0.6	2.0	1.5	1.5	0.8	1.6	1.3	5.1	1.2	1.9	2.7	0.4	1.3	1.6	1.3	1.2	3.7	7.7	5.7	4.2	0.5	1.1	4.9	3.9	1.7	8.1	7.9	3.3	3.1	5.5	2.1	1.3	7.2	3.6	5.0	1.7	9.3	9.2	8.2	7.0	6.2	4.3	0.2	4.8	5.9	0.5	0.6	4.4	1.4	1.8	4.1	9.3	8.9	5.6	4.4	4.0	7.1	2.9	2.5	7.7	4.0	6.2	6.6	2.3	1.8	2.2	3.1	3.4	3.8	1.2	2.9	6.1	3.9	3.1	1.8	2.8	5.2	3.6	7.2	2.6	3.5	7.2	2.1	4.1	4.3	0.0	0.1	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.1	1.1	1.1	1.2	1.8	1.1	1.0	1.1	1.0	1.1	0.8	1.2	1.2	2.1	0.0	1.1	15.0	4.0	0.6	2.6	1.2	1.2	30.0	1.5	1.3	1.1	0.0	2.1	5.5	12.5	4.2	5.8	0.6	0.0	0.3	8.1	2.0	2.2	2.8	4.2	5.5	11.4	0.8	1.4	2.3	1.5	1.1	3.8	9.6	3.3	0.3	1.4	30.3	11.0	0.3	0.0	1.3	3.1	7.4	1.2	2.5	5.4	5.6	1.4	7.2	2.1	7.5	30.9	0.2	0.2	3.0	3.4	2.0	0.7	0.5	1.9	15.7	0.0	4.5	2.0	35.7	16.5	1.9	0.1	1.4	1.4	5.3	1.1	2.3
DERL3	"C22orf14, derlin-3, FLJ43842, IZP6, MGC71803"	ENSG00000099958	"Derlin 3"	Q96Q80	22	23834503-23839128	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.6;pancreas: 60.8;salivary gland: 51.1"	"Cell type enriched"	"Detected in many"	6	"Plasma cells: 1428.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"plasmacytoid DC: 187.4"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 187.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 26.9;RPMI-8226: 23.6;U-266/70: 48.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB037234, HPA049306"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB037234: AB_1840802, HPA049306: "	"unprognostic (2.01e-3)"	"prognostic favorable (8.70e-5)"	"unprognostic (9.72e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.77e-3)"	"prognostic favorable (8.01e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.76e-13)"	"unprognostic (1.53e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-1)"	2.6	3.2	1.4	4.3	1.4	1.8	5.4	1.3	2.2	6.1	1.9	30.6	10.0	3.7	0.2	4.3	7.1	2.3	7.7	1.3	1.6	5.7	9.1	9.2	9.2	1.8	2.2	2.0	60.8	0.8	8.1	0.8	1.7	3.3	10.9	0.2	51.1	3.8	2.7	0.8	33.7	0.7	1.7	61.6	29.4	24.8	1.7	1.6	14.6	0.2	17.6	3.6	2.3	1.5	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.5	4.8	0.9	0.0	1.4	0.0	1.1	1.3	0.0	0.5	4.8	0.4	4.6	0.0	0.7	3.2	0.6	0.0	0.2	0.5	0.0	0.1	0.1	0.5	0.8	26.9	0.0	0.0	1.3	2.2	1.0	2.3	0.3	4.2	0.0	23.6	0.9	0.3	0.6	0.1	0.1	0.0	0.2	0.7	0.0	1.5	0.0	0.0	0.0	0.4	0.1	48.5	6.3	8.3	0.8	6.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	13.8	0.0	0.0	0.0	12.4	0.1	0.0	0.1	0.0	0.0	187.4	0.0	1.3	1.4	1.4	1.3	2.2	1.3	1.6	1.8	2.2	1.7	1.7	1.7	1.5	0.5	0.0	1.1	0.3	183.8	1.8	1.5	3.7	0.6	1.1	19.3	1.8	3.5	1.5	4.1	0.0	2.1	0.8	141.7	2.7	0.0	0.5	113.2	33.8	0.9	1.1	1.8	8.2	0.3	5.8	6.2	2.2	7.7	1.7	2.5	15.7	4.6	7.8	3.4	0.0	1.7	7.9	4.1	2.2	2.1	158.2	2.5	5.4	224.1	1.9	0.5	0.8	0.0	1.0	0.5	1.1	0.5	4.1	1428.8	2.5	0.8	0.5	30.3	0.6	0.0	0.8	2.6	67.0	32.9	1.3	2.0	15.5	17.9	2.1	10.7	2.0
DLC1	"ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12"	ENSG00000164741	"DLC1 Rho GTPase activating protein"	Q96QB1	8	13083361-13604610	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 250.0;Alveolar cells type 2: 225.9;Excitatory neurons: 208.8;Microglial cells: 317.6;Oligodendrocyte precursor cells: 244.3;Oligodendrocytes: 707.2;Sertoli cells: 223.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 4.3;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	19	"granulocytes: 4.3;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 83.2;U-2197: 98.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017753	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA017753: AB_10600805"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.79e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.67e-1)"	52.5	10.6	17.8	8.8	28.7	2.6	29.6	21.8	18.2	13.5	4.8	19.6	5.6	16.1	5.3	6.3	14.7	19.1	21.5	22.9	21.3	13.7	20.4	42.9	3.8	27.8	23.5	9.5	9.0	6.1	5.3	24.2	29.0	6.7	6.2	1.5	5.6	4.2	7.2	7.1	11.5	19.1	18.8	16.4	13.6	4.0	22.5	2.1	15.7	10.3	1.8	15.4	11.1	38.0	0.1	0.7	6.6	0.0	69.4	35.5	20.3	39.3	33.7	40.7	48.6	11.5	6.6	0.0	9.7	51.4	39.4	6.6	4.3	7.4	83.2	0.0	7.2	39.5	0.1	21.7	31.8	0.0	13.7	36.6	0.6	62.6	46.7	43.3	46.7	0.1	2.7	0.0	33.6	0.8	0.0	0.0	0.7	1.4	4.7	0.0	0.0	0.0	19.7	24.4	0.0	2.9	0.0	1.1	31.8	27.4	0.0	0.0	61.7	45.5	18.8	98.7	15.3	0.1	0.0	0.0	31.6	0.3	63.4	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	17.8	28.7	21.8	18.2	22.9	21.3	27.8	23.5	29.0	18.8	22.5	38.0	171.7	250.0	225.9	177.3	2.3	14.8	2.5	4.8	5.2	0.9	9.3	8.3	37.8	24.3	19.7	3.7	0.0	7.8	0.6	0.4	1.9	3.1	8.4	15.3	36.1	138.4	1.2	25.2	208.8	4.4	2.3	74.2	4.6	27.3	68.2	0.1	193.1	25.7	3.6	13.5	151.8	1.2	0.0	18.6	17.0	4.3	72.4	6.2	24.9	317.6	0.2	1.0	0.0	244.3	707.2	3.0	1.3	36.1	1.9	1.4	6.1	1.9	3.0	1.9	223.5	50.0	138.0	6.2	11.4	1.8	9.2	2.7	3.6	31.1	2.9	1.7
DLG1	"dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97"	ENSG00000075711	"Discs large MAGUK scaffold protein 1"	Q12959	3	197042560-197299330	"Predicted intracellular proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 422.9;Oligodendrocytes: 1542.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016307, HPA069593"	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	"Plasma membrane"	"CAB016307: AB_2092015, HPA069593: "	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.56e-3)"	"unprognostic (3.54e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-1)"	20.7	14.5	26.4	14.7	57.0	16.2	18.4	33.2	36.4	23.8	15.4	24.2	24.0	19.7	11.6	37.6	16.1	17.1	19.4	25.4	29.3	27.6	25.9	18.0	14.7	36.9	43.3	23.3	17.2	31.7	14.4	21.3	34.8	15.9	26.3	38.8	20.2	18.6	25.2	18.8	25.4	21.2	19.9	13.0	22.9	15.5	50.3	27.1	43.3	28.2	20.6	20.3	20.5	73.5	128.0	20.0	40.3	75.7	34.2	36.2	40.7	52.2	46.2	49.2	59.0	60.4	59.8	41.5	127.1	47.7	95.7	86.4	39.3	76.4	97.7	10.9	22.5	35.2	31.1	40.5	35.2	35.0	33.3	27.8	43.3	49.1	101.3	163.1	64.8	32.2	26.7	51.4	125.6	41.5	51.3	12.9	35.3	71.1	35.4	26.7	51.6	26.8	51.9	55.3	19.7	32.3	72.9	49.5	49.4	46.7	108.8	26.0	62.5	127.5	33.5	36.1	79.9	76.0	50.6	50.6	50.3	51.8	40.0	2.5	0.7	1.2	0.8	0.7	1.3	1.6	1.3	0.9	0.8	1.2	1.3	1.3	2.4	1.1	0.4	1.1	1.0	0.8	26.4	57.0	33.2	36.4	25.4	29.3	36.9	43.3	34.8	19.9	50.3	73.5	24.0	25.6	25.7	113.3	28.5	53.3	52.3	45.5	40.5	42.0	29.6	23.0	25.6	35.8	44.6	49.7	95.9	48.9	25.2	72.4	5.9	22.8	12.9	51.8	37.4	28.1	28.9	17.5	422.9	20.2	19.5	27.7	51.5	68.5	12.0	29.9	27.8	54.6	14.9	37.0	117.8	34.4	28.5	26.4	26.0	19.2	28.6	19.2	37.4	165.8	18.3	71.9	43.3	257.3	1542.2	30.3	48.0	25.6	34.1	52.3	50.6	20.8	66.3	101.7	13.1	40.5	25.5	31.2	37.9	66.7	70.8	25.0	30.6	29.3	38.8	106.8
DLX1		ENSG00000144355	"Distal-less homeobox 1"	P56177	2	172084740-172089677	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 18.8"	"Cell type enriched"	"Detected in some"	23	"Inhibitory neurons: 30.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 18.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 134.5;U-138 MG: 36.9;WM-115: 42.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 28.6;olfactory bulb: 82.6"	"Region enriched"	"Detected in many"	4	"olfactory bulb: 48.8"	"HPA007175, HPA045884"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA007175: , HPA045884: AB_10960361"	"unprognostic (2.14e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.92e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.40e-9)"	"unprognostic (2.22e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.91e-3)"	0.1	1.3	5.9	0.2	4.8	0.0	0.1	0.0	4.4	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.5	18.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.0	3.5	0.0	1.0	0.1	0.3	0.1	0.2	2.7	2.4	0.6	0.6	134.5	2.0	4.5	0.3	3.2	6.5	7.7	4.1	1.0	0.2	0.0	7.8	7.2	7.5	9.4	7.4	1.2	5.2	0.3	33.3	21.1	14.4	5.7	0.1	7.9	15.9	0.0	2.2	1.9	3.2	5.4	0.0	6.7	12.4	0.0	6.3	8.1	0.1	1.9	0.1	0.0	22.9	0.4	15.8	0.0	0.9	4.5	11.3	0.0	6.1	0.8	17.5	0.4	5.2	9.5	7.1	36.9	0.2	16.4	16.4	0.2	0.0	0.1	15.2	21.4	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	4.8	0.0	4.4	3.5	18.8	0.0	0.2	0.0	0.0	3.5	2.7	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMRT2		ENSG00000173253	"Doublesex and mab-3 related transcription factor 2"	Q9Y5R5	9	1049858-1057552	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.2;lymphoid tissue: 20.9;parathyroid gland: 46.4"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 115.4;Ionocytes: 46.8;Skeletal myocytes: 22.7"	"Group enriched"	"Detected in many"	4	"lung cancer: 3.0;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;RH-30: 5.0;RPMI-8226: 19.4;SK-MEL-30: 5.2;THP-1: 3.6;WM-115: 3.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	"HPA003498, HPA029297"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Vesicles,Centriolar satellite"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Vesicles, Centriolar satellite"	"HPA003498: , HPA029297: AB_10600905"	"unprognostic (5.67e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.93e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.27e-3)"	4.7	0.1	1.7	0.1	3.4	0.0	5.3	3.1	2.7	0.1	0.2	1.6	0.0	0.1	1.1	0.3	0.6	0.0	0.1	1.9	1.9	41.2	0.0	3.1	0.2	3.0	3.1	0.0	0.0	46.4	0.5	0.2	2.9	0.3	0.9	0.4	1.3	1.4	13.3	0.3	0.1	0.0	1.7	0.0	0.0	0.8	2.8	20.9	0.1	2.5	0.1	0.0	0.2	8.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.0	19.4	0.0	0.8	2.9	0.0	0.0	0.0	5.2	0.3	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.4	3.1	2.7	1.9	1.9	3.0	3.1	2.9	1.7	2.8	8.5	0.5	0.0	0.0	0.3	0.2	0.5	0.6	1.8	0.0	0.1	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.1	0.1	1.8	115.4	0.0	4.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	4.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.0	46.8	0.0	1.1	0.4	0.6	0.2	3.6	0.0	0.0	0.3	0.0	0.5	11.1	0.0	1.9	0.0	0.4	0.2	0.0	0.4	0.6	2.4	0.0	22.7	0.7	4.0	3.0	0.2	0.1	0.1	0.1	0.0	1.8	0.4
DNAJA3	"hTid-1, TID1"	ENSG00000103423	"DnaJ heat shock protein family (Hsp40) member A3"	Q96EY1	16	4425805-4456775	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016095, HPA040875, HPA044229"	Approved		Supported	Vesicles,Mitochondria		NA	NA		16000	"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Vesicles	"CAB016095: AB_668801, HPA040875: AB_2677183, HPA044229: AB_2678865"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (1.79e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-1)"	18.9	44.3	15.7	11.8	16.3	6.4	18.3	17.5	18.7	19.9	15.3	25.2	17.5	18.6	6.8	27.8	18.0	8.1	43.6	16.0	16.8	26.7	65.7	15.8	13.3	16.5	16.1	20.7	26.5	23.9	20.2	12.3	17.2	18.7	12.6	8.7	20.2	12.4	90.5	22.7	21.2	10.4	16.6	19.3	23.9	23.6	17.5	11.5	18.7	48.3	11.9	23.8	20.5	16.8	26.4	53.7	16.1	33.1	20.5	18.8	34.6	34.2	22.9	45.1	36.1	40.2	38.7	50.2	32.9	20.3	31.3	38.4	55.7	39.7	24.8	42.2	35.8	25.4	48.8	40.4	50.8	47.5	24.4	22.6	46.6	40.0	66.1	20.5	20.4	36.7	63.1	39.7	27.8	60.9	39.6	33.8	35.6	48.2	43.2	51.5	27.6	92.7	32.5	28.0	43.7	17.3	38.2	77.6	62.0	13.7	46.7	38.3	22.2	35.8	24.5	80.1	44.4	38.5	56.6	69.7	17.9	45.0	39.8	1.4	5.3	3.2	10.3	8.7	12.4	12.1	9.6	9.8	7.6	10.0	12.9	10.4	0.8	11.1	6.9	5.4	10.8	10.5	15.7	16.3	17.5	18.7	16.0	16.8	16.5	16.1	17.2	16.6	17.5	16.8	10.9	12.8	8.1	11.4	23.7	15.7	18.5	12.6	25.0	23.0	14.8	10.8	36.3	14.3	13.0	25.8	10.4	42.8	8.2	17.9	45.0	21.8	62.6	8.9	13.5	13.3	17.5	18.7	19.4	12.2	34.3	13.6	18.8	10.0	12.7	17.9	8.9	46.1	16.6	23.5	20.4	17.5	16.2	10.1	7.0	30.5	19.3	10.0	21.4	6.5	15.2	18.5	16.5	10.6	15.2	13.9	15.5	22.2	19.9	28.9	21.5	25.9	9.2	23.2	13.1	14.2	14.2	50.5	33.7	23.5	16.9	28.5	17.5	29.8	32.7	16.7
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427598-15450635	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.1"	"Group enriched"	"Detected in all"	6	"Early spermatids: 268.7;Late spermatids: 389.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 137.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	12.9	9.0	9.2	10.5	8.9	57.1	9.1	7.2	9.4	7.2	7.7	9.0	10.6	7.9	7.6	9.8	7.0	10.4	5.1	10.3	11.1	11.2	19.0	8.3	10.7	9.6	10.3	5.6	9.8	11.8	8.6	10.2	12.3	10.0	9.9	7.7	6.9	6.8	5.3	10.7	10.0	8.3	7.8	9.8	11.4	7.3	10.6	10.6	10.5	5.8	11.1	11.5	5.8	7.9	10.3	16.6	17.1	17.6	9.8	8.3	137.4	14.7	10.5	16.7	16.3	22.7	11.4	28.7	9.3	10.9	10.9	8.6	22.5	13.2	19.2	23.6	16.2	24.8	14.5	20.8	22.1	23.6	19.2	11.0	22.8	24.3	16.2	12.8	16.8	23.1	26.9	20.6	14.1	21.2	23.6	13.2	30.7	19.3	16.9	21.3	14.2	16.0	14.5	17.8	17.6	30.6	18.2	16.7	17.6	21.9	25.2	18.5	16.6	17.5	12.8	15.6	21.8	27.1	58.3	29.7	17.0	27.7	21.1	8.0	7.1	4.6	11.1	5.4	14.3	4.9	9.1	8.7	4.2	3.6	5.4	8.7	6.5	8.1	6.9	9.8	10.9	4.4	9.2	8.9	7.2	9.4	10.3	11.1	9.6	10.3	12.3	7.8	10.6	7.9	11.5	9.6	17.3	6.8	14.2	46.9	9.1	6.0	14.2	8.1	15.8	7.7	4.8	15.7	9.0	12.9	6.2	8.0	29.1	15.5	9.8	8.6	268.7	10.8	16.0	11.8	34.3	7.8	16.4	8.2	14.6	13.9	16.3	14.1	10.2	9.9	12.1	30.4	15.8	21.9	14.0	12.5	12.2	30.7	31.6	389.5	11.5	37.6	23.2	3.7	19.4	5.5	22.6	5.5	10.7	15.6	10.3	12.0	12.2	16.1	16.0	29.7	8.6	6.4	26.3	13.6	11.0	21.5	11.6	17.7	54.3	35.8	22.0	4.3	12.8	19.9
EEF2KMT	"EFM3, FAM86A, MGC19636, SB153"	ENSG00000118894	"Eukaryotic elongation factor 2 lysine methyltransferase"	Q96G04	16	5084284-5097795	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 189.0;Late spermatids: 393.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 104.8"	"Low region specificity"	"Detected in all"							HPA041610	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA041610: AB_2677581"	"unprognostic (4.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.70e-2)"	"prognostic unfavorable (8.85e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (2.35e-4)"	4.6	5.9	3.2	4.0	3.2	1.1	4.9	2.9	3.4	5.0	3.3	5.0	5.1	6.6	2.7	6.0	4.9	2.8	5.7	2.7	3.4	6.8	8.2	3.7	4.5	3.4	3.5	3.7	6.8	5.8	5.0	2.3	3.4	4.8	3.5	1.1	5.4	4.3	8.5	4.3	4.1	5.2	2.9	4.7	5.3	10.6	3.9	2.4	4.9	3.4	3.5	6.0	4.5	2.9	6.3	20.1	8.9	16.5	9.2	7.3	11.3	11.8	6.7	11.6	7.3	15.1	18.2	17.9	7.6	12.2	15.1	13.5	14.5	14.6	8.5	18.7	15.3	7.7	8.6	25.5	11.5	16.4	9.5	8.4	10.9	13.5	23.6	5.4	11.6	21.3	13.8	16.1	9.6	42.0	7.7	9.8	16.3	33.7	13.6	17.9	9.9	104.8	12.6	8.1	11.0	9.2	14.4	20.0	8.6	6.9	14.0	5.7	7.1	18.7	12.6	59.8	12.3	10.3	13.8	11.8	5.4	12.9	18.3	10.1	7.2	0.7	10.7	13.7	15.8	12.8	10.4	11.6	9.7	9.5	7.9	11.9	0.9	10.5	17.2	2.8	17.8	8.3	3.2	3.2	2.9	3.4	2.7	3.4	3.4	3.5	3.4	2.9	3.9	2.9	7.2	3.2	3.7	0.3	8.6	0.0	9.1	0.0	8.0	2.6	9.7	11.4	1.1	7.2	2.5	5.5	0.0	6.0	3.6	1.8	31.3	18.5	189.0	6.8	14.7	7.3	3.6	3.8	0.7	18.3	12.5	6.0	6.1	4.2	1.3	9.9	6.4	9.9	14.6	6.7	0.9	4.6	0.0	4.1	0.0	393.3	7.8	5.8	0.0	1.9	5.7	7.3	6.2	0.5	1.5	17.0	2.9	3.8	10.2	23.4	3.4	19.6	7.3	2.8	0.0	5.3	6.4	5.8	16.8	12.8	0.0	4.1	5.9	16.2	5.3	8.5
EGR3	PILOT	ENSG00000179388	"Early growth response 3"	Q06889	8	22687659-22693480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2;skin 1: 45.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 284.3;Glandular and luminal cells: 116.6;granulocytes: 108.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 47.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.5;HMC-1: 9.5;MCF7: 31.9;SK-MEL-30: 22.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"amygdala: 19.3;basal ganglia: 52.5;cerebral cortex: 47.8;hippocampal formation: 41.3;olfactory bulb: 33.7"	"HPA006206, CAB009373"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB009373: AB_2097202, HPA006206: AB_10602491"	"prognostic favorable (1.83e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.44e-2)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.48e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.07e-2)"	29.0	24.5	7.7	19.0	9.9	10.1	10.3	0.6	47.2	9.5	0.0	4.6	1.5	5.6	0.4	5.9	17.3	30.0	12.1	16.1	0.0	5.8	2.9	5.8	11.4	5.1	0.0	15.3	4.5	13.8	6.8	1.0	2.0	14.4	3.2	4.5	3.1	0.9	1.9	45.6	3.9	12.5	1.3	3.3	6.5	5.4	0.0	19.5	8.4	3.2	5.9	14.8	3.6	5.8	0.2	0.0	0.2	0.3	1.8	5.5	0.1	0.6	0.6	0.0	0.1	0.1	0.0	0.1	0.1	1.3	0.4	0.5	0.2	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.5	0.6	0.2	0.2	0.0	0.8	0.1	0.2	0.3	0.1	0.0	31.9	0.0	0.2	0.1	2.2	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.1	0.5	0.0	22.5	0.3	1.4	0.1	0.0	0.3	0.1	0.2	0.4	0.4	0.1	0.0	0.9	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	9.9	0.6	47.2	16.1	0.0	5.1	0.0	2.0	1.3	0.0	5.8	80.2	6.4	11.2	0.3	46.7	23.1	31.9	43.8	39.3	2.3	73.0	68.2	47.1	0.0	12.2	0.0	0.0	1.3	9.3	3.5	0.0	3.3	18.4	47.1	52.7	36.5	284.3	0.0	16.0	4.2	1.3	33.9	35.2	116.6	108.7	21.8	37.5	0.5	4.7	0.0	0.9	19.2	8.2	19.0	20.3	11.6	3.1	27.8	21.4	3.7	0.0	5.1	0.0	1.0	0.7	4.5	2.2	0.4	3.7	16.1	0.2	0.1	5.7	1.3	0.0	41.3	35.9	0.3	0.2	16.5	50.0	9.7	11.5	6.5	7.0	9.8
EIF1AD	"haponin, MGC11102"	ENSG00000175376	"Eukaryotic translation initiation factor 1A domain containing"	Q8N9N8	11	65996545-66002176	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054991, HPA058735"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Vesicles"	Cytosol	"HPA054991: AB_2682664, HPA058735: AB_2683802"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (1.30e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.96e-1)"	15.7	17.7	15.3	19.9	15.8	44.6	16.0	18.7	19.8	13.1	14.4	15.8	15.1	15.9	16.2	21.0	15.3	13.0	17.1	16.4	17.7	15.2	17.3	15.0	23.4	16.1	15.7	20.4	19.2	17.1	16.6	21.1	16.3	13.4	14.7	16.6	16.8	14.9	27.2	23.1	16.9	14.8	14.8	20.0	16.1	19.4	17.3	19.9	13.8	23.3	27.6	17.1	14.5	18.4	51.0	43.9	35.0	35.9	27.6	28.8	32.8	36.4	34.6	44.2	37.7	44.8	47.5	38.2	62.6	41.2	38.0	34.9	42.2	48.8	41.5	35.1	21.7	54.4	52.0	46.4	33.7	50.3	41.8	24.1	41.9	65.3	44.1	31.2	31.0	40.9	81.1	54.4	64.7	68.7	46.6	55.1	25.9	23.3	47.5	50.3	35.9	75.0	25.6	31.8	26.5	31.2	39.3	54.7	41.5	28.1	53.1	31.0	36.5	59.7	39.9	47.8	36.1	66.7	85.5	79.8	42.9	33.8	39.5	52.6	20.5	13.5	17.7	16.6	13.6	19.4	15.0	13.0	21.3	19.0	14.1	13.5	13.1	16.4	21.3	12.7	15.3	13.3	15.3	15.8	18.7	19.8	16.4	17.7	16.1	15.7	16.3	14.8	17.3	18.4	8.2	3.2	5.4	3.3	16.2	37.7	12.2	13.4	12.5	7.2	14.2	9.1	16.2	14.3	7.3	5.5	14.6	16.3	17.7	11.6	15.6	12.7	18.3	9.0	8.3	11.6	2.4	21.0	3.0	13.1	23.0	11.4	7.1	10.5	12.7	31.7	16.4	16.5	24.5	11.8	2.8	11.2	6.1	10.4	29.5	14.3	12.2	14.4	12.4	1.0	17.6	10.5	17.5	5.5	4.5	29.0	15.2	5.7	22.6	13.2	13.8	15.7	10.6	18.5	6.6	9.8	27.0	31.3	23.2	15.7	48.9	25.3	16.2	7.4	10.9	13.2
EPC1	Epl1	ENSG00000120616	"Enhancer of polycomb homolog 1"	Q9H2F5	10	32267751-32378798	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 149.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028931			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"HPA028931: "	"unprognostic (6.94e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.93e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.80e-2)"	"unprognostic (3.83e-3)"	"unprognostic (7.43e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-3)"	14.4	9.6	12.5	13.9	13.7	149.7	19.4	21.2	14.5	17.5	12.0	15.9	11.5	20.6	15.8	11.1	14.8	12.8	11.9	12.4	12.0	11.9	13.8	14.7	21.5	12.4	12.7	23.4	14.4	14.6	10.3	11.7	13.0	15.0	16.1	19.3	15.0	10.3	22.7	13.8	12.9	16.8	12.5	18.6	13.9	14.4	12.4	31.9	16.8	23.4	17.6	15.2	14.1	16.2	12.0	9.6	21.4	17.9	10.6	14.1	12.4	12.2	6.9	15.6	12.8	10.7	15.1	21.8	8.0	13.6	8.2	12.1	12.1	10.4	10.8	15.9	19.4	18.0	13.5	19.2	11.4	14.1	24.7	12.9	15.8	9.3	7.3	13.9	12.8	18.3	18.8	27.7	12.6	12.9	21.5	10.1	5.3	11.4	8.4	27.7	18.3	11.2	12.1	10.9	18.7	17.8	11.4	8.3	20.1	11.8	8.6	18.7	11.6	9.3	22.7	7.8	10.6	11.3	12.2	35.6	10.0	21.1	8.4	65.8	15.3	36.3	18.9	10.2	16.0	27.4	16.9	15.0	9.1	30.9	17.5	16.1	46.8	13.4	13.2	27.4	21.1	7.7	12.5	13.7	21.2	14.5	12.4	12.0	12.4	12.7	13.0	12.5	12.4	16.2	103.8	41.7	50.9	133.2	166.8	28.6	85.0	54.0	78.6	101.4	69.6	84.3	32.4	52.9	49.2	40.5	68.8	34.9	182.6	55.5	9.8	51.5	11.8	54.1	86.7	70.1	98.6	74.9	108.0	43.6	40.7	71.8	58.1	65.8	85.4	74.9	58.5	35.8	35.2	114.4	106.7	63.9	50.8	55.7	46.8	13.1	94.8	84.4	40.9	134.0	75.4	57.3	148.3	161.9	131.8	49.9	52.3	68.1	139.4	71.6	50.4	20.5	44.1	85.8	98.6	134.9	82.5	77.8	58.3	62.9	24.9	46.1	175.3	56.5	51.0	72.4
ESR2	"ER-beta, Erb, NR3A2"	ENSG00000140009	"Estrogen receptor 2"	Q92731	14	64084232-64338112	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 6.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.4;Granulosa cells: 26.6;Late spermatids: 93.7;Rod photoreceptor cells: 35.6;Spermatocytes: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.2;U-266/70: 9.8;U-698: 16.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 6.1"	"HPA068406, CAB079300"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Vesicles	"CAB079300: , HPA068406: "	"unprognostic (7.63e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.27e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.89e-2)"	1.5	6.1	1.2	1.2	0.6	1.0	0.9	3.0	0.8	1.4	3.5	0.9	1.0	1.2	0.4	0.7	1.0	0.5	0.6	0.5	0.9	1.5	0.7	0.6	2.1	0.7	0.6	5.4	2.1	0.1	0.8	0.2	1.0	1.5	1.0	2.0	0.8	0.2	1.4	1.0	1.3	0.3	0.3	1.8	1.0	5.7	1.7	2.5	0.6	0.2	1.6	1.1	0.6	0.9	0.8	0.4	0.7	0.6	0.0	0.1	1.5	0.2	0.0	0.1	0.1	0.3	0.9	3.1	0.1	0.1	0.4	1.0	0.8	0.0	0.1	0.7	0.4	0.3	1.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.3	1.1	0.5	4.2	0.2	0.8	0.5	0.2	0.7	0.6	0.4	0.5	0.4	0.3	0.1	1.3	2.2	0.6	0.4	0.2	1.1	0.4	0.7	0.1	0.5	0.4	1.0	0.2	0.1	9.8	3.1	16.4	0.2	0.1	0.8	0.3	0.1	0.5	0.3	0.2	0.2	0.5	0.2	0.4	0.0	0.7	0.4	0.3	0.6	0.2	0.3	1.1	0.2	0.1	1.2	0.6	3.0	0.8	0.5	0.9	0.7	0.6	1.0	0.3	1.7	0.9	0.9	6.4	0.0	6.8	5.5	0.3	2.2	0.4	2.8	1.6	0.3	0.1	0.9	4.3	0.9	0.0	6.2	0.7	5.2	0.1	0.0	0.3	61.4	3.5	0.9	3.0	0.0	0.4	12.4	0.7	0.5	2.2	0.0	4.9	1.3	26.6	1.1	0.1	0.1	0.0	17.9	0.8	0.0	0.0	0.3	93.7	0.9	0.2	1.8	7.5	0.1	0.9	6.2	10.6	7.6	0.5	0.1	1.2	16.6	3.8	0.4	0.1	1.7	35.6	0.0	1.5	1.4	28.0	1.4	0.5	0.1	1.1	3.0	16.4	0.8	1.8
FAAP24	"C19orf40, FLJ46828, MGC32020"	ENSG00000131944	"FA core complex associated protein 24"	Q9BTP7	19	32972209-32978229	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 14.6;Spermatocytes: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041168	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"HPA041168: AB_10960496"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (6.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (4.00e-7)"	"unprognostic (4.37e-3)"	"unprognostic (5.30e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.15e-1)"	1.7	1.4	0.8	2.6	0.7	3.5	1.8	1.2	1.1	1.0	1.1	1.7	1.8	1.3	2.4	1.8	1.4	2.3	0.7	0.8	0.6	1.2	1.4	1.4	3.1	1.4	0.6	2.5	0.9	0.4	0.8	1.6	1.0	4.8	2.5	0.5	1.2	1.1	0.5	2.8	2.2	1.5	0.4	2.4	1.4	6.2	0.9	2.6	1.8	0.2	3.5	1.5	1.2	2.2	6.0	15.0	5.7	9.3	3.2	6.3	4.9	7.7	8.2	14.5	18.8	10.3	9.7	7.0	11.2	3.2	11.4	4.2	11.7	5.9	11.5	19.4	5.4	15.3	5.8	7.6	1.7	5.2	7.5	3.5	3.5	9.0	5.3	2.3	5.9	11.2	8.2	7.1	11.1	6.7	11.6	7.1	2.6	8.7	6.7	10.2	5.1	3.9	2.9	3.6	5.9	4.9	8.7	9.9	6.1	6.2	6.6	13.7	3.5	14.2	6.6	6.2	7.2	5.5	12.4	9.6	10.1	11.9	9.6	15.3	5.7	8.8	3.2	6.9	3.8	6.4	4.0	4.9	3.6	6.2	3.6	5.2	13.9	7.1	7.8	6.9	5.6	3.2	0.8	0.7	1.2	1.1	0.8	0.6	1.4	0.6	1.0	0.4	0.9	2.2	1.7	3.2	1.1	0.0	3.0	0.0	3.3	0.0	1.8	1.5	3.9	3.6	0.5	2.8	1.3	3.7	2.1	11.1	6.5	1.2	1.9	1.6	7.2	4.4	3.0	2.1	1.2	7.4	0.0	8.0	14.6	3.1	0.5	6.3	1.3	7.1	3.6	0.4	8.2	5.0	0.0	2.4	0.0	5.1	0.0	12.3	3.4	3.5	0.0	0.0	7.0	0.6	2.1	0.0	0.0	4.2	2.4	3.4	2.6	3.2	3.5	1.0	0.0	1.0	0.0	2.7	2.2	22.6	8.3	2.7	0.0	5.1	2.5	5.8	2.7	2.6
FAM110A	"bA371L19.3, C20orf55"	ENSG00000125898	"Family with sequence similarity 110 member A"	Q9BQ89	20	833715-857463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 71.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 71.7;Extravillous trophoblasts: 138.2;Langerhans cells: 74.2;Macrophages: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 543.5;eosinophil: 163.4;intermediate monocyte: 160.6;non-classical monocyte: 248.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 543.5;monocytes: 248.6"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 84.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034110, HPA069240"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol		Yes	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB034110: AB_1562838, HPA069240: AB_2686103"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (9.64e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.42e-3)"	"unprognostic (4.21e-3)"	4.2	5.5	4.2	5.9	5.2	8.8	9.0	3.1	3.6	10.1	3.9	5.5	10.0	2.5	4.7	39.3	2.5	2.3	4.0	2.8	3.4	8.8	3.6	12.3	6.7	5.5	5.3	2.8	5.5	11.0	7.9	6.6	5.6	19.3	3.2	1.2	18.4	3.6	4.0	71.2	9.7	1.1	3.3	23.4	6.1	3.7	6.6	6.9	7.6	0.6	7.8	9.2	18.4	3.6	27.7	7.3	4.1	7.6	4.4	1.9	27.8	8.5	4.7	5.3	4.7	16.0	16.9	8.9	3.7	5.3	7.6	43.7	3.3	22.2	4.4	7.3	2.3	18.6	4.9	4.2	2.0	5.1	6.3	1.2	27.1	7.3	7.1	1.6	3.6	8.1	10.2	21.5	4.9	16.4	14.3	13.8	5.3	17.7	12.3	14.1	7.0	11.7	4.1	19.6	7.7	9.1	7.4	84.0	3.8	1.7	34.9	7.5	4.8	12.6	9.1	11.5	9.6	7.8	7.3	3.8	2.0	13.2	9.2	543.5	28.3	163.4	13.2	160.6	11.7	7.0	23.7	27.2	36.2	11.7	28.1	27.9	15.3	6.9	248.6	3.9	43.0	24.2	4.2	5.2	3.1	3.6	2.8	3.4	5.5	5.3	5.6	3.3	6.6	3.6	3.5	0.0	7.0	0.0	18.5	32.6	17.0	31.6	71.7	0.3	26.7	20.1	2.9	7.2	15.7	11.0	0.0	41.5	24.3	5.1	1.9	10.1	9.9	3.0	1.7	8.0	10.8	16.2	0.5	6.0	138.2	3.6	5.1	5.2	51.5	1.4	17.2	0.7	20.0	5.0	0.4	8.8	16.2	36.7	74.2	24.3	3.4	70.0	7.2	1.9	29.9	0.3	25.7	0.5	0.1	13.4	7.8	1.9	3.5	20.9	16.1	2.4	7.4	2.6	6.6	1.1	4.3	3.4	4.9	57.7	36.8	31.3	26.1	14.2	10.4	24.6
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 53.7;testis: 31.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.7;Early spermatids: 90.6;Granulosa cells: 167.2;Late spermatids: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.3;HEL: 38.6;HL-60: 38.7;NB-4: 60.7;THP-1: 53.5;U-937: 35.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	2.9	2.0	3.8	13.8	5.6	21.7	1.7	3.6	6.3	1.4	1.8	2.4	2.7	1.5	0.3	1.7	1.3	3.1	26.5	5.1	3.7	1.6	1.5	6.1	24.5	5.6	4.1	1.4	1.1	1.1	1.2	5.3	4.9	1.4	1.6	4.6	2.7	0.9	53.7	1.2	8.9	1.8	4.6	21.6	3.8	31.9	5.8	21.1	1.6	20.2	14.9	3.5	1.1	5.7	0.7	0.3	2.5	5.6	1.7	0.5	39.3	0.3	0.3	0.5	0.2	0.3	0.2	17.1	0.2	0.3	0.8	0.1	16.0	0.2	0.1	4.4	1.4	38.6	0.6	0.3	0.6	38.7	1.5	0.4	0.8	0.0	0.1	0.5	22.2	10.8	13.8	4.7	0.5	6.0	1.7	60.7	2.6	0.3	0.6	4.0	2.3	23.7	0.2	0.1	1.5	2.1	2.3	0.8	2.4	0.9	1.4	53.5	0.6	2.3	2.4	1.3	0.1	3.4	1.9	9.7	0.3	35.9	0.6	0.5	9.7	17.6	9.2	12.6	7.4	14.2	8.9	10.1	6.0	15.9	11.0	9.3	9.8	3.1	9.9	2.7	9.5	8.7	3.8	5.6	3.6	6.3	5.1	3.7	5.6	4.1	4.9	4.6	5.8	5.7	3.2	0.0	1.5	0.0	15.5	0.9	0.0	0.0	0.0	55.7	0.4	0.5	17.6	0.0	0.0	1.8	0.0	1.1	19.0	0.0	0.0	0.1	90.6	0.1	0.2	6.8	0.0	3.4	5.0	0.0	37.6	3.1	0.5	0.1	1.3	167.2	6.4	0.5	25.7	0.0	1.7	0.0	0.0	21.7	10.6	120.3	5.0	14.8	1.8	15.9	15.6	0.8	30.9	1.0	0.1	0.1	0.0	3.4	12.0	0.0	0.0	0.2	0.0	1.8	0.0	0.6	6.3	2.2	1.2	0.0	0.9	1.4	17.4	1.0	0.0	0.1
FAM86B1	MGC16279	ENSG00000186523	"Family with sequence similarity 86 member B1"	Q8N7N1	8	12182096-12194133	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 5.4;pituitary gland: 6.4"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 17.5;Proximal tubular cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.5"									"HPA041610, HPA055718"	Uncertain		Uncertain	Vesicles		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA041610: AB_2677581, HPA055718: AB_2682895"	"unprognostic (1.90e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.58e-2)"	0.5	0.7	0.9	0.4	2.2	0.5	1.0	0.2	5.4	2.2	0.0	1.4	0.8	2.3	0.4	0.6	2.4	0.5	0.9	2.6	0.1	1.1	0.3	0.8	0.3	2.0	0.0	3.7	0.9	0.4	6.4	0.1	0.1	2.4	0.0	1.7	0.8	0.3	0.8	1.0	0.6	0.1	0.0	0.6	0.7	0.5	0.5	0.1	1.3	0.0	0.0	1.2	1.5	0.0	0.2	1.2	0.0	2.5	0.0	0.4	1.0	2.0	0.2	0.6	0.3	0.7	0.5	0.5	0.1	0.1	0.7	2.2	0.4	0.7	0.2	0.2	0.3	0.1	0.3	0.3	1.1	0.9	0.9	0.1	0.2	0.2	1.7	0.4	0.1	0.9	0.8	0.7	0.0	1.1	0.0	0.6	0.8	0.7	0.2	0.7	0.5	0.1	0.1	0.6	2.1	0.4	0.2	0.2	0.3	0.2	1.0	0.0	0.0	0.4	0.4	1.8	0.5	0.2	0.6	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.2	0.2	5.4	2.6	0.1	2.0	0.0	0.1	0.0	0.5	0.0	1.2	3.2	1.8	0.7	0.9	1.1	3.1	1.0	3.4	2.1	4.7	5.0	0.5	8.6	3.0	1.8	2.1	1.5	0.4	0.8	5.9	5.1	5.8	4.7	2.3	1.6	4.2	1.3	0.3	1.8	1.6	2.6	1.5	1.5	1.3	17.5	2.5	1.3	1.9	1.7	0.3	1.5	0.0	1.3	0.6	6.2	1.8	0.7	3.6	0.0	0.1	2.7	4.1	0.0	0.1	3.5	0.3	2.6	0.1	7.0	0.8	10.3	8.5	1.7	0.0	3.3	2.1	0.9	0.8	3.8	1.3	1.1	0.8	2.3	2.4	1.8
FAM86B2		ENSG00000145002	"Family with sequence similarity 86 member B2"	P0C5J1	8	12425614-12436343	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.2;Early spermatids: 1.6;Granulosa cells: 2.7;Late spermatids: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTERT-HME1: 5.3;RPMI-8226: 12.5"									"HPA041610, HPA055718"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA041610: AB_2677581, HPA055718: AB_2682895"	"unprognostic (3.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.04e-4)"	"unprognostic (9.37e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.13e-2)"	0.3	0.4	0.1	0.1	0.2	0.0	0.4	0.1	0.3	0.6	0.1	0.3	0.1	0.5	0.0	0.9	1.4	0.1	0.1	0.2	0.2	0.5	0.3	0.3	0.0	0.2	0.3	0.6	0.6	0.4	1.0	0.0	0.1	0.4	0.1	0.1	0.3	0.4	0.1	0.3	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.0	0.9	0.0	0.0	0.4	0.4	0.1	0.2	0.6	0.1	0.0	0.2	1.1	1.3	0.2	0.6	0.4	1.0	0.4	1.1	0.7	0.0	1.2	0.3	0.2	0.9	1.5	0.0	0.0	0.0	0.2	0.9	0.0	1.0	0.0	0.0	0.3	1.3	1.3	5.3	0.0	0.0	0.0	1.1	0.2	0.0	0.3	0.0	0.3	1.0	1.9	0.4	0.1	0.1	12.5	0.0	0.9	1.6	0.0	0.4	1.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.1	0.3	0.2	0.2	0.2	0.3	0.1	0.0	0.2	0.1	0.1	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	2.7	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0
FCGR1A	"CD64, CD64A"	ENSG00000150337	"Fc fragment of IgG receptor Ia"	P12314	1	149782671-149791675	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 93.3;lymphoid tissue: 41.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 283.3;Kupffer cells: 140.9;Late spermatids: 64.9;Macrophages: 94.9"	"Cancer enriched"	"Detected in many"	4	"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 131.5;intermediate monocyte: 54.7;myeloid DC: 35.6;neutrophil: 93.4"	"Group enriched"	"Detected in many"	53	"dendritic cells: 35.6;granulocytes: 93.4;monocytes: 131.5"	"Cell line enriched"	"Detected in some"	5	"THP-1: 191.6"					"Low region specificity"	"Detected in all"			HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (5.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (4.83e-8)"	"unprognostic (1.28e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.03e-2)"	12.2	7.2	8.4	41.3	8.9	17.9	3.6	8.8	12.8	4.2	8.4	2.3	1.1	1.6	93.3	1.7	1.8	8.2	2.2	8.6	9.4	2.8	4.2	28.6	14.4	14.6	10.6	2.3	4.3	2.7	2.5	32.6	13.0	1.6	2.1	2.3	1.9	2.4	0.3	0.4	1.3	19.1	13.2	12.5	2.1	3.7	12.2	1.4	1.4	0.8	0.8	14.7	0.8	18.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	13.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.3	191.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	24.4	0.0	2.0	131.5	1.6	0.0	54.7	0.7	1.6	0.0	0.3	35.6	0.0	0.0	0.1	93.4	0.0	11.8	0.9	0.3	48.5	8.4	8.9	8.8	12.8	8.6	9.4	14.6	10.6	13.0	13.2	12.2	18.9	0.3	0.0	3.1	0.0	0.8	0.1	0.0	0.0	0.6	1.5	0.2	0.8	1.7	1.5	1.3	0.0	2.1	2.7	0.0	0.0	0.0	0.0	30.8	0.1	0.1	9.3	0.0	2.7	0.1	0.0	1.3	1.0	0.0	0.1	0.0	0.2	1.8	0.5	283.3	0.0	0.1	0.0	0.0	140.9	6.0	64.9	0.3	94.9	0.0	7.5	34.7	0.3	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.7	1.3	6.6	0.2	0.3	0.6	0.4	0.1	0.0	4.1	0.6	0.1	0.1	0.0
FCGR1B	CD64b	ENSG00000198019	"Fc fragment of IgG receptor Ib"	Q92637	1	121087345-121097161	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 51.5;lymphoid tissue: 18.9"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 86.5;Kupffer cells: 51.5;Late spermatids: 14.6;Macrophages: 36.6;monocytes: 16.4;Sertoli cells: 19.7"	"Cancer enriched"	"Detected in single"	4	"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 31.2;neutrophil: 36.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 36.3;monocytes: 31.2"	"Group enriched"	"Detected in some"	6	"NB-4: 19.8;THP-1: 73.9"									HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (3.21e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.24e-10)"	"unprognostic (8.99e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.93e-2)"	5.0	3.0	4.4	18.9	4.5	6.6	1.8	4.5	7.8	1.0	3.7	0.7	0.5	0.7	51.5	0.7	0.8	1.9	1.1	4.6	4.7	1.4	1.7	6.8	2.2	6.1	5.7	0.6	2.6	0.7	1.0	11.0	6.2	0.8	0.8	0.8	0.9	0.6	0.4	0.2	0.7	5.8	6.0	7.2	0.9	0.7	6.2	0.4	2.1	0.1	0.3	4.0	0.4	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.9	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	19.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.3	1.0	73.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	31.2	0.6	0.0	19.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	36.3	0.0	12.4	0.3	0.0	8.8	4.4	4.5	4.5	7.8	4.6	4.7	6.1	5.7	6.2	6.0	6.2	6.4	0.4	0.0	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.1	0.6	2.2	0.0	0.6	0.0	2.1	0.8	0.1	0.1	0.0	0.0	7.7	0.2	0.2	2.0	0.0	0.8	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.4	0.4	0.3	86.5	3.3	0.1	0.0	0.0	51.5	4.1	14.6	1.2	36.6	0.0	11.2	16.4	0.1	1.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	19.7	0.6	0.1	0.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.1
FOSB	"AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291"	ENSG00000125740	"FosB proto-oncogene, AP-1 transcription factor subunit"	P53539	19	45467995-45475179	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1627.1;Skeletal myocytes: 2234.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 45.6"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 11.4;HMC-1: 13.3;hTCEpi: 8.1;Karpas-707: 6.8;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010267, HPA054663"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB010267: AB_640583, HPA054663: AB_2682562"	"unprognostic (7.22e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.72e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.04e-2)"	394.7	121.6	2.1	118.4	5.5	433.8	91.7	35.7	45.6	150.3	4.8	37.6	24.8	46.6	3.9	187.7	404.1	347.1	48.9	11.1	7.8	34.7	85.5	113.5	67.7	1.5	1.6	274.4	126.3	46.2	27.3	57.8	1.5	118.5	78.4	10.7	76.8	29.6	3.3	267.8	63.1	353.7	0.8	21.8	104.4	8.8	1.2	152.2	316.0	81.3	1.6	213.9	11.0	3.8	0.4	0.6	0.1	0.3	1.2	0.3	1.8	2.3	1.0	0.7	0.7	0.5	1.0	2.0	0.4	1.5	11.4	0.8	0.5	1.6	0.5	0.3	0.7	0.6	0.8	0.4	0.8	1.1	13.3	0.5	8.1	1.7	1.9	0.4	0.9	2.3	0.8	6.8	0.2	0.2	0.2	1.2	0.4	1.0	0.4	0.5	0.1	1.4	0.6	1.3	3.1	0.4	1.4	9.6	1.2	1.9	0.5	0.8	0.1	0.5	0.6	1.1	0.7	5.1	0.8	0.5	1.1	0.8	1.3	0.9	1.2	1.0	0.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.1	2.1	5.5	35.7	45.6	11.1	7.8	1.5	1.6	1.5	0.8	1.2	3.8	1048.7	685.9	761.3	2.6	445.7	380.5	533.4	162.4	865.6	50.6	1627.1	1523.2	177.8	370.3	174.4	11.0	135.5	237.5	359.6	551.1	1.9	145.5	10.1	667.9	1204.4	442.6	877.0	68.6	1.3	74.2	301.9	788.2	911.3	1541.3	830.4	239.3	393.7	77.9	210.3	8.4	0.3	898.4	42.7	345.2	353.4	11.3	240.2	797.3	172.5	1.0	16.3	186.1	1.0	0.0	0.3	111.6	457.3	59.5	503.4	307.3	417.8	2.7	111.5	217.6	302.4	2234.0	608.8	3.3	4.5	476.3	380.9	396.9	481.8	174.2	616.5	208.5
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109734	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 44.0;salivary gland: 11.4"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 132.2"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"MCF7: 1.4;SuSa: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.5	0.1	0.0	0.1	3.0	0.0	0.0	11.4	1.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.5	0.2	0.0	0.0	7.6	6.5	0.3	0.0	0.3	1.8	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	132.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.0
FOXK2	"ILF, ILF1"	ENSG00000141568	"Forkhead box K2"	Q01167	17	82519713-82644662	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027523, HPA073491"	Approved		Supported	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Mitochondria"	"HPA027523: AB_10601013, HPA073491: "	"unprognostic (2.39e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	14.0	24.0	10.7	12.6	13.2	8.0	12.1	14.7	16.3	14.2	1.2	18.1	9.3	19.7	9.8	20.2	13.2	10.0	17.1	12.4	10.5	12.7	13.1	14.2	12.5	5.8	7.1	14.7	15.4	20.0	17.7	15.7	6.3	13.3	9.4	11.6	12.1	12.5	43.0	18.8	12.1	16.4	3.0	11.6	14.7	28.1	9.4	18.4	15.4	28.4	11.9	15.5	13.4	12.7	48.4	50.4	46.3	50.9	26.2	28.5	31.0	27.6	31.6	47.4	47.9	49.1	30.1	40.7	19.6	34.4	52.3	27.6	49.7	32.0	44.4	28.3	47.9	42.3	32.7	49.4	41.0	47.3	27.2	27.2	57.2	50.4	56.8	29.2	48.9	43.7	57.7	40.7	26.3	28.8	81.8	30.4	26.5	39.7	38.2	53.0	39.4	34.2	21.7	40.1	76.2	56.1	27.4	69.0	65.1	48.8	48.7	54.3	38.3	62.2	43.2	42.2	56.6	46.7	45.1	53.5	33.4	39.0	33.4	1.5	1.0	1.2	1.4	0.7	1.1	1.5	1.1	1.4	1.2	1.0	0.8	0.9	0.1	1.6	0.9	2.0	1.3	0.6	10.7	13.2	14.7	16.3	12.4	10.5	5.8	7.1	6.3	3.0	9.4	12.7	21.5	51.3	27.1	23.5	11.5	37.2	8.0	10.6	10.2	19.2	17.7	15.7	19.5	7.2	16.2	14.7	12.5	11.9	19.3	15.6	3.9	8.7	15.6	19.4	22.4	14.9	10.9	7.8	44.6	10.7	8.8	13.2	14.3	26.7	2.5	22.1	10.8	13.4	20.0	47.1	39.6	12.6	8.2	17.3	22.0	24.1	9.3	19.2	12.4	20.6	13.9	12.3	6.2	33.2	49.1	11.4	12.4	13.2	13.3	13.6	12.2	7.1	13.9	16.7	0.0	19.8	16.6	15.0	10.3	17.0	43.0	9.7	11.6	30.6	13.0	10.7
FOXN2	HTLF	ENSG00000170802	"Forkhead box N2"	P32314	2	48314637-48379295	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 54.0;brain: 53.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 152.3;Oligodendrocytes: 282.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003485	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA003485: AB_1078905"	"unprognostic (5.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.65e-3)"	"prognostic favorable (3.85e-4)"	"unprognostic (4.00e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (2.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.12e-2)"	17.9	5.5	13.3	15.4	30.3	54.0	8.0	25.3	19.0	7.7	4.2	7.7	8.3	6.7	4.2	9.3	5.5	9.7	8.6	13.9	16.3	6.6	19.8	9.5	19.4	24.1	21.0	5.9	8.9	9.5	3.0	13.4	21.9	5.0	8.0	3.4	5.5	4.2	4.8	3.6	10.3	9.8	20.0	18.1	7.9	6.3	19.2	14.9	6.9	6.4	17.1	10.6	3.9	53.3	13.1	19.5	22.2	19.6	17.2	12.7	24.3	14.4	15.8	11.9	13.2	17.3	15.9	28.4	18.7	17.0	14.5	16.2	13.7	16.5	17.2	22.3	11.7	56.1	13.3	17.4	30.0	30.9	42.1	11.4	6.9	12.9	22.3	9.6	12.8	11.6	26.6	32.7	19.5	10.1	34.4	20.3	16.8	9.8	10.2	17.0	46.5	23.2	10.2	16.5	12.4	12.6	6.9	13.2	24.9	7.5	5.7	18.0	15.0	16.0	16.1	15.2	15.2	17.8	14.2	40.5	13.9	27.5	22.2	120.9	32.4	129.6	24.0	26.2	27.4	21.2	23.1	22.4	33.6	20.6	17.2	17.7	40.8	25.7	36.4	20.8	28.8	17.2	13.3	30.3	25.3	19.0	13.9	16.3	24.1	21.0	21.9	20.0	19.2	53.3	22.1	0.0	7.4	66.6	31.3	15.6	27.5	10.0	15.4	6.7	5.4	5.6	11.1	14.3	6.1	1.8	0.0	6.7	28.3	7.0	5.9	6.0	4.8	8.9	17.2	21.8	2.4	22.5	28.1	5.4	32.1	13.3	14.3	13.3	22.8	1.2	20.7	19.7	17.9	13.5	25.2	8.0	8.2	39.5	47.3	4.7	12.2	44.4	12.4	35.6	44.1	7.8	26.8	152.3	282.0	11.0	7.1	11.3	31.0	35.2	11.3	4.8	3.3	3.6	6.6	17.8	27.4	22.7	13.1	11.9	21.2	16.6	38.3	2.8	8.9	35.9
FPGT	GFPP	ENSG00000254685	"Fucose-1-phosphate guanylyltransferase"	O14772	1	74198212-74234086	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072331			Uncertain	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA072331: "	"unprognostic (1.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.18e-3)"	"unprognostic (4.32e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.86e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.91e-1)"	10.5	10.5	3.7	9.9	5.6	4.2	12.9	5.4	4.9	8.9	6.2	12.0	11.7	8.7	10.6	10.7	9.2	13.2	8.7	4.0	5.0	15.4	14.1	8.9	9.0	5.8	5.4	13.3	10.4	13.5	5.3	10.8	6.2	9.9	11.1	6.8	10.6	8.5	4.9	12.0	12.3	8.8	5.3	10.1	12.6	8.1	5.0	8.5	19.5	5.6	9.8	8.3	6.0	8.3	12.4	10.1	7.5	11.0	17.0	15.8	11.2	16.0	10.6	10.8	12.7	5.7	9.1	7.6	19.2	9.5	12.2	10.3	13.6	14.6	17.1	15.4	5.8	17.3	11.1	9.7	14.1	13.2	12.7	13.1	18.6	10.8	5.1	7.4	11.3	10.5	18.2	8.8	17.1	3.3	7.4	2.7	8.2	15.9	9.1	7.8	17.5	10.8	9.5	8.9	7.8	7.8	11.8	17.1	18.6	2.4	20.6	14.9	10.3	4.7	8.8	25.8	12.2	9.6	7.3	10.2	19.0	12.8	16.2	19.5	20.1	21.7	5.5	20.5	6.5	5.0	5.5	5.2	12.6	6.1	6.2	5.6	6.1	5.8	18.4	1.2	7.6	10.7	3.7	5.6	5.4	4.9	4.0	5.0	5.8	5.4	6.2	5.3	5.0	8.3	7.1	6.4	3.2	0.0	3.0	6.8	4.9	13.3	4.6	7.1	7.6	5.6	10.2	14.3	9.3	11.0	2.1	12.7	2.5	7.8	19.6	5.3	8.9	6.0	4.8	4.9	6.0	9.5	0.0	7.1	11.0	7.0	4.1	4.2	5.1	4.9	6.4	9.8	15.1	3.3	0.0	7.3	6.1	9.4	4.6	7.3	10.2	10.3	5.4	0.0	9.0	10.6	8.2	0.0	0.0	6.5	8.9	5.7	1.2	2.5	11.0	15.3	12.7	5.5	26.3	5.8	7.2	9.7	10.4	5.7	6.5	6.2	5.2	4.9	7.3	3.0
FTO	"ALKBH9, KIAA1752, MGC5149"	ENSG00000140718	"FTO alpha-ketoglutarate dependent dioxygenase"	Q9C0B1	16	53701692-54158512	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 173.3;Excitatory neurons: 226.1;Inhibitory neurons: 240.7;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 282.5;Respiratory ciliated cells: 182.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017123, HPA041086, HPA068695"	Enhanced		Supported	Vesicles,Cytosol		No	No		540000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Vesicles	"CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117"	"unprognostic (9.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.30e-3)"	"unprognostic (6.11e-3)"	24.4	33.6	31.8	12.5	36.6	8.2	36.3	30.1	37.7	25.8	31.0	22.2	7.7	26.9	21.4	17.2	25.3	21.6	27.1	35.2	39.5	25.0	17.4	36.8	15.0	29.2	31.3	27.2	20.7	40.6	26.2	20.1	31.9	20.0	14.1	38.4	18.9	23.9	33.1	21.4	12.5	29.9	30.5	16.4	15.0	8.3	33.8	17.0	27.5	23.0	14.8	21.9	18.5	43.9	15.1	26.8	35.0	35.9	67.3	50.4	11.5	35.6	32.2	29.3	8.5	16.8	19.3	34.4	38.2	46.3	16.6	21.7	32.4	34.9	42.5	16.0	25.5	15.5	33.6	31.7	46.2	12.5	17.1	55.9	36.5	26.6	32.5	36.6	44.1	25.1	15.2	8.4	48.1	11.8	28.0	19.2	18.1	15.5	17.5	42.2	52.9	32.3	44.6	12.3	43.0	29.7	40.4	23.6	10.8	33.7	31.1	29.3	42.4	36.4	23.9	19.8	22.1	15.9	13.9	35.0	33.9	22.9	28.7	14.9	17.9	9.7	25.6	22.7	32.4	17.6	24.4	25.9	23.8	17.4	22.5	24.4	2.9	26.4	16.5	9.5	26.6	23.1	31.8	36.6	30.1	37.7	35.2	39.5	29.2	31.3	31.9	30.5	33.8	43.9	15.1	80.1	62.0	173.3	10.3	12.4	10.0	8.6	13.6	22.8	69.1	39.5	22.3	15.7	54.4	7.3	12.5	9.3	10.2	4.8	7.9	9.0	39.1	11.0	18.3	17.4	6.6	9.7	226.1	5.7	7.4	23.1	9.7	9.9	25.9	16.8	11.0	13.8	9.2	16.8	240.7	6.6	10.2	9.0	13.2	69.9	14.3	11.8	10.6	134.0	5.5	19.6	10.3	210.6	282.5	5.5	5.0	15.1	18.7	6.0	4.5	15.8	182.7	14.1	13.1	21.6	16.8	3.5	3.4	11.0	9.1	5.1	12.9	17.8	6.3	7.9
GABRD		ENSG00000187730	"Gamma-aminobutyric acid type A receptor subunit delta"	O14764	1	2019329-2030758	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 49.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.7;Excitatory neurons: 30.0;Horizontal cells: 13.5;Inhibitory neurons: 37.4;Spermatogonia: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HMC-1: 1.2;MCF7: 4.4;NB-4: 2.7;SH-SY5Y: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044371	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA044371: AB_2678916"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-8)"	"unprognostic (6.34e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (4.12e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.16e-2)"	0.3	1.5	12.8	0.0	16.9	0.0	0.5	49.6	40.5	0.1	0.1	0.2	0.0	0.3	0.1	0.3	0.2	0.4	0.7	14.7	5.4	0.7	0.2	0.9	0.2	14.3	18.1	0.2	0.1	0.7	2.7	0.1	20.2	0.2	0.0	1.4	0.3	0.0	0.3	0.4	0.2	0.3	1.0	0.3	0.1	3.6	29.7	0.1	0.9	0.4	0.0	0.2	0.2	14.7	0.0	0.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	2.7	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.8	16.9	49.6	40.5	14.7	5.4	14.3	18.1	20.2	1.0	29.7	14.7	1.0	3.2	3.6	4.9	0.1	0.5	0.0	0.0	0.0	14.7	0.3	0.0	0.9	0.0	6.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	3.4	0.0	0.0	30.0	0.0	0.3	0.5	0.0	0.2	2.5	0.3	0.0	0.0	0.1	13.5	37.4	0.0	0.0	0.0	0.3	0.2	0.0	0.9	0.0	8.4	0.0	1.4	0.0	3.0	4.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.4	1.6	0.0	0.0	4.8	0.1	11.3	0.1	0.0	0.3	0.4	0.2	0.1	0.1
GAL3ST1	CST	ENSG00000128242	"Galactose-3-O-sulfotransferase 1"	Q99999	22	30554635-30574665	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.6;intestine: 24.4;kidney: 18.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Muller glia cells: 35.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 53.6;Proximal enterocytes: 48.1;Proximal tubular cells: 24.6"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 38.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 27.6;CACO-2: 7.7;EFO-21: 14.6;K-562: 6.6;OE19: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001220, HPA077138"	Approved		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Nucleoplasm	"HPA001220: AB_1078933, HPA077138: "	"unprognostic (2.69e-2)"	"unprognostic (3.12e-4)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	1.3	0.2	14.8	0.4	33.3	0.8	1.1	27.7	25.8	2.7	0.3	5.2	23.0	2.4	1.7	0.5	3.1	5.2	1.1	14.6	18.3	18.4	4.0	1.9	0.7	32.9	29.0	2.3	6.9	0.7	1.5	0.9	31.0	3.1	2.4	2.3	0.5	1.4	3.1	1.6	24.4	0.3	23.2	0.3	8.2	5.0	29.1	0.1	0.2	0.3	0.0	1.6	1.8	51.6	0.0	27.6	0.5	0.2	0.0	0.0	2.0	0.0	0.2	0.0	0.0	7.7	3.8	0.4	14.6	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.7	0.4	0.4	5.7	0.6	0.2	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.4	6.6	0.6	0.0	0.2	0.3	1.1	3.9	10.6	0.4	0.2	0.0	0.7	1.1	0.1	0.3	1.8	0.0	0.4	0.2	0.7	0.2	0.2	0.8	0.2	0.2	0.3	0.0	2.4	1.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.6	0.0	0.0	14.8	33.3	27.7	25.8	14.6	18.3	32.9	29.0	31.0	23.2	29.1	51.6	0.5	0.0	0.0	2.3	0.3	0.4	0.1	0.0	0.0	0.8	0.6	3.3	0.6	30.0	0.0	3.7	0.0	0.1	0.0	14.0	15.6	7.0	1.1	1.1	0.3	0.3	10.9	2.7	2.0	11.1	0.1	0.3	5.1	2.4	0.0	0.9	0.0	1.6	0.1	0.0	1.9	5.7	0.0	0.3	0.3	0.8	1.5	0.2	0.0	0.0	0.0	35.3	0.0	26.7	53.6	5.0	8.8	2.2	0.1	0.4	48.1	24.6	0.1	1.3	0.0	2.1	0.3	12.4	14.3	0.0	0.3	0.3	0.2	0.0	7.6	0.1
GAPT	"C5orf29, FLJ33641"	ENSG00000175857	"GRB2 binding adaptor protein, transmembrane"	Q8N292	5	58491435-58497090	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 16.9;lymphoid tissue: 42.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 84.8;dendritic cells: 160.1;granulocytes: 55.0;Macrophages: 43.0;monocytes: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 1000.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 1000.3"	"Cell line enhanced"	"Detected in some"		"HEL: 71.5;HL-60: 41.8;NB-4: 43.3;THP-1: 33.7;U-937: 118.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA011048, HPA011070"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA011048: , HPA011070: AB_1848887"	"unprognostic (9.79e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.36e-2)"	"unprognostic (8.09e-4)"	"unprognostic (4.32e-1)"	"unprognostic (1.23e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-2)"	1.7	0.8	0.7	28.5	0.7	16.9	2.3	0.7	1.1	2.7	1.3	2.7	3.7	1.3	1.1	2.1	1.6	5.7	0.7	0.7	1.0	0.8	2.0	4.2	25.3	1.3	1.1	0.4	1.1	1.1	0.6	1.0	1.3	1.8	3.8	0.5	1.9	1.2	0.2	0.8	6.6	4.7	1.0	18.2	3.7	0.7	1.1	6.9	0.6	0.7	42.7	6.0	0.5	1.8	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	71.5	0.2	0.0	0.0	41.8	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	43.3	0.0	0.0	0.0	17.7	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	33.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	118.4	0.0	125.5	66.7	1000.3	0.4	46.5	0.5	97.0	0.4	0.4	76.8	97.4	0.3	0.3	82.0	1.4	59.3	205.4	0.3	32.0	0.7	0.7	0.7	1.1	0.7	1.0	1.3	1.1	1.3	1.0	1.1	1.8	0.4	3.2	1.9	0.0	84.8	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.2	0.0	0.6	0.0	0.0	0.0	160.1	0.0	0.0	0.0	1.6	0.0	0.1	0.9	0.0	8.8	0.0	0.0	0.1	0.4	0.5	0.0	55.0	0.0	0.4	0.0	14.3	0.0	0.0	0.0	0.0	19.4	6.0	0.5	0.0	43.0	0.0	1.9	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24594811-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis, Lipid metabolism"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 174.8;liver: 115.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1;Cholangiocytes: 48.6;Distal enterocytes: 54.1;Ductal cells: 82.6;Hepatocytes: 40.8;Proximal enterocytes: 111.7;Proximal tubular cells: 62.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 37.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 103.6;Karpas-707: 165.8;OE19: 169.5;RPMI-8226: 210.3;RPTEC TERT1: 203.2"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	3.3	2.4	5.5	6.4	6.7	12.0	24.7	7.0	7.5	28.7	5.1	20.3	84.7	3.0	72.0	3.3	3.3	47.1	7.2	5.1	5.1	174.8	115.7	42.6	5.4	7.2	6.6	3.2	63.1	0.2	5.5	2.4	7.8	48.8	11.0	1.6	9.9	21.6	1.9	4.1	80.4	2.2	5.9	13.3	31.3	18.4	7.1	6.5	15.9	0.4	6.2	5.7	4.3	9.2	1.0	79.7	1.0	0.3	0.0	0.5	2.2	0.5	1.7	0.8	1.0	11.7	18.3	1.0	16.2	0.1	14.8	11.0	6.2	0.8	0.5	103.6	12.3	0.6	40.8	64.3	5.5	1.5	33.2	2.1	0.9	2.5	1.7	1.4	0.5	19.0	8.4	165.8	1.0	1.7	1.6	52.4	6.4	169.5	0.7	0.7	6.8	210.3	203.2	2.9	0.5	1.2	0.4	33.3	0.8	22.2	32.4	39.6	6.4	10.6	9.3	46.6	0.9	48.2	18.4	0.7	19.0	58.7	0.5	4.8	12.3	0.2	1.0	6.0	2.9	2.2	5.0	2.4	6.5	0.2	0.6	1.4	15.9	4.9	4.0	0.1	6.5	5.6	5.5	6.7	7.0	7.5	5.1	5.1	7.2	6.6	7.8	5.9	7.1	9.2	0.2	80.1	22.8	3.3	2.8	0.8	0.1	0.3	4.6	0.5	5.9	2.3	0.7	48.6	4.9	1.8	0.0	1.4	0.7	54.1	1.9	82.6	1.8	1.2	0.6	0.7	1.2	5.3	4.4	8.1	0.4	3.9	15.3	5.1	5.7	0.1	1.8	40.8	4.9	0.0	4.1	4.4	4.1	2.5	1.7	6.7	0.0	2.9	1.8	1.0	5.8	2.5	0.0	1.5	5.7	20.9	20.1	0.4	12.8	2.0	111.7	62.9	1.6	0.1	0.0	0.1	1.0	0.6	0.8	0.4	0.4	0.8	4.0	0.0	6.5	0.1
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 8.7;thyroid gland: 8.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.2;Early spermatids: 5.6;Late spermatids: 18.7;Proximal tubular cells: 3.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;HeLa: 3.5;Karpas-707: 1.3;U-2197: 8.9"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.7	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.1	1.5	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.2	1.0	0.1	0.0	8.5	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.3	0.3	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.0	3.2	7.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.4	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GIMAP4	"FLJ11110, HIMAP4, IAN1, IMAP4"	ENSG00000133574	"GTPase, IMAP family member 4"	Q9NUV9	7	150567369-150573953	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 127.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 182.3;Endothelial cells: 195.2;Hepatic stellate cells: 222.0;Kupffer cells: 197.2;Macrophages: 110.0;monocytes: 176.0;NK-cells: 344.0;T-cells: 186.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	26	"HUVEC TERT2: 326.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019135, HPA019137, HPA027198"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"		"HPA019135: AB_1849670, HPA019137: AB_1849672, HPA027198: AB_10602599"	"unprognostic (5.03e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.08e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-1)"	46.1	18.3	15.0	75.1	15.6	4.2	31.8	16.2	21.2	19.7	16.3	21.2	16.5	23.0	9.6	12.0	18.7	24.6	31.3	14.3	16.0	17.3	29.9	50.8	127.7	19.2	18.0	7.7	6.7	9.6	6.0	48.7	18.0	10.2	22.4	1.5	11.2	13.3	17.5	8.4	25.0	38.3	18.8	115.6	18.0	4.2	16.4	30.5	21.1	48.1	85.1	31.1	11.6	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	326.4	3.4	0.1	0.3	0.0	0.0	0.4	0.2	0.4	0.0	0.0	12.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.5	370.2	5.2	325.8	390.9	404.2	3.0	408.0	402.8	122.1	1.3	424.3	361.9	339.7	263.4	320.4	5.3	312.1	776.9	15.0	15.6	16.2	21.2	14.3	16.0	19.2	18.0	18.0	18.8	16.4	18.7	182.3	3.2	12.4	0.3	7.3	6.8	0.2	0.0	3.4	0.1	2.2	4.7	9.9	5.7	1.8	11.0	0.0	0.6	82.6	0.0	0.0	0.2	0.6	0.3	0.4	195.2	0.0	9.7	0.5	0.2	0.8	9.0	2.0	0.3	6.3	0.0	222.0	3.7	96.4	0.0	0.1	0.0	0.0	197.2	20.9	1.7	5.0	110.0	10.6	18.7	176.0	0.2	344.0	0.0	0.1	0.1	0.0	0.0	14.7	0.4	0.0	1.9	0.7	0.4	13.1	3.9	7.9	0.0	0.8	1.1	6.1	0.8	186.2	0.8	0.0	0.3
GIPR		ENSG00000010310	"Gastric inhibitory polypeptide receptor"	P48546	19	45668221-45683722	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 22.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 29.9;Gastric mucus-secreting cells: 28.1;Respiratory ciliated cells: 44.5;Rod photoreceptor cells: 17.4"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 4.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.8;HMC-1: 20.6;SCLC-21H: 13.9;U-266/70: 16.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB022710, HPA068054"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"CAB022710: , HPA068054: "	"unprognostic (2.40e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-4)"	"unprognostic (1.82e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.59e-2)"	10.0	0.3	1.8	3.1	2.6	2.0	9.0	2.3	3.3	2.5	2.7	6.9	3.7	0.3	0.7	2.5	10.2	1.4	15.2	1.8	2.7	3.8	0.7	5.6	2.7	4.1	4.7	0.1	10.8	5.6	0.4	0.2	4.5	7.1	4.9	13.1	7.8	0.4	0.3	4.2	4.2	0.3	1.7	4.0	22.7	0.2	4.4	0.6	2.5	0.0	2.4	2.6	3.4	4.4	0.7	0.4	1.3	0.7	0.6	0.0	0.1	1.0	0.8	0.0	0.7	0.4	3.9	1.9	0.6	0.8	0.7	2.0	0.3	0.2	0.1	9.8	0.3	1.6	1.0	0.3	0.1	0.6	20.6	0.0	0.3	0.1	0.0	1.8	0.0	2.1	4.5	2.2	0.0	0.2	0.1	1.1	0.0	2.9	0.7	0.5	0.4	4.4	0.5	0.9	13.9	1.2	0.0	0.8	0.2	0.5	2.0	3.1	0.4	0.0	0.5	0.3	0.2	16.7	0.2	0.4	0.6	1.5	0.3	1.1	0.1	0.5	0.5	0.2	0.1	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.5	0.9	0.0	0.2	0.4	0.2	1.8	2.6	2.3	3.3	1.8	2.7	4.1	4.7	4.5	1.7	4.4	4.4	1.4	3.2	6.3	0.0	1.0	0.9	3.4	2.9	0.0	0.3	2.0	0.5	4.0	5.7	9.8	5.5	0.0	0.0	3.7	13.2	0.0	2.2	0.4	7.1	0.1	0.5	29.9	0.0	0.2	3.6	0.1	0.5	28.1	0.7	1.3	0.1	0.0	0.0	0.1	0.0	0.4	6.8	4.1	0.0	7.8	0.2	0.0	1.4	0.0	0.0	0.5	0.2	1.0	0.0	5.0	5.6	11.3	0.0	4.0	1.5	0.3	0.1	44.5	17.4	13.1	0.3	3.5	0.2	0.3	1.5	0.4	0.1	2.1	0.1	1.9	2.8
GLIPR2	"C9orf19, GAPR-1"	ENSG00000122694	"GLI pathogenesis related 2"	Q9H4G4	9	36136536-36163913	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 188.5;Langerhans cells: 203.6;Macrophages: 117.6;monocytes: 203.0;NK-cells: 180.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.6;HDLM-2: 72.9;TIME: 127.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029478	Approved		Uncertain	Vesicles,Microtubules		NA	NA		19000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Microtubules	"HPA029478: AB_10670038"	"unprognostic (1.57e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (6.54e-7)"	"unprognostic (6.57e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-2)"	38.5	20.9	17.6	52.7	22.8	73.8	32.4	21.0	22.6	45.9	14.1	73.7	14.7	77.8	15.1	18.6	36.9	24.1	24.2	17.2	19.3	8.8	6.9	62.6	29.9	24.8	22.1	13.3	5.6	2.5	4.9	8.8	22.3	38.3	33.1	2.7	15.3	39.3	7.7	12.2	32.2	63.8	22.8	41.3	25.3	3.4	26.7	18.7	15.8	11.1	19.2	38.8	27.4	27.6	3.7	2.9	20.9	22.3	71.6	33.3	2.4	32.9	20.0	7.8	14.1	1.3	0.3	0.2	10.2	30.9	19.7	0.2	7.9	1.1	4.7	72.9	6.4	8.8	6.2	0.4	27.9	5.7	28.3	23.4	1.0	44.5	7.8	14.0	62.5	22.6	0.4	5.0	17.4	7.9	27.9	15.2	20.1	0.3	10.7	18.9	44.1	1.0	1.6	1.8	5.6	11.3	4.4	2.2	3.6	42.2	2.3	24.0	127.3	10.7	24.8	9.6	28.0	7.8	2.2	12.7	11.0	35.0	2.5	268.6	360.9	540.3	168.4	162.5	89.1	24.4	114.3	108.2	208.3	24.5	47.0	74.7	657.0	125.5	124.9	18.5	132.2	414.0	17.6	22.8	21.0	22.6	17.2	19.3	24.8	22.1	22.3	22.8	26.7	27.6	11.9	3.2	25.4	4.6	22.3	13.4	2.5	14.7	1.8	0.3	46.9	19.0	2.6	2.8	30.9	5.5	0.0	3.8	66.9	14.7	0.0	21.2	0.7	1.8	33.9	13.3	8.4	58.7	1.1	1.3	3.3	54.3	11.7	2.1	52.6	1.9	16.1	0.9	188.5	0.0	0.8	42.4	14.2	83.2	203.6	2.3	18.0	117.6	62.2	2.8	203.0	21.4	180.2	3.0	28.6	5.2	16.1	25.9	22.8	16.0	4.0	1.1	64.3	0.5	46.0	44.7	43.2	0.9	6.4	0.9	10.2	3.4	75.5	10.9	45.3	3.3
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144688-79175318	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.6;dendritic cells: 30.6;Plasma cells: 4.2;T-cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"JURKAT: 42.3;MOLT-4: 75.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041025, HPA058306"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"HPA041025: AB_10794260, HPA058306: "	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"	0.8	0.4	0.5	6.9	0.3	2.5	0.9	0.6	0.6	0.4	0.3	1.0	2.0	0.5	0.6	0.3	0.3	1.1	0.3	0.4	0.4	0.5	1.0	1.9	15.2	0.7	0.5	0.2	0.1	0.1	0.1	0.2	0.7	0.7	1.6	0.2	1.5	0.1	0.2	0.2	3.6	0.3	0.3	8.1	2.1	0.1	0.4	16.9	0.9	0.1	10.4	1.4	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	1.2	0.0	0.0	75.1	0.1	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.2	0.0	0.0	0.0	6.5	0.0	3.6	3.6	2.0	1.2	2.5	4.8	6.1	0.1	2.6	4.2	4.9	0.3	4.6	5.5	1.0	4.8	1.6	0.5	0.3	0.6	0.6	0.4	0.4	0.7	0.5	0.7	0.3	0.4	0.5	0.7	0.0	2.4	0.0	6.6	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.6	1.8	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.5	0.1	0.0	0.0
GPR37L1	ETBR-LP-2	ENSG00000170075	"G protein-coupled receptor 37 like 1"	O60883	1	202122917-202133592	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 76.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 91.7;Muller glia cells: 59.6;Oligodendrocyte precursor cells: 89.0;Oligodendrocytes: 20.4"	"Cancer enriched"	"Detected in some"	57	"glioma: 36.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 1.2;MCF7: 1.5;T-47d: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061629, HPA064454"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cell Junctions"	"Vesicles, Plasma membrane"	"HPA061629: , HPA064454: AB_2685268"	"unprognostic (2.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-3)"	"unprognostic (4.52e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.26e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.49e-1)"	0.1	0.2	55.2	0.0	71.1	0.2	0.0	60.7	52.2	0.2	10.6	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.1	48.0	50.7	0.0	0.2	0.0	0.0	66.7	67.0	0.0	0.0	0.0	0.6	0.0	53.7	0.2	0.2	2.8	0.1	0.3	0.1	0.1	0.3	0.1	59.4	0.0	0.2	0.3	76.4	0.0	0.1	0.1	0.0	0.0	0.1	53.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	55.2	71.1	60.7	52.2	48.0	50.7	66.7	67.0	53.7	59.4	76.4	53.1	0.0	0.0	0.0	91.7	0.1	0.4	0.5	0.7	0.0	1.2	0.3	0.3	1.1	1.5	1.7	0.0	4.2	0.1	0.0	4.9	0.0	3.2	4.5	0.9	0.2	0.1	0.0	0.0	0.4	1.2	1.0	0.2	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.8	0.9	0.1	0.0	2.8	0.0	59.6	0.0	89.0	20.4	2.1	2.7	1.9	0.0	0.8	1.3	0.1	1.1	4.9	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.7	0.1	0.2	0.7	1.0
GRAMD1B	"KIAA1201, LINC01059"	ENSG00000023171	"GRAM domain containing 1B"	Q3KR37	11	123358428-123627774	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.8;choroid plexus: 91.8;retina: 96.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 94.7;Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Inhibitory neurons: 102.8;Oligodendrocyte precursor cells: 95.0;Rod photoreceptor cells: 92.3;Theca cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 7.0"	"Group enriched"	"Detected in many"	4	"A549: 62.4;HDLM-2: 168.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008557, HPA075204"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum, Plasma membrane"	Vesicles	"HPA008557: AB_1079197, HPA075204: "	"unprognostic (1.86e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (4.30e-7)"	"unprognostic (1.39e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	1.8	258.8	22.5	4.3	27.4	18.6	1.1	80.1	52.3	0.9	91.8	1.6	34.6	1.1	9.4	0.6	3.6	12.1	15.0	55.6	19.4	15.5	1.5	2.6	5.4	25.7	20.1	15.2	2.4	0.7	16.6	5.0	24.2	1.1	1.1	96.7	1.9	2.0	3.4	0.5	25.2	1.2	9.4	3.6	11.4	16.8	33.5	6.6	4.9	2.2	3.5	1.2	0.8	26.1	0.1	62.4	3.5	0.1	0.3	0.7	9.5	20.5	14.6	4.1	1.8	2.6	0.4	3.8	10.4	10.1	6.8	0.0	6.2	0.0	4.3	168.5	5.0	0.0	28.3	0.7	0.0	22.1	0.0	1.0	0.1	7.1	0.0	5.2	1.8	1.6	0.0	0.2	3.7	0.5	3.8	7.2	7.6	28.3	23.0	10.8	9.8	6.8	0.2	0.0	20.0	16.3	4.9	0.5	0.1	8.1	0.5	12.0	12.3	23.8	3.2	4.2	1.0	0.0	0.0	0.0	4.6	20.5	1.1	0.0	1.2	0.4	0.4	0.7	0.2	0.0	1.5	1.2	1.7	0.0	0.2	0.2	0.1	1.6	0.7	7.0	0.7	0.5	22.5	27.4	80.1	52.3	55.6	19.4	25.7	20.1	24.2	9.4	33.5	26.1	1.4	0.0	0.5	94.7	0.6	0.0	0.0	0.1	1.2	44.3	1.1	1.0	5.7	21.5	0.2	5.5	114.7	6.9	17.9	0.1	3.9	0.7	9.6	1.6	0.6	1.0	0.0	0.0	120.7	0.4	3.7	1.6	16.3	0.9	0.0	41.9	0.7	0.0	2.6	45.4	102.8	1.8	0.0	3.8	2.6	2.7	0.6	7.5	0.0	37.5	2.5	23.4	0.0	95.0	5.5	3.9	1.3	0.7	2.4	0.1	17.3	8.9	0.4	92.3	0.0	3.0	4.2	3.9	1.9	0.1	0.4	2.5	7.2	109.3	1.5	0.0
GRHL1	"LBP-32, MGR, TFCP2L2"	ENSG00000134317	"Grainyhead like transcription factor 1"	Q9NZI5	2	9951693-10002277	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.6;skin 1: 87.7;vagina: 66.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Cytotrophoblasts: 61.9;Extravillous trophoblasts: 80.5;Suprabasal keratinocytes: 132.7;Syncytiotrophoblasts: 184.6;Urothelial cells: 104.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 212.3;RT4: 41.4;SK-BR-3: 112.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005798, HPA006420"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Vesicles	"HPA005798: AB_1079026, HPA006420: AB_1079025"	"unprognostic (2.26e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.33e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.14e-1)"	4.5	1.3	2.2	1.2	2.3	8.7	39.8	0.8	2.8	31.0	1.0	1.5	1.2	1.0	7.3	119.6	2.2	3.0	2.5	2.7	2.5	4.0	12.2	5.0	1.0	0.8	1.5	0.4	4.2	29.0	3.6	26.7	0.9	11.4	1.0	11.4	44.7	7.3	1.1	87.7	0.7	0.7	0.6	0.8	3.7	3.2	4.3	0.9	2.9	0.4	26.1	13.9	66.9	1.7	10.9	0.2	1.2	3.0	0.4	0.5	212.3	1.0	1.5	0.7	1.2	0.9	7.5	1.4	0.4	0.1	1.5	6.5	13.0	1.4	3.1	3.2	5.9	0.3	2.3	4.3	0.3	0.7	1.2	0.4	5.5	6.0	0.0	0.0	1.1	2.3	2.2	4.1	0.0	14.3	2.2	1.7	0.8	3.5	2.5	0.9	1.0	1.9	1.4	41.4	2.4	1.6	2.0	112.3	2.7	17.4	13.7	0.4	1.2	0.6	2.6	3.3	1.3	2.7	1.7	1.5	0.6	1.7	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	1.7	2.2	2.3	0.8	2.8	2.7	2.5	0.8	1.5	0.9	0.6	4.3	1.7	2.2	3.2	8.1	3.9	1.2	40.0	23.1	10.7	2.8	25.5	37.1	19.9	2.1	1.5	31.1	20.2	62.6	61.9	1.3	1.2	0.0	2.9	6.4	4.5	1.3	4.2	3.5	0.0	14.6	9.1	80.5	5.4	3.1	9.6	10.2	0.4	2.5	7.7	7.7	11.8	6.0	0.8	4.1	1.0	15.7	3.0	0.0	10.6	21.4	1.9	1.0	1.1	0.0	4.0	1.0	5.7	0.1	0.4	1.0	31.5	0.1	2.4	18.6	11.5	0.0	3.0	3.7	9.6	5.1	35.2	132.7	184.6	2.1	0.1	1.2	104.6
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379572-6393981	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 228.3;Late spermatids: 391.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Cell Junctions"	"HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163"	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	35.0	38.1	36.7	34.0	38.4	71.0	34.2	43.6	43.0	48.8	30.2	41.2	40.5	48.5	25.9	46.0	44.8	36.1	32.8	39.1	35.8	37.6	30.0	31.5	43.5	34.4	34.3	73.6	57.5	42.6	49.8	26.8	34.6	39.5	23.3	24.9	43.8	31.7	36.8	36.8	39.2	25.1	30.1	36.4	43.9	68.3	36.1	37.1	49.6	22.6	29.8	37.3	41.0	36.1	115.6	97.1	62.0	100.9	46.5	73.1	47.3	81.7	84.7	112.0	106.0	104.4	48.5	76.3	111.9	67.2	73.5	109.9	69.3	65.6	57.1	106.6	90.1	97.2	60.7	86.9	78.6	107.1	79.5	82.8	78.2	85.5	64.1	86.4	69.0	72.9	115.9	91.7	63.9	96.2	115.4	79.7	108.2	59.7	124.3	101.5	68.0	94.6	67.5	74.2	76.1	99.8	83.0	64.5	95.6	36.4	84.0	94.0	79.8	78.5	62.6	134.0	110.1	153.9	197.2	79.7	98.1	124.9	91.0	10.2	29.7	20.8	26.1	28.4	29.7	32.9	23.5	24.9	23.3	31.6	27.0	24.6	40.1	27.6	30.2	30.3	25.4	19.8	36.7	38.4	43.6	43.0	39.1	35.8	34.4	34.3	34.6	30.1	36.1	36.1	29.2	48.1	56.6	5.2	51.9	24.3	50.2	40.5	53.5	27.6	43.1	34.7	28.9	32.9	58.4	25.8	8.4	46.1	51.6	88.2	21.5	48.5	228.3	70.5	70.7	41.0	30.5	51.7	6.9	50.8	43.0	43.3	51.0	57.4	63.8	32.7	58.9	26.0	60.2	25.2	7.0	53.4	24.4	54.8	25.9	391.6	44.4	42.1	33.8	5.6	66.0	35.6	49.4	3.5	4.9	47.4	66.0	49.7	55.4	29.9	65.3	48.8	83.6	33.5	32.9	44.8	52.9	71.8	38.3	44.9	21.0	54.0	48.3	41.8	54.4	40.6
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696599	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 68.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 34.4;Enteroendocrine cells: 176.7;Intestinal goblet cells: 56.0;Paneth cells: 97.9;Proximal enterocytes: 81.5;Undifferentiated cells: 47.6"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.4;CACO-2: 1.1;CAPAN-2: 1.7;SiHa: 1.6"	"Region enhanced"	"Detected in some"		"midbrain: 1.8"	"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.5	0.2	0.1	3.4	0.3	0.5	0.0	0.2	0.1	0.0	3.0	37.2	68.2	0.3	0.0	1.9	0.0	0.9	2.2	0.2	0.3	0.4	0.3	0.2	0.4	0.4	0.3	0.0	2.2	0.0	0.0	0.2	0.4	0.3	41.4	0.1	0.6	0.0	0.7	1.0	66.5	1.4	0.5	0.2	1.9	0.4	0.3	0.0	0.5	0.0	0.3	0.5	0.2	0.5	0.4	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.3	1.1	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.2	0.1	0.2	0.3	0.4	0.3	0.4	0.5	0.3	0.5	0.0	0.0	0.0	1.3	6.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.1	0.1	0.0	0.0	176.7	0.0	1.4	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	56.0	0.0	0.3	0.3	0.2	0.0	0.3	0.0	1.0	0.3	0.0	0.0	1.0	0.2	0.4	97.9	0.0	0.1	0.0	81.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	47.6	0.0
HK2		ENSG00000159399	"Hexokinase 2"	P52789	2	74834127-74893359	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 144.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 216.4;Early spermatids: 89.5;Paneth cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 51.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 172.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028587, HPA061711"	Enhanced		Supported	Vesicles,Centrosome,Mitochondria,Cytosol		NA	NA		100000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Mitochondria, Cytosol"	"Vesicles, Centrosome"	"HPA028587: AB_10602605, HPA061711: "	"unprognostic (1.28e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.67e-2)"	58.2	2.7	2.7	14.6	3.9	45.7	16.0	4.8	5.6	7.8	2.7	46.6	2.8	5.1	66.1	19.9	9.7	9.5	7.9	3.5	3.6	1.9	2.7	15.2	5.8	11.1	6.3	14.9	2.9	2.5	1.9	13.1	8.5	4.9	37.3	144.0	14.7	1.1	45.6	14.6	13.0	3.3	5.9	6.9	18.7	32.8	6.0	3.7	14.1	83.7	7.8	27.1	15.9	8.6	55.9	0.4	12.5	45.4	103.3	10.8	46.5	21.3	30.6	23.4	33.4	44.0	9.8	40.7	20.1	9.9	30.2	19.0	57.0	44.7	67.0	11.6	12.5	55.1	12.4	61.0	32.5	80.8	86.3	18.2	47.3	44.5	77.1	26.3	11.3	23.0	49.2	0.2	6.9	39.6	19.8	82.0	45.3	52.4	38.2	31.8	26.2	31.7	14.2	77.2	9.2	44.6	13.5	67.4	27.4	17.8	3.6	12.8	9.4	74.0	13.4	31.2	39.2	27.1	8.2	20.2	172.5	57.9	19.9	16.8	14.0	51.7	0.2	11.0	0.6	1.2	0.8	0.1	11.8	1.3	1.2	1.2	11.2	0.0	7.7	0.3	1.5	4.7	2.7	3.9	4.8	5.6	3.5	3.6	11.1	6.3	8.5	5.9	6.0	8.6	1.6	16.0	45.3	4.9	5.7	51.6	9.5	26.7	5.7	14.8	16.0	5.6	7.2	4.3	24.2	5.5	83.4	2.3	0.6	216.4	0.0	4.6	89.5	5.8	4.1	4.4	39.0	4.2	0.2	4.5	33.5	6.4	14.8	15.0	22.2	27.2	1.4	0.3	15.8	21.9	0.1	37.7	6.1	20.8	35.1	46.0	14.6	22.8	23.2	25.3	18.9	6.3	2.1	0.5	0.7	25.6	108.3	7.9	4.7	34.3	5.4	0.2	15.2	42.1	13.1	19.9	3.3	3.9	4.2	10.7	57.0	8.2	3.6	5.8	51.7	70.0
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.7"	"Group enriched"	"Detected in many"	18	"granulocytes: 1056.2;Hofbauer cells: 631.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 18.1"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 18.1"	"Group enriched"	"Detected in some"	8	"HEL: 46.2;HMC-1: 13.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		250000	"Cluster 46: Basophils - DNA binding"	"Cluster 19: Lung - Lung function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	3.4	1.9	2.2	1.1	2.1	1.1	4.0	2.3	3.1	3.5	2.1	5.1	5.8	2.4	2.3	2.9	1.4	6.9	1.8	2.3	2.3	1.5	0.8	9.4	0.6	2.7	2.6	0.5	0.5	0.8	0.4	18.7	2.9	2.6	5.3	0.1	1.5	1.3	0.5	3.3	5.6	3.3	2.6	0.3	2.8	0.7	3.1	2.0	0.3	1.7	0.9	4.8	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	3.5	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.2	2.1	2.3	3.1	2.3	2.3	2.7	2.6	2.9	2.6	3.1	3.5	0.3	12.8	44.7	1.0	0.2	4.1	0.8	0.0	0.6	0.0	0.2	0.8	0.3	0.0	3.7	0.0	0.0	3.6	0.7	0.5	0.0	0.5	0.1	0.2	0.0	2.0	7.1	12.2	0.8	0.0	3.0	3.0	3.6	0.0	1056.2	0.0	0.0	0.0	631.9	0.0	0.6	0.0	0.0	11.4	13.1	0.0	0.3	16.3	3.6	32.8	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.4	2.1	3.9	0.0	0.0	1.5	0.1	0.0	0.6	0.4	0.0	0.1	0.0	5.4	5.5	20.5	0.3	0.9	0.2
HSDL1	SDR12C3	ENSG00000103160	"Hydroxysteroid dehydrogenase like 1"	Q3SXM5	16	84122141-84145192	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 45.4;Rod photoreceptor cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045745			Supported	"Vesicles,Intermediate filaments,Mitochondria"		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria	"Vesicles, Intermediate filaments"	"HPA045745: AB_2679440"	"unprognostic (2.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.66e-1)"	"prognostic favorable (4.20e-7)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.14e-2)"	7.5	15.4	14.3	7.1	14.6	4.4	11.9	10.9	13.0	10.6	10.7	7.4	6.2	13.2	10.5	7.8	12.6	7.1	15.7	14.0	18.3	10.8	5.1	9.1	9.0	15.0	14.8	22.0	4.9	15.1	11.9	9.1	18.6	9.8	6.9	34.3	7.3	11.1	20.7	8.0	5.7	10.8	9.5	8.0	6.4	13.2	17.0	14.1	26.8	30.5	9.2	7.3	7.1	10.2	11.1	12.6	57.4	19.8	20.7	14.5	14.6	13.8	13.1	17.0	8.9	14.5	18.8	22.7	24.7	12.4	18.8	7.6	31.1	12.1	26.9	4.9	18.9	10.9	7.9	32.5	21.0	17.1	19.2	11.0	20.0	24.1	15.4	21.9	20.9	30.6	23.0	28.2	34.3	27.3	37.8	17.4	29.5	6.4	13.3	36.7	20.4	8.4	16.6	12.0	27.1	20.2	35.0	5.6	39.0	28.5	34.4	10.2	17.5	19.2	22.9	13.9	11.3	44.1	38.1	36.9	22.8	12.3	18.2	21.2	5.0	11.1	3.8	3.4	5.0	5.0	4.1	4.6	2.8	7.5	5.3	5.6	5.5	4.3	6.3	0.0	5.4	4.4	14.3	14.6	10.9	13.0	14.0	18.3	15.0	14.8	18.6	9.5	17.0	10.2	8.9	12.8	16.4	7.8	8.2	4.8	4.6	6.4	8.6	20.2	10.2	8.3	16.7	1.5	8.6	3.7	14.6	6.9	4.4	3.7	5.9	7.9	38.5	11.4	10.5	7.7	9.5	5.7	12.4	6.7	6.6	7.7	3.6	11.0	1.3	38.6	9.3	4.1	12.2	45.4	15.8	3.7	4.1	6.9	3.5	12.2	5.9	10.4	5.4	11.2	6.1	28.4	5.2	15.6	13.0	6.8	2.5	10.1	10.1	5.2	3.9	8.0	13.7	44.2	0.0	8.0	7.8	35.8	30.1	8.8	7.0	8.8	6.6	12.7	4.5	4.8
HSPB9	CT51	ENSG00000260325	"Heat shock protein family B (small) member 9"	Q9BQS6	17	42122804-42123352	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 17.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 375.3;Late spermatids: 1017.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053091			Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA053091: "	"unprognostic (2.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.42e-6)"	"unprognostic (2.31e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.68e-4)"	"unprognostic (4.78e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.24e-1)"	0.4	0.2	1.3	0.4	1.4	0.6	0.2	1.6	1.7	0.2	0.9	0.3	0.3	0.2	0.0	0.1	0.7	0.6	0.2	1.2	1.3	0.5	3.6	0.2	0.4	1.4	1.2	1.3	4.8	0.2	0.5	0.2	1.4	0.5	0.0	0.0	2.9	0.5	1.5	0.4	0.4	0.1	1.2	0.5	0.4	17.8	1.4	0.0	0.2	1.0	0.0	0.2	0.2	1.7	0.2	0.2	0.3	0.9	0.0	0.0	3.3	0.0	0.0	0.0	0.3	1.0	0.1	0.3	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.3	3.0	0.5	1.2	0.4	0.0	0.3	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	0.2	0.0	0.4	0.3	1.1	0.1	0.3	0.0	0.1	0.2	1.0	0.0	0.7	1.4	0.3	0.0	1.5	0.2	0.1	0.2	0.1	0.4	0.7	0.0	0.6	0.2	0.6	0.3	0.6	0.1	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	1.3	1.4	1.6	1.7	1.2	1.3	1.4	1.2	1.4	1.2	1.4	1.7	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.6	0.6	0.6	0.5	0.6	2.8	0.0	0.0	2.1	3.2	0.2	0.4	19.6	0.0	375.3	0.5	0.3	0.6	0.0	0.0	0.1	1.1	0.8	0.7	0.0	0.3	0.0	0.5	1.8	15.3	0.2	3.3	0.1	0.7	0.0	0.8	0.4	1017.0	7.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.3	6.8	0.0	0.4	0.6	0.9	0.1	0.4	0.0	0.8	0.3	127.3	4.5	0.1	0.3	0.3	0.2	0.6	0.3	0.2
IDI2	IPPI2	ENSG00000148377	"Isopentenyl-diphosphate delta isomerase 2"	Q9BXS1	10	1018910-1025859	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"skeletal muscle: 273.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Glandular and luminal cells: 1.1;Horizontal cells: 1.7;Skeletal myocytes: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA041254			Uncertain	Vesicles		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"	Vesicles		"HPA041254: AB_10794270"									"unprognostic (6.69e-3)"	"unprognostic (4.05e-2)"				"unprognostic (1.64e-1)"				0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	1.2	0.0	0.0	273.8	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	11.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.4	0.3	0.0	0.1	0.2	0.2	0.0	0.6	0.3	0.5	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.9	0.5	0.4	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.2	1.7	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2
IFITM5	"BRIL, DSPA1, fragilis4, Hrmp1"	ENSG00000206013	"Interferon induced transmembrane protein 5"	A6NNB3	11	298200-299526	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Mineral balance"	"Developmental protein"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 4.9;pancreas: 7.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	8	"cerebral cortex: 4.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039258			Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA039258: AB_10673608"	"unprognostic (9.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.46e-2)"		"unprognostic (4.20e-2)"	"unprognostic (4.42e-2)"		"unprognostic (8.31e-2)"	"unprognostic (7.99e-3)"		"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"		"unprognostic (4.90e-2)"	0.1	0.0	0.0	0.1	0.0	0.7	0.2	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.4	0.1	0.1	0.1	0.0	7.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGDCC3	"HsT18880, PUNC"	ENSG00000174498	"Immunoglobulin superfamily DCC subclass member 3"	Q8IVU1	15	65327127-65378002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3;parathyroid gland: 5.1;placenta: 6.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 33.3;Cytotrophoblasts: 104.8;Early spermatids: 37.6;Late spermatids: 98.6;Syncytiotrophoblasts: 41.3"	"Group enriched"	"Detected in many"	5	"glioma: 2.2;testis cancer: 5.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 105.8;CACO-2: 27.4;Hep G2: 87.8;SuSa: 41.9"	"Low region specificity"	"Detected in many"							HPA015713			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles"		"HPA015713: "	"unprognostic (7.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.24e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.67e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.77e-5)"	"unprognostic (4.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-2)"	0.0	0.2	2.3	0.0	2.0	0.0	0.8	4.3	3.2	1.0	0.0	0.4	0.0	0.7	0.1	0.0	0.6	0.1	0.1	2.6	1.9	0.2	0.0	0.0	0.0	2.4	2.7	0.8	0.0	5.1	1.9	6.0	2.4	0.1	0.0	1.0	0.0	0.1	0.1	0.1	0.1	0.2	1.6	0.0	0.2	2.8	3.0	1.4	0.9	0.0	0.0	0.1	0.4	1.9	0.0	0.0	105.8	4.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	27.4	0.2	0.0	0.3	0.0	0.0	0.0	7.2	0.0	0.0	0.0	1.0	0.0	0.2	87.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	16.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	2.2	1.5	0.1	0.1	0.0	41.9	3.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.0	4.3	3.2	2.6	1.9	2.4	2.7	2.4	1.6	3.0	1.9	0.1	0.0	0.0	15.3	0.0	0.0	0.2	0.0	0.0	4.1	2.2	1.0	0.6	0.0	0.0	1.8	33.3	104.8	0.0	0.4	0.0	0.0	37.6	0.4	4.8	1.0	0.0	0.0	2.8	0.0	4.3	3.0	0.0	0.6	0.0	0.1	0.0	0.0	7.2	0.0	7.0	0.0	0.0	0.0	0.0	98.6	0.6	0.1	0.0	1.0	0.0	3.7	0.0	16.1	8.9	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.7	0.4	1.3	11.0	0.0	0.0	41.3	0.1	0.1	0.2	0.0
IGFBPL1	bA113O24.1	ENSG00000137142	"Insulin like growth factor binding protein like 1"	Q8WX77	9	38406528-38424454	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"thyroid gland: 16.5"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;Excitatory neurons: 2.5;Hofbauer cells: 1.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 2.5;Spermatogonia: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 360.4;NTERA-2: 104.2;RH-30: 97.5;SCLC-21H: 334.3;SH-SY5Y: 332.6;SuSa: 241.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051354	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"HPA051354: "	"unprognostic (5.63e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.67e-2)"	0.8	1.5	2.4	0.5	4.2	0.5	0.1	3.4	2.8	0.2	1.4	0.5	0.9	0.7	0.1	0.3	0.3	0.6	1.3	2.6	2.0	0.2	0.3	0.8	0.2	1.5	2.3	0.1	0.9	0.0	1.1	0.6	1.7	0.4	0.3	0.3	0.1	1.6	0.2	0.2	0.6	1.1	1.0	0.1	1.6	2.1	2.8	2.9	16.5	0.0	0.1	0.5	0.1	1.8	0.0	8.6	360.4	0.4	0.0	0.0	0.2	2.4	0.0	0.5	0.3	0.1	0.2	0.1	1.3	0.3	0.0	0.1	44.0	0.0	0.5	0.0	2.7	0.1	1.2	0.2	0.0	1.7	1.2	0.4	0.0	0.0	0.0	0.2	0.0	1.6	0.2	0.2	2.5	0.1	0.3	0.2	104.2	0.5	0.7	0.1	97.5	0.9	0.0	0.2	334.3	332.6	6.4	0.5	0.0	241.3	2.3	2.3	0.4	0.1	7.7	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.0	2.4	4.2	3.4	2.8	2.6	2.0	1.5	2.3	1.7	1.0	2.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.3	0.6	0.1	0.0	1.8	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0
IL17RB	"CRL4, EVI27, IL17BR, IL17RH1"	ENSG00000056736	"Interleukin 17 receptor B"	Q9NRM6	3	53846568-53865794	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9;kidney: 59.8;liver: 33.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Enteroendocrine cells: 29.2;Oligodendrocyte precursor cells: 37.7;Proximal tubular cells: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.2;Hep G2: 59.5;OE19: 46.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005482	Enhanced		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"HPA005482: AB_1234567"	"unprognostic (1.85e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (8.10e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (7.15e-3)"	0.9	2.0	20.2	2.3	21.4	0.5	5.7	22.7	28.9	18.1	16.6	6.8	5.8	5.1	0.7	1.7	3.3	2.4	2.7	19.4	20.2	59.8	33.3	3.8	2.5	18.7	19.9	1.5	7.8	1.1	4.2	0.9	19.0	2.4	6.9	4.8	4.9	0.6	1.3	2.2	5.9	0.8	18.9	1.2	3.6	2.5	23.2	0.3	2.9	0.2	0.7	0.8	1.3	23.6	1.5	3.1	4.5	3.4	0.1	0.0	7.1	3.1	0.1	0.1	0.0	20.2	1.4	4.6	1.0	1.0	1.7	0.8	12.2	0.0	0.0	1.6	3.5	6.0	6.1	59.5	0.0	5.6	3.2	0.0	0.0	0.0	0.0	3.8	0.0	1.6	4.9	2.1	0.1	4.2	0.9	2.3	12.1	46.2	2.6	1.7	1.9	5.3	1.4	5.3	6.4	3.7	10.1	2.4	1.9	3.3	9.2	2.0	2.5	3.0	3.3	2.6	3.9	4.7	5.6	2.9	2.7	3.3	1.7	1.3	0.2	0.0	0.2	0.2	0.1	0.1	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.3	0.9	0.1	20.2	21.4	22.7	28.9	19.4	20.2	18.7	19.9	19.0	18.9	23.2	23.6	0.2	0.0	4.1	48.3	0.2	0.3	2.0	0.0	0.0	0.1	8.2	4.4	4.1	17.2	1.3	0.0	0.0	1.4	0.3	4.3	9.8	4.8	1.0	0.5	1.0	0.2	29.2	0.0	0.5	1.6	1.0	0.6	4.6	1.7	2.5	0.4	0.4	13.1	0.1	0.0	2.5	8.7	2.0	0.0	1.1	0.7	1.2	1.2	0.0	1.9	0.0	4.4	0.0	37.7	4.3	1.8	3.0	0.4	0.0	4.4	2.9	78.0	0.0	0.1	0.0	0.3	0.5	0.4	1.0	0.0	0.1	0.4	0.9	0.0	10.2	0.6
INSIG1	"CL-6, MGC1405"	ENSG00000186480	"Insulin induced gene 1"	O15503	7	155297776-155310235	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 563.4"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 4121.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 142.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"intermediate monocyte: 272.8;non-classical monocyte: 500.8"	"Lineage enriched"	"Detected in all"	6	"monocytes: 500.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 1228.9;RPMI-8226: 605.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071524			Uncertain	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA071524: "	"unprognostic (8.11e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.62e-4)"	"unprognostic (4.97e-2)"	79.2	37.3	25.3	35.4	36.9	45.5	37.4	47.1	39.1	25.5	58.0	29.8	53.0	19.5	31.8	40.1	17.6	31.6	21.0	30.2	40.9	45.6	563.4	43.2	30.9	61.1	51.7	24.0	111.7	17.4	18.9	34.2	62.8	62.6	26.4	40.5	70.9	11.3	9.0	42.5	35.2	20.3	36.6	19.0	61.1	34.4	36.5	40.4	12.5	12.0	25.3	36.7	23.3	86.3	158.9	29.0	76.8	48.1	200.6	265.5	41.9	12.5	179.1	36.9	242.6	18.1	225.2	104.0	35.7	98.2	282.2	83.9	53.1	92.6	43.3	32.3	155.5	28.6	51.7	0.0	99.0	49.3	448.7	165.6	50.4	281.8	25.8	27.3	49.8	202.8	53.2	1228.9	47.9	82.2	238.7	128.6	80.0	30.4	20.4	43.5	0.2	605.1	291.6	77.8	57.2	45.5	41.6	29.9	67.8	28.7	29.0	162.0	56.3	40.5	11.8	77.2	33.3	296.8	57.4	93.3	177.6	187.2	38.2	21.3	29.7	13.4	49.3	272.8	25.5	46.5	32.8	41.9	78.5	60.2	32.6	36.7	62.6	27.5	500.8	44.7	77.0	85.2	25.3	36.9	47.1	39.1	30.2	40.9	61.1	51.7	62.8	36.6	36.5	86.3	91.4	41.7	121.5	39.8	100.5	140.2	59.4	148.2	74.6	16.5	58.0	31.6	43.6	35.8	114.4	40.5	10.4	47.7	79.0	129.1	17.6	52.0	21.2	30.8	11.6	135.6	126.8	38.3	11.1	140.4	189.0	120.4	57.6	67.4	60.4	18.1	33.2	828.9	46.9	38.7	16.9	91.5	185.1	63.6	4121.3	9.7	15.8	381.0	247.3	7.5	29.6	88.7	34.0	17.1	61.8	53.6	86.6	18.4	100.1	180.4	29.1	9.4	68.3	18.1	19.7	36.3	62.0	33.6	45.0	135.8	155.3	130.4	108.2	20.6	48.0	158.5
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 15.8;heart muscle: 14.3;skin 1: 22.5;vagina: 12.2"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 48.6;Basal squamous epithelial cells: 50.7;Breast myoepithelial cells: 15.6;Prostatic glandular cells: 13.3;Squamous epithelial cells: 26.5;Suprabasal keratinocytes: 20.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 5.4;head and neck cancer: 7.3;lung cancer: 1.8;prostate cancer: 6.9;testis cancer: 7.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.8;HaCaT: 16.3;HBEC3-KT: 8.1;MCF7: 8.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"medulla oblongata: 1.2;pons: 1.5"	HPA064094			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Vesicles"		"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.2	0.0	0.0	0.0	0.0	0.1	3.2	0.7	0.0	3.7	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	14.3	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.9	0.0	1.2	9.9	0.0	0.0	9.5	0.0	0.6	22.5	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	16.3	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	8.3	1.1	0.1	0.1	4.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.8	0.7	1.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	48.6	2.8	0.1	50.7	0.0	1.4	15.6	6.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.1	26.5	20.2	3.7	0.0	0.0	0.0	1.7
ITPR3	IP3R3	ENSG00000096433	"Inositol 1,4,5-trisphosphate receptor type 3"	Q14573	6	33620365-33696574	"Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.0;Gastric mucus-secreting cells: 127.4;Late spermatids: 220.4;Pancreatic endocrine cells: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 164.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003915, HPA064704"	Approved		Uncertain	Vesicles		No	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA003915: AB_1851845, HPA064704: "	"unprognostic (2.57e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.08e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-2)"	16.3	11.4	5.5	17.0	5.0	6.1	14.6	3.8	5.3	18.0	3.7	26.2	29.1	8.5	13.1	18.1	14.0	15.3	15.0	3.8	3.9	16.4	2.2	30.6	20.4	5.6	5.0	13.5	11.3	2.8	7.4	4.3	5.2	13.9	18.4	0.8	18.5	11.2	4.5	58.9	35.1	4.7	4.7	39.8	41.5	15.4	7.0	14.3	54.0	5.1	21.0	12.1	24.0	3.9	73.7	34.0	6.3	0.3	6.2	19.3	40.9	24.8	62.8	30.5	27.4	46.7	55.9	62.6	26.1	17.9	76.1	70.9	28.6	66.7	15.7	36.8	24.0	0.1	102.6	52.0	14.1	11.3	7.9	14.0	59.2	76.7	164.7	66.5	52.1	24.5	25.0	19.7	33.3	35.0	19.0	6.4	6.2	55.8	49.4	29.0	0.1	37.1	107.6	50.9	57.3	2.1	42.8	61.6	60.2	6.9	21.2	5.9	71.8	41.1	20.1	53.1	55.2	13.5	14.3	29.4	32.8	16.6	24.1	0.8	0.0	0.0	0.8	0.0	0.6	0.4	0.4	0.5	0.0	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.7	0.2	5.5	5.0	3.8	5.3	3.8	3.9	5.6	5.0	5.2	4.7	7.0	3.9	12.4	48.1	58.9	0.3	13.5	26.5	10.9	27.9	18.2	1.5	9.3	9.9	2.7	12.8	20.2	31.3	0.0	0.3	10.9	52.9	0.0	28.4	123.0	19.1	9.1	18.2	23.9	6.6	1.1	30.2	6.3	9.2	127.4	43.1	0.0	0.2	12.5	0.4	0.5	0.0	1.6	41.6	10.2	0.6	6.9	220.4	23.3	2.6	12.4	23.4	3.2	0.4	4.1	0.5	0.4	89.7	41.6	13.9	18.7	20.5	45.9	0.2	12.1	1.2	6.6	3.9	3.3	1.6	3.2	14.5	25.4	0.5	13.1	5.8	35.6	20.7
ITPRIP	"bA127L20.2, DANGER, KIAA1754"	ENSG00000148841	"Inositol 1,4,5-trisphosphate receptor interacting protein"	Q8IWB1	10	104309698-104338465	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 203.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 98.0;Hepatic stellate cells: 82.1;Squamous epithelial cells: 108.4;Suprabasal keratinocytes: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 30.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 103.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043626			Uncertain	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"HPA043626: AB_10963078"	"unprognostic (2.45e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.20e-1)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (9.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.11e-3)"	36.3	13.7	5.7	16.9	5.9	203.2	25.4	5.3	10.5	31.6	15.5	13.6	3.1	16.3	3.7	52.9	15.1	21.2	72.5	5.5	6.6	18.0	13.3	38.5	10.4	8.0	6.3	29.1	9.4	8.0	15.9	26.8	6.4	14.0	5.0	1.7	14.1	9.0	10.1	66.3	8.8	18.2	7.0	12.6	12.3	7.4	8.0	12.8	21.1	10.4	11.9	23.7	43.5	7.7	6.4	16.1	19.2	8.6	32.8	31.4	10.9	35.0	75.9	25.8	32.0	1.2	2.8	11.2	7.7	22.5	51.2	20.7	6.5	17.4	26.6	9.6	7.6	6.6	24.6	4.9	64.3	15.9	12.3	29.2	103.5	53.8	42.8	29.9	48.7	11.4	28.4	21.5	32.0	2.7	3.1	17.0	14.3	2.2	17.9	14.3	9.9	6.8	10.6	2.8	10.7	7.0	6.7	7.8	16.0	11.6	0.6	11.8	82.7	51.9	13.6	34.5	34.5	7.8	9.8	7.3	38.0	27.9	24.8	4.4	9.5	14.0	4.5	5.8	4.5	2.5	2.7	2.6	6.2	2.8	3.2	2.9	30.6	5.0	5.8	4.2	2.3	21.3	5.7	5.9	5.3	10.5	5.5	6.6	8.0	6.3	6.4	7.0	8.0	7.7	98.0	3.2	8.3	1.3	9.0	37.9	15.3	13.2	44.3	0.0	3.0	2.4	7.8	1.5	9.0	3.7	0.0	7.3	37.0	1.7	0.0	3.7	6.3	11.7	10.0	42.5	0.0	8.8	0.6	2.4	22.6	15.5	3.6	46.7	20.3	3.6	82.1	2.3	10.8	0.0	0.4	2.6	2.0	17.2	20.6	1.6	5.0	28.1	8.8	6.5	7.0	3.8	10.3	0.5	0.9	3.0	0.5	5.7	13.6	5.8	0.2	0.5	5.2	0.6	13.1	6.3	14.7	8.1	1.8	108.4	72.7	5.1	23.8	4.4	1.1	20.5
JMJD4	FLJ12517	ENSG00000081692	"Jumonji domain containing 4"	Q9H9V9	1	227730425-227735411	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 74.0;Late spermatids: 204.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027260, HPA052861"	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Vesicles	"HPA027260: AB_10602608, HPA052861: AB_2681975"	"unprognostic (1.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.68e-3)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.68e-1)"	6.8	12.8	8.5	4.8	7.9	3.6	7.1	7.7	9.4	6.2	8.1	6.2	4.3	8.1	4.8	6.8	7.0	4.1	7.4	8.6	8.4	7.4	11.9	5.2	6.9	9.0	9.2	7.9	9.6	5.8	10.0	4.0	9.3	9.7	2.4	1.6	8.7	5.6	10.2	6.0	6.2	4.2	8.3	9.0	5.9	14.8	8.6	6.5	6.4	4.7	4.4	6.8	4.6	8.9	18.4	26.4	8.4	9.3	9.0	5.1	31.0	11.3	11.6	17.0	10.4	22.6	15.2	24.3	16.8	10.7	9.1	18.1	5.8	17.9	2.0	13.2	29.4	14.9	13.3	17.8	15.8	15.7	7.1	9.0	11.1	16.2	11.8	6.7	8.8	17.5	19.7	7.8	8.3	15.4	19.5	8.3	14.6	13.9	42.2	17.8	10.3	21.9	10.1	16.7	16.4	11.1	10.8	37.4	14.5	4.3	30.2	16.9	7.7	8.6	8.8	10.6	21.0	14.5	5.0	9.3	8.6	7.6	24.1	3.2	7.2	2.8	11.1	7.4	12.2	8.7	8.4	7.7	6.6	8.6	13.1	11.4	0.7	14.3	4.1	13.2	10.2	8.0	8.5	7.9	7.7	9.4	8.6	8.4	9.0	9.2	9.3	8.3	8.6	8.9	7.0	6.4	7.2	4.6	7.9	4.1	8.0	8.6	1.8	14.0	16.6	13.2	3.7	4.3	7.4	7.3	0.0	13.1	7.2	8.8	5.9	21.7	74.0	5.2	11.0	6.9	9.0	13.9	4.4	28.9	14.0	9.7	10.7	4.9	7.0	12.7	6.8	14.5	16.9	11.8	3.3	6.9	2.0	7.6	2.1	204.9	11.5	6.1	12.4	2.8	11.0	12.2	13.4	3.0	2.1	23.7	5.6	4.1	14.7	11.0	12.9	12.5	7.7	14.7	6.6	6.7	8.2	36.1	7.5	7.4	4.7	9.6	7.3	13.3	7.3	7.5
JTB	"hJT, PAR"	ENSG00000143543	"Jumping translocation breakpoint"	O76095	1	153974269-153977674	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006514	Approved		Uncertain	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA006514: AB_1079164"	"unprognostic (1.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.40e-1)"	"unprognostic (5.66e-3)"	"unprognostic (8.62e-3)"	"unprognostic (5.60e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.00e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.58e-3)"	105.6	119.8	121.1	60.4	125.1	127.0	103.0	122.3	153.9	99.8	149.0	117.8	89.5	89.8	96.3	110.8	91.8	53.7	121.0	120.8	122.2	135.4	207.1	110.2	80.4	125.4	122.2	98.4	232.2	93.9	185.9	68.0	121.5	131.0	86.7	49.8	162.0	68.0	166.5	99.8	115.3	50.1	123.3	136.9	164.8	46.6	126.6	77.7	120.5	82.7	80.2	96.3	89.4	123.4	206.3	139.4	57.9	108.0	189.0	116.2	163.5	144.6	142.3	95.9	96.0	135.3	166.7	193.7	198.7	171.8	59.1	181.0	151.0	113.2	78.1	180.5	296.0	112.5	158.4	139.0	198.1	221.4	165.7	110.4	210.4	101.1	119.1	131.0	115.4	223.7	169.3	139.2	68.4	359.6	161.5	280.5	125.8	402.1	239.1	163.9	79.3	393.1	123.7	110.9	158.4	158.8	115.3	332.7	208.4	107.4	209.1	316.4	89.6	46.5	80.4	144.4	189.0	201.8	244.7	211.3	114.5	209.6	103.7	98.7	119.5	173.2	74.7	86.4	90.9	143.5	104.0	118.7	88.9	139.9	107.0	85.6	104.9	85.3	96.5	147.4	98.5	97.7	121.1	125.1	122.3	153.9	120.8	122.2	125.4	122.2	121.5	123.3	126.6	123.4	127.7	80.1	101.1	15.7	184.3	156.8	177.4	227.5	104.7	56.6	253.4	207.3	96.5	213.1	171.4	99.3	22.9	308.8	237.3	273.4	258.2	251.9	7.1	145.0	95.3	120.4	212.0	178.8	26.3	411.8	405.0	155.6	149.9	125.9	82.5	113.2	125.7	341.3	289.1	57.2	24.0	423.4	213.6	235.8	185.8	20.1	151.6	176.3	170.7	19.7	207.9	140.4	257.5	19.6	29.1	274.1	302.2	123.4	344.8	346.0	368.2	274.1	138.2	60.2	105.2	105.3	114.0	58.9	71.5	173.4	190.2	289.5	173.6	136.6	315.2	304.0
KANSL3	"FLJ10081, KIAA1310, NSL3, Rcd1"	ENSG00000114982	"KAT8 regulatory NSL complex subunit 3"	Q9P2N6	2	96593170-96642787	"Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035017, HPA035018"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Vesicles	"HPA035017: AB_2674414, HPA035018: AB_10601763"	"unprognostic (2.19e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-3)"	"unprognostic (4.99e-3)"	11.8	9.9	1.9	8.6	2.4	14.9	12.3	1.6	3.1	13.7	8.1	11.8	7.2	15.0	7.7	8.9	12.5	6.9	10.7	2.9	2.6	8.8	6.4	9.9	8.2	2.1	2.9	15.1	9.8	15.1	8.8	9.0	2.3	11.2	6.9	6.3	12.5	14.7	33.9	10.8	12.0	10.6	3.3	10.1	9.8	12.8	3.3	13.1	12.9	21.1	8.9	13.0	10.8	2.3	13.1	7.9	26.0	19.4	10.6	6.4	11.4	9.7	15.2	20.1	21.4	15.1	7.8	18.1	14.6	16.2	14.7	8.2	18.8	9.4	17.5	12.8	14.8	26.0	8.1	16.2	15.0	17.4	9.0	15.0	5.8	12.8	11.4	12.0	11.0	21.0	18.6	12.8	12.8	6.9	32.3	13.5	12.5	6.7	12.8	26.2	16.5	10.6	12.4	12.7	26.8	16.9	12.3	11.8	11.8	14.7	11.4	5.5	15.9	13.5	11.8	9.8	8.9	10.1	6.7	15.7	7.0	19.9	12.2	2.4	1.3	0.5	2.8	1.5	2.1	1.6	1.7	2.9	0.7	1.5	1.2	2.3	0.2	3.1	1.3	0.7	1.1	1.7	1.9	2.4	1.6	3.1	2.9	2.6	2.1	2.9	2.3	3.3	3.3	2.3	11.6	44.8	30.8	29.0	10.5	4.6	9.9	8.1	9.1	15.0	14.8	12.2	23.8	10.0	18.8	11.0	43.8	8.1	10.0	15.0	3.9	10.5	13.4	13.0	13.7	12.1	13.1	6.7	35.6	9.6	4.3	12.7	17.3	13.5	18.3	33.1	15.7	12.7	8.1	15.2	36.2	18.4	10.2	12.5	5.6	28.6	9.9	11.2	7.2	16.9	13.7	10.2	9.2	29.7	37.3	13.2	7.9	12.8	10.6	10.3	10.7	5.8	13.1	29.5	13.1	16.0	13.6	23.3	9.7	11.3	6.5	11.1	14.2	18.3	15.6	10.1
KAT5	"cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5"	ENSG00000172977	"Lysine acetyltransferase 5"	Q92993	11	65711996-65719604	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016953, HPA074328"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Vesicles, Cytosol"	"HPA016953: AB_1851277, HPA074328: "	"unprognostic (2.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.10e-13)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-2)"	31.6	30.0	38.7	23.8	41.0	52.9	32.1	41.7	48.8	39.5	38.6	43.6	21.6	45.1	33.7	34.9	44.9	20.5	32.4	37.9	38.9	32.9	26.3	29.5	28.0	40.0	39.5	39.2	32.7	45.6	33.7	29.9	41.2	33.1	27.0	31.0	29.6	36.3	42.8	47.6	32.2	35.2	40.0	34.3	35.9	45.2	39.9	39.3	38.2	34.6	30.2	39.5	34.8	43.8	37.2	44.1	40.1	29.6	31.3	32.7	41.1	26.7	43.6	44.0	38.0	32.6	42.2	34.3	36.2	47.4	47.5	30.8	50.8	45.1	26.4	44.4	32.5	50.6	36.3	38.9	44.6	55.7	56.4	35.2	49.7	28.9	59.0	33.7	28.1	39.1	52.5	51.1	42.0	68.2	45.7	62.3	33.9	26.8	28.4	38.2	26.5	63.3	40.6	56.2	37.1	38.9	25.4	46.5	51.2	20.8	45.9	34.2	36.3	33.9	30.4	27.6	28.0	38.7	43.7	50.4	29.7	27.0	29.3	42.7	33.6	58.8	33.4	32.0	29.6	28.2	28.8	34.2	34.1	30.4	36.5	29.8	34.8	35.8	34.6	20.9	31.0	36.4	38.7	41.0	41.7	48.8	37.9	38.9	40.0	39.5	41.2	40.0	39.9	43.8	17.6	12.8	17.5	10.7	26.0	21.2	44.2	60.2	17.6	44.9	17.3	15.0	1.0	25.8	33.8	29.5	31.3	51.3	25.6	27.1	35.2	42.2	11.1	20.2	14.2	18.7	30.4	12.4	7.5	51.5	42.6	21.1	20.4	19.8	33.7	27.0	18.2	10.9	36.3	38.7	8.7	25.1	42.7	17.6	15.2	11.1	28.0	20.4	42.7	3.7	38.8	40.3	33.0	7.1	13.8	39.4	30.6	38.7	10.4	24.2	23.3	32.6	30.0	44.8	46.0	27.6	27.0	61.1	27.8	14.6	21.3	102.5	21.6	29.2	26.2	31.0
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium inwardly rectifying channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 196.1;parathyroid gland: 269.2;thyroid gland: 139.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 54.3;Collecting duct cells: 244.6;Distal tubular cells: 41.1;Oligodendrocyte precursor cells: 54.8;Proximal tubular cells: 95.2"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 279.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.58e-4)"	"unprognostic (3.88e-1)"	0.3	0.4	10.0	0.4	14.0	0.6	3.8	22.7	11.6	0.1	2.3	0.6	0.7	0.5	15.9	0.3	5.1	18.8	0.6	6.8	39.5	196.1	1.3	0.9	0.8	39.7	37.6	0.2	44.2	269.2	1.0	0.9	25.7	0.2	0.2	1.2	11.8	21.7	0.3	0.8	2.5	0.0	29.9	1.5	23.4	1.7	27.3	0.2	139.4	0.0	0.1	0.0	0.0	20.8	0.1	0.4	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.8	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	12.7	0.0	0.0	279.8	0.2	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.2	0.8	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.3	0.3	0.1	0.0	0.3	0.2	0.2	1.6	0.3	0.0	0.1	0.3	0.1	10.0	14.0	22.7	11.6	6.8	39.5	39.7	37.6	25.7	29.9	27.3	20.8	0.1	0.0	0.0	12.1	0.0	0.0	0.0	2.7	0.0	0.0	2.3	1.1	0.4	54.3	2.6	244.6	0.0	0.0	0.0	0.0	41.1	12.4	0.0	2.8	0.1	0.0	0.0	0.0	1.0	1.4	0.0	0.3	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	54.8	0.1	6.0	0.0	0.0	0.0	0.0	1.0	95.2	9.8	0.0	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0
KCNRG		ENSG00000198553	"Potassium channel regulator"	Q8N5I3	13	50015254-50020922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"fallopian tube: 35.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.4;Endometrial ciliated cells: 46.0;Late spermatids: 12.6;Respiratory ciliated cells: 88.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001027			Uncertain	Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA001027: "	"unprognostic (1.85e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-2)"	"prognostic favorable (2.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.16e-2)"	0.6	0.3	0.5	0.6	2.3	1.9	0.8	3.2	1.6	1.4	0.1	0.6	0.5	1.3	0.5	0.8	35.7	0.4	0.6	0.5	1.2	0.8	0.4	3.1	0.6	2.1	0.9	0.5	0.4	1.1	0.5	0.2	1.3	0.6	0.8	0.8	0.5	0.4	0.6	0.9	0.6	0.5	0.6	0.6	0.5	2.0	1.5	0.6	0.5	0.5	0.6	0.7	0.5	3.5	0.4	0.3	1.1	0.4	0.4	0.5	0.2	0.0	0.9	0.8	0.0	1.3	0.4	0.8	0.2	1.1	0.5	0.5	0.8	0.3	0.6	0.6	0.5	1.7	0.5	0.7	1.0	1.5	0.4	0.6	0.8	0.5	1.4	0.7	1.6	3.1	0.7	0.1	1.0	0.5	1.6	1.5	0.9	1.0	0.6	1.0	0.0	0.0	0.7	1.0	1.0	2.2	0.3	0.7	0.8	0.6	0.6	0.4	0.5	0.7	0.3	0.4	0.3	0.1	0.2	0.9	0.2	0.5	0.2	1.0	0.3	0.2	0.1	0.3	0.2	0.4	0.1	0.3	0.3	0.6	0.2	0.2	1.2	0.4	0.2	0.3	0.4	0.1	0.5	2.3	3.2	1.6	0.5	1.2	2.1	0.9	1.3	0.6	1.5	3.5	1.1	0.0	2.7	0.7	0.9	0.1	0.9	3.8	0.0	1.0	0.6	0.9	0.5	0.0	6.2	0.0	2.1	0.8	0.5	0.8	0.0	0.5	19.4	46.0	1.0	0.8	4.2	0.0	0.7	1.4	0.5	0.8	0.0	1.0	0.0	0.5	0.0	0.3	0.5	3.3	0.7	0.9	0.0	0.0	0.3	12.6	0.6	1.3	0.0	0.0	1.3	0.7	0.0	1.0	0.5	0.6	0.3	0.7	0.0	0.9	0.8	2.1	88.6	1.2	0.0	1.4	1.5	11.4	1.5	0.0	0.1	0.7	0.5	0.5	0.7	1.3
KLF15	KKLF	ENSG00000163884	"Kruppel like factor 15"	Q9UIH9	3	126342635-126357408	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 92.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.9;Cardiomyocytes: 29.7;Distal tubular cells: 29.4;Hepatocytes: 66.9;Peritubular cells: 19.9;Proximal tubular cells: 22.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 57.4;HHSteC: 34.8;RPMI-8226: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003286, HPA028866"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA003286: , HPA028866: AB_10600819"	"unprognostic (3.77e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (3.27e-7)"	"unprognostic (6.75e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.58e-3)"	36.5	6.2	42.2	0.8	50.7	0.1	25.4	45.1	69.5	15.8	37.5	18.6	1.2	19.1	4.1	7.1	29.7	3.5	31.4	41.7	40.6	20.3	92.5	18.6	1.8	64.9	45.9	46.3	48.5	4.5	10.4	1.7	47.2	17.6	0.9	3.9	19.7	5.2	67.3	10.3	10.2	2.5	44.9	3.6	30.2	5.6	44.7	1.2	11.1	32.4	0.8	27.0	12.0	48.4	0.8	0.0	2.2	9.2	57.4	1.0	10.0	0.6	1.4	0.7	1.3	1.1	0.0	3.4	0.9	0.0	1.7	0.1	5.3	0.1	0.2	0.2	2.0	0.1	0.8	7.9	34.8	0.0	0.2	5.4	0.5	0.0	1.2	0.0	0.6	4.5	4.3	7.4	0.2	0.7	0.0	1.3	6.6	1.3	0.3	4.7	0.2	20.2	0.1	0.8	0.7	7.7	0.1	0.3	10.2	3.3	0.5	4.6	0.3	0.3	0.4	0.3	0.3	4.7	0.6	0.7	0.2	1.5	1.3	25.1	7.6	10.3	7.0	10.2	8.2	12.3	7.3	7.4	8.2	11.4	9.4	11.3	16.7	12.8	9.3	9.0	10.5	11.7	42.2	50.7	45.1	69.5	41.7	40.6	64.9	45.9	47.2	44.9	44.7	48.4	1.5	6.4	4.6	22.9	0.8	0.0	2.9	0.2	0.6	1.3	7.8	1.8	29.7	15.7	0.7	0.0	0.0	0.1	0.1	0.0	29.4	0.1	0.1	2.5	4.4	2.1	0.0	2.7	0.6	0.0	0.2	8.1	3.1	3.4	0.0	13.7	8.2	66.9	0.1	0.0	2.8	0.1	0.0	2.6	0.0	0.8	12.2	0.4	1.8	2.8	0.0	12.0	0.0	15.1	5.7	0.4	0.0	19.9	0.9	5.2	0.0	22.1	0.8	3.3	0.0	12.0	5.5	0.1	0.1	0.3	0.0	0.3	0.5	0.6	0.1	1.8
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077541	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 242.0;skin 1: 234.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1105.5;Basal squamous epithelial cells: 757.5;Glandular and luminal cells: 678.2;Squamous epithelial cells: 1028.4;Suprabasal keratinocytes: 685.9;Urothelial cells: 1495.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	21	"basophil: 24.0"	"Lineage enriched"	"Detected in single"	140	"granulocytes: 24.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 111.8;HaCaT: 128.8;HBEC3-KT: 112.2;hTCEpi: 156.1;OE19: 246.3;RT4: 136.3;SiHa: 114.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 23.2"	HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	6.5	5.9	4.2	18.0	9.1	63.5	36.2	0.6	3.3	49.9	2.7	161.2	130.4	6.7	6.6	242.0	37.5	55.9	3.3	2.6	3.4	8.5	4.7	29.6	2.0	0.8	3.4	4.5	11.9	0.5	10.9	18.8	0.7	23.1	145.4	0.4	79.8	14.4	19.2	234.9	146.2	6.6	0.5	1.5	82.2	12.0	4.1	12.0	25.7	7.8	53.6	111.5	122.2	1.0	22.3	31.1	0.2	0.4	1.1	1.5	34.1	12.9	29.8	5.6	6.9	28.5	111.8	0.4	68.9	11.4	2.3	128.8	39.0	112.2	8.9	0.9	11.0	0.4	61.9	2.8	7.8	10.5	1.9	8.1	156.1	1.7	61.1	5.7	0.1	3.8	1.6	2.2	25.5	7.9	2.1	0.8	1.4	246.3	43.3	2.0	28.3	2.5	87.3	136.3	2.9	1.3	114.5	18.3	8.5	13.9	2.5	2.5	0.3	7.8	23.1	0.2	5.4	3.7	1.9	3.8	10.8	2.1	9.5	24.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	4.2	9.1	0.6	3.3	2.6	3.4	0.8	3.4	0.7	0.5	4.1	1.0	7.8	163.5	123.3	0.7	5.2	518.9	1105.5	185.6	757.5	0.4	79.9	57.0	6.0	91.5	218.5	36.8	2.1	77.8	4.6	420.7	21.5	31.8	448.3	302.1	44.1	12.5	203.2	0.4	1.6	46.1	98.5	33.4	425.1	678.2	3.8	0.9	2.2	4.7	6.1	10.1	11.6	387.4	46.8	0.9	34.6	241.4	6.5	12.4	58.7	1.9	4.3	0.0	1.0	1.0	0.6	88.6	374.9	1.5	15.7	632.1	260.0	3.5	159.3	0.2	0.0	38.4	32.4	8.8	26.3	1028.4	685.9	58.0	17.4	0.5	505.4	1495.5
KLF6	"BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9"	ENSG00000067082	"Kruppel like factor 6"	Q99612	10	3775996-3785281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 436.6"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 2075.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013529, HPA069585"	Supported		Supported	Nucleoplasm,Nucleoli,Vesicles,Cytosol		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Vesicles, Cytosol"	"CAB013529: AB_2533431, HPA069585: AB_2686157"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.35e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (8.07e-3)"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.37e-2)"	211.3	46.9	19.0	122.1	18.0	436.6	129.7	19.2	22.4	95.4	21.9	92.1	55.4	98.1	17.7	165.5	77.2	181.9	49.7	18.0	19.2	64.1	141.8	117.0	65.4	29.4	20.1	47.3	118.3	31.8	12.0	98.2	25.2	32.8	99.6	18.4	73.8	33.7	84.9	197.1	106.0	208.2	22.7	64.3	73.2	14.6	23.0	56.8	193.9	41.3	45.0	136.3	92.7	25.0	55.0	14.7	27.2	9.0	155.1	154.3	17.1	91.7	46.5	95.9	64.8	38.0	71.4	15.6	20.8	100.0	74.5	32.7	17.0	84.9	79.5	76.6	10.2	2.2	17.5	35.8	66.4	10.3	51.5	51.4	158.2	68.6	129.3	34.2	99.3	10.1	17.5	117.9	123.6	4.0	19.4	15.9	10.2	29.2	26.0	12.6	28.2	55.5	94.1	53.4	12.0	11.5	22.5	64.0	142.8	73.5	32.0	8.6	130.9	128.7	17.8	76.9	43.0	22.6	78.1	28.6	34.7	13.7	40.8	318.8	85.2	234.1	129.8	74.2	115.9	81.1	147.4	131.5	67.6	70.9	44.9	69.0	391.6	72.5	104.6	152.8	120.6	148.7	19.0	18.0	19.2	22.4	18.0	19.2	29.4	20.1	25.2	22.7	23.0	25.0	511.0	1246.8	489.4	14.0	716.9	585.5	1298.4	625.8	1227.0	39.6	985.9	630.0	63.6	544.7	451.9	138.0	33.3	163.1	518.3	1507.0	21.5	808.6	58.0	1065.6	618.9	469.9	397.3	77.9	18.5	553.0	473.8	545.5	1120.3	1905.9	626.7	195.9	248.4	309.9	583.6	37.0	10.0	746.7	429.3	968.7	885.1	53.2	130.5	992.1	483.8	58.1	609.8	42.9	150.4	7.5	4.3	857.9	949.9	133.9	1172.5	600.2	1009.9	97.4	342.0	90.1	138.1	194.8	441.8	9.0	19.4	2075.6	628.2	195.9	920.5	67.1	542.0	572.5
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412315-10420595	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;brain: 2.1;lymphoid tissue: 4.0"	"Group enriched"	"Detected in some"	4	"dendritic cells: 19.2;Oligodendrocyte precursor cells: 36.2;T-cells: 15.9"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 63.1"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 63.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.4;GAMG: 2.8;HEL: 1.3;HeLa: 7.0;HSkMC: 1.2;SuSa: 1.3;U-698: 1.9"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA039910: , HPA062570: AB_2684795"	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"		0.2	0.1	1.3	0.3	1.4	1.9	0.1	0.7	2.1	0.1	0.2	0.5	0.8	0.5	0.1	0.2	0.2	0.6	0.0	1.3	1.7	0.1	0.5	0.6	1.7	1.7	1.1	0.1	0.1	0.0	0.0	0.1	1.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	1.3	0.1	1.3	4.0	0.6	0.2	1.3	0.4	0.1	0.0	0.8	0.1	0.1	2.1	0.0	0.0	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.6	0.0	0.0	0.0	1.3	7.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	7.0	0.0	0.0	0.1	8.7	0.6	63.1	0.0	0.0	0.0	3.6	1.3	1.4	0.7	2.1	1.3	1.7	1.7	1.1	1.2	1.3	1.3	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.7	0.1	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	1.0	36.2	2.3	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.1
KRIT1	"CAM, CCM1"	ENSG00000001631	"KRIT1 ankyrin repeat containing"	O00522	7	92198969-92246166	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 177.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049606	Supported		Uncertain	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"HPA049606: AB_2680832"	"unprognostic (8.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.04e-1)"	11.4	13.6	6.5	16.2	8.9	8.5	11.8	15.8	11.3	13.1	11.7	12.1	14.5	17.1	14.1	13.3	14.0	15.7	18.9	7.4	9.5	14.1	12.1	10.7	14.7	6.7	6.9	20.3	15.9	23.8	11.4	13.6	7.9	12.1	12.6	16.3	14.1	11.2	16.3	14.0	12.2	14.1	5.7	14.7	13.7	18.8	7.8	19.4	22.4	17.5	15.8	13.6	10.8	14.2	27.6	22.0	26.8	27.4	21.2	15.9	19.6	25.5	18.3	12.0	12.3	18.8	31.1	25.9	24.6	14.8	25.9	24.1	21.9	12.7	18.5	23.0	31.4	25.2	26.6	13.2	15.2	34.9	34.5	22.3	21.8	15.0	16.9	20.7	16.2	21.8	51.4	40.5	18.9	30.7	40.6	26.0	26.6	22.4	16.3	28.4	35.5	34.1	10.8	30.9	27.4	33.5	27.7	38.3	22.9	28.2	22.0	20.6	25.1	37.3	28.2	46.9	18.3	25.6	31.1	50.4	19.5	29.6	34.4	13.4	5.5	5.4	6.5	4.0	6.6	10.8	7.5	9.5	5.6	8.5	9.5	8.3	2.2	12.0	2.9	7.6	7.7	3.3	6.5	8.9	15.8	11.3	7.4	9.5	6.7	6.9	7.9	5.7	7.8	14.2	40.6	16.0	34.3	47.0	38.9	19.9	25.7	27.3	40.5	43.7	35.5	34.3	27.6	20.0	26.8	42.3	33.3	37.3	39.2	22.0	46.9	24.0	29.7	30.0	44.1	36.2	20.4	29.2	76.9	24.2	30.0	39.7	35.7	27.9	36.7	49.4	44.6	29.7	19.3	28.6	92.6	23.1	20.3	22.1	16.2	19.5	51.3	23.4	7.2	35.6	29.9	39.9	41.2	46.8	115.4	22.1	33.1	54.2	38.0	22.4	32.2	36.3	36.9	53.1	39.5	43.8	36.8	177.1	90.1	43.1	25.1	28.0	33.0	41.8	23.7	20.5
L3HYPDH	"C14orf149, FLJ25436"	ENSG00000126790	"Trans-L-3-hydroxyproline dehydratase"	Q96EM0	14	59460363-59484408	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056694	Approved		Uncertain	Vesicles		NA	NA		49000	"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA056694: AB_2683210"	"unprognostic (3.39e-2)"	"unprognostic (5.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.14e-1)"	18.1	14.0	4.8	12.5	5.2	4.8	16.3	9.9	6.6	15.9	10.0	10.6	11.0	16.0	8.5	9.2	15.4	11.5	14.8	5.0	5.8	17.4	17.3	11.2	17.5	7.9	5.8	18.0	12.6	12.2	14.8	10.4	7.4	13.5	10.2	5.2	13.0	11.9	8.9	9.7	13.8	11.9	5.6	13.0	10.5	17.1	4.8	4.3	16.6	5.6	13.7	13.4	14.5	8.3	12.0	31.8	6.8	16.2	14.4	37.6	9.5	31.7	25.1	17.9	17.4	6.4	21.1	4.1	13.0	17.7	31.8	31.8	11.1	17.0	17.7	7.0	14.4	11.0	30.1	23.7	16.2	10.0	7.6	27.3	11.4	18.0	27.6	27.8	22.3	11.3	14.8	18.4	18.8	14.3	3.8	16.4	10.9	4.7	28.5	5.5	11.1	16.6	28.7	6.8	6.9	9.9	29.8	12.2	11.9	5.6	12.8	6.4	31.3	20.9	25.6	16.4	37.5	4.7	2.3	4.0	35.9	8.3	41.7	0.0	3.5	0.5	3.2	5.1	2.4	1.5	1.7	2.0	5.7	1.4	2.5	0.9	0.0	5.6	2.4	3.2	0.8	1.8	4.8	5.2	9.9	6.6	5.0	5.8	7.9	5.8	7.4	5.6	4.8	8.3	11.2	3.2	6.1	11.1	10.9	5.2	5.4	4.2	6.2	2.9	5.6	8.6	8.7	5.7	4.3	3.7	2.1	13.7	3.5	1.0	7.9	7.7	12.2	6.8	17.5	8.1	3.0	5.5	26.7	2.5	11.4	16.0	4.6	2.3	14.0	6.5	11.0	16.8	8.3	1.7	18.9	4.3	4.1	4.6	2.9	7.4	19.3	4.9	3.6	10.3	3.5	4.6	4.1	10.6	17.1	4.4	1.0	12.0	5.5	6.6	3.4	47.0	17.3	2.7	13.1	17.4	11.6	14.1	5.7	7.5	3.4	4.9	6.0	11.9	3.5	2.0
LINGO4	LRRN6D	ENSG00000213171	"Leucine rich repeat and Ig domain containing 4"	Q6UY18	1	151800264-151805419	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 21.3;tongue: 5.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 1.8;hypothalamus: 1.0;midbrain: 2.7;pons and medulla: 4.0;thalamus: 1.4"	"Region enriched"	"Detected in many"	7	"spinal cord: 19.7"	HPA060781	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 80: Striated muscle - Unknown function"		"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA060781: AB_2684361"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.94e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.94e-4)"	"unprognostic (3.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (5.60e-2)"	0.0	2.0	0.1	0.1	0.1	0.0	0.1	4.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.7	0.1	0.7	0.3	0.5	0.3	1.1	0.2	0.2	2.8	1.6	0.0	0.4	0.5	1.4	0.0	3.9	0.7	0.1	0.1	0.6	0.2	21.3	0.6	0.2	0.0	1.3	0.1	0.4	0.6	1.6	1.2	0.6	5.6	0.2	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.2	0.3	0.5	2.8	1.6	3.9	1.3	1.6	2.1	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464956-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"testis: 275.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 1002.6;Spermatocytes: 677.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	8.2	16.8	10.7	6.8	10.7	14.9	7.9	11.4	13.1	10.4	10.7	8.9	5.3	10.0	2.3	7.7	13.8	3.9	9.7	13.0	11.5	11.4	15.0	10.1	8.1	12.1	14.4	9.4	9.3	8.7	17.6	3.1	12.2	8.6	2.3	3.4	7.6	6.1	13.2	6.7	17.1	4.2	10.8	24.3	9.0	275.2	12.1	8.7	10.0	5.3	7.3	8.9	7.3	10.2	18.6	24.6	13.0	36.8	9.4	7.2	21.0	19.6	11.9	30.5	20.9	23.7	10.3	44.8	27.5	13.9	36.3	19.2	18.7	16.4	9.0	16.6	39.2	10.0	11.1	14.8	12.7	17.6	17.4	6.7	9.9	35.4	7.5	10.2	16.2	33.9	44.5	13.3	16.8	54.3	53.4	42.1	28.7	22.0	37.8	28.2	12.2	48.5	9.2	11.3	17.7	50.7	21.0	20.1	19.3	14.6	11.2	14.4	11.1	17.3	37.7	54.8	30.8	50.5	94.3	43.6	19.3	17.1	31.4	10.6	2.6	9.9	9.7	4.0	9.0	10.0	8.4	8.4	2.7	11.8	5.2	6.9	5.5	10.5	3.8	9.7	9.3	6.0	10.7	10.7	11.4	13.1	13.0	11.5	12.1	14.4	12.2	10.8	12.1	10.2	9.1	0.0	1.1	5.5	10.6	10.5	6.4	16.5	3.4	11.7	5.5	5.0	0.8	2.8	12.8	12.9	2.1	9.2	10.8	8.6	7.9	12.3	1002.6	54.4	7.3	6.5	7.8	13.7	4.7	10.5	12.4	7.0	10.7	13.7	0.0	14.8	5.7	7.2	8.8	5.0	5.0	9.8	18.3	3.4	4.0	172.3	19.0	5.0	5.4	2.8	7.2	7.9	10.3	4.5	2.8	12.4	11.2	15.8	20.2	3.9	8.6	15.9	65.3	11.4	0.0	5.4	13.6	677.0	38.3	4.5	9.8	6.2	9.3	22.2	7.5	3.4
MAK16	"MAK16L, RBM13"	ENSG00000198042	"MAK16 homolog"	Q9BXY0	8	33485182-33501262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044417, HPA050574"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Vesicles"		"HPA044417: AB_2678935, HPA050574: AB_2681181"	"unprognostic (2.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.47e-1)"	9.9	6.2	4.7	9.3	4.8	9.2	8.9	5.1	5.7	6.6	4.1	5.7	5.4	7.2	5.1	8.0	5.9	6.5	7.0	4.5	6.4	7.2	9.0	5.6	11.1	5.3	6.3	7.5	9.3	5.9	4.5	7.8	5.8	6.1	6.5	4.0	5.6	5.6	8.4	7.4	5.0	7.7	5.3	6.5	5.4	5.6	5.5	8.8	8.5	8.0	10.8	12.2	5.1	6.0	14.1	19.3	13.2	30.6	15.2	18.1	19.9	25.0	16.2	26.4	24.6	28.5	12.0	49.7	23.8	22.1	22.5	18.3	45.6	27.8	35.0	10.8	12.3	46.9	13.2	25.6	22.9	19.3	27.4	19.1	24.8	34.8	40.4	9.4	19.6	33.5	59.5	27.5	22.0	16.1	68.9	22.4	71.4	34.4	13.2	23.9	20.1	22.2	22.2	23.7	33.6	26.7	15.5	21.1	30.4	16.2	14.7	19.5	17.8	24.9	19.3	32.6	28.9	13.8	16.4	50.4	15.3	39.7	27.0	0.0	2.4	0.6	3.2	5.0	3.6	2.0	3.2	2.8	2.9	2.5	4.0	4.3	0.4	4.4	7.9	3.0	2.6	2.3	4.7	4.8	5.1	5.7	4.5	6.4	5.3	6.3	5.8	5.3	5.5	6.0	12.8	16.0	9.7	3.6	12.8	15.6	15.2	5.6	13.1	5.1	7.9	9.0	12.9	10.0	11.3	9.2	2.1	11.5	7.8	3.9	7.9	10.6	1.8	9.8	19.8	12.7	1.8	15.8	5.8	7.8	15.8	15.8	8.2	10.5	9.5	10.8	5.3	7.3	8.7	10.1	6.0	6.7	6.1	5.3	4.7	1.3	9.0	7.8	1.8	2.8	7.7	2.9	10.3	7.1	4.7	11.5	5.0	7.5	12.1	15.3	4.1	10.2	10.5	5.1	6.6	17.6	14.4	13.8	19.2	12.7	14.9	7.5	9.9	13.8	7.4	12.3
MAN1B1	"ERManI, MANA-ER, MRT15"	ENSG00000177239	"Mannosidase alpha class 1B member 1"	Q9UKM7	9	137086985-137109183	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051516	Approved		Uncertain	Vesicles		NA	NA		940000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA051516: AB_2681518"	"unprognostic (1.21e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.67e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.44e-3)"	25.3	32.2	21.3	12.1	21.2	9.1	25.1	21.1	32.9	22.6	26.3	24.1	15.5	20.7	20.4	32.1	22.0	20.1	27.3	22.4	23.1	31.8	39.6	23.0	15.4	22.6	22.7	28.0	36.0	20.0	32.6	21.4	25.2	26.1	9.9	3.6	34.2	15.2	17.6	32.6	22.9	12.1	21.7	28.7	25.6	28.3	22.9	13.8	27.1	9.9	10.1	22.0	21.9	22.8	22.8	50.7	18.2	49.9	67.0	57.7	57.0	37.9	78.4	48.6	43.7	24.9	67.4	20.0	118.8	64.7	69.2	74.3	11.0	36.3	9.1	27.7	17.3	8.7	41.2	33.2	59.6	16.0	33.1	65.1	66.9	29.1	25.1	67.1	32.4	26.5	24.5	32.7	36.4	45.0	16.7	37.8	23.5	67.3	50.0	9.7	30.6	63.9	41.6	11.3	20.4	18.3	55.2	55.9	38.7	9.6	63.5	31.5	46.5	69.6	25.9	52.9	43.6	13.0	11.1	13.3	84.6	19.9	61.6	17.9	31.2	27.0	32.4	34.4	30.2	19.1	25.1	30.4	36.0	16.4	24.3	25.0	9.0	31.0	42.2	26.6	34.5	32.1	21.3	21.2	21.1	32.9	22.4	23.1	22.6	22.7	25.2	21.7	22.9	22.8	18.8	19.2	27.3	23.5	18.3	11.6	12.6	33.0	12.0	20.7	23.5	21.7	10.3	14.3	21.5	25.8	16.7	53.2	24.3	39.1	7.9	32.0	5.8	21.5	16.4	19.7	30.5	14.3	13.0	32.0	72.4	26.9	23.4	20.3	21.0	47.8	25.0	25.2	32.1	30.3	10.2	28.1	22.4	22.9	17.4	6.8	21.1	21.8	23.2	11.2	29.3	16.0	16.5	6.6	12.8	27.6	25.0	21.8	25.4	9.0	35.9	15.9	24.9	19.3	13.1	19.4	20.2	16.1	28.4	16.3	16.2	45.4	21.5	41.1	25.6	8.2
MAN1C1	HMIC	ENSG00000117643	"Mannosidase alpha class 1C member 1"	Q9NR34	1	25616791-25786206	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Excitatory neurons: 72.8;Hepatic stellate cells: 63.9;Hepatocytes: 57.8;Inhibitory neurons: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"AF22: 30.5;HSkMC: 108.9;U-266/70: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048352	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA		1800000	"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Vesicles"		"HPA048352: AB_2680368"	"unprognostic (2.75e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.18e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.18e-2)"	12.5	11.6	13.3	9.4	15.2	2.2	6.2	16.6	16.1	19.6	27.3	10.0	4.5	14.5	7.5	7.0	9.7	18.6	10.1	15.9	16.9	25.4	29.6	9.2	12.4	45.1	23.2	17.3	3.6	24.0	17.1	21.1	26.1	17.6	4.6	11.0	5.7	17.9	4.6	8.1	6.1	19.9	29.4	19.3	7.3	4.2	16.4	10.5	26.0	5.5	9.4	12.3	9.1	37.8	0.1	0.4	30.5	6.4	22.4	17.2	8.6	0.4	5.8	1.4	0.4	0.6	0.2	0.1	0.3	2.3	3.9	0.4	3.0	0.3	0.6	9.8	1.3	0.6	0.5	0.1	2.6	5.2	12.0	108.9	0.5	0.7	0.0	0.4	0.1	1.2	0.1	1.3	0.0	1.6	0.0	5.8	7.8	0.1	0.2	0.6	18.9	0.6	0.2	0.7	17.7	0.6	0.7	4.7	1.5	5.5	2.4	3.6	0.1	0.0	1.6	20.1	0.7	31.7	0.1	0.1	4.6	10.7	1.5	0.3	0.9	0.4	0.3	0.6	0.5	0.2	2.1	0.9	0.3	0.5	4.7	2.7	0.6	0.4	0.8	0.2	0.5	0.7	13.3	15.2	16.6	16.1	15.9	16.9	45.1	23.2	26.1	29.4	16.4	37.8	5.8	3.2	3.2	18.3	2.0	6.6	2.9	3.6	5.2	23.5	1.1	1.5	7.0	4.3	7.3	22.0	54.2	10.6	1.6	0.5	9.8	1.0	0.3	0.4	8.1	8.4	3.0	2.7	72.8	3.8	0.9	23.3	1.1	0.6	2.5	0.3	63.9	57.8	24.8	21.9	65.8	0.1	16.2	19.0	4.3	2.1	27.1	6.8	1.8	39.4	3.3	17.8	3.1	25.1	21.7	1.4	0.3	22.2	2.2	2.0	0.0	23.3	2.2	4.4	6.6	17.0	7.1	0.2	2.9	1.0	5.3	42.7	6.9	0.7	0.2	1.9
METAP1D	"MAP1D, Metap1l"	ENSG00000172878	"Methionyl aminopeptidase type 1D, mitochondrial"	Q6UB28	2	171999943-172082430	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.5;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030298, HPA030299, HPA077742"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA030298: AB_2673419, HPA030299: AB_10602421, HPA077742: "	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.44e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.92e-2)"	4.4	4.9	4.3	2.4	4.5	3.5	3.9	3.7	5.0	5.4	3.7	4.6	2.3	4.5	2.8	3.4	6.7	2.0	4.8	4.1	5.1	4.5	6.0	2.3	2.8	4.1	4.1	11.9	8.1	2.2	4.3	1.8	4.6	5.6	3.2	2.5	4.1	3.7	7.8	3.4	4.1	2.8	3.6	5.8	4.6	2.8	4.3	1.2	3.6	5.6	2.0	4.2	3.8	5.0	3.6	2.8	4.1	13.5	5.9	7.7	8.3	4.1	4.1	6.4	4.1	6.4	4.7	1.8	7.2	4.3	6.6	6.4	9.1	7.2	6.5	6.3	10.6	10.2	7.8	8.6	6.2	6.1	2.6	5.8	10.9	6.4	10.2	5.5	3.6	6.9	14.8	5.1	4.9	4.4	3.5	8.2	7.4	10.4	3.4	7.7	3.5	3.3	4.5	5.0	8.4	3.2	2.9	5.8	10.2	3.6	6.7	8.1	4.4	8.1	6.4	5.0	4.0	6.3	6.1	4.0	5.8	11.9	7.9	0.0	0.0	0.0	0.4	0.4	0.2	0.3	0.5	0.2	0.1	0.7	0.5	1.1	0.0	0.4	0.0	0.0	0.4	0.2	4.3	4.5	3.7	5.0	4.1	5.1	4.1	4.1	4.6	3.6	4.3	5.0	6.1	0.0	4.6	23.8	15.4	5.6	10.3	7.5	22.8	5.8	9.2	8.9	4.5	7.2	3.5	3.7	2.1	4.1	2.7	1.3	7.9	2.5	1.2	2.7	14.7	5.4	0.0	16.8	19.6	3.5	4.7	10.9	8.2	2.5	4.5	17.9	6.4	6.4	3.9	5.0	39.5	2.9	2.0	2.5	2.2	2.3	33.5	2.2	5.4	14.0	1.0	3.7	9.2	35.7	35.5	1.4	1.3	26.4	9.9	4.3	0.6	5.7	2.0	6.1	13.1	18.1	9.5	9.8	12.2	11.6	5.7	1.9	7.5	14.5	5.7	5.1
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831351-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 292.9;lymphoid tissue: 107.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 219.1;Kupffer cells: 408.5;Langerhans cells: 241.7;Macrophages: 412.0;monocytes: 1118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 6012.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 6012.8"	"Group enriched"	"Detected in some"	14	"NB-4: 151.8;THP-1: 282.7;U-937: 185.5"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol"		NA	NA		400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Nucleoli, Nucleoli rim, Vesicles, Cytosol"	"HPA034532: AB_10669677, HPA073215: AB_2686582"	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	24.2	14.9	2.7	82.4	2.8	292.9	6.0	2.9	4.4	6.3	3.2	6.7	3.7	4.0	1.4	7.4	5.7	26.6	4.3	2.6	3.1	3.6	11.5	47.3	15.6	5.2	4.3	2.2	4.8	3.7	1.6	20.4	4.3	3.8	7.7	12.1	5.7	3.5	3.8	5.1	7.7	20.7	5.1	107.8	4.5	5.1	4.2	14.4	3.8	19.0	14.5	23.4	1.8	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	282.7	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	185.5	0.0	155.4	1354.4	243.8	2.6	534.3	3.7	33.5	1.6	1.9	616.5	15.3	1.6	1.4	6012.8	2.8	270.6	9.6	1.5	1099.5	2.7	2.8	2.9	4.4	2.6	3.1	5.2	4.3	4.3	5.1	4.2	5.4	2.6	35.3	56.0	0.0	34.7	2.4	0.0	0.0	0.0	1.2	1.1	3.4	0.9	5.7	9.3	0.0	0.0	0.9	5.9	0.0	0.0	0.0	0.4	0.1	0.1	5.0	0.0	22.3	0.0	0.4	1.3	6.5	0.5	0.1	44.1	0.0	3.9	2.2	219.1	0.0	0.1	0.0	0.0	408.5	241.7	3.3	1.2	412.0	1.8	33.7	1118.9	136.1	26.8	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	1.7	8.0	4.8	13.1	1.5	8.2	0.9	0.3	0.4	2.3	1.0	11.7	0.0	0.0	0.1
MPLKIP	"C7orf11, ORF20, TTDN1"	ENSG00000168303	"M-phase specific PLK1 interacting protein"	Q8TAP9	7	40126027-40134622	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058457, HPA065463"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA058457: AB_2683724, HPA065463: AB_2685493"	"unprognostic (5.59e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.08e-2)"	2.9	3.8	2.6	2.0	2.6	2.4	2.8	4.7	3.0	2.8	3.0	2.8	2.2	2.6	2.0	3.1	2.5	1.2	2.1	2.6	2.3	4.2	8.0	2.1	2.6	2.4	2.3	2.8	2.9	2.5	3.0	1.8	2.6	2.5	1.8	3.1	2.7	1.5	2.4	3.0	2.6	1.1	2.0	3.1	2.4	2.3	2.5	3.3	3.0	1.4	2.0	2.5	2.7	4.0	8.2	2.5	4.8	6.6	4.3	4.9	4.9	3.1	3.3	4.4	4.3	3.1	4.0	6.8	4.2	3.0	8.7	10.3	3.0	5.3	5.6	5.2	9.2	5.4	3.7	6.9	4.9	6.7	5.2	4.8	6.7	3.4	4.1	4.5	5.1	7.5	13.1	5.5	4.4	4.1	6.8	20.4	6.7	6.7	7.4	9.6	3.3	8.9	5.0	2.1	7.1	8.4	5.0	4.8	7.7	6.2	6.1	9.3	5.5	2.8	7.5	3.6	4.7	8.6	9.6	10.9	4.4	10.5	7.6	20.6	11.2	16.8	8.0	10.8	9.0	16.9	10.1	9.4	11.8	15.3	11.3	9.9	9.2	10.6	10.4	13.1	14.2	13.1	2.6	2.6	4.7	3.0	2.6	2.3	2.4	2.3	2.6	2.0	2.5	4.0	49.8	51.3	34.5	6.5	53.3	110.1	96.2	151.8	58.6	43.5	53.8	66.2	18.0	67.2	79.6	58.8	25.0	110.8	41.3	60.3	117.4	66.6	118.4	73.6	62.3	58.0	48.6	52.2	7.4	54.6	79.7	51.1	35.7	56.6	51.3	63.6	47.2	133.4	69.0	53.8	8.1	63.4	85.5	59.3	62.6	38.6	75.8	50.4	58.7	7.5	74.6	52.9	66.9	12.1	12.5	59.9	97.2	55.3	36.3	76.2	61.6	190.5	91.1	50.1	52.6	57.1	58.4	66.6	53.9	67.1	134.1	95.6	46.8	125.7	82.3	105.7
MRAP	"B27, C21orf61, FALP"	ENSG00000170262	"Melanocortin 2 receptor accessory protein"	Q8TCY5	21	32291813-32314784	"Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"adipose tissue: 75.6;adrenal gland: 166.5;breast: 44.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 16.1;Granulosa cells: 43.7;Horizontal cells: 43.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 1.5;HSkMC: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011024, HPA011093"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	Vesicles	"HPA011024: AB_10599292, HPA011093: AB_10600889"	"unprognostic (1.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-1)"		"unprognostic (1.11e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.30e-6)"	"unprognostic (3.32e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.76e-2)"	75.6	166.5	0.1	1.8	0.1	0.0	44.2	0.0	0.5	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.0	0.6	2.0	0.1	0.0	0.3	2.4	1.0	0.1	0.2	0.0	2.0	0.7	0.0	0.1	1.7	0.1	0.0	0.2	1.0	2.0	0.0	0.2	1.3	3.5	0.1	0.0	0.0	0.6	0.5	0.0	0.1	0.7	0.2	0.0	1.4	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.7	0.2	0.4	0.2	0.8	0.2	0.5	0.0	1.9	0.1	0.5	0.7	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.4	0.0	0.1	0.0	0.0	0.7	0.0	0.1	1.3	0.0	0.0	0.0	43.7	0.0	1.7	0.1	43.7	0.6	0.0	0.0	0.0	0.0	6.6	0.6	0.1	0.0	0.0	0.0	0.3	0.0	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.6	1.6	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47403067-47663146	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 46.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes		28000	"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	8.1	7.5	8.3	12.8	10.5	15.7	15.7	14.6	10.6	9.7	12.2	11.9	7.8	11.7	14.0	9.5	12.4	5.8	10.1	9.6	9.0	8.2	6.7	8.1	23.7	8.6	8.0	8.7	6.5	14.8	6.2	11.6	9.5	8.6	15.0	34.9	8.5	7.7	7.1	11.1	9.3	8.8	8.5	10.8	8.1	16.2	7.9	32.6	15.8	7.2	25.0	7.9	6.4	8.9	114.3	35.3	103.3	57.9	7.3	21.2	64.3	62.9	33.3	80.9	76.9	72.3	50.1	141.2	84.6	23.8	56.6	49.8	78.6	37.4	122.3	68.1	55.8	99.3	42.3	65.6	7.7	97.7	34.9	12.3	11.2	68.1	19.0	19.1	45.2	3.9	165.1	34.0	63.1	44.2	119.6	75.4	195.7	69.3	45.1	151.1	182.2	84.4	35.8	57.3	85.9	91.6	58.4	49.2	48.0	83.6	46.9	38.8	18.7	55.5	70.9	57.1	74.6	20.8	63.4	180.1	33.1	72.5	35.4	3.0	1.3	4.9	8.0	4.4	9.3	6.7	7.7	10.3	2.5	7.9	12.6	13.1	1.0	14.2	3.9	3.4	11.8	6.5	8.3	10.5	14.6	10.6	9.6	9.0	8.6	8.0	9.5	8.5	7.9	8.9	14.7	9.6	11.5	18.6	13.0	8.3	7.9	14.4	8.6	17.4	7.5	7.1	15.6	5.7	12.6	9.2	45.9	19.9	14.2	6.6	3.9	11.5	17.8	21.0	11.3	13.4	3.5	54.1	59.9	8.4	20.7	12.2	7.1	18.8	12.0	28.2	5.0	1.6	11.4	11.8	58.0	12.1	14.2	4.1	4.6	22.8	5.3	5.1	8.8	16.9	5.5	22.6	17.5	35.7	54.7	7.3	5.0	6.4	12.4	2.8	5.4	4.5	23.3	41.1	0.0	9.8	9.0	56.5	50.8	9.3	6.5	5.1	12.8	24.3	13.5	3.8
MSH6	GTBP	ENSG00000116062	"MutS homolog 6"	P52701	2	47695530-47810063	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 119.6;Theca cells: 114.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 31.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009091, HPA028376, HPA028446, CAB070870"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	Yes		15000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182"	"unprognostic (5.10e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.48e-2)"	11.7	22.7	9.3	17.7	13.7	24.0	16.2	15.0	12.7	15.5	12.7	13.0	9.0	27.7	10.2	11.7	17.8	10.9	9.3	8.9	11.5	12.1	19.8	11.6	28.4	12.7	11.7	53.0	31.3	17.0	9.8	20.3	13.0	15.0	12.4	21.6	10.8	15.6	10.5	13.1	9.8	27.2	10.7	12.7	10.9	35.3	11.3	36.3	17.2	11.2	31.0	12.8	12.2	19.9	116.5	77.6	128.4	37.5	42.3	46.3	67.9	63.6	51.1	60.2	59.8	67.2	41.4	158.1	84.5	59.5	82.0	46.0	130.3	74.3	82.1	80.7	69.0	117.0	60.8	71.1	28.8	131.5	37.8	38.6	28.3	60.7	41.6	53.8	40.8	5.3	115.9	69.8	61.8	85.5	144.2	80.1	130.7	81.3	37.7	219.6	204.3	84.7	44.5	76.2	92.8	100.3	79.1	40.4	42.7	124.3	54.6	42.6	33.4	72.2	92.3	54.6	80.6	63.8	79.3	276.2	61.9	77.9	42.4	7.7	3.7	3.8	4.8	6.2	5.5	4.3	5.5	5.0	5.5	4.2	8.4	4.5	2.5	5.9	6.4	2.7	5.3	3.6	9.3	13.7	15.0	12.7	8.9	11.5	12.7	11.7	13.0	10.7	11.3	19.9	19.8	28.9	21.4	5.9	19.2	25.2	22.0	12.3	31.9	25.4	14.4	15.1	8.6	2.8	21.8	7.3	35.5	35.6	20.7	7.4	3.9	15.7	46.4	27.1	31.1	18.4	4.8	47.1	8.5	9.6	21.8	24.0	8.6	31.7	17.7	119.6	13.6	10.2	13.0	15.2	12.1	9.7	20.3	5.6	13.2	17.5	25.4	16.8	3.6	7.5	10.0	22.7	8.2	9.5	27.4	9.1	3.7	22.6	31.1	16.1	2.6	6.7	22.1	31.4	6.6	27.4	33.0	54.3	48.8	22.0	17.5	9.6	19.8	114.9	12.1	11.7
MSS51	"FLJ39565, ZMYND17"	ENSG00000166343	"MSS51 mitochondrial translational activator"	Q4VC12	10	73423579-73433561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 261.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.3;Excitatory neurons: 11.9;Inhibitory neurons: 9.7;Oligodendrocyte precursor cells: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038564			Uncertain	Vesicles,Cytosol		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Cytosol	"HPA038564: AB_10674687"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.50e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-7)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-2)"	1.9	1.5	1.5	1.5	1.8	1.6	1.7	4.3	2.0	3.2	1.6	2.3	1.2	2.1	1.7	1.4	2.2	1.2	10.9	1.5	0.6	1.7	1.6	2.2	1.8	0.2	0.3	3.0	1.9	56.2	2.3	0.6	0.2	2.5	1.3	2.5	1.7	0.8	261.3	3.7	2.7	1.1	0.0	3.9	1.8	1.4	0.7	1.5	1.5	5.9	1.5	2.2	2.2	1.3	0.9	0.6	1.5	2.7	2.1	2.8	1.2	0.7	0.5	0.3	0.6	0.3	0.7	2.1	0.2	0.7	0.1	1.1	1.0	0.2	0.8	1.1	0.9	1.7	1.3	0.5	0.7	1.1	1.7	2.4	0.7	0.6	1.7	2.1	0.2	0.8	0.6	1.0	1.2	0.2	0.9	1.6	0.4	0.5	0.7	0.5	4.1	0.1	0.8	0.9	0.3	0.8	0.5	1.0	0.9	1.4	0.9	0.9	1.3	1.2	0.7	0.4	1.7	0.6	2.1	1.1	0.5	1.9	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.8	4.3	2.0	1.5	0.6	0.2	0.3	0.2	0.0	0.7	1.3	0.9	0.0	3.6	4.6	1.0	0.5	0.1	0.6	0.0	1.4	0.4	0.5	5.3	0.0	0.2	0.0	0.0	0.3	0.4	0.4	0.0	0.4	0.3	0.4	0.7	1.2	0.0	1.3	11.9	0.4	0.2	0.8	1.1	0.8	5.1	1.8	1.4	0.2	0.2	0.0	9.7	0.4	0.0	0.8	0.6	0.3	3.1	0.5	0.0	4.7	1.1	0.5	1.0	6.0	3.4	0.2	3.9	1.5	0.4	0.5	0.6	0.2	0.3	1.2	0.0	4.0	0.6	0.7	0.3	0.0	0.0	0.1	1.1	1.4	0.6	0.2
MTFR2	"DUFD1, FAM54A"	ENSG00000146410	"Mitochondrial fission regulator 2"	Q6P444	6	136231024-136250335	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3;lymphoid tissue: 6.4;testis: 7.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 23.6;Spermatocytes: 27.6;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA029792, HPA029794"	Approved		Uncertain	Vesicles		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles		"HPA029792: AB_10600210, HPA029794: AB_10600535"	"unprognostic (6.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (3.93e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.60e-6)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.82e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.64e-2)"	0.8	0.5	0.4	3.6	0.3	16.3	1.0	0.4	0.6	0.6	0.2	2.9	2.8	0.5	0.3	2.6	0.3	0.3	0.3	0.4	0.3	0.6	0.4	1.2	6.4	0.4	0.5	0.3	0.4	0.0	0.4	1.8	0.3	0.4	3.8	0.5	0.8	0.2	1.2	1.9	2.3	1.1	0.4	2.2	1.2	7.0	0.4	6.2	0.3	0.1	5.3	0.8	0.9	0.4	15.2	11.5	9.7	18.2	1.6	2.8	17.4	19.6	13.6	22.8	31.7	20.7	12.2	39.2	11.7	7.9	30.1	23.1	22.3	14.4	33.8	22.1	17.1	31.0	7.8	18.9	1.0	57.4	28.1	2.3	3.1	25.5	16.1	2.7	12.4	33.8	33.9	29.6	17.2	20.2	32.5	47.8	9.8	20.2	14.1	29.3	15.5	19.7	9.9	11.6	7.7	7.6	12.4	21.5	11.3	11.9	9.1	39.1	6.8	11.3	11.8	40.2	30.4	11.2	28.3	26.1	6.5	38.5	17.6	0.0	0.2	0.0	0.3	0.9	0.1	0.4	0.4	0.7	0.9	0.3	0.0	0.4	0.0	0.0	0.7	0.7	0.7	0.3	0.4	0.3	0.4	0.6	0.4	0.3	0.4	0.5	0.3	0.4	0.4	0.4	2.0	0.0	1.1	0.0	2.2	1.0	0.6	3.1	0.0	0.0	3.4	3.6	0.4	0.0	2.3	0.0	0.0	8.4	1.3	2.2	0.0	1.1	7.9	2.4	1.3	1.7	0.0	9.9	0.5	2.5	23.6	1.5	2.6	2.5	1.3	3.5	0.7	0.5	6.6	0.0	0.4	2.1	4.1	3.8	2.1	5.9	0.3	2.5	0.0	1.0	2.3	0.0	1.0	0.5	0.0	1.3	0.4	0.0	7.4	1.2	1.3	1.4	2.5	0.0	0.0	5.3	1.8	27.6	13.0	5.3	0.3	3.0	3.1	0.8	4.6	0.9
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555386	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles		No	No		47000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (9.70e-2)"	12.3	11.0	3.8	13.4	3.8	11.4	15.9	1.3	7.6	13.3	0.8	11.9	9.6	14.6	4.6	17.0	15.2	6.2	11.0	5.0	4.2	9.8	10.8	11.4	13.8	5.2	4.9	14.1	24.4	6.7	12.7	5.2	3.5	17.1	5.1	3.8	18.9	10.1	27.9	22.0	12.9	7.3	2.1	14.0	12.4	8.1	3.4	7.4	11.2	8.0	8.7	14.9	13.8	3.8	60.1	90.0	11.9	56.2	15.4	17.1	40.8	39.8	17.5	39.5	30.8	67.1	24.4	80.4	47.2	23.9	19.8	74.2	50.1	61.3	19.0	40.3	133.8	38.8	58.3	62.2	25.2	45.5	34.7	25.7	34.6	58.8	29.1	11.0	26.6	45.0	64.2	37.1	18.2	51.4	54.2	19.5	56.0	19.1	48.0	69.8	19.7	54.0	9.8	45.5	25.5	48.5	40.8	29.7	28.2	8.6	27.5	19.1	34.3	35.1	31.5	32.7	118.6	32.1	26.5	34.4	32.5	53.9	45.3	0.0	1.9	0.3	2.8	1.6	3.4	2.9	2.3	3.1	2.9	1.7	2.5	2.8	0.1	2.4	3.4	2.1	1.0	2.7	3.8	3.8	1.3	7.6	5.0	4.2	5.2	4.9	3.5	2.1	3.4	3.8	13.4	9.6	14.5	4.6	13.1	12.9	6.8	7.1	12.0	8.2	12.9	14.4	4.1	8.6	13.3	3.7	12.5	2.9	5.8	9.2	0.0	7.7	0.5	6.7	15.3	17.0	11.4	7.2	11.3	12.7	5.4	10.2	10.7	8.5	5.1	12.2	8.6	7.8	6.5	10.1	6.1	8.0	4.1	4.5	6.8	0.6	5.6	6.3	3.6	7.5	3.8	3.8	6.2	3.5	6.5	8.2	4.5	12.0	13.7	13.9	4.6	3.2	12.2	6.2	6.6	10.8	12.9	2.6	11.1	12.8	11.9	1.1	9.7	13.8	12.4	6.2
MYCBP2	"FLJ10106, KIAA0916, PAM, PHR1"	ENSG00000005810	"MYC binding protein 2"	O75592	13	77044657-77327094	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 425.4;Inhibitory neurons: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 110.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058807			Supported	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA058807: AB_2732627"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	69.9	22.2	42.3	19.0	46.2	32.8	49.3	37.3	52.4	43.4	18.8	29.4	9.0	27.2	29.8	45.9	29.2	12.5	32.9	48.6	35.9	22.6	24.5	28.3	40.0	34.6	29.6	43.1	30.9	14.9	32.3	10.9	36.9	28.0	12.5	28.9	29.1	13.3	26.5	79.7	34.8	11.9	30.1	56.4	24.9	26.3	33.9	34.6	27.2	18.1	37.8	30.4	41.5	38.7	21.6	10.8	12.9	14.1	62.9	27.9	7.5	13.4	19.8	11.5	14.7	9.7	11.0	61.4	8.3	26.6	11.2	19.5	22.4	24.7	15.5	24.5	22.2	52.2	22.2	20.1	21.4	110.8	17.7	31.5	20.2	10.6	20.8	11.4	26.5	22.3	11.3	18.8	20.7	13.1	30.5	74.3	6.8	28.7	13.6	34.2	13.1	15.0	19.6	21.1	20.2	9.4	16.2	23.1	12.8	13.0	8.6	83.8	35.0	10.9	9.1	7.3	13.0	20.3	15.0	42.7	22.1	89.2	11.3	1.4	2.0	2.0	3.2	2.1	2.8	4.9	3.6	2.8	1.9	4.3	4.1	3.2	1.8	2.8	1.6	2.7	4.5	1.4	42.3	46.2	37.3	52.4	48.6	35.9	34.6	29.6	36.9	30.1	33.9	38.7	92.2	38.5	52.2	158.7	170.3	82.3	39.9	32.6	63.7	229.3	36.8	38.4	69.7	25.8	30.9	35.0	104.3	46.1	109.2	14.2	1.9	26.1	56.0	50.9	61.1	83.8	32.6	46.9	425.4	33.1	31.5	80.6	38.2	66.6	48.2	34.0	44.6	52.4	41.8	218.7	471.3	19.7	26.4	106.9	48.2	23.4	65.9	100.4	32.0	282.9	116.7	121.5	120.5	338.8	212.5	30.2	15.8	96.3	121.9	53.7	15.2	13.2	19.5	94.8	105.2	76.7	76.0	81.5	71.6	129.1	150.7	43.9	121.5	67.4	28.1	42.4
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.6"	"Group enriched"	"Detected in some"	5	"Adipocytes: 123.0;Endothelial cells: 141.3;Hepatic stellate cells: 230.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	33	"eosinophil: 30.7"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 30.7"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 124.6;TIME: 104.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047992			Approved	Nucleoplasm,Vesicles		NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	26.6	3.2	6.8	5.2	6.9	1.2	21.4	6.9	10.2	9.0	5.2	6.1	3.5	10.1	4.5	4.6	9.2	10.5	17.1	6.3	7.1	6.6	13.1	15.6	6.2	7.7	6.9	3.6	2.7	4.3	2.2	20.7	8.6	4.4	5.8	1.0	3.7	3.8	12.8	4.7	5.6	12.4	6.8	49.6	4.5	1.8	10.0	2.5	12.2	20.5	3.0	8.1	7.3	7.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	17.7	0.1	0.0	0.2	0.0	0.1	0.0	23.0	0.3	0.0	0.7	0.1	0.1	0.0	0.2	0.2	0.3	0.0	124.6	0.0	0.3	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	104.4	0.5	0.8	1.5	0.0	1.1	0.0	15.6	0.0	0.0	0.0	0.9	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.6	6.8	6.9	6.9	10.2	6.3	7.1	7.7	6.9	8.6	6.8	10.0	7.5	123.0	0.0	5.2	0.7	0.8	7.1	0.2	0.1	2.8	0.2	0.4	0.9	3.1	2.8	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	10.2	1.3	0.2	141.3	0.0	13.7	0.1	0.2	0.0	4.0	0.0	0.1	1.3	0.0	230.6	2.1	0.1	0.0	0.1	0.0	0.0	7.3	7.3	3.7	0.3	13.3	14.2	30.9	0.1	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.5	0.0	0.0	17.7	0.0	0.0	1.5	2.2	0.1	0.1	0.5	5.5	0.0	0.9	0.5	0.0	0.7
NANOG	"FLJ12581, FLJ40451"	ENSG00000111704	"Nanog homeobox"	Q9H9S0	12	7787794-7799146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 8.4;Spermatocytes: 5.5"	"Cancer enriched"	"Detected in single"	1164	"testis cancer: 58.1"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 125.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB019380, HPA072117"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"CAB019380: , HPA072117: "	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"		"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.46e-2)"		"unprognostic (6.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.51e-7)"	"unprognostic (3.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.85e-2)"	0.0	0.1	0.3	0.1	0.7	0.4	0.1	1.9	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.4	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	125.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.5	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2	0.7	0.3	0.2	1.7	0.1	0.0	0.3	0.7	1.9	0.4	0.3	0.1	0.3	0.1	0.3	0.1	0.4	0.7	0.4	0.0	0.0	0.0	0.2	1.7	1.8	0.8	0.0	2.2	0.3	0.1	0.8	0.0	0.3	0.0	8.4	1.6	1.4	0.1	0.0	0.4	1.0	0.3	0.5	0.6	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.3	0.0	2.1	0.7	0.6	0.5	0.0	0.0	0.3	2.0	0.3	0.0	0.3	1.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.4	1.5	0.0	0.9	0.0	0.3	0.9	1.0	0.0	1.7	0.4	5.5	0.6	0.0	0.6	0.7	0.7	0.7	0.4	1.8
NANOGP8		ENSG00000255192	"Nanog homeobox retrogene P8"	Q6NSW7	15	35083410-35085295	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	415	"testis cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	69	"NTERA-2: 33.2;SuSa: 11.6"									HPA072117			Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 5: NTERA-2 - Transcription"		Nucleoplasm	Vesicles	"HPA072117: "										"unprognostic (1.58e-1)"			"unprognostic (9.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.37e-1)"			0.1	0.1	0.7	0.0	3.7	0.2	0.1	2.1	1.8	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.2	0.1	0.1	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.7	1.2	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	3.7	2.1	1.8	0.2	0.5	0.3	0.2	0.4	0.2	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NHLRC1	"bA204B7.2, EPM2B"	ENSG00000187566	"NHL repeat containing E3 ubiquitin protein ligase 1"	Q6VVB1	6	18120440-18122677	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	Transferase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 5.0;Exocrine glandular cells: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 6.8;K-562: 6.1;SCLC-21H: 6.1"	"Low region specificity"	"Detected in all"							HPA066030			Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA066030: "	"unprognostic (1.61e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (6.95e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (5.30e-4)"	1.2	1.4	2.0	0.8	2.3	1.1	2.0	1.5	2.6	0.8	0.8	1.5	1.4	0.8	2.6	1.1	1.4	0.6	1.8	2.4	1.9	0.8	4.1	1.2	0.6	2.5	1.8	1.4	1.8	1.2	1.2	0.5	2.7	1.2	1.3	2.0	2.3	1.0	2.6	3.8	1.9	0.8	1.6	1.1	1.3	0.7	2.0	1.0	1.6	1.5	0.8	0.9	0.8	3.6	2.6	1.5	0.6	0.0	1.3	1.2	0.0	2.6	0.8	0.9	0.5	0.1	2.1	0.0	6.8	1.9	0.2	3.0	0.0	1.7	0.7	0.1	0.9	0.4	1.0	0.1	2.0	0.0	1.7	2.1	2.5	1.0	0.9	0.6	2.1	0.0	6.1	0.1	2.1	2.8	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.1	1.4	2.8	6.1	0.1	5.3	4.3	1.6	0.6	3.1	1.7	0.4	0.2	1.3	1.8	0.1	0.1	0.0	0.1	0.1	0.0	2.6	0.5	4.4	0.4	0.6	4.9	0.8	2.3	1.1	0.5	4.7	1.3	1.5	1.0	0.3	1.6	2.3	0.6	1.3	1.8	2.0	2.3	1.5	2.6	2.4	1.9	2.5	1.8	2.7	1.6	2.0	3.6	0.8	0.0	2.2	0.3	0.2	1.9	1.4	1.4	1.8	0.4	1.5	2.0	0.9	1.5	2.3	0.0	0.0	0.4	0.0	0.2	0.0	2.9	0.0	0.6	1.3	0.3	3.5	5.0	1.0	3.7	0.0	0.8	1.5	0.5	1.3	0.8	0.4	1.1	1.2	0.0	0.7	0.3	0.0	0.8	0.6	0.0	0.6	1.5	1.8	1.0	0.5	1.1	0.0	1.5	1.2	2.0	0.3	0.0	0.0	0.2	0.6	1.2	0.8	1.0	0.0	0.3	0.8	0.2	0.2	1.3	1.8	0.4	0.1	1.1	0.5	0.5
NKX2-1	"BCH, NKX2A, TITF1, TTF-1, TTF1"	ENSG00000136352	"NK2 homeobox 1"	P43699	14	36516392-36521149	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lung: 53.1;thyroid gland: 172.4"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 137.8;Alveolar cells type 2: 124.8"	"Group enriched"	"Detected in some"	39	"lung cancer: 30.9;thyroid cancer: 103.2"	"Region enhanced"	"Detected in many"		"thalamus: 17.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SCLC-21H: 78.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.2;hypothalamus: 10.2"	"Group enriched"	"Detected in some"	13	"basal ganglia: 4.3;hypothalamus: 10.4"	"CAB000078, CAB053633, HPA074316"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus, Vesicles"		"CAB000078: , CAB053633: AB_442138, HPA074316: "		"unprognostic (3.79e-1)"		"unprognostic (4.25e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.26e-2)"				"unprognostic (2.23e-1)"		"unprognostic (1.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.18e-1)"	0.0	0.1	1.1	0.0	2.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	10.1	0.0	0.0	53.1	0.0	0.0	0.3	0.1	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	17.8	0.0	172.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	78.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.0	0.0	4.0	0.1	10.1	0.0	0.3	0.0	0.0	17.8	0.1	0.0	137.8	124.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.5;lymphoid tissue: 13.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 10.3;dendritic cells: 18.8;NK-cells: 37.0;T-cells: 23.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.8;HEL: 8.7;HL-60: 18.6;HMC-1: 9.0;JURKAT: 9.2;NB-4: 19.7;U-698: 28.9;U-937: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: AB_2680242"	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	1.0	0.8	0.3	7.8	0.4	4.1	0.7	0.8	0.7	0.9	1.0	1.5	1.7	0.9	0.4	0.8	1.2	1.4	1.5	0.3	0.0	1.3	1.1	2.4	13.6	0.3	0.3	0.7	0.5	0.2	0.9	0.9	0.1	1.1	1.2	1.1	1.1	0.3	1.1	0.5	6.5	0.5	0.0	11.8	2.1	0.9	0.3	11.3	1.5	0.9	11.1	1.5	0.8	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	8.8	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.2	8.7	0.1	0.0	0.0	18.6	9.0	0.0	0.0	0.0	0.0	0.5	0.2	9.2	0.2	0.0	0.0	0.4	7.7	19.7	0.0	0.0	0.1	5.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	0.1	4.9	0.5	0.3	0.1	0.2	0.1	0.4	0.2	28.9	0.2	13.6	0.1	2.9	0.0	0.0	2.3	0.0	2.1	0.8	1.7	2.2	0.0	0.6	1.4	1.5	0.0	2.6	0.0	0.0	2.0	2.1	0.3	0.4	0.8	0.7	0.3	0.0	0.3	0.3	0.1	0.0	0.3	0.1	1.7	3.2	0.0	1.0	10.3	0.0	0.3	0.0	0.0	1.6	0.4	0.3	4.6	1.5	0.6	1.8	4.2	0.0	18.8	0.0	0.0	0.0	4.0	1.3	0.8	2.3	0.0	6.5	3.8	0.0	0.0	0.5	1.5	0.7	2.5	0.2	3.9	0.1	0.1	0.0	3.7	0.0	0.0	1.0	0.0	1.3	0.0	1.1	0.0	1.9	1.3	0.3	37.0	1.0	0.6	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.7	5.1	0.0	0.9	0.7	0.5	0.3	0.0	0.0	0.0	23.8	0.1	0.0	0.3
NLRC4	"CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf"	ENSG00000091106	"NLR family CARD domain containing 4"	Q9NPP4	2	32224453-32265732	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.3;lung: 6.2;lymphoid tissue: 11.4"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 11.9;Kupffer cells: 21.0;Macrophages: 14.5;Microglial cells: 10.3;monocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"classical monocyte: 49.3;intermediate monocyte: 56.9;myeloid DC: 32.2;neutrophil: 24.6;non-classical monocyte: 44.2"	"Group enriched"	"Detected in many"	32	"dendritic cells: 32.2;granulocytes: 24.6;monocytes: 56.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.1"	"Not detected"	"Not detected"							"HPA006592, HPA075894"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA006592: AB_2667620, HPA075894: "	"unprognostic (7.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.33e-2)"	"unprognostic (6.03e-6)"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.63e-1)"	3.4	1.4	0.4	8.7	0.5	8.3	0.7	0.4	0.8	0.6	0.6	0.9	0.9	0.4	0.0	0.6	0.8	1.4	1.2	0.4	0.4	0.5	1.6	6.2	2.3	0.6	0.5	0.3	0.8	0.1	0.6	2.1	0.6	0.4	0.8	0.6	0.5	0.2	1.0	0.3	1.3	2.3	0.5	11.4	0.6	0.4	0.9	0.7	0.4	0.3	1.2	2.0	0.3	0.8	0.1	0.2	0.3	0.7	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.3	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.3	0.5	0.1	0.4	0.0	3.1	0.5	0.0	0.3	0.0	1.4	0.4	0.0	0.1	0.3	0.2	0.0	0.0	0.2	1.4	0.1	0.2	0.2	0.1	0.4	0.5	0.0	0.3	0.3	0.7	0.2	0.2	1.2	0.5	0.1	1.4	0.1	0.3	0.3	0.2	0.4	0.3	0.8	1.2	0.4	1.3	0.4	0.5	49.3	5.8	0.1	56.9	0.4	0.6	0.0	0.0	32.2	1.1	0.0	0.1	24.6	0.3	44.2	0.4	0.2	18.6	0.4	0.5	0.4	0.8	0.4	0.4	0.6	0.5	0.6	0.5	0.9	0.8	0.2	0.0	1.8	1.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	4.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	1.1	0.0	11.9	0.0	3.3	0.0	0.0	21.0	1.0	0.0	0.0	14.5	0.0	10.3	18.4	0.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.0
NOX3	GP91-3	ENSG00000074771	"NADPH oxidase 3"	Q9HBY0	6	155395368-155455839	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"MCF7: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073837			Uncertain	Vesicles		NA	NA					"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA073837: "					"unprognostic (3.42e-1)"													0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPAP1	C15orf2	ENSG00000185823	"Nuclear pore associated protein 1"	Q9NZP6	15	24675775-24683393	"Predicted intracellular proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.8;testis: 2.9"	"Cell type enriched"	"Detected in some"	5	"Granulosa cells: 125.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA018828, HPA019562"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA018828: AB_2669941, HPA019562: AB_2670190"										"unprognostic (4.40e-2)"	"unprognostic (1.85e-2)"		"unprognostic (6.98e-3)"	"unprognostic (7.45e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.11e-3)"	0.0	0.0	0.9	0.0	1.8	0.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.5	1.7	0.9	0.0	0.0	0.1	0.9	0.7	0.5	0.4	0.0	0.5	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.1	2.9	1.5	0.0	0.5	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	1.8	0.1	1.1	0.5	1.7	0.9	0.7	0.5	0.5	1.5	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.2	0.7	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	125.9	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.3	24.1	12.7	0.0	0.0	0.0	0.0	0.5	0.0	0.2
NPHP4	"KIAA0673, POC10, SLSN4"	ENSG00000131697	"Nephrocystin 4"	O75161	1	5862811-5992473	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Ciliopathy, Disease variant, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.2;Cone photoreceptor cells: 33.3;Excitatory neurons: 47.1;Inhibitory neurons: 30.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.7;hippocampal formation: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063852, HPA065526"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Nuclear bodies, Vesicles"	"HPA063852: , HPA065526: AB_2685505"	"unprognostic (1.82e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	2.7	2.2	1.0	2.3	0.8	3.7	2.7	0.0	2.7	2.9	2.5	2.2	2.1	2.8	2.3	2.0	7.9	2.1	1.9	3.1	0.0	2.2	1.3	3.0	2.3	0.0	0.0	2.9	2.4	2.7	7.8	1.6	0.0	2.2	1.2	2.4	2.2	2.3	2.2	4.9	2.1	2.2	0.0	2.2	2.0	5.3	0.0	2.5	6.7	1.9	1.1	2.1	2.5	0.0	7.8	4.8	5.4	4.3	4.7	6.8	4.1	3.9	3.9	5.3	4.2	4.1	6.5	4.0	9.6	4.6	3.6	7.4	2.7	6.6	2.7	5.1	7.3	3.4	8.1	4.1	3.7	6.5	5.1	5.6	3.2	6.3	3.9	3.4	3.8	9.4	6.2	4.1	2.4	5.9	8.3	7.1	1.0	4.0	5.5	7.1	3.4	6.5	2.6	1.0	17.0	5.5	6.1	4.5	6.5	2.3	6.0	7.2	3.7	7.6	3.2	13.0	4.8	5.0	7.0	4.2	3.4	8.3	2.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	1.0	0.8	0.0	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.1	24.2	1.3	4.0	1.2	1.8	3.4	7.3	3.0	3.6	3.1	4.3	3.9	3.7	33.3	0.6	2.2	2.1	1.9	1.6	2.0	10.2	3.3	2.9	3.6	3.2	47.1	1.8	0.5	3.5	4.1	3.0	0.0	4.0	1.8	1.5	2.0	5.0	30.8	2.2	2.0	3.5	3.7	1.4	4.1	2.4	10.6	14.0	1.8	6.3	2.1	10.6	17.3	2.1	2.2	2.2	2.6	1.8	1.1	1.9	10.9	18.2	6.6	1.6	2.7	11.6	6.5	1.9	5.3	1.1	1.7	4.0	1.7	1.1
NRG3		ENSG00000185737	"Neuregulin 3"	P56975	10	81875194-82987179	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.3;retina: 5.2"	"Group enriched"	"Detected in some"	18	"Astrocytes: 2921.6;Excitatory neurons: 3761.0;Inhibitory neurons: 3088.3;Oligodendrocyte precursor cells: 1175.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;SK-MEL-30: 2.7;U-2 OS: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075789			Uncertain	Vesicles	"Secreted in brain"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA075789: "	"unprognostic (6.15e-3)"		"unprognostic (2.43e-2)"	"unprognostic (1.65e-5)"	"unprognostic (1.89e-1)"	"unprognostic (7.03e-4)"	"unprognostic (1.85e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.31e-4)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.27e-4)"	0.1	0.4	16.4	0.3	11.4	0.0	1.3	0.0	17.3	0.1	0.0	0.4	0.1	0.0	0.0	0.1	4.7	2.8	0.4	16.1	2.6	0.7	0.5	0.7	0.1	1.2	6.3	0.0	0.1	0.1	2.0	0.3	0.4	0.1	0.1	5.2	2.6	0.2	0.0	0.6	0.1	0.1	2.5	0.1	0.3	1.8	9.9	0.0	0.2	0.1	0.0	0.1	0.0	3.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	11.4	0.0	17.3	16.1	2.6	1.2	6.3	0.4	2.5	9.9	3.5	0.1	0.0	0.0	2921.6	0.1	0.0	0.0	0.0	0.0	15.9	0.7	0.6	0.8	2.8	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.9	31.4	0.0	0.0	0.7	0.0	0.0	3761.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	3088.3	0.0	0.0	0.0	0.0	12.8	0.6	0.1	0.0	148.0	0.0	6.7	0.0	1175.2	50.2	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5
ODF2	"CT134, ODF84"	ENSG00000136811	"Outer dense fiber of sperm tails 2"	Q5BJF6	9	128455186-128501292	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"testis: 317.6"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 8228.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001874, HPA048841"	Enhanced		Supported	Vesicles,Centrosome		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	Vesicles	"HPA001874: AB_1079522, HPA048841: AB_2680536"	"unprognostic (4.54e-3)"	"unprognostic (9.91e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.93e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.65e-2)"	14.3	11.8	9.6	22.1	9.8	31.1	14.2	17.9	13.5	20.4	40.1	15.7	10.3	21.9	11.0	12.4	22.6	13.2	14.4	11.1	10.7	14.1	16.4	14.4	25.6	13.4	16.1	15.1	13.2	15.3	30.8	15.9	11.6	16.1	15.1	14.9	12.9	14.7	8.9	19.3	13.7	20.5	9.7	20.5	13.7	317.6	11.7	34.8	13.2	5.3	26.6	17.0	14.4	9.9	44.2	52.2	85.3	97.7	33.3	39.6	68.6	72.3	33.7	58.9	30.8	51.8	31.6	78.6	26.7	59.2	45.7	112.7	62.9	43.1	59.4	52.2	29.3	69.8	84.9	43.8	19.3	76.2	84.5	32.8	26.9	62.6	43.9	36.5	52.0	58.8	83.9	42.9	56.3	134.9	81.5	92.7	33.4	89.7	37.2	73.6	82.0	60.9	30.7	33.6	51.2	43.6	67.8	64.0	22.9	38.3	59.8	54.8	49.9	73.1	44.6	84.9	71.7	79.6	123.9	55.9	33.4	68.4	64.8	21.6	9.2	10.3	11.4	13.4	13.6	8.2	10.2	12.2	8.8	7.0	7.2	9.3	3.0	12.0	17.8	8.3	8.1	10.1	9.6	9.8	17.9	13.5	11.1	10.7	13.4	16.1	11.6	9.7	11.7	9.9	14.2	6.4	6.8	9.8	14.4	16.7	16.7	7.4	19.9	9.8	11.2	9.5	10.6	11.5	8.5	7.3	10.4	13.1	13.7	4.6	11.7	10.6	1914.4	39.4	16.3	18.3	3.6	29.8	18.5	9.0	16.8	14.0	10.2	13.4	19.6	10.1	8.2	9.6	12.4	8.4	16.6	10.9	12.2	10.2	14.9	8228.0	42.6	12.9	10.6	12.2	11.1	8.6	9.2	14.1	9.8	7.4	3.2	33.8	16.1	16.1	3.0	6.9	46.6	8.9	13.1	11.1	16.7	268.1	58.3	13.8	13.2	33.2	16.8	11.4	7.6	12.9
OIP5	"CT86, hMIS18beta, MIS18B"	ENSG00000104147	"Opa interacting protein 5"	O43482	15	41309273-41332591	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.3;skeletal muscle: 10.3;testis: 20.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.9;Extravillous trophoblasts: 24.0;Spermatocytes: 110.6;Spermatogonia: 56.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA052271, HPA059602"	Enhanced		Supported	"Nuclear speckles,Vesicles"		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"	Vesicles	"HPA052271: AB_2681780, HPA059602: AB_2684079"	"unprognostic (5.17e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.94e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.79e-4)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (5.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.84e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.86e-2)"	0.6	1.7	0.1	3.3	0.2	10.3	1.2	1.2	0.4	0.9	0.2	4.1	3.5	0.8	0.3	3.8	0.4	0.6	1.5	0.2	0.2	0.3	1.2	0.5	5.8	0.2	0.4	1.5	0.3	0.1	0.1	2.3	0.4	0.5	3.9	0.7	0.8	0.6	10.3	3.3	3.9	1.1	0.1	1.7	1.5	20.9	0.2	9.1	0.4	0.8	5.2	0.7	1.3	0.5	33.7	17.8	34.3	24.9	1.7	2.1	32.4	20.0	9.3	24.5	26.1	31.8	16.2	19.8	17.0	7.7	37.8	51.0	35.7	16.1	19.2	42.4	40.1	42.4	49.8	33.6	0.4	46.5	22.1	0.7	3.2	13.8	14.5	5.2	21.1	40.8	59.4	37.3	16.5	16.3	27.1	34.8	30.9	50.4	37.9	32.9	28.4	30.5	11.1	15.4	53.7	17.5	33.7	34.3	9.6	13.7	33.7	26.3	10.0	24.5	37.3	24.6	36.6	17.0	83.2	71.1	7.1	56.5	35.9	0.0	0.4	0.5	0.2	0.7	0.8	1.0	0.7	0.8	0.7	1.2	1.3	0.8	0.0	1.2	0.4	4.1	3.1	0.8	0.1	0.2	1.2	0.4	0.2	0.2	0.2	0.4	0.4	0.1	0.2	0.5	0.2	0.0	0.5	1.0	2.7	4.1	0.9	3.6	1.2	0.0	1.1	2.2	0.2	0.0	1.8	0.0	0.0	15.0	1.7	2.3	0.0	0.4	12.0	1.9	0.6	0.9	0.0	45.9	2.2	0.4	24.0	1.7	5.1	1.1	1.3	5.2	0.0	0.8	7.5	0.0	2.1	3.0	8.2	2.2	1.8	10.8	0.9	1.2	0.0	0.0	0.6	1.1	2.1	1.5	2.5	0.2	0.5	1.2	10.9	0.4	0.9	0.3	0.0	0.3	6.6	1.0	1.1	110.6	56.8	8.3	2.4	3.8	1.2	2.1	7.6	0.9
OLFM3	NOE3	ENSG00000118733	"Olfactomedin 3"	Q96PB7	1	101802560-101996926	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 12.0;retina: 7.4"	"Group enriched"	"Detected in some"	17	"Excitatory neurons: 653.3;Inhibitory neurons: 174.6"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AF22: 5.7;HAP1: 3.9;HEL: 3.6;SCLC-21H: 2.2;SH-SY5Y: 2.2"	"Region enhanced"	"Detected in all"		"cerebellum: 177.3"	"Low region specificity"	"Detected in all"			HPA050297			Uncertain	Vesicles	"Secreted in brain"	NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA050297: "			"unprognostic (4.19e-1)"	"unprognostic (4.19e-4)"	"unprognostic (1.26e-1)"				"unprognostic (4.61e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.47e-2)"			"unprognostic (3.58e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.68e-2)"		0.0	1.3	2.9	0.3	5.0	0.0	0.0	6.9	12.0	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.0	0.0	0.0	6.4	3.9	0.4	0.0	0.0	0.0	1.2	1.9	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.5	7.4	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.2	0.1	3.7	0.0	0.3	0.0	0.0	0.0	0.0	4.6	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	2.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	5.0	6.9	12.0	6.4	3.9	1.2	1.9	1.2	0.0	3.7	4.6	0.1	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	23.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	653.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	174.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.7	0.0	8.5	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	6.5	0.0	0.0
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 494.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"	Yes	No		60000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavorable (9.01e-4)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	28.1	26.0	25.7	20.8	26.4	15.5	26.3	29.6	58.5	31.9	34.7	16.3	11.0	27.0	18.9	10.1	41.1	26.3	38.7	26.5	27.1	35.8	72.8	27.8	16.2	32.9	30.0	34.9	17.5	17.0	11.6	65.3	33.0	20.0	17.4	33.3	13.0	18.4	110.9	17.4	14.4	28.5	30.2	19.6	19.8	19.3	30.1	12.9	13.9	54.0	14.6	29.6	18.2	39.0	84.0	21.2	60.1	117.6	181.2	138.3	50.1	239.9	215.8	90.8	215.8	35.6	63.6	28.4	89.7	239.0	55.1	92.5	38.3	87.7	197.1	36.5	14.5	24.4	18.6	42.5	75.3	45.1	16.4	84.5	50.3	77.7	101.6	494.2	43.5	23.8	38.3	14.7	79.3	22.4	17.9	42.9	21.6	38.9	92.3	16.4	40.2	52.4	51.0	35.6	5.5	33.7	49.2	143.2	58.3	135.0	21.9	41.9	41.9	110.5	44.8	31.3	56.9	81.8	31.3	13.7	198.1	64.5	54.9	1.1	18.8	14.9	6.7	23.5	8.7	8.2	8.1	7.9	20.7	9.2	5.9	6.1	10.4	5.2	25.7	16.6	10.7	9.1	25.7	26.4	29.6	58.5	26.5	27.1	32.9	30.0	33.0	30.2	30.1	39.0	29.0	6.4	28.4	87.1	31.7	36.3	33.0	138.0	22.2	13.5	23.8	15.7	42.0	7.2	69.2	23.9	27.1	31.5	24.9	25.1	0.0	33.1	16.8	85.6	89.2	25.9	10.3	7.2	48.8	19.5	116.4	67.7	14.3	131.4	40.5	16.9	20.0	29.8	43.9	11.8	41.6	9.5	46.8	54.1	75.7	8.1	51.9	51.5	44.4	62.8	39.0	34.0	6.2	86.5	44.8	36.6	27.1	47.0	32.9	24.9	13.5	25.1	94.6	17.2	39.5	37.0	44.7	61.7	34.0	9.8	23.9	33.2	27.7	31.1	7.0	17.6
P4HTM	"EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4"	ENSG00000178467	"Prolyl 4-hydroxylase, transmembrane"	Q9NXG6	3	48989889-49007153	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 155.3;Respiratory ciliated cells: 169.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007199	Supported		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Vesicles, Cytosol"		"HPA007199: AB_1855272"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-2)"	"prognostic favorable (3.28e-5)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.65e-3)"	13.3	37.1	50.6	4.9	53.3	5.9	12.4	44.3	67.9	18.4	89.7	14.7	12.1	17.6	18.7	8.2	39.8	11.2	26.2	53.5	57.3	29.8	11.9	15.7	6.5	52.2	49.6	20.0	38.5	39.4	75.9	11.0	51.5	18.5	7.4	16.4	19.6	16.8	15.2	10.1	13.0	7.4	45.8	10.7	25.1	23.6	53.3	5.5	26.5	11.3	3.8	12.8	13.1	49.6	8.6	27.9	4.8	0.1	15.5	17.6	0.4	16.8	24.6	13.2	14.8	6.3	55.6	8.1	15.8	21.6	10.5	4.8	12.5	6.6	4.1	30.4	19.5	0.0	42.1	0.0	38.6	8.3	0.2	11.0	6.3	13.4	1.1	51.4	15.0	0.1	0.0	37.9	6.5	48.1	1.2	1.0	6.8	52.6	31.2	0.0	0.0	53.5	24.4	15.9	20.9	0.2	17.7	25.0	0.1	1.1	20.1	13.1	9.9	8.0	6.1	19.9	14.5	50.0	28.6	0.1	54.9	0.7	7.1	8.0	9.0	5.9	6.7	3.5	9.6	8.4	12.3	11.7	9.4	15.9	13.0	8.3	0.8	5.9	4.5	1.6	17.0	6.0	50.6	53.3	44.3	67.9	53.5	57.3	52.2	49.6	51.5	45.8	53.3	49.6	15.1	22.4	17.3	36.2	16.1	9.2	34.6	41.1	12.5	72.9	28.7	23.0	12.0	41.5	44.0	46.0	87.6	31.4	13.4	27.4	19.6	38.3	138.4	106.4	23.7	12.6	80.9	12.4	55.7	39.1	9.9	28.1	48.9	31.2	22.9	31.6	15.4	8.5	16.8	117.8	48.6	40.4	65.1	6.3	12.8	155.3	30.4	13.0	12.4	20.6	11.3	58.4	14.4	17.1	32.3	23.6	51.8	25.9	28.9	24.4	56.2	30.4	169.4	72.5	19.7	32.9	24.7	32.5	7.0	12.9	10.4	26.1	25.0	23.9	40.9	31.2
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833269-37034268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 39.7"	"Cell type enriched"	"Detected in some"	29	"B-cells: 91.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 6.5"	"Group enriched"	"Detected in some"	43	"memory B-cell: 39.0;naive B-cell: 26.0"	"Lineage enriched"	"Detected in single"	52	"B-cells: 39.0"	"Group enriched"	"Detected in some"	9	"Daudi: 66.6;REH: 194.1;U-698: 87.1"	"Region enriched"	"Detected in single"	11	"midbrain: 3.9"	"Low region specificity"	"Detected in all"			"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.3	0.1	0.4	14.9	0.3	9.4	0.1	0.5	0.5	0.0	0.2	0.8	0.5	0.2	0.1	0.2	0.0	0.8	0.2	0.3	0.6	0.1	0.2	0.3	39.7	1.1	6.5	0.0	0.0	0.0	0.2	0.1	4.1	0.3	0.8	0.5	1.0	0.0	3.1	0.0	6.6	0.0	0.8	18.7	1.6	0.6	1.9	2.8	0.2	0.0	36.2	1.1	0.0	0.3	0.1	0.3	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	66.6	0.1	0.0	0.1	0.2	0.1	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.1	0.3	1.9	0.3	0.4	194.1	0.4	0.3	0.0	0.0	13.2	2.9	0.1	0.7	0.0	0.0	0.0	7.5	0.2	0.0	0.2	0.1	0.0	0.2	0.1	87.1	0.0	1.5	0.1	0.7	0.0	0.1	0.0	0.1	0.1	39.0	0.0	0.0	0.1	26.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.7	0.4	0.3	0.5	0.5	0.3	0.6	1.1	6.5	4.1	0.8	1.9	0.3	0.0	0.0	0.0	0.7	91.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.3	0.0	3.1	0.0	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.3	0.0	0.1	0.0	2.7	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.6	0.2	0.2	0.0	0.0	2.0	0.0	0.0	0.3
PCDHGA10	PCDH-GAMMA-A10	ENSG00000253846	"Protocadherin gamma subfamily A, 10"	Q9Y5H3	5	141412987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.7;Cone photoreceptor cells: 16.7;Horizontal cells: 23.5;Skeletal myocytes: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 14.6;HSkMC: 16.1;T-47d: 19.7;U-2197: 11.6"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077276"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: "	"unprognostic (2.92e-1)"	"unprognostic (2.17e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.64e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.83e-3)"	1.6	1.6	3.5	0.4	3.2	0.1	1.1	4.1	2.4	1.3	0.8	1.0	0.8	1.3	0.7	1.7	1.3	1.4	1.0	2.7	3.8	0.5	1.5	1.3	0.4	3.3	3.1	1.3	0.6	2.1	0.8	3.6	3.4	1.4	0.9	2.5	1.8	1.8	1.1	2.0	1.0	1.1	4.2	0.9	2.0	0.5	3.9	0.4	2.1	0.3	0.5	0.8	1.3	3.8	0.0	0.0	14.6	7.5	6.3	2.7	6.9	2.6	0.1	3.6	5.6	0.3	0.9	0.8	9.6	3.7	0.2	0.4	3.5	2.4	2.8	0.9	0.1	0.0	0.3	0.0	2.5	1.5	0.3	16.1	0.4	2.4	1.0	0.4	1.4	0.3	0.0	0.1	9.0	0.1	0.1	0.4	1.4	0.0	0.1	0.2	1.2	0.0	2.4	0.1	2.0	0.7	0.4	0.1	0.4	3.5	19.7	1.9	3.3	6.7	0.4	11.6	0.1	0.2	1.2	0.1	3.4	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	3.2	4.1	2.4	2.7	3.8	3.3	3.1	3.4	4.2	3.9	3.8	5.8	0.0	2.0	0.0	0.9	0.1	2.3	0.6	1.2	27.7	2.2	2.2	3.4	1.5	1.6	1.8	16.7	2.1	1.3	0.7	0.0	1.0	0.0	1.3	7.7	4.8	1.2	0.4	0.0	1.4	1.3	4.8	1.5	2.0	1.3	1.0	4.6	1.7	1.0	23.5	0.0	1.6	0.0	0.0	0.0	0.2	3.4	0.7	1.8	0.0	0.0	5.7	0.0	0.0	0.0	3.1	0.4	2.2	0.5	2.8	0.4	0.5	0.0	6.7	6.6	14.9	3.7	0.4	0.7	1.2	0.4	0.4	0.5	3.0	1.3	1.5
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512975	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Bipolar cells: 2.5;Hepatic stellate cells: 1.1;Horizontal cells: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;ASC TERT1: 25.9;GAMG: 47.4;hTERT-RPE1: 69.8;WM-115: 43.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	0.8	0.7	1.4	0.7	1.8	0.0	0.6	5.1	1.3	0.8	0.7	1.0	0.2	0.7	0.3	0.7	0.9	0.5	1.6	2.1	2.3	0.5	0.4	0.6	0.4	1.8	1.2	1.1	0.5	0.3	0.6	2.2	2.1	0.5	0.3	3.1	0.7	0.7	1.1	1.7	0.4	0.8	2.4	0.3	0.4	0.8	1.9	0.3	0.8	0.5	0.3	0.6	0.8	2.9	0.0	0.0	0.7	2.4	24.3	25.9	0.9	5.5	10.6	4.2	6.6	0.1	0.2	0.6	9.1	5.6	47.4	3.7	0.1	0.6	6.6	0.2	2.4	0.1	0.1	0.0	4.0	0.4	0.0	19.0	0.3	7.4	0.1	69.8	6.5	1.2	0.0	0.1	0.1	0.0	0.0	0.3	2.9	0.0	0.1	17.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	21.3	9.9	0.5	3.2	7.9	0.8	0.1	0.6	0.1	0.0	0.4	0.0	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	1.8	5.1	1.3	2.1	2.3	1.8	1.2	2.1	2.4	1.9	2.9	0.5	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.1	0.5	0.8	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.1	0.0	0.2	1.1	0.0	0.4	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.6	0.3	0.1	0.1	0.7	0.0	0.1	0.0	0.2	0.1	0.1
PCDHGB4	"CDH20, FIB2, PCDH-GAMMA-B4"	ENSG00000253953	"Protocadherin gamma subfamily B, 4"	Q9UN71	5	141387698-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.1;Horizontal cells: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.3;SuSa: 15.5;TIME: 22.7"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.33e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.27e-2)"	1.3	1.1	1.3	0.4	1.5	0.0	0.9	4.4	1.4	1.5	1.8	1.1	0.2	1.6	1.5	0.7	1.3	0.5	1.5	2.0	3.2	1.4	1.6	1.1	0.1	2.0	2.0	2.4	1.0	1.9	1.2	3.0	1.5	1.2	0.4	1.4	1.6	1.4	1.0	1.7	0.5	1.0	1.4	0.4	0.4	0.5	2.5	0.7	1.7	0.8	0.2	1.0	1.1	1.5	0.0	1.1	11.1	0.1	6.9	8.5	1.3	10.8	43.3	4.4	3.0	0.0	0.0	0.4	8.3	0.3	0.2	3.3	0.0	0.0	4.6	0.0	0.0	0.0	0.2	2.4	2.8	0.0	0.0	8.4	0.1	4.1	0.0	0.1	6.7	0.0	0.4	0.1	0.0	0.0	1.1	0.2	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	15.5	5.6	4.2	22.7	6.0	1.8	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	1.5	4.4	1.4	2.0	3.2	2.0	2.0	1.5	1.4	2.5	1.5	0.2	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Bipolar cells: 1.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 66.3;ASC TERT1: 49.6;BJ hTERT+ SV40 Large T+: 29.2;BJ hTERT+ SV40 Large T+ RasG12V: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.8	2.7	3.6	1.1	3.6	0.0	1.8	5.8	3.1	2.0	3.3	1.7	0.7	3.1	2.0	1.9	2.8	1.6	2.9	3.9	6.4	2.2	2.1	2.7	0.4	5.1	4.7	5.7	3.8	20.3	1.7	4.8	5.4	3.0	0.9	3.1	4.7	3.9	2.1	3.8	0.8	2.8	5.3	1.3	1.5	1.9	4.9	1.3	4.5	1.9	0.8	1.9	2.1	6.1	0.0	2.4	0.3	0.0	66.3	49.6	1.3	18.3	0.0	29.2	32.5	2.9	10.0	10.6	23.4	20.5	0.0	13.9	0.0	7.6	16.4	0.0	3.1	0.0	0.0	0.1	6.9	0.0	6.5	17.6	1.5	1.7	9.4	12.6	9.0	0.0	0.2	0.0	1.0	8.1	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	1.6	5.5	0.0	0.1	0.0	0.1	0.0	2.0	19.1	0.1	9.2	0.0	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.6	5.8	3.1	3.9	6.4	5.1	4.7	5.4	5.3	4.9	6.1	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.2	1.5	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.8	0.5	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.1
PCDHGB6	PCDH-GAMMA-B6	ENSG00000253305	"Protocadherin gamma subfamily B, 6"	Q9Y5F9	5	141408021-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.9;Cone photoreceptor cells: 6.2;Horizontal cells: 10.1;Skeletal myocytes: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 16.0;EFO-21: 5.4;HSkMC: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.71e-4)"	3.1	3.1	3.0	0.9	3.6	0.4	2.2	5.0	2.4	2.9	2.9	2.4	0.5	3.2	2.0	1.2	2.9	1.7	2.4	2.5	3.5	1.1	1.3	2.0	0.7	3.6	3.5	6.0	1.2	2.8	1.8	3.1	3.2	1.4	0.7	2.8	2.2	2.4	2.9	2.1	1.0	1.9	3.3	1.5	1.1	0.6	3.7	0.6	2.6	1.5	0.6	1.8	2.3	3.9	0.0	0.1	16.0	0.1	0.5	0.6	0.8	1.4	0.0	0.4	0.9	0.2	0.2	1.4	5.4	0.9	0.2	0.3	0.0	0.3	1.0	0.0	0.3	0.0	0.2	0.1	1.3	0.1	0.1	3.6	1.8	0.8	0.1	0.1	0.5	0.3	0.1	0.2	0.1	0.3	0.1	1.1	0.6	0.0	0.0	0.2	0.0	0.1	2.5	0.2	0.2	0.3	0.0	0.1	0.1	0.4	1.2	0.3	2.6	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	3.0	3.6	5.0	2.4	2.5	3.5	3.6	3.5	3.2	3.3	3.7	3.9	3.6	3.2	0.5	0.0	1.0	0.0	1.5	0.0	0.0	6.9	0.6	0.4	3.9	0.0	1.3	0.0	6.2	0.2	0.6	0.4	0.0	0.7	0.0	0.6	3.8	2.6	0.0	0.0	0.0	1.2	0.1	3.3	1.1	0.5	0.0	0.4	1.4	0.7	0.3	10.1	0.0	0.4	0.0	0.0	0.0	0.2	1.8	0.2	0.0	0.0	0.1	2.7	0.0	0.0	0.0	2.0	0.1	1.2	1.5	0.8	0.1	0.3	0.7	2.5	0.0	5.2	3.2	0.2	0.5	0.3	0.1	0.1	0.7	0.8	0.4	0.8
PCDHGB7	"ME6, PCDH-GAMMA-B7"	ENSG00000254122	"Protocadherin gamma subfamily B, 7"	Q9Y5F8	5	141417645-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Bipolar cells: 7.9;Fibroblasts: 3.4;Horizontal cells: 3.3;Skeletal myocytes: 5.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"AN3-CA: 86.7;HSkMC: 26.7;hTERT-RPE1: 72.4"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.22e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-2)"	5.2	4.6	4.6	1.8	4.7	0.1	4.2	10.8	3.5	4.9	5.0	5.0	0.9	5.7	2.2	3.0	4.4	4.4	4.3	4.5	7.0	2.4	1.5	5.8	1.2	6.0	6.0	8.1	1.7	4.3	2.2	5.5	5.3	3.8	1.7	5.8	3.7	5.5	3.0	3.3	2.1	5.1	7.7	2.7	2.4	1.9	5.0	1.5	4.0	4.1	0.9	3.3	3.8	7.3	0.0	0.0	2.9	86.7	1.9	0.3	0.9	5.7	0.7	2.1	4.3	0.1	5.3	0.7	4.6	11.7	0.8	1.4	0.2	1.0	2.0	0.1	0.6	0.0	0.2	0.0	6.4	0.5	0.1	26.7	0.7	1.7	0.9	72.4	4.6	0.2	0.0	0.0	0.3	0.0	0.0	0.1	1.0	0.0	0.6	10.1	1.9	0.0	0.2	0.0	9.3	12.8	0.2	0.0	0.0	1.0	1.0	0.9	11.5	10.3	0.2	0.9	0.1	0.1	0.2	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.6	4.7	10.8	3.5	4.5	7.0	6.0	6.0	5.3	7.7	5.0	7.3	2.2	3.2	1.3	0.0	0.3	0.4	0.8	0.0	0.0	7.9	0.3	0.5	1.4	0.0	0.1	0.0	2.1	0.1	0.0	0.0	0.0	0.2	0.1	0.4	2.1	2.2	0.0	0.0	0.0	0.5	0.1	3.4	0.0	0.3	1.3	0.5	0.4	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.0	1.9	0.1	0.4	0.0	0.3	0.0	0.7	0.0	5.9	2.2	0.0	0.1	0.5	0.4	0.0	0.0	1.2	0.1	0.2
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 31.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.1;Horizontal cells: 3.3"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 9.1;SCLC-21H: 7.3;SH-SY5Y: 14.2;SuSa: 10.0"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.2	1.1	17.3	0.1	12.2	0.0	0.2	19.3	14.6	0.3	0.1	0.6	0.0	0.4	0.2	0.2	0.3	0.2	2.2	12.7	13.9	0.1	0.1	0.4	0.1	12.9	21.9	0.3	0.3	0.0	1.1	0.1	10.3	0.2	0.1	6.6	0.3	0.1	0.7	0.5	0.1	0.2	22.4	0.1	0.2	0.9	14.3	0.0	0.1	0.3	0.2	0.2	0.3	31.4	0.0	0.0	0.9	0.2	0.2	0.7	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.8	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	1.3	0.0	0.0	9.1	0.5	0.0	0.0	0.1	7.3	14.2	0.1	0.0	0.1	10.0	0.1	0.3	0.1	0.8	0.1	0.2	0.6	0.2	0.0	0.2	0.6	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	12.2	19.3	14.6	12.7	13.9	12.9	21.9	10.3	22.4	14.3	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489081-141512975	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 28.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 4.6;SuSa: 7.4;U-138 MG: 14.4;U-251 MG: 6.5;U-87 MG: 8.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA076140"	Supported		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"		"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	0.3	0.5	5.6	0.1	8.6	0.0	0.3	0.0	11.7	0.8	0.0	1.3	0.0	1.2	0.2	0.3	0.7	0.2	5.3	28.4	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.7	0.4	0.0	1.2	0.1	0.0	0.5	0.0	1.2	0.4	0.5	1.2	0.5	0.2	0.7	0.0	0.1	0.3	0.6	0.3	0.1	0.2	0.2	0.0	0.5	0.6	0.0	0.0	0.0	0.3	0.3	0.3	1.5	0.1	0.8	0.5	0.4	0.5	0.0	0.0	0.4	1.4	2.2	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	4.6	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	7.4	0.1	0.2	0.1	14.4	0.2	0.2	6.5	0.0	0.0	0.0	8.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.6	0.0	11.7	28.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDCD11	"ALG-4, KIAA0185, NFBP, RRP5"	ENSG00000148843	"Programmed cell death 11"	Q14690	10	103396626-103446294	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017924, CAB026472"	Approved		Supported	"Nucleoli rim,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli rim"	Vesicles	"CAB026472: , HPA017924: AB_10601045"	"unprognostic (1.34e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.59e-2)"	8.1	7.8	4.1	10.0	4.8	7.5	9.4	4.5	4.6	8.7	4.5	7.7	5.9	9.9	5.9	11.7	9.0	4.4	7.5	4.4	4.7	9.8	9.1	7.3	11.0	4.4	4.5	10.4	11.6	8.5	6.4	7.5	4.6	8.0	7.9	6.1	7.2	6.2	15.8	15.5	7.7	9.1	4.1	9.5	7.3	14.8	5.1	11.9	6.9	8.1	11.8	9.9	8.4	5.0	27.4	39.8	27.2	77.0	23.3	20.9	30.5	29.6	20.7	29.2	23.7	54.7	26.3	74.9	20.5	21.4	18.0	48.0	70.6	37.1	32.5	34.8	47.5	43.7	26.0	44.2	27.7	88.0	28.7	21.8	33.3	44.8	101.3	21.0	31.6	19.4	71.5	32.7	28.4	30.9	44.5	49.9	55.9	21.7	37.9	44.3	39.0	34.1	18.1	26.6	18.2	34.1	19.9	23.2	32.6	26.4	22.8	24.8	34.5	21.5	27.0	29.0	55.9	41.2	61.8	69.5	19.0	83.3	16.2	0.1	2.8	0.9	3.2	2.6	5.2	3.4	3.1	2.7	2.8	2.2	2.7	3.2	0.3	2.1	2.3	3.3	2.3	2.5	4.1	4.8	4.5	4.6	4.4	4.7	4.4	4.5	4.6	4.1	5.1	5.0	8.8	12.8	14.1	5.9	13.6	16.4	9.3	10.8	8.0	15.0	18.6	15.6	14.6	20.0	17.4	9.2	29.2	12.8	18.1	9.6	13.7	23.6	61.2	12.6	25.4	14.4	9.5	14.9	11.8	15.8	15.8	14.0	5.6	11.7	18.9	18.5	8.9	24.5	10.9	6.7	9.3	12.9	4.1	7.7	5.2	19.6	11.1	10.7	10.6	8.4	9.8	4.9	9.2	7.5	7.6	29.1	4.9	10.1	9.6	17.9	4.4	8.2	20.2	13.8	6.6	16.8	11.0	27.5	30.7	14.0	16.9	8.2	11.6	19.0	19.9	8.7
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 2050.3"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 4448.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basophil: 127.0;NK-cell: 220.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 127.0;NK-cells: 220.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.2;NB-4: 5.8;NTERA-2: 8.9;REH: 11.9;SuSa: 6.2"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.7"	"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles		"HPA045118: AB_2732517"	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	1.5	0.3	0.0	4.7	0.1	7.8	0.9	0.2	0.5	1.0	0.2	1.6	0.6	0.2	0.1	0.8	0.7	2.5	0.4	0.1	0.7	2.1	4.2	3.0	20.6	0.1	0.2	0.0	0.0	0.1	0.1	12.0	0.2	0.2	1.0	2050.3	0.5	0.4	1.2	0.3	1.6	0.9	0.1	19.9	1.7	0.8	0.3	8.3	0.4	0.3	7.1	3.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	5.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.8	0.2	0.1	0.2	0.4	0.3	0.0	5.8	8.9	0.0	0.0	11.9	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.1	0.1	6.2	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.1	0.6	0.9	0.4	3.1	0.1	127.0	18.1	30.5	4.1	26.2	1.3	2.7	0.8	2.3	28.9	5.1	2.1	7.4	2.4	220.2	15.5	2.9	0.1	13.5	0.0	0.1	0.2	0.5	0.1	0.7	0.1	0.2	0.2	0.1	0.3	0.2	0.3	0.0	0.6	0.3	1.1	0.9	0.0	0.0	0.6	422.5	0.3	0.4	0.2	0.0	0.0	5.5	517.1	0.2	4.3	0.1	1.9	0.4	0.8	1.5	0.3	27.2	0.0	1.7	0.2	0.2	0.4	0.2	0.0	0.5	23.6	0.1	2.9	0.2	22.6	262.5	0.1	0.2	0.0	4.8	8.0	2.3	0.0	4.4	3.6	0.0	13.3	709.0	11.3	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.1	1.0	0.0	4448.6	0.0	0.1	0.1	1.1	0.2	0.3	1.4	0.3	1.7	2.1	0.0	0.1
PDE6H		ENSG00000139053	"Phosphodiesterase 6H"	Q13956	12	14973042-14981865	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"retina: 911.3"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 831.9;Rod photoreceptor cells: 218.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.0"	"Low region specificity"	"Detected in single"							HPA045118	Supported		Uncertain	Vesicles		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles		"HPA045118: AB_2732517"					"unprognostic (1.47e-3)"										"unprognostic (1.07e-2)"			0.0	0.4	0.3	0.0	0.4	4.0	0.0	0.1	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	911.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.1	1.0	0.3	2.3	0.3	0.4	0.5	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.9	0.0	0.0	0.1	0.0	0.0	0.0	831.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.5	0.0	21.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	23.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.6	81.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0
PEMT	"PEMPT, PEMT2"	ENSG00000133027	"Phosphatidylethanolamine N-methyltransferase"	Q9UBM1	17	17505563-17591708	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 166.2;liver: 267.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 122.9;Hepatocytes: 220.1;Peritubular cells: 346.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042375, HPA073930"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Endoplasmic reticulum, Mitochondria"	"Vesicles, Cytosol"	"HPA042375: AB_10796905, HPA073930: "	"unprognostic (1.39e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.77e-6)"	"unprognostic (2.85e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.63e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.60e-2)"	71.6	33.9	13.2	5.2	13.6	9.2	92.7	16.3	20.0	47.4	12.7	13.6	15.0	36.9	166.2	26.8	26.5	5.4	24.5	13.0	15.2	30.2	267.4	25.8	5.2	14.9	15.3	27.9	32.2	13.3	24.7	7.3	16.8	30.8	3.4	2.8	27.1	24.0	29.5	34.3	13.7	6.8	15.1	12.8	19.5	40.8	14.2	5.6	33.5	10.7	4.5	21.1	24.2	17.2	34.3	64.7	16.5	43.4	34.6	23.8	25.1	21.6	19.0	28.5	22.4	38.2	22.6	29.8	38.1	21.9	21.6	39.9	24.6	12.8	7.2	22.2	86.9	14.8	33.2	55.4	38.4	13.5	21.4	24.9	26.7	19.2	29.1	9.7	15.7	41.3	14.6	12.3	12.9	66.0	23.9	24.2	23.2	65.5	52.4	22.2	26.7	27.5	24.1	12.5	16.7	39.5	15.3	10.1	39.2	31.5	15.6	5.1	13.9	28.1	28.2	47.4	18.9	17.0	12.1	5.5	25.9	18.5	23.6	1.9	41.1	2.1	16.9	39.0	24.8	23.5	22.2	21.5	30.5	28.3	17.2	19.4	3.1	29.3	28.0	27.7	22.4	21.3	13.2	13.6	16.3	20.0	13.0	15.2	14.9	15.3	16.8	15.1	14.2	17.2	38.1	16.0	17.5	4.9	12.4	18.2	21.0	27.9	39.3	4.5	33.0	45.1	15.5	11.5	24.9	27.6	0.0	19.5	5.9	9.3	17.6	33.3	2.9	21.8	122.9	18.5	68.8	17.1	5.4	38.5	21.6	30.4	8.2	23.8	12.7	52.4	10.4	220.1	23.5	5.0	6.8	30.9	24.4	13.7	12.2	14.9	94.8	11.2	21.4	3.7	5.7	34.7	2.1	9.5	4.0	25.7	10.8	346.8	15.3	35.1	21.7	32.3	14.2	6.1	6.6	20.0	23.6	21.0	24.9	39.5	18.2	14.6	12.5	49.3	24.1	23.8
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 252.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 143.6;Leydig cells: 138.5;Theca cells: 205.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 99.0;RH-30: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: AB_2682893"	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.94e-6)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	37.7	74.8	4.1	18.5	5.2	21.7	29.6	1.9	7.0	31.4	5.8	28.8	9.6	29.5	9.0	32.9	20.8	26.9	26.4	3.8	2.9	17.0	3.6	26.7	12.1	3.6	4.1	36.5	27.7	9.5	81.6	252.3	3.9	26.0	21.3	1.6	30.1	12.1	12.2	61.9	20.6	19.7	3.2	15.6	26.9	8.7	6.0	6.6	13.8	22.3	12.1	39.6	34.4	4.0	0.2	5.0	99.0	0.1	39.4	78.0	0.3	32.9	21.6	16.1	33.5	0.3	6.0	2.7	16.0	30.4	4.0	0.0	0.8	12.0	32.2	3.1	4.4	45.2	58.7	0.9	13.9	40.9	8.9	60.5	4.6	15.8	13.8	23.4	33.5	16.1	4.4	0.8	18.0	6.2	16.9	19.8	17.2	0.0	3.7	20.7	94.1	0.1	33.1	1.1	8.7	10.3	51.0	0.1	0.1	29.6	0.1	50.1	19.8	0.2	35.2	77.7	36.4	9.1	9.0	0.6	25.3	16.6	2.0	4.9	12.0	25.1	1.4	9.1	1.4	3.7	1.3	1.9	14.9	5.8	0.9	1.5	21.7	2.2	2.9	6.7	2.0	3.8	4.1	5.2	1.9	7.0	3.8	2.9	3.6	4.1	3.9	3.2	6.0	4.0	19.5	51.3	51.0	28.4	15.2	21.7	14.6	5.3	34.1	2.1	16.8	14.0	8.4	5.7	12.6	5.5	0.0	4.6	19.0	16.1	7.9	11.8	1.8	8.6	91.9	23.8	16.7	19.3	60.3	11.3	15.0	143.6	11.7	13.0	18.4	38.7	8.6	0.2	20.3	8.4	76.6	33.6	18.3	26.8	27.8	5.5	138.5	26.8	8.8	49.6	37.6	0.9	2.1	10.6	5.5	13.0	22.5	97.0	5.7	52.0	4.3	15.3	4.4	0.4	13.1	61.7	31.1	0.9	1.0	24.1	43.3	9.9	10.0	205.8	28.5	19.7
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917496	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 103.8;urinary bladder: 128.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 635.9;Basal respiratory cells: 237.3;Pancreatic endocrine cells: 613.9;Prostatic glandular cells: 695.0;Urothelial cells: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.0;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 856.0;LHCN-M2: 822.4;RPTEC TERT1: 3100.7;U-251 MG: 869.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070796	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	647000	88000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"HPA070796: "	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	57.6	4.8	2.5	41.7	2.7	36.2	17.6	2.7	8.9	9.3	4.4	13.1	11.9	22.0	16.7	14.4	10.3	28.5	23.1	2.4	2.9	103.8	5.0	22.0	14.3	3.8	2.9	2.3	10.1	8.3	2.9	36.5	5.4	9.1	18.2	0.3	17.3	13.7	10.8	25.5	13.7	23.4	3.3	40.6	15.7	3.7	4.7	5.9	17.9	18.9	7.2	128.5	16.2	4.7	171.1	88.9	36.8	1.7	3.1	59.5	2.0	101.9	461.6	40.0	62.2	2.3	856.0	0.1	184.0	14.5	416.9	114.1	0.9	165.8	44.8	9.9	0.0	0.1	4.4	1.7	72.6	15.6	32.3	158.7	20.2	271.4	103.7	447.0	114.7	1.0	1.1	0.9	822.4	0.2	0.2	22.7	10.8	0.3	244.5	0.4	112.6	0.9	3100.7	130.6	0.1	0.2	0.3	4.0	2.4	25.4	1.2	22.9	300.6	3.5	20.3	21.6	869.8	0.2	1.3	1.6	216.0	25.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	0.0	0.0	2.0	0.0	0.1	2.5	2.7	2.7	8.9	2.4	2.9	3.8	2.9	5.4	3.3	4.7	4.7	29.0	3.2	4.6	0.3	1.4	37.3	635.9	237.3	19.9	0.0	3.0	24.4	2.5	0.0	103.6	29.5	0.0	28.0	1.6	0.6	68.4	62.7	0.5	50.7	22.2	46.4	3.5	0.0	0.2	21.3	21.7	69.7	0.0	68.9	31.1	0.1	3.9	0.0	39.8	0.0	0.3	0.1	140.4	4.0	33.1	1.3	2.5	53.4	7.2	4.7	23.8	0.0	0.0	0.5	0.2	613.9	0.3	0.0	0.5	695.0	0.0	1.4	35.4	0.0	6.6	27.6	65.2	0.0	0.2	60.6	29.5	17.5	4.7	0.6	1.7	869.6
PLEK2		ENSG00000100558	"Pleckstrin 2"	Q9NYT0	14	67386984-67412167	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 51.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 149.0;Pancreatic endocrine cells: 179.8;Suprabasal keratinocytes: 90.6;Theca cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 91.0;CAPAN-2: 94.4;HBEC3-KT: 177.4;PC-3: 64.1;TIME: 69.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001208	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	Cytosol	"HPA001208: AB_1079631"	"unprognostic (4.41e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (8.26e-5)"	"unprognostic (1.06e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.59e-2)"	0.8	51.1	0.3	5.5	0.3	12.7	3.9	0.8	0.6	3.9	0.1	25.1	29.6	1.5	32.4	16.4	1.7	3.9	0.3	0.4	0.2	9.7	29.7	1.6	0.2	0.3	0.2	0.6	7.9	7.0	1.3	1.5	0.3	7.7	28.7	0.1	6.8	4.2	0.3	26.5	32.6	1.3	0.2	0.6	20.6	3.1	0.4	22.9	23.5	0.2	5.5	12.1	7.9	0.4	91.0	13.4	0.0	0.1	0.0	1.0	8.4	17.9	2.7	4.2	5.2	48.8	94.4	0.0	17.3	2.5	0.2	42.4	0.1	177.4	9.6	0.1	0.7	0.0	19.4	0.4	3.8	0.0	0.0	1.9	12.3	4.6	55.4	0.0	14.8	0.0	0.4	0.4	3.0	28.9	0.0	0.2	0.3	57.4	64.1	0.0	0.1	14.0	30.0	2.4	0.7	0.2	17.0	7.9	5.2	0.9	11.6	0.9	69.3	0.0	54.1	0.3	0.4	0.3	0.2	0.3	10.7	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.4	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.8	0.6	0.4	0.2	0.3	0.2	0.3	0.2	0.4	0.4	0.1	0.0	1.1	1.0	0.6	149.0	29.0	69.9	37.0	0.0	4.9	6.0	0.5	10.0	11.8	5.5	0.0	1.0	0.0	25.0	3.9	42.1	0.1	2.3	0.2	2.0	8.4	16.0	0.8	46.3	5.5	4.2	37.2	2.2	0.0	24.0	0.0	11.5	6.8	0.0	0.6	68.5	26.4	1.3	57.1	0.3	0.3	7.4	21.4	0.0	5.2	0.0	0.0	0.5	0.3	179.8	23.9	0.0	0.0	15.8	47.9	3.2	4.5	0.0	0.0	0.0	4.6	0.4	2.3	21.2	90.6	1.5	1.3	107.7	54.8	25.5
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 236.8;Sertoli cells: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.43e-4)"	58.1	34.6	46.3	35.2	51.2	16.1	41.2	48.6	56.6	65.4	46.4	47.3	37.7	65.0	30.5	21.3	51.1	42.0	71.2	44.5	47.4	45.5	78.1	44.4	15.4	49.6	50.8	54.4	39.0	36.9	29.6	83.8	52.4	34.7	23.2	10.6	75.9	40.6	40.5	27.2	35.6	78.4	44.8	31.5	35.5	11.6	52.2	7.9	34.9	41.6	12.9	42.4	36.0	53.1	112.5	91.4	51.3	239.7	343.4	190.6	39.0	330.4	436.1	170.4	287.1	105.2	71.5	63.1	339.5	367.3	125.9	93.4	75.6	115.6	115.6	66.2	78.3	34.0	136.6	137.3	212.5	21.9	162.7	234.0	59.7	206.2	81.9	573.3	305.0	14.8	97.6	30.9	180.2	71.1	5.7	58.6	22.9	115.4	131.6	25.8	100.0	141.0	98.7	24.3	19.2	77.7	137.3	97.4	164.8	80.4	48.3	55.9	298.7	190.1	141.6	236.3	161.9	71.4	123.7	38.7	425.1	75.5	316.8	0.0	40.3	2.0	17.3	34.4	3.1	1.7	3.0	8.4	32.7	3.4	1.2	6.4	35.5	5.4	32.3	4.9	2.0	22.6	46.3	51.2	48.6	56.6	44.5	47.4	49.6	50.8	52.4	44.8	52.2	53.1	19.4	0.0	7.9	9.4	3.7	7.0	8.0	22.8	8.0	5.7	17.9	17.5	18.3	8.6	8.6	11.0	2.1	39.7	8.7	14.8	3.9	30.3	1.0	11.0	62.2	33.9	8.4	3.0	4.2	9.8	236.8	47.5	17.3	24.8	0.0	20.4	36.8	37.1	46.3	6.7	5.8	12.5	4.1	26.5	8.3	2.4	44.4	16.3	10.6	15.9	17.9	7.9	15.5	3.0	9.8	22.4	15.4	24.5	19.4	8.0	41.5	16.7	4.5	3.1	105.2	77.2	47.3	0.5	3.3	7.4	5.1	33.7	5.5	37.1	16.6	3.9
PMAIP1	"APR, NOXA"	ENSG00000141682	"Phorbol-12-myristate-13-acetate-induced protein 1"	Q13794	18	59899996-59904305	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 88.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 803.1;Endometrial ciliated cells: 463.6;Glandular and luminal cells: 529.8;Squamous epithelial cells: 474.5;Suprabasal keratinocytes: 691.2;Urothelial cells: 569.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 169.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 169.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 207.5;U-138 MG: 202.1"									HPA051063	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA051063: AB_2681330"	"unprognostic (1.35e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.12e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.09e-1)"	2.0	0.7	2.8	8.0	2.7	88.1	3.9	2.6	5.1	6.5	3.0	2.5	3.7	5.4	0.2	13.7	2.9	8.0	0.9	2.6	2.8	2.3	2.1	3.8	14.7	2.8	2.7	0.7	1.2	14.8	16.7	13.4	3.0	3.6	3.4	2.0	3.6	1.3	1.5	24.1	3.9	1.9	2.7	4.6	2.5	3.1	3.7	12.1	2.1	1.5	14.2	17.3	7.9	2.4	26.6	17.4	5.2	1.6	8.8	69.0	19.8	125.4	84.1	71.5	70.7	1.7	32.5	104.6	17.0	23.5	207.5	38.4	21.0	11.8	70.4	33.7	154.5	19.4	26.0	4.6	87.6	67.1	28.2	28.7	30.8	93.8	48.5	26.1	24.0	46.7	26.7	17.5	24.1	2.6	53.8	20.1	151.7	2.7	32.7	54.1	28.8	39.1	41.9	24.2	39.7	32.7	6.1	3.2	71.5	56.1	5.3	54.6	90.6	202.1	54.0	10.3	141.4	2.8	0.3	92.1	16.8	37.6	48.5	169.8	16.7	103.6	10.9	26.2	9.6	33.8	5.0	6.8	12.1	25.0	4.1	5.9	53.5	6.3	32.1	10.2	25.2	15.1	2.8	2.7	2.6	5.1	2.6	2.8	2.8	2.7	3.0	2.7	3.7	2.4	29.2	32.1	25.7	0.7	175.3	803.1	316.2	236.4	415.4	0.2	111.8	82.0	4.7	12.8	129.6	3.7	2.1	120.3	125.3	141.1	0.0	54.7	0.8	463.6	48.8	48.5	133.4	5.5	0.0	67.0	14.7	32.9	168.2	529.8	31.8	11.8	7.9	0.5	89.5	0.0	0.0	146.8	181.0	37.2	363.3	1.1	0.9	140.6	74.7	7.5	142.4	0.3	34.0	0.0	0.2	100.1	123.6	1.2	63.1	265.7	94.7	0.5	101.5	0.7	0.0	10.8	32.0	0.3	19.8	474.5	691.2	315.2	117.0	19.8	122.2	569.2
POLB		ENSG00000070501	"DNA polymerase beta"	P06746	8	42338454-42371808	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 254.5;Late spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 280.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011616, HPA049104, HPA069013"	Enhanced		Uncertain	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"CAB011616: AB_731977, HPA049104: AB_2680632, HPA069013: "	"unprognostic (1.67e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.77e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.65e-4)"	12.4	17.5	26.6	13.5	27.4	51.3	27.4	82.3	35.5	18.9	24.3	12.3	10.8	12.9	19.7	26.5	13.2	17.4	26.1	28.1	29.0	18.0	33.9	14.2	20.2	27.1	27.8	20.4	16.9	18.8	26.7	11.1	28.9	24.8	13.2	18.0	30.3	11.3	85.3	23.1	10.8	10.6	27.6	17.2	14.0	53.1	30.2	24.8	14.2	70.0	22.2	30.8	18.9	28.9	40.2	23.5	40.6	80.4	21.8	20.7	33.8	25.2	29.3	41.5	37.7	33.1	46.0	36.4	31.1	16.5	43.4	20.0	34.1	29.5	50.3	23.8	36.7	26.5	18.2	45.3	34.1	18.6	280.6	18.8	34.4	30.1	35.4	51.8	32.1	77.2	58.4	22.4	40.3	23.6	78.0	52.6	54.4	48.4	26.7	44.2	40.8	31.4	78.4	32.1	22.7	41.8	29.9	19.9	79.0	41.4	52.5	31.5	17.8	19.1	27.0	48.8	24.6	32.5	58.4	52.2	19.3	39.4	52.2	47.6	15.1	48.1	12.0	18.8	13.3	12.2	12.5	13.0	15.7	11.1	14.1	13.3	63.6	22.2	26.3	84.9	19.3	11.5	26.6	27.4	82.3	35.5	28.1	29.0	27.1	27.8	28.9	27.6	30.2	28.9	13.9	3.2	13.6	6.8	20.2	16.8	30.1	14.2	31.3	2.9	14.3	15.1	21.6	7.2	20.7	7.3	8.4	7.5	51.9	3.1	5.9	11.7	254.5	13.8	7.7	12.5	6.0	7.6	15.8	9.6	7.0	9.7	10.2	9.9	23.4	12.7	8.6	12.7	7.4	6.7	20.3	5.4	4.1	5.7	9.9	133.9	7.2	18.2	7.2	19.7	11.2	8.3	13.4	12.5	16.7	33.6	5.8	3.8	21.9	41.6	4.3	6.8	16.4	4.4	0.0	6.6	12.3	19.4	15.4	27.3	20.0	11.1	16.2	7.8	6.6	31.6
PPFIA3	"KIAA0654, LPNA3, MGC126567, MGC126569"	ENSG00000177380	"PTPRF interacting protein alpha 3"	O75145	19	49119544-49151026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;pituitary gland: 45.0;skin 1: 42.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 40.8;Horizontal cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 23.1;PC-3: 36.1;SK-BR-3: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043567, HPA050340"	Enhanced		Uncertain	"Nucleoli fibrillar center,Vesicles"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoli fibrillar center, Vesicles"		"HPA043567: AB_2678558, HPA050340: AB_2681096"	"prognostic unfavorable (3.09e-4)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-3)"	"prognostic favorable (8.65e-4)"	"unprognostic (3.46e-1)"	"prognostic favorable (6.46e-7)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.27e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.41e-3)"	"unprognostic (5.21e-3)"	"unprognostic (8.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.32e-1)"	2.0	4.5	16.4	0.8	18.8	0.2	2.7	11.7	28.6	4.6	0.0	6.6	3.0	2.2	0.3	14.1	1.9	0.6	3.1	18.2	11.4	3.1	2.7	2.9	0.8	10.1	8.7	1.3	4.7	2.1	45.0	0.4	9.9	5.6	1.0	3.7	5.3	0.6	1.4	42.3	3.7	0.4	3.5	2.2	2.4	4.2	11.7	2.4	2.8	0.2	1.1	1.4	8.1	16.6	3.3	3.3	3.3	8.0	0.1	0.0	6.0	0.4	0.4	1.5	2.2	2.2	1.3	7.3	4.3	0.4	2.4	1.7	5.0	0.7	0.4	7.9	10.8	4.6	3.5	1.7	0.4	1.9	11.4	0.4	1.8	1.0	0.5	0.7	0.0	12.1	9.0	11.2	0.1	14.2	2.3	3.2	1.4	23.1	36.1	7.6	6.5	3.6	0.5	1.6	7.2	9.5	1.3	29.7	3.3	0.0	16.5	4.4	0.7	1.7	6.1	1.1	0.2	21.0	18.2	5.4	1.7	7.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	18.8	11.7	28.6	18.2	11.4	10.1	8.7	9.9	3.5	11.7	16.6	15.7	0.0	0.6	8.5	0.8	7.1	8.0	3.5	11.4	40.8	10.4	6.1	4.2	8.6	3.0	5.5	14.6	0.5	3.6	19.3	19.6	2.7	1.2	1.3	3.6	15.2	26.5	2.7	19.9	4.4	2.1	3.4	3.6	2.4	0.0	2.7	23.2	8.6	2.5	43.7	21.5	26.3	8.2	2.2	2.4	1.7	5.6	2.7	16.0	2.8	0.0	16.2	0.0	10.6	2.7	1.9	13.7	3.8	1.2	18.2	15.0	4.6	0.9	17.9	0.0	0.6	5.5	2.5	5.9	8.7	11.8	0.5	0.7	13.2	20.4	6.3
PPP1R15A	GADD34	ENSG00000087074	"Protein phosphatase 1 regulatory subunit 15A"	O75807	19	48872421-48876058	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 575.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 340.1"	"Group enriched"	"Detected in all"	5	"dendritic cells: 114.6;granulocytes: 340.1"	"Cell line enhanced"	"Detected in all"		"HHSteC: 282.8;hTERT-HME1: 493.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018395, HPA020240"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"CAB018395: AB_2237473, HPA020240: AB_1849404"	"unprognostic (2.43e-3)"	"unprognostic (3.21e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.43e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.94e-2)"	199.1	84.7	33.3	49.5	37.4	575.6	97.7	45.9	54.1	99.5	66.9	78.9	36.0	70.1	11.3	98.3	147.4	82.0	185.6	34.8	36.2	95.0	85.1	226.7	33.1	44.8	32.7	101.2	33.4	23.1	65.0	74.8	42.9	60.5	45.5	10.9	41.6	38.6	88.5	191.5	58.8	101.8	29.4	69.0	90.7	23.3	38.7	52.0	69.4	60.6	20.2	110.6	108.4	46.9	55.8	23.7	24.9	20.5	71.2	40.4	39.3	95.1	148.0	106.5	95.9	36.5	27.6	19.1	25.0	69.0	145.5	39.4	9.3	49.7	79.8	10.7	14.4	86.4	14.4	18.1	282.8	20.2	119.2	55.1	135.5	147.0	493.7	48.0	56.3	21.5	118.2	155.6	69.5	6.1	11.1	27.9	6.2	100.3	42.3	12.6	23.1	6.5	22.3	63.8	14.2	24.3	49.2	33.2	230.2	26.0	11.9	36.1	60.6	126.3	31.8	89.3	58.5	82.8	72.1	17.9	46.2	13.7	154.8	161.8	49.4	91.3	22.5	31.1	19.6	36.7	22.2	18.7	35.9	29.7	12.3	11.0	340.1	13.8	37.6	114.6	31.5	36.9	33.3	37.4	45.9	54.1	34.8	36.2	44.8	32.7	42.9	29.4	38.7	46.9	499.1	288.4	225.1	2.3	387.2	482.2	989.5	232.0	730.1	25.0	294.3	220.7	173.3	127.2	204.3	12.9	35.5	104.8	290.3	435.6	3.9	224.0	4.6	619.6	427.4	370.4	170.9	213.5	4.1	94.5	219.0	466.3	430.7	1063.2	708.1	53.3	150.0	14.4	195.0	35.3	4.1	354.1	140.4	146.7	904.4	5.1	58.7	615.3	396.6	9.4	105.1	50.5	20.6	1.0	2.0	233.4	421.8	23.0	477.1	731.5	348.7	9.0	246.2	27.7	85.5	483.5	612.1	7.0	9.5	573.1	431.0	288.4	427.9	102.8	321.8	733.9
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 49.2;skin 1: 39.8"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 183.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 91.3;RPTEC TERT1: 35.9"									HPA020361	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favorable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	7.9	0.7	5.8	0.4	6.4	0.0	8.5	3.1	9.0	5.0	34.0	3.1	5.6	1.5	0.1	11.6	5.8	0.1	18.6	6.5	2.8	16.7	15.6	20.6	0.2	7.3	4.7	0.5	1.4	0.0	5.4	0.2	2.5	3.2	0.3	0.6	4.2	0.2	49.2	39.8	32.5	0.0	3.3	0.5	3.5	1.7	7.6	0.3	7.4	6.2	0.8	4.2	8.5	3.4	0.0	0.8	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.0	0.0	2.9	3.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	4.5	91.3	0.0	0.0	0.0	0.4	35.9	0.9	0.1	0.2	0.8	1.4	0.3	5.2	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	6.4	3.1	9.0	6.5	2.8	7.3	4.7	2.5	3.3	7.6	3.4	0.1	16.0	25.6	183.1	0.0	5.1	0.3	13.1	0.0	0.0	0.2	0.1	1.8	0.0	11.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.6	1.2	0.2	0.4	3.5	0.0	0.5	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	2.0	0.0	1.5	0.1	0.0	0.1	21.4	17.8	0.0	0.6	0.0	14.1	2.1	0.0	2.3	0.0	0.0	0.0	8.0	0.1	21.0	0.1	0.0	1.1	0.6	0.2	0.4	1.0	15.2	0.0	0.3	0.0	1.6	0.2
PRPS1L1	"PRPS3, PRPSL"	ENSG00000229937	"Phosphoribosyl pyrophosphate synthetase 1 like 1"	P21108	7	18026770-18027846	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	315	"testis: 31.5"	"Group enriched"	"Detected in some"	7	"Early spermatids: 71.0;Spermatocytes: 129.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051269			Uncertain	Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA051269: "					"unprognostic (2.39e-2)"									"unprognostic (3.18e-2)"	"unprognostic (1.11e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	6.6	0.0	1.1	129.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR15		ENSG00000176532	"Proline rich 15"	Q8IV56	7	29563835-29567293	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 62.6;intestine: 81.4;stomach 1: 49.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 263.0;Granulosa cells: 194.2;Proximal enterocytes: 122.4;Respiratory ciliated cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.7;HaCaT: 45.1;OE19: 97.7;RT4: 34.5;SK-BR-3: 74.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA040996, HPA048121"	Enhanced		Uncertain	"Vesicles,Cell Junctions"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Cell Junctions"	"HPA040996: AB_2677241, HPA048121: AB_2680271"	"unprognostic (5.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (1.30e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.58e-2)"	6.5	0.7	0.6	4.8	0.4	1.1	9.2	0.1	0.7	62.6	0.0	81.4	72.3	18.1	21.6	1.0	9.0	7.8	1.3	0.4	1.0	16.9	0.3	2.3	0.4	0.6	0.4	5.9	3.0	1.4	3.0	4.8	0.5	2.5	52.6	0.0	7.5	3.1	0.2	0.3	72.4	2.3	0.6	0.2	49.3	0.9	1.3	0.1	1.1	0.0	0.7	16.6	0.5	0.6	16.8	23.3	0.0	0.0	8.7	10.7	29.3	0.7	1.1	0.4	0.2	20.5	38.7	0.0	4.1	5.5	0.6	45.1	4.9	0.0	0.0	0.0	3.3	1.3	4.5	22.7	2.8	0.0	0.1	0.1	7.3	0.0	1.7	0.0	0.1	1.5	0.0	0.0	0.0	3.9	0.6	3.2	3.5	97.7	18.5	0.1	0.0	21.4	26.5	34.5	0.5	0.3	2.3	74.9	0.0	12.8	5.4	0.0	19.9	0.5	0.0	0.1	0.9	1.8	3.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.1	0.7	0.4	1.0	0.6	0.4	0.5	0.6	1.3	0.6	1.8	0.0	0.5	0.0	0.4	0.1	1.2	11.0	0.0	0.0	10.0	7.1	0.5	12.8	16.4	38.6	0.0	14.2	0.2	263.0	29.4	6.9	0.8	31.3	2.3	1.2	8.4	0.0	0.1	21.8	9.9	1.3	16.8	34.7	0.0	194.2	0.4	0.2	2.7	0.0	0.0	45.3	26.4	0.0	0.3	0.1	1.5	2.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	14.4	58.5	2.2	0.1	3.0	122.4	14.4	63.1	0.0	0.0	0.0	7.8	0.0	0.4	1.2	0.0	6.3	0.6	0.4	56.9	23.3
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.1;lymphoid tissue: 30.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 75.4;Hofbauer cells: 71.7;Kupffer cells: 93.0;Langerhans cells: 67.8;Macrophages: 64.5;monocytes: 52.8;Pancreatic endocrine cells: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 256.7;eosinophil: 906.5;neutrophil: 747.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 906.5;monocytes: 256.7"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 36.6;HMC-1: 131.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	10.4	2.4	4.3	30.8	4.7	41.1	3.4	4.7	5.6	3.4	4.1	5.5	4.1	1.7	1.2	7.2	2.6	7.2	2.0	3.8	5.1	2.7	4.1	17.8	13.5	8.9	6.6	1.3	2.0	1.6	0.6	7.3	7.7	1.5	6.7	0.5	2.3	1.5	0.7	5.4	6.3	7.9	8.1	14.4	3.8	1.3	7.2	3.6	1.9	2.6	18.0	14.4	1.9	11.8	20.1	0.2	0.1	0.4	0.2	0.0	0.5	0.0	0.0	0.7	0.2	0.2	5.7	1.3	0.1	0.1	0.3	13.5	0.5	36.6	0.8	0.4	0.6	7.7	0.2	0.9	0.1	1.9	131.3	0.0	6.0	0.4	0.4	0.0	0.2	0.1	0.5	0.4	0.0	1.3	0.2	19.3	0.6	0.5	0.2	0.3	0.1	0.1	8.7	2.1	0.3	0.1	0.1	18.1	0.2	0.4	0.4	5.4	0.1	0.2	0.7	0.0	0.2	1.2	1.1	5.6	0.1	2.4	0.6	61.7	256.7	906.5	0.6	77.9	1.2	12.5	0.4	0.4	116.1	6.7	0.5	0.7	747.1	0.7	34.1	1.3	1.2	112.4	4.3	4.7	4.7	5.6	3.8	5.1	8.9	6.6	7.7	8.1	7.2	11.8	2.1	6.4	6.7	0.0	4.1	6.5	2.0	37.9	5.2	1.5	0.8	0.5	2.2	1.5	20.9	1.8	2.1	0.6	2.9	0.4	0.0	18.1	0.4	0.5	0.2	7.3	0.0	4.0	0.9	5.1	0.5	1.3	1.1	0.5	75.4	2.0	2.9	1.0	71.7	0.0	0.7	0.0	18.3	93.0	67.8	0.2	0.6	64.5	0.0	15.0	52.8	0.2	0.0	1.5	6.6	89.8	0.6	0.0	0.5	0.6	0.3	0.2	20.2	0.9	0.0	0.6	1.0	2.3	0.7	3.2	2.8	1.5	2.0	0.0	0.4	9.4
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680922	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.7;seminal vesicle: 127.4;urinary bladder: 162.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 342.9;Fibroblasts: 270.7;granulocytes: 347.6;Langerhans cells: 305.6;Macrophages: 173.1;Urothelial cells: 151.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 11.7"	"Cell line enriched"	"Detected in many"	4	"BJ hTERT+: 405.5"	"Region enhanced"	"Detected in many"		"hippocampal formation: 15.1"	"Low region specificity"	"Detected in many"			"CAB000113, HPA001335"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum, Vesicles"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	17.0	7.9	1.4	13.9	2.5	116.7	3.0	1.1	4.1	62.2	2.7	14.9	2.6	8.9	0.7	6.9	5.1	31.6	11.7	1.9	1.4	10.2	8.0	34.3	8.9	2.0	1.6	2.6	2.2	5.6	3.1	8.4	1.5	25.0	9.9	0.3	1.2	127.4	0.4	1.6	3.6	12.2	1.9	2.8	14.8	0.2	1.8	5.2	3.2	6.5	0.6	162.5	2.2	2.6	0.0	21.8	0.1	0.0	2.5	2.1	0.0	93.4	405.5	0.6	3.6	15.0	17.2	0.0	0.0	0.1	2.5	12.2	0.0	7.6	1.3	0.0	0.0	0.8	2.2	0.0	13.2	0.0	0.2	0.8	2.7	11.3	28.7	1.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	5.5	1.5	0.0	1.0	0.0	0.9	2.7	0.0	0.1	1.5	19.3	0.6	13.5	0.6	0.2	0.0	0.0	27.7	0.4	2.3	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.0	1.4	2.5	1.1	4.1	1.9	1.4	2.0	1.6	1.5	1.9	1.8	2.6	5.2	342.9	77.7	0.0	7.4	118.8	59.1	72.8	12.5	0.0	2.6	12.8	2.5	0.0	79.7	0.0	0.0	0.2	4.2	0.3	0.0	0.8	0.2	50.0	9.9	31.1	1.2	3.6	3.8	0.2	0.3	270.7	2.0	98.9	347.6	3.8	13.6	0.2	12.1	0.0	1.0	1.0	8.2	21.0	305.6	0.0	0.0	173.1	35.6	3.7	3.4	0.1	0.0	0.0	0.1	4.9	0.1	0.0	2.0	122.6	0.2	0.3	13.1	0.3	0.0	1.8	12.8	0.1	0.4	3.3	28.4	0.5	10.8	3.7	1.2	151.6
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	4	"B-cells: 67.4;dendritic cells: 176.0;NK-cells: 108.1;Plasma cells: 79.6;T-cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 69.3;HL-60: 27.7;U-266/70: 29.2;U-698: 37.5;U-937: 28.4"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	2.0	1.5	0.2	11.5	0.2	38.0	2.3	0.4	0.5	1.8	0.6	4.0	6.4	1.0	1.1	1.7	0.9	4.8	0.6	0.1	0.2	0.6	2.0	7.5	20.3	0.5	0.2	0.6	1.3	0.3	0.3	0.8	0.4	1.0	4.3	0.4	1.3	0.6	0.3	0.9	8.6	1.6	0.2	13.2	5.2	1.4	0.6	20.0	0.7	0.2	13.5	4.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.4	0.0	0.7	0.0	0.4	69.3	0.1	0.2	0.0	0.0	0.0	0.1	0.5	6.5	0.0	10.0	0.0	0.0	0.2	27.7	21.1	5.7	0.0	2.8	0.2	5.1	10.6	17.2	0.1	15.7	10.3	0.2	20.1	15.7	0.0	0.1	0.0	1.2	6.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	5.0	16.0	0.3	0.4	0.5	29.2	6.6	37.5	11.1	28.4	0.1	15.8	4.8	25.0	17.0	1.3	20.1	9.9	8.4	13.6	8.7	7.4	5.0	12.1	2.4	11.0	0.6	5.2	14.5	7.3	0.2	0.2	0.4	0.5	0.1	0.2	0.5	0.2	0.4	0.2	0.6	0.8	2.2	0.0	6.5	0.7	67.4	2.5	0.2	0.0	1.2	0.7	2.2	2.4	0.8	0.0	0.2	1.8	2.1	0.1	176.0	2.2	0.0	0.1	0.4	0.7	0.5	1.7	0.0	16.6	3.2	0.6	0.3	2.2	12.8	1.0	27.8	0.0	0.4	0.5	7.1	0.0	2.5	1.2	0.0	17.3	26.8	1.0	0.0	26.4	3.6	2.8	14.4	0.0	108.1	0.0	1.7	0.5	0.8	0.0	79.6	0.3	4.3	0.1	2.2	0.5	13.1	0.6	1.4	0.4	0.6	0.3	2.7	0.1	151.2	0.0	2.2	0.3
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	32.8	11.6	3.8	248.5	3.3	208.6	13.9	4.4	4.3	14.9	6.9	26.4	27.4	11.3	5.6	15.1	8.4	45.7	7.3	3.5	5.6	7.0	29.6	68.6	329.9	12.9	8.6	5.7	5.6	4.0	2.9	23.5	11.5	11.6	30.5	2.0	13.8	6.6	4.6	5.7	42.9	25.3	7.9	202.5	37.9	5.5	6.9	306.9	7.0	7.6	251.2	62.1	5.2	14.7	0.4	0.0	0.2	0.2	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.1	209.9	0.3	0.7	0.2	0.3	0.0	0.2	0.4	0.6	0.0	118.0	0.2	0.1	0.0	108.1	0.7	0.0	0.0	0.3	0.0	0.4	0.5	266.4	2.4	3.3	0.3	0.1	161.1	65.0	0.5	0.2	0.2	4.6	0.4	0.3	0.1	0.1	1.2	1.8	0.1	0.4	0.5	0.2	0.3	87.0	1.3	0.0	0.8	0.8	0.4	93.7	91.2	123.4	0.1	94.5	0.4	226.1	480.0	521.4	634.4	885.8	541.8	249.0	437.0	618.1	385.8	245.8	489.8	494.1	844.3	506.9	1015.8	57.4	508.6	1340.6	3.8	3.3	4.4	4.3	3.5	5.6	12.9	8.6	11.5	7.9	6.9	14.7	12.6	44.8	62.3	0.7	525.2	15.8	0.9	0.0	4.0	0.3	6.0	9.3	4.6	5.7	14.2	1.8	0.0	0.6	1026.4	1.0	0.0	0.7	2.4	2.3	2.3	15.1	1.2	58.8	0.7	0.0	0.9	17.2	46.9	2.7	246.5	0.1	14.6	6.9	96.0	0.0	1.7	0.4	0.0	334.9	214.5	3.5	1.2	534.1	21.4	201.4	554.9	0.1	769.3	2.5	0.7	0.1	0.8	0.0	474.2	1.1	0.1	2.5	11.7	0.2	6.6	7.4	6.7	0.3	0.6	1.8	15.2	0.8	1049.1	5.4	0.9	0.8
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase receptor type K"	Q15262	6	127968785-128520616	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 889.9;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 1278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 1.6;naive B-cell: 2.9"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	10.7	4.2	13.4	9.7	20.6	0.2	25.6	16.7	18.6	13.5	8.6	27.3	32.8	12.1	8.2	9.7	14.9	32.5	12.4	15.9	14.5	14.9	29.6	19.4	6.9	16.8	16.7	15.1	26.2	10.2	7.0	21.8	17.8	18.9	27.6	4.6	15.3	19.0	5.9	12.2	28.5	15.9	14.5	7.9	30.5	2.2	16.4	10.2	11.7	9.9	8.7	20.9	12.3	29.8	17.3	16.7	10.9	1.0	24.9	31.9	11.0	43.6	86.3	18.4	16.6	28.8	15.0	0.1	13.4	40.7	50.8	49.0	10.2	35.9	26.7	50.3	19.4	0.3	23.6	45.7	29.7	0.0	1.7	23.9	35.4	35.9	49.6	50.8	54.0	14.7	0.0	1.1	49.3	33.6	26.6	0.1	11.9	34.5	22.6	94.8	21.7	3.1	51.1	33.4	43.8	0.1	45.2	55.6	2.7	12.4	14.6	1.1	86.9	30.0	18.4	54.8	42.2	0.7	6.0	0.0	38.1	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.9	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.1	13.4	20.6	16.7	18.6	15.9	14.5	16.8	16.7	17.8	14.5	16.4	29.8	39.2	25.6	33.5	155.7	17.5	63.5	88.1	45.2	60.3	7.3	56.6	26.5	22.2	101.5	44.1	18.4	4.2	24.8	0.8	75.2	0.0	63.2	4.6	30.6	11.5	46.6	43.9	0.0	889.9	61.3	4.1	28.6	77.5	77.5	1.3	13.4	11.4	40.9	6.4	10.1	55.3	44.2	8.2	1.6	8.8	2.7	17.1	2.2	17.8	200.5	1.7	5.1	0.0	313.1	1278.1	124.2	53.8	18.0	1.0	115.8	68.7	13.4	25.9	0.7	59.2	20.1	41.5	11.3	8.9	27.0	38.1	26.8	3.4	14.1	56.6	157.0
RAB26		ENSG00000167964	"RAB26, member RAS oncogene family"	Q9ULW5	16	2140803-2154165	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.9;choroid plexus: 43.0;liver: 45.9;pancreas: 42.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 36.1;Enteroendocrine cells: 99.4;Excitatory neurons: 52.0;Inhibitory neurons: 28.3;Intestinal goblet cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 20.1;HeLa: 23.2;MCF7: 13.5;SCLC-21H: 27.2;SK-BR-3: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075624			Uncertain	"Vesicles,Plasma membrane,Centrosome"	"Intracellular and membrane"	No	No				"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Vesicles, Plasma membrane"	Centrosome	"HPA075624: "	"unprognostic (1.01e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (7.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.92e-3)"	0.3	1.1	53.5	0.1	55.8	0.2	0.9	57.7	84.9	1.7	43.0	5.7	5.6	0.2	1.8	1.6	0.6	0.8	1.8	60.7	46.2	1.4	45.9	0.3	0.3	48.0	45.4	0.2	42.7	3.4	34.0	0.0	49.1	4.9	5.1	6.8	18.4	0.8	1.1	1.5	6.4	0.1	44.0	0.7	13.7	1.0	47.6	0.3	1.7	2.1	0.8	0.8	0.7	51.9	1.7	20.1	0.1	5.1	0.3	0.1	0.1	0.9	1.6	0.7	1.3	0.6	4.0	0.3	1.4	1.3	0.6	3.2	1.1	0.4	0.1	2.2	2.1	0.8	23.2	1.8	0.8	0.0	0.6	0.8	0.2	0.2	0.3	4.6	0.4	3.2	0.4	0.0	2.3	13.5	0.1	1.0	1.2	6.5	1.8	1.7	1.6	3.5	7.7	1.4	27.2	5.4	0.6	24.9	1.0	0.3	8.2	0.3	0.9	0.0	3.5	0.4	0.4	2.9	0.1	0.3	0.5	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	53.5	55.8	57.7	84.9	60.7	46.2	48.0	45.4	49.1	44.0	47.6	51.9	0.2	0.0	1.1	6.5	1.3	1.3	1.6	1.4	8.0	36.1	1.4	1.4	1.6	1.5	3.4	0.0	4.2	0.0	0.0	2.6	0.0	0.4	0.1	1.0	0.3	0.4	99.4	0.0	52.0	1.0	0.0	0.4	12.8	0.4	0.0	0.5	1.1	8.1	0.2	1.7	28.3	41.9	4.1	0.3	0.0	0.1	0.0	0.1	3.6	8.4	0.0	10.7	0.0	20.1	3.6	0.5	1.8	0.0	3.8	1.5	10.5	0.6	2.3	9.1	0.0	0.3	0.3	0.0	2.4	1.5	0.1	0.1	0.2	0.3	3.2	2.6
RAB33A	RabS10	ENSG00000134594	"RAB33A, member RAS oncogene family"	Q14088	X	130171962-130184870	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.5;choroid plexus: 16.4;heart muscle: 15.2"	"Cell type enhanced"	"Detected in many"		"granulocytes: 22.9;Melanocytes: 12.4;NK-cells: 22.6;Oligodendrocytes: 23.5;T-cells: 12.9"	"Group enriched"	"Detected in many"	6	"glioma: 10.7;melanoma: 2.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 111.4;Karpas-707: 126.8;U-266/70: 88.5;U-937: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059737	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA059737: AB_2684115"	"unprognostic (5.40e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.03e-2)"	"unprognostic (8.28e-2)"	"unprognostic (7.00e-6)"	"unprognostic (2.51e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.61e-1)"	2.3	1.3	23.6	4.0	28.2	6.3	1.3	27.9	31.6	2.3	16.4	0.9	0.7	1.7	0.5	0.5	1.6	2.6	15.2	24.4	24.4	1.7	0.9	1.7	11.6	29.0	24.7	1.4	0.2	2.0	2.2	1.4	29.7	0.4	1.0	7.6	0.5	0.1	0.1	1.1	2.2	0.7	27.8	2.5	1.4	0.6	25.7	4.8	0.6	0.2	12.3	1.7	0.8	41.5	0.3	0.2	7.5	0.0	3.2	1.0	0.1	1.0	2.2	1.9	3.2	0.1	0.8	5.8	0.1	0.6	0.5	0.2	9.4	0.2	2.0	30.2	0.1	35.0	0.1	0.0	31.3	28.4	111.4	1.0	0.2	0.6	1.3	1.0	0.8	34.7	0.1	126.8	0.3	0.3	13.1	9.7	1.1	0.1	1.3	0.0	0.0	1.6	0.2	0.0	24.3	19.4	0.2	0.3	0.5	0.4	0.0	15.2	0.2	0.1	0.1	0.4	0.2	88.5	29.7	0.0	3.9	55.1	0.0	39.9	1.3	87.4	32.0	0.8	20.0	20.2	29.0	32.5	10.0	8.8	27.8	40.0	4.1	19.5	5.4	1.0	72.8	18.1	23.6	28.2	27.9	31.6	24.4	24.4	29.0	24.7	29.7	27.8	25.7	41.5	1.7	0.0	1.1	1.6	3.2	1.9	0.6	0.5	1.2	10.9	0.3	1.0	8.4	2.8	0.2	0.0	2.1	0.9	8.9	0.0	0.0	0.0	1.2	0.4	0.8	2.0	0.0	6.6	4.0	0.2	1.3	4.5	0.0	0.8	22.9	2.9	2.5	0.1	1.9	5.0	3.2	0.4	2.0	0.3	12.0	1.2	1.8	6.3	12.4	1.9	2.5	1.6	22.6	4.5	23.5	0.8	0.0	0.4	3.3	0.4	0.0	0.2	0.3	9.3	0.0	0.0	2.2	0.1	1.2	0.2	1.1	1.4	12.9	0.2	0.3	0.6
RAB40A	"Rar-2, RAR2A"	ENSG00000172476	"RAB40A, member RAS oncogene family"	Q8WXH6	X	103499130-103519489	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"epididymis: 8.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 4.9;Excitatory neurons: 7.4;Inhibitory neurons: 7.3;Microglial cells: 5.6;Oligodendrocyte precursor cells: 6.6;Oligodendrocytes: 3.3;Peritubular cells: 6.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.3;NTERA-2: 3.7"									HPA076172			Uncertain	Vesicles		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA076172: "	"unprognostic (3.49e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.49e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.43e-1)"	"unprognostic (7.36e-4)"	"unprognostic (7.85e-3)"	"unprognostic (9.39e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.11e-3)"	2.0	1.2	1.0	0.2	3.1	0.1	0.9	0.7	1.4	3.0	6.4	0.6	0.4	4.5	8.0	7.1	2.3	0.5	0.7	1.6	1.2	1.3	0.3	1.3	0.2	0.8	0.3	4.6	0.5	0.2	2.4	0.6	0.3	3.5	0.3	1.3	0.4	2.1	0.2	0.5	0.5	0.9	0.0	0.6	0.8	3.8	1.1	0.1	0.7	0.2	0.1	2.3	1.5	1.0	0.2	0.9	3.3	0.1	0.7	0.9	1.6	1.0	0.2	0.1	0.3	0.7	0.5	0.8	1.2	0.2	1.0	0.0	0.2	0.0	0.1	0.0	2.0	0.2	1.8	0.2	0.3	0.0	0.1	0.7	0.1	0.3	0.2	1.2	0.2	0.3	1.2	0.5	0.3	0.2	0.2	0.1	3.7	0.0	0.5	0.0	0.2	0.0	0.0	0.3	1.4	1.7	0.3	0.0	0.7	0.9	0.0	0.1	1.7	1.3	0.8	2.1	0.9	0.6	0.4	0.6	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.1	0.7	1.4	1.6	1.2	0.8	0.3	0.3	0.0	1.1	1.0	0.3	0.0	0.0	4.9	0.0	0.0	0.7	0.1	0.0	0.2	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.0	7.4	0.0	0.2	0.2	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	7.3	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.0	5.6	0.0	0.2	0.0	6.6	3.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.0	0.0
RAB40AL	"RAR2, RLGP"	ENSG00000102128	"RAB40A like"	P0C0E4	X	102937272-102938300	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.8;Cone photoreceptor cells: 2.1;Enteroendocrine cells: 3.0;Hepatic stellate cells: 2.2;Horizontal cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA076172			Uncertain	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA076172: "	"unprognostic (1.99e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.90e-10)"	"unprognostic (4.74e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.64e-2)"	0.1	0.1	0.5	0.0	0.4	0.0	0.1	0.2	1.1	0.1	0.3	0.1	0.1	0.2	0.3	0.1	0.1	0.0	0.1	0.5	0.4	0.1	0.2	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.2	1.1	0.5	0.4	0.3	0.0	0.3	0.0	0.1	0.8	0.2	0.0	0.0	0.0	0.4	0.1	0.1	0.0	1.2	1.8	0.1	0.1	0.1	0.0	0.0	0.0	2.1	0.9	1.3	0.6	0.0	0.0	0.1	0.1	0.2	0.4	3.0	0.4	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.1	2.2	0.9	0.4	1.7	0.0	0.2	0.0	0.8	0.0	1.0	1.5	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	1.5	0.0	0.5	0.4	0.0	0.0	0.6	0.0	1.2	0.1	0.3	0.3	0.1	0.0	0.7	0.0	0.1	0.6	0.3
RAB41		ENSG00000147127	"RAB41, member RAS oncogene family"	Q5JT25	X	70282093-70285002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"retina: 65.5"	"Cell type enriched"	"Detected in some"	19	"Cone photoreceptor cells: 533.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2197: 3.7;U-87 MG: 4.6"									"HPA001510, HPA065289"	Uncertain		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Vesicles, Plasma membrane"	"HPA001510: AB_1079733, HPA065289: "	"unprognostic (1.32e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.63e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (9.89e-2)"	0.2	0.8	0.5	0.5	0.6	0.4	0.1	0.3	0.9	0.1	0.0	0.3	0.4	0.2	0.0	0.3	0.2	0.5	0.6	0.3	0.4	0.3	0.1	0.3	0.5	0.5	0.5	0.8	0.1	0.0	0.2	0.2	0.4	0.2	0.0	65.5	1.0	0.0	0.5	1.3	0.7	0.0	0.4	0.5	0.2	4.0	1.0	0.0	0.8	0.0	0.0	0.3	0.1	0.5	0.5	0.5	1.3	0.5	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.6	0.5	0.6	1.1	0.0	1.1	0.6	0.0	0.0	0.0	0.8	1.3	0.1	1.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.5	1.2	0.0	0.3	0.8	0.5	0.8	1.7	1.7	0.3	0.9	0.9	0.0	0.4	0.8	1.5	0.5	0.3	1.5	0.6	0.3	1.4	1.6	0.6	0.7	3.7	0.8	0.7	1.1	0.8	4.6	1.1	1.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.3	0.9	0.3	0.4	0.5	0.5	0.4	0.4	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	533.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	28.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAD1	"HRAD1, REC1"	ENSG00000113456	"RAD1 checkpoint DNA exonuclease"	O60671	5	34905260-34918989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006692	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles"		"HPA006692: AB_2667645"	"prognostic unfavorable (6.30e-4)"	"unprognostic (1.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-3)"	3.5	8.1	3.2	4.8	3.5	8.4	5.8	3.9	4.6	6.8	5.3	4.1	4.9	5.6	5.4	4.9	3.9	4.6	8.9	3.8	4.6	5.1	4.3	7.5	8.9	3.5	2.7	5.7	4.4	5.1	3.5	8.1	3.2	6.8	4.3	8.7	4.9	4.8	10.9	6.7	4.8	4.6	1.9	4.9	4.8	7.9	3.4	6.3	6.3	8.6	6.2	5.2	4.7	3.8	8.5	10.2	12.3	20.5	7.9	9.4	17.2	15.1	12.0	13.0	10.6	12.2	12.3	25.0	5.2	11.2	15.7	8.4	12.6	7.6	14.4	10.1	12.7	12.9	34.0	8.0	11.9	16.5	11.9	7.8	7.3	13.9	9.3	6.1	6.2	11.0	22.7	13.2	11.2	10.2	19.6	13.9	15.4	6.0	15.7	17.1	24.0	8.6	6.7	9.0	12.4	13.3	30.0	19.9	13.3	7.6	12.5	14.8	6.2	17.9	13.3	9.7	14.4	7.9	13.8	20.3	11.1	28.6	12.5	7.4	2.9	6.5	5.3	2.8	6.9	8.6	5.8	7.6	3.1	9.1	8.2	6.8	1.6	4.5	2.8	6.9	4.9	2.6	3.2	3.5	3.9	4.6	3.8	4.6	3.5	2.7	3.2	1.9	3.4	3.8	11.5	22.4	43.2	5.9	18.3	29.2	20.2	29.3	13.1	25.3	23.9	18.4	25.7	14.3	21.3	20.2	27.1	82.3	20.4	11.9	19.6	18.1	22.0	13.1	16.6	14.1	13.1	28.2	6.6	22.5	54.4	18.7	6.1	12.0	21.5	39.1	10.0	14.8	23.4	23.5	9.0	12.7	30.5	12.0	19.3	16.8	25.1	13.1	17.8	6.5	12.7	23.9	9.2	7.5	9.1	17.8	13.8	21.8	18.0	21.9	13.4	16.4	14.6	35.6	13.1	19.6	19.4	72.5	58.6	15.6	28.6	80.6	22.3	27.4	13.0	25.8
RCN3	RLP49	ENSG00000142552	"Reticulocalbin 3"	Q96D15	19	49528003-49546962	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.7;Fibroblasts: 105.1;Leydig cells: 38.2;Peritubular cells: 44.8;Smooth muscle cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 6.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 2.5;NK-cells: 1.8;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 166.6;ASC diff: 283.3;ASC TERT1: 175.4;BJ: 353.8;BJ hTERT+ SV40 Large T+ RasG12V: 179.6;fHDF/TERT166: 304.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043134, HPA050402"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		1600000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA043134: AB_2678332, HPA050402: AB_2681114"	"unprognostic (7.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.87e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.47e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (5.80e-12)"	"unprognostic (5.26e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.20e-3)"	67.9	35.3	15.8	33.6	17.2	6.8	48.2	15.5	24.1	78.8	23.5	43.5	39.9	47.4	4.4	11.4	41.4	25.2	56.7	16.0	19.1	41.2	62.3	40.8	8.7	17.4	17.0	50.0	16.4	3.9	20.7	31.1	19.0	32.4	11.4	1.4	19.1	12.1	11.7	25.3	43.2	25.7	16.8	65.9	23.4	17.2	24.5	4.0	26.4	7.5	4.1	43.2	46.3	18.8	3.2	4.3	2.7	166.6	283.3	175.4	1.9	353.8	86.5	122.0	179.6	4.2	1.3	1.3	19.5	304.0	1.3	0.3	6.8	0.5	49.2	0.1	2.5	19.5	1.5	9.1	105.7	0.1	43.0	119.5	0.2	93.2	0.4	3.2	43.8	2.3	8.7	1.0	87.8	2.9	0.1	2.0	1.4	8.8	24.5	0.5	3.9	4.0	1.4	0.0	1.7	10.5	0.3	1.1	0.3	2.8	1.3	11.5	121.4	1.7	52.4	135.3	0.1	14.9	44.5	2.6	7.9	9.6	13.4	0.0	0.2	1.6	0.7	0.0	0.7	0.4	1.7	0.6	0.4	0.2	6.8	2.3	2.5	1.8	0.3	0.2	1.6	1.1	15.8	17.2	15.5	24.1	16.0	19.1	17.4	17.0	19.0	16.8	24.5	18.8	12.0	0.0	6.1	4.6	2.8	18.6	0.6	2.9	3.4	0.8	1.7	3.3	2.1	1.5	0.8	1.8	0.0	2.5	1.4	10.5	1.9	1.6	2.2	1.5	54.7	10.6	1.2	0.0	1.0	0.5	5.0	105.1	6.6	1.6	1.3	7.0	27.1	3.7	22.6	1.7	1.1	7.6	0.0	11.4	23.2	3.0	38.2	11.9	10.6	10.3	3.1	0.6	0.0	1.5	0.8	1.5	7.9	44.8	4.8	0.9	13.1	0.6	0.9	0.8	13.1	37.5	66.5	6.5	6.8	2.8	13.9	6.2	2.2	17.2	8.0	0.4
RDH5	"HSD17B9, RDH1, SDR9C5"	ENSG00000135437	"Retinol dehydrogenase 5"	Q92781	12	55720367-55724705	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sensory transduction, Steroid metabolism, Vision"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 94.5;liver: 58.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Proximal enterocytes: 49.9;Rod photoreceptor cells: 62.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 28.5;ASC TERT1: 24.3;hTEC/SVTERT24-B: 15.3;hTERT-RPE1: 24.5;LHCN-M2: 15.4;U-87 MG: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063345			Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA063345: AB_2684992"	"unprognostic (1.04e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.27e-2)"	94.5	1.8	2.2	4.1	2.5	1.0	34.2	2.2	2.6	2.5	3.5	13.6	18.5	4.2	7.8	3.1	4.6	4.2	9.2	2.0	2.2	9.0	58.9	1.9	1.8	2.7	2.5	2.1	3.5	0.3	1.7	0.6	2.4	4.4	4.4	3.2	3.3	2.2	6.1	2.7	15.5	19.5	2.5	2.2	5.9	2.4	2.8	0.9	2.7	7.6	0.7	5.5	2.2	3.4	0.7	1.4	0.8	0.5	28.5	24.3	0.6	3.8	4.2	0.7	1.4	0.5	7.9	1.0	0.7	2.1	0.2	0.3	0.3	0.1	0.6	1.0	1.3	0.1	2.0	2.1	0.8	0.1	0.3	10.5	1.0	15.3	0.1	24.5	0.3	0.5	0.2	1.3	15.4	0.7	0.4	0.2	0.3	3.7	2.3	0.6	0.4	0.5	0.2	0.8	0.2	1.1	0.2	0.5	3.4	0.2	0.7	0.6	0.5	1.5	1.5	1.1	0.9	1.1	0.5	0.2	26.7	0.4	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.5	0.2	0.0	0.2	0.0	0.2	0.3	0.2	0.5	0.0	0.0	2.2	2.5	2.2	2.6	2.0	2.2	2.7	2.5	2.4	2.5	2.8	3.4	2.5	9.6	2.2	0.0	4.6	1.9	4.5	3.9	0.6	24.3	2.7	5.0	3.9	10.0	2.4	1.8	62.6	2.2	5.3	23.5	1.9	2.1	0.8	1.8	2.9	3.7	11.5	0.0	0.0	2.6	1.2	3.9	11.2	1.5	0.0	4.9	3.6	18.4	0.6	16.8	0.0	10.3	0.0	4.5	7.9	2.3	13.4	2.3	5.4	0.0	4.7	8.2	12.3	0.0	0.0	3.6	18.6	6.8	0.7	3.2	49.9	13.0	4.7	62.9	13.1	14.0	9.3	3.9	6.4	0.8	1.7	1.5	4.8	5.3	15.9	3.1
RELL2	"C5orf16, FLJ90583"	ENSG00000164620	"RELT like 2"	Q8NC24	5	141636950-141641064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;parathyroid gland: 16.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 28.5;Horizontal cells: 65.6;Inhibitory neurons: 28.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.7;JURKAT: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077928			Uncertain	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA077928: "	"unprognostic (3.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.76e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.85e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.31e-2)"	"unprognostic (6.58e-2)"	1.0	5.9	14.4	1.3	12.8	1.0	1.3	18.8	38.2	1.6	5.4	1.4	1.5	2.1	0.6	3.5	0.8	1.0	1.0	13.4	19.3	3.7	1.9	3.3	2.5	34.1	18.9	0.8	1.4	16.1	15.7	2.3	31.4	2.1	0.7	3.6	2.7	0.5	0.3	2.7	2.8	0.8	10.6	5.8	1.1	6.0	28.5	4.8	2.8	0.0	2.5	1.5	1.8	17.6	1.6	4.3	4.3	7.7	3.2	1.1	2.0	3.6	6.7	11.4	16.9	16.6	1.6	0.2	1.7	5.4	24.9	7.0	4.1	15.1	2.9	4.7	2.5	10.3	10.0	7.8	5.2	3.5	31.7	2.2	9.3	10.6	7.7	2.5	3.1	32.9	3.4	5.3	2.6	2.1	5.8	1.6	4.8	5.7	2.3	0.4	1.0	6.7	3.6	3.9	7.0	7.6	3.3	15.1	2.7	0.6	5.4	8.4	3.8	8.8	4.1	7.1	6.6	3.2	9.0	23.4	4.5	14.5	5.6	0.0	0.8	0.0	1.6	2.0	0.6	1.4	1.7	1.6	1.3	0.8	1.5	0.8	0.6	0.0	1.4	4.5	3.2	1.2	14.4	12.8	18.8	38.2	13.4	19.3	34.1	18.9	31.4	10.6	28.5	17.6	1.1	0.0	0.6	4.2	6.0	4.6	1.5	2.6	2.8	10.5	2.3	2.4	0.3	1.5	2.0	1.8	12.5	0.2	10.0	4.2	1.9	3.3	1.8	0.3	0.8	2.0	1.2	0.0	28.5	2.5	4.1	0.8	0.5	0.2	0.0	0.4	0.4	0.2	4.2	65.6	28.8	2.4	4.1	4.4	3.5	4.7	0.6	5.1	7.2	4.7	2.3	6.6	5.2	2.5	2.8	2.1	5.0	1.5	1.7	2.7	1.2	5.6	1.9	8.6	0.0	0.3	1.3	17.8	7.5	3.6	4.3	6.2	5.5	0.9	0.9	2.2
RFX5		ENSG00000143390	"Regulatory factor X5"	P48382	1	151340640-151347326	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018519, HPA079241"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Vesicles	"HPA018519: AB_1856209, HPA079241: "	"unprognostic (1.17e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	18.4	25.6	13.3	43.3	13.7	24.0	14.9	17.8	13.2	18.2	11.7	22.7	31.6	22.0	13.1	18.3	18.4	23.4	18.3	12.3	16.8	18.3	13.1	27.9	67.7	17.1	17.6	10.1	9.6	22.1	18.1	12.4	18.5	20.4	28.1	14.6	16.0	25.1	17.0	13.1	26.1	31.8	15.4	50.7	19.6	15.5	15.7	50.5	23.7	23.8	71.8	26.5	11.4	13.3	37.7	41.8	57.6	32.8	27.6	24.0	12.6	17.8	30.0	43.6	57.7	13.7	50.9	145.2	63.9	21.5	42.6	59.5	24.9	34.4	31.9	177.4	39.7	54.8	89.4	23.0	17.7	48.9	59.4	25.2	18.8	28.8	13.2	35.7	39.9	92.0	26.8	88.3	33.8	34.2	78.7	36.2	41.9	30.5	21.2	97.1	32.3	80.1	42.0	49.1	20.4	60.0	35.7	55.0	52.8	69.2	51.6	114.3	39.9	23.8	25.1	11.8	33.7	110.9	118.2	168.6	37.8	26.4	31.3	5.6	22.6	11.5	17.4	28.2	15.3	47.9	13.9	17.4	47.4	53.3	10.9	12.2	3.1	31.4	30.8	25.1	28.5	21.5	13.3	13.7	17.8	13.2	12.3	16.8	17.1	17.6	18.5	15.4	15.7	13.3	8.4	9.6	7.5	4.9	32.0	6.6	12.5	11.4	14.2	7.6	9.4	6.5	5.1	8.6	12.1	7.3	0.0	8.8	16.9	3.8	9.8	15.7	8.4	7.5	6.3	9.9	4.2	16.6	3.2	9.2	3.4	6.1	5.6	12.8	24.1	9.4	10.8	7.3	12.4	1.7	7.0	5.1	10.2	18.5	15.7	17.9	5.0	13.3	5.4	8.4	40.8	7.2	21.6	3.0	2.4	8.6	2.7	9.8	9.5	14.1	11.2	10.7	7.4	2.7	6.6	5.3	5.7	15.5	7.5	14.2	6.1	3.4	13.7	15.7	7.3	14.6
RGPD4	"DKFZp686P0288, RGP4"	ENSG00000196862	"RANBP2 like and GRIP domain containing 4"	Q7Z3J3	2	107826892-107892544	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.7"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 5.8;Early spermatids: 10.4;Late spermatids: 3.1;Spermatocytes: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear membrane, Vesicles"		"HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (4.96e-2)"	"unprognostic (3.04e-1)"			"unprognostic (4.38e-1)"	"unprognostic (1.31e-1)"		"unprognostic (2.46e-1)"		"unprognostic (1.29e-1)"	"unprognostic (3.05e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.69e-2)"		0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.2	0.2	0.8	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.3	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.1	1.0	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.3	3.7	0.5	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.2	0.5	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.0	0.3	0.2	0.0	0.1	0.3	0.1	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.3	0.2	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0
RGPD5	"BS-63, DKFZp686I1842, RGP5"	ENSG00000015568	"RANBP2 like and GRIP domain containing 5"	Q99666	2	109792758-109857705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 20.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane, Vesicles"		"HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.50e-2)"				"unprognostic (1.55e-1)"			"unprognostic (3.49e-1)"		"unprognostic (2.23e-1)"		"unprognostic (4.23e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.19e-3)"		"unprognostic (3.19e-1)"		10.2	8.3	12.0	5.8	16.4	13.8	10.3	5.9	21.9	8.1	8.1	8.2	7.4	10.4	17.5	5.4	7.6	7.2	8.9	16.5	14.7	7.3	6.8	10.3	6.0	3.5	3.4	13.0	13.5	14.7	8.2	11.1	4.3	12.3	7.2	22.3	7.0	9.6	6.5	11.6	7.4	7.4	2.7	6.4	7.0	41.2	12.6	3.8	14.4	9.7	5.3	7.5	3.9	14.0	24.3	7.8	26.0	19.5	7.7	8.0	1.2	19.3	16.1	13.8	11.2	20.9	7.8	0.6	12.4	11.7	14.6	8.0	14.3	7.0	17.3	3.7	6.4	18.5	4.1	10.2	8.8	1.5	3.1	8.5	9.5	13.3	14.2	14.5	9.4	7.6	8.8	5.4	10.7	4.5	4.0	0.6	12.7	3.0	9.9	4.3	14.4	0.1	10.4	13.7	31.9	4.5	10.0	1.5	14.0	16.5	0.5	5.4	15.6	14.3	21.1	1.0	14.1	12.2	0.5	0.6	11.7	0.2	4.6	5.4	2.0	2.5	1.9	1.0	3.6	1.7	1.5	2.1	1.4	4.2	2.0	2.1	5.5	2.0	1.2	2.5	1.9	0.6	12.0	16.4	5.9	21.9	16.5	14.7	3.5	3.4	4.3	2.7	12.6	14.0	12.9	3.2	11.8	0.0	9.0	3.4	5.0	0.8	2.8	17.7	2.5	1.4	13.8	0.0	3.7	12.9	16.7	2.4	15.9	1.7	0.0	1.7	4.1	12.3	12.0	7.4	5.3	0.0	7.3	1.0	1.8	7.4	5.1	18.6	0.0	9.4	4.2	0.9	1.8	3.3	4.5	1.4	0.0	2.9	6.5	1.7	2.5	6.6	1.8	1.0	0.9	3.8	0.0	0.0	0.2	1.5	1.7	1.2	10.7	5.5	1.7	0.4	2.6	20.3	0.0	9.7	7.8	4.1	2.9	1.2	3.3	4.4	12.4	1.6	1.0	7.3
RGPD6	RGP6	ENSG00000183054	"RANBP2 like and GRIP domain containing 6"	Q99666	2	110513802-110577222	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 9.6;Alveolar cells type 2: 17.1;Club cells: 8.1;Excitatory neurons: 10.7;Inhibitory neurons: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.5;SCLC-21H: 10.5"									"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear membrane, Vesicles"		"HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (1.11e-2)"				"unprognostic (6.38e-2)"			"unprognostic (1.18e-1)"		"unprognostic (3.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.14e-4)"		"unprognostic (2.04e-1)"		12.9	8.4	5.0	0.7	2.3	6.3	13.3	6.3	6.4	13.3	6.4	11.5	1.5	9.7	0.9	7.4	12.2	0.0	12.9	2.3	4.9	9.5	14.0	14.4	2.3	4.5	1.5	15.2	18.1	2.0	22.9	1.8	2.8	14.8	0.6	1.9	9.7	0.1	14.7	17.2	12.0	1.0	3.9	9.6	11.8	31.9	2.5	0.7	14.2	2.1	0.7	10.8	10.7	7.6	7.0	2.6	1.2	2.0	0.0	0.5	2.9	1.3	0.0	0.8	0.1	5.7	1.5	0.4	4.2	2.5	3.4	5.2	0.2	2.4	0.0	1.6	11.5	6.8	0.9	1.0	0.1	2.2	0.3	0.4	1.5	1.3	3.1	1.0	0.0	2.1	2.7	2.0	0.0	3.7	1.8	0.0	7.6	1.4	6.7	2.6	4.1	0.0	2.6	0.7	10.5	4.8	1.1	0.2	3.1	4.1	0.1	0.4	1.5	1.4	4.0	0.4	6.0	3.8	0.4	0.5	2.6	0.0	2.5	4.7	1.5	2.0	1.6	0.8	2.4	2.0	2.3	1.7	1.0	3.1	2.3	1.4	4.7	1.5	1.8	2.2	0.5	0.3	5.0	2.3	6.3	6.4	2.3	4.9	4.5	1.5	2.8	3.9	2.5	7.6	0.1	9.6	17.1	0.0	0.3	0.9	0.2	0.0	0.0	0.0	0.1	0.1	1.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	10.7	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	7.0	0.0	0.0	0.0	0.3	0.3	0.0	0.5	1.8	1.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.3
RGPD8	"RanBP2alpha, RANBP2L1"	ENSG00000169629	"RANBP2 like and GRIP domain containing 8"	O14715	2	112368369-112434488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 15.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Early spermatids: 24.3;Excitatory neurons: 9.8;Late spermatids: 10.1;Microglial cells: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 16.2;hTEC/SVTERT24-B: 13.4"									"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Vesicles"		"HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-3)"	"unprognostic (3.17e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-2)"	4.3	1.8	2.7	2.8	3.6	10.6	4.5	8.6	7.6	2.8	4.5	2.1	1.6	3.1	5.4	1.4	2.2	2.9	1.8	3.7	3.5	2.4	5.1	3.3	2.4	2.2	2.4	3.2	3.0	2.2	2.6	3.3	1.9	2.6	2.3	7.9	2.5	2.9	1.7	3.8	2.1	2.6	1.1	3.0	1.7	15.6	2.6	3.2	2.4	2.2	3.0	2.6	1.6	5.5	6.1	2.6	4.3	2.6	1.6	3.6	0.1	2.4	1.9	2.3	1.5	5.3	0.4	0.0	1.7	4.0	2.0	2.9	12.3	1.7	2.4	8.7	4.0	16.2	4.5	4.1	2.2	0.1	0.2	0.6	2.2	13.4	3.4	5.7	1.9	2.8	8.4	0.4	3.6	2.5	8.7	2.1	3.0	0.9	3.7	0.0	0.5	0.1	1.3	2.5	2.7	0.5	8.1	0.1	1.7	3.0	1.2	6.8	8.9	1.3	1.8	6.9	4.4	0.0	0.0	0.0	0.5	2.9	0.3	1.3	0.4	0.4	1.0	0.3	1.4	0.5	0.7	0.9	0.4	0.6	1.0	0.6	0.3	0.5	0.8	0.7	0.4	0.3	2.7	3.6	8.6	7.6	3.7	3.5	2.2	2.4	1.9	1.1	2.6	5.5	1.0	9.6	3.6	1.6	2.8	0.4	0.4	0.2	5.2	0.8	0.3	0.3	8.0	1.5	1.9	0.0	2.1	0.2	0.7	0.1	0.0	0.5	24.3	0.6	0.5	1.5	0.0	2.5	9.8	1.1	0.1	2.2	2.6	0.6	5.1	0.6	0.7	0.2	0.4	0.0	7.0	0.4	0.0	0.6	0.8	10.1	0.3	2.0	0.0	9.4	2.3	0.4	0.0	7.5	5.2	0.9	0.0	0.0	2.4	0.0	0.0	0.1	6.7	0.7	0.0	0.9	0.9	6.8	2.7	2.7	0.0	0.4	3.1	0.0	0.0	0.3
RGS6		ENSG00000182732	"Regulator of G protein signaling 6"	P49758	14	71932429-72566530	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 97.3;Early spermatids: 173.5;Excitatory neurons: 652.7;Inhibitory neurons: 256.1;Late spermatids: 298.0"	"Group enriched"	"Detected in some"	7	"glioma: 3.1;thyroid cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 11.5;Karpas-707: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003067	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA003067: AB_1079807"	"unprognostic (7.18e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.24e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.68e-2)"	4.7	0.2	1.1	0.6	2.2	1.4	4.0	0.6	8.6	4.9	0.0	1.0	0.3	1.4	2.6	0.4	2.2	1.2	11.2	3.5	2.8	2.6	0.1	0.9	0.1	19.2	16.0	1.2	0.2	8.1	1.7	3.0	20.2	0.4	1.0	1.7	0.8	1.4	1.1	0.9	0.8	1.3	5.4	0.9	0.4	10.6	6.4	0.3	5.7	0.8	0.5	0.7	0.9	3.4	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	40.1	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.5	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.3	1.2	1.1	2.2	0.6	8.6	3.5	2.8	19.2	16.0	20.2	5.4	6.4	3.4	5.8	0.0	0.0	97.3	0.2	0.3	0.0	0.0	0.0	2.2	2.1	2.4	22.6	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	173.5	2.8	0.9	2.6	0.0	5.3	652.7	0.2	0.1	3.1	0.0	7.1	0.0	0.4	0.0	0.0	0.2	0.0	256.1	0.0	0.0	0.0	0.0	298.0	1.8	8.3	0.0	44.0	5.1	0.0	0.0	36.2	8.9	0.0	0.0	7.5	0.2	0.0	0.0	0.4	0.0	0.4	13.1	0.4	18.6	2.3	1.3	0.2	0.1	0.8	0.5	0.1	0.0	0.7
RHBDF1	"C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1"	ENSG00000007384	"Rhomboid 5 homolog 1"	Q96CC6	16	58059-76355	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077399			Uncertain	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA077399: "	"unprognostic (2.62e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.54e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.22e-2)"	41.9	11.5	14.5	6.0	14.4	0.5	44.3	13.5	19.5	65.1	13.3	38.2	7.5	38.1	13.0	47.0	36.4	22.1	51.7	14.3	13.5	24.7	13.2	58.5	5.5	14.5	14.4	55.6	23.4	8.9	13.3	27.5	13.9	61.2	7.1	2.5	38.3	16.5	34.1	46.1	24.8	10.5	14.0	19.3	28.5	8.0	14.7	1.2	33.4	16.9	5.5	44.6	61.4	13.5	10.8	17.3	9.7	22.5	37.2	45.7	31.8	29.1	53.8	20.1	19.1	23.5	36.9	0.6	11.8	31.1	10.2	33.6	4.8	19.6	3.4	0.5	5.3	0.4	18.8	6.6	41.4	0.3	18.3	38.3	20.3	51.9	8.6	35.5	31.4	0.1	4.1	0.4	32.2	60.6	0.1	3.5	8.8	22.7	14.5	0.3	11.5	0.9	22.7	11.0	0.3	2.4	8.4	31.8	18.7	11.9	49.1	3.8	32.6	31.5	21.9	24.8	8.1	0.2	0.7	0.3	22.0	0.6	50.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	14.4	13.5	19.5	14.3	13.5	14.5	14.4	13.9	14.0	14.7	13.5	10.5	19.2	6.2	9.1	0.3	6.8	9.9	15.2	5.2	0.8	17.8	13.5	9.9	22.8	15.8	9.2	66.7	19.0	0.3	21.9	0.0	21.4	1.1	3.8	9.9	9.2	0.0	0.0	1.7	8.0	16.3	20.6	15.8	11.2	0.0	8.7	8.2	3.0	2.2	0.0	0.6	9.8	18.3	0.6	5.1	1.1	19.6	0.4	16.0	5.6	0.0	6.9	0.0	16.6	0.7	28.4	13.6	13.9	0.2	25.8	2.1	2.3	5.3	4.9	13.1	10.8	22.3	0.3	1.9	6.6	5.5	30.6	0.8	16.4	3.8	17.9
RHOBTB3	KIAA0878	ENSG00000164292	"Rho related BTB domain containing 3"	O94955	5	95713522-95824383	"Predicted intracellular proteins"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Leydig cells: 397.3;Peritubular cells: 314.8;Skeletal myocytes: 347.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.3;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 250.6;HaCaT: 332.7;SuSa: 315.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000265			Uncertain	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA000265: "	"unprognostic (1.68e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.39e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.00e-3)"	"unprognostic (9.29e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.56e-3)"	"unprognostic (7.01e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.23e-1)"	"unprognostic (8.21e-2)"	79.8	38.3	58.8	11.9	81.2	8.1	23.8	59.1	64.2	27.7	12.1	22.5	14.8	13.1	27.0	17.0	16.5	19.7	33.7	55.6	47.8	28.3	21.7	16.9	6.8	81.5	56.4	83.0	111.1	55.6	13.2	54.0	52.1	28.8	20.8	29.0	41.9	20.6	29.8	13.2	16.6	20.6	50.6	11.3	22.6	21.4	64.5	8.3	19.9	32.7	2.3	25.5	13.4	67.4	53.7	20.4	51.1	55.1	188.4	108.5	0.5	91.0	86.4	34.7	54.0	96.5	9.6	0.2	250.6	45.8	88.5	332.7	27.7	6.6	59.4	2.2	36.6	18.3	185.8	28.9	148.6	4.3	25.5	176.6	4.8	52.0	0.9	147.6	27.0	15.5	74.7	13.4	139.3	14.8	5.8	14.9	19.7	33.4	33.4	8.2	100.3	6.5	29.1	35.6	90.3	118.9	71.8	31.0	85.7	315.9	23.6	26.3	44.5	46.1	195.7	31.1	35.8	13.5	28.3	2.7	14.8	1.1	76.8	0.1	0.6	7.3	1.9	0.3	0.7	0.5	1.4	1.6	0.1	0.1	1.8	0.4	0.4	0.3	1.0	0.8	0.8	0.6	58.8	81.2	59.1	64.2	55.6	47.8	81.5	56.4	52.1	50.6	64.5	67.4	23.4	176.3	13.3	229.9	5.4	10.8	65.8	25.9	13.6	68.3	81.2	44.1	79.4	44.3	49.8	141.6	20.9	62.2	15.7	21.4	60.7	69.7	11.4	55.3	118.6	15.7	92.0	32.6	35.2	111.0	139.7	201.3	3.1	76.8	100.1	178.3	14.3	77.3	33.3	6.7	57.3	66.9	14.2	23.0	11.6	22.1	397.3	20.4	42.7	30.0	3.7	270.3	71.1	117.6	64.8	40.7	70.1	314.8	7.1	53.8	19.9	3.1	33.7	35.9	32.9	347.6	99.2	4.6	8.8	10.1	27.4	115.2	9.8	177.2	84.5	102.2
RIMBP3	"KIAA1666, RIMBP3.1, RIMBP3A"	ENSG00000275793	"RIMS binding protein 3"	Q9UFD9	22	18605815-18611919	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"brain: 35.7;choroid plexus: 24.5;testis: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.0;THP-1: 3.2"									HPA001183	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"		"HPA001183: AB_1079205"	"unprognostic (1.55e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	"unprognostic (6.06e-3)"	"unprognostic (9.58e-2)"	"unprognostic (8.49e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.69e-3)"	"unprognostic (7.95e-2)"	0.1	0.2	7.9	0.4	10.8	0.1	0.0	35.7	22.0	0.1	24.5	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	11.0	11.7	0.0	0.0	0.2	0.8	14.9	10.1	0.1	0.1	0.3	0.1	0.2	26.2	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	19.6	0.7	0.2	28.4	13.5	1.0	0.4	0.0	0.5	0.0	0.0	32.4	0.4	1.3	0.5	0.4	0.7	0.3	0.0	0.5	1.4	0.6	0.7	0.0	0.0	0.3	0.6	0.2	0.4	0.3	0.3	0.0	0.1	1.4	0.4	0.6	0.3	0.5	0.0	2.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	1.1	0.2	0.3	0.5	0.6	3.0	1.7	0.6	0.6	0.1	1.2	1.6	0.2	0.1	0.1	0.8	0.1	1.2	0.0	0.2	0.1	0.1	3.2	0.1	1.0	0.7	0.5	0.3	0.0	0.4	0.3	0.5	0.7	1.1	0.0	0.2	0.2	0.1	0.1	0.4	0.1	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.3	0.0	0.0	0.2	0.3	7.9	10.8	35.7	22.0	11.0	11.7	14.9	10.1	26.2	19.6	13.5	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RIMBP3B		ENSG00000274600	"RIMS binding protein 3B"	A6NNM3	22	21383374-21389478	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"brain: 41.3;choroid plexus: 18.4;testis: 13.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;RH-30: 1.1;THP-1: 2.1"									HPA001183	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Vesicles, Plasma membrane"		"HPA001183: AB_1079205"	"unprognostic (3.78e-1)"	"unprognostic (3.54e-2)"			"unprognostic (1.53e-2)"			"unprognostic (1.51e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.35e-2)"		"unprognostic (4.37e-1)"	"unprognostic (3.61e-4)"	"unprognostic (1.69e-2)"		"unprognostic (7.11e-2)"		0.0	0.1	8.2	0.4	12.8	0.0	0.0	41.3	19.1	0.0	18.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	10.4	13.6	0.0	0.0	0.1	0.3	16.5	12.6	0.0	0.1	0.2	0.0	0.2	19.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	16.2	0.2	0.0	13.6	13.2	0.4	0.1	0.0	0.2	0.0	0.0	29.6	0.0	0.5	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.2	0.2	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.2	0.9	1.2	0.1	0.2	0.1	0.8	1.1	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	2.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.2	0.1	8.2	12.8	41.3	19.1	10.4	13.6	16.5	12.6	19.2	16.2	13.2	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RIMBP3C		ENSG00000183246	"RIMS binding protein 3C"	A6NJZ7	22	21545678-21551461	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 6.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 30.7;Late spermatids: 49.4;Spermatocytes: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA001183	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"		"HPA001183: AB_1079205"	"unprognostic (1.74e-1)"	"unprognostic (4.05e-2)"			"unprognostic (3.49e-2)"	"unprognostic (2.18e-1)"		"unprognostic (8.30e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.17e-6)"	"unprognostic (3.04e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.76e-6)"	"unprognostic (1.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	49.4	0.6	0.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RUNDC3B	"RPIB9, RPIP9"	ENSG00000105784	"RUN domain containing 3B"	Q96NL0	7	87627548-87832296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 7.3;brain: 6.3;liver: 5.6"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 167.5;Inhibitory neurons: 170.9;Microglial cells: 108.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.2;HEK 293: 1.0;SCLC-21H: 2.7;SH-SY5Y: 1.2;U-138 MG: 1.0;U-266/70: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056968, HPA057155, HPA075760"	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Vesicles	"HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: "	"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.42e-5)"	"unprognostic (4.44e-1)"	"prognostic favorable (2.62e-6)"	"unprognostic (1.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.55e-2)"	0.4	7.3	3.1	0.1	2.9	0.0	0.6	6.3	3.9	1.4	0.0	1.3	2.8	1.9	0.6	0.5	1.0	0.9	0.7	2.0	3.7	1.9	5.6	0.4	0.2	2.5	1.5	1.2	0.1	0.3	0.2	0.0	2.2	0.6	1.5	1.7	0.3	0.4	0.1	0.5	2.5	2.1	0.8	0.1	0.1	1.9	4.0	0.1	0.2	0.1	0.2	0.5	0.3	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.0	0.0	0.5	0.4	0.0	0.5	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	2.7	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.9	6.3	3.9	2.0	3.7	2.5	1.5	2.2	0.8	4.0	1.3	15.3	0.0	0.0	5.5	0.6	4.8	0.1	0.1	2.2	7.9	1.0	1.1	2.5	7.2	0.1	0.0	6.2	0.5	0.9	12.2	1.9	1.1	4.6	5.6	0.5	30.8	0.0	2.7	167.5	0.2	0.8	1.1	0.0	2.0	0.0	0.7	1.4	18.9	0.1	11.8	170.9	2.9	0.0	0.0	2.3	1.7	4.1	0.6	3.6	108.7	0.2	0.7	4.1	15.1	5.7	0.6	6.5	1.5	0.1	0.2	18.2	11.6	0.2	8.0	0.0	0.3	2.0	21.2	18.8	0.4	3.0	1.2	0.8	1.6	4.2	0.1
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598604-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 1499.3;choroid plexus: 781.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.3;Breast myoepithelial cells: 124.8;Granulosa cells: 261.7;Langerhans cells: 206.8;Melanocytes: 99.6;Oligodendrocytes: 332.1"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 360.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 360.9"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 547.1;WM-115: 992.8"									"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		300000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	151.1	25.7	877.1	10.5	1072.5	2.3	87.0	1254.5	1191.2	28.6	781.0	121.0	7.4	2.4	12.1	14.6	6.9	14.3	28.1	858.4	989.0	3.6	3.2	6.4	21.4	1491.0	1054.2	5.6	5.0	0.3	44.7	0.8	1359.0	29.3	14.2	14.1	19.3	26.2	3.6	15.8	36.3	6.8	1162.2	26.2	23.6	2.4	998.8	18.4	5.2	6.4	20.3	15.9	26.9	1499.3	0.5	0.0	110.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.9	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	15.9	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.5	0.0	0.0	547.1	0.0	0.1	0.5	0.0	0.3	0.3	0.0	3.2	0.0	0.3	0.0	1.4	6.7	992.8	0.1	0.5	0.2	360.9	9.5	103.3	0.2	1.0	67.6	16.3	1.4	3.2	153.1	3.2	58.7	10.1	3.9	0.0	63.6	877.1	1072.5	1254.5	1191.2	858.4	989.0	1491.0	1054.2	1359.0	1162.2	998.8	1499.3	4.5	3.2	4.8	126.3	4.6	16.8	0.7	0.0	17.6	1.3	41.2	124.8	6.0	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.1	0.4	0.1	0.1	2.7	0.0	2.7	0.9	0.0	0.1	4.4	0.5	0.2	0.0	261.7	4.6	0.4	9.3	0.0	1.4	0.0	0.0	38.6	206.8	1.7	5.6	37.0	99.6	9.4	33.3	25.7	63.8	83.4	332.1	0.1	0.0	0.0	2.2	0.1	0.0	0.1	0.0	4.7	0.0	5.6	7.8	0.1	0.1	0.7	12.6	0.1	37.9	0.0	0.2	0.4
SARS2	"FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS"	ENSG00000104835	"Seryl-tRNA synthetase 2, mitochondrial"	Q9NP81	19	38915266-38930763	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.1;Late spermatids: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA052730, HPA056957"	Approved		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"	"unprognostic (3.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.62e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.62e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.69e-2)"	7.3	17.3	4.2	7.2	4.7	9.3	8.2	4.4	6.8	9.7	3.6	10.1	9.3	9.3	2.8	14.3	8.5	5.9	12.4	4.7	4.4	14.6	18.7	6.6	9.8	5.0	4.4	9.8	15.9	7.8	11.9	7.6	5.3	12.2	5.3	2.3	11.3	6.2	16.4	12.3	10.2	5.1	4.2	12.0	11.9	10.7	4.4	7.5	14.4	11.5	6.6	9.4	9.6	5.4	17.6	47.3	15.5	10.7	5.8	13.3	23.7	10.7	12.6	23.1	17.7	36.0	18.4	17.2	16.3	12.5	9.7	13.9	14.7	29.2	5.3	12.7	24.4	33.7	17.7	32.0	15.4	29.1	31.9	20.7	13.5	14.5	7.6	9.5	14.2	26.3	29.9	14.2	10.6	28.4	21.4	20.7	18.5	21.6	8.5	31.2	16.4	18.6	20.5	36.2	29.1	18.1	14.2	32.7	8.9	4.6	21.8	19.1	11.4	13.7	17.7	11.7	15.1	11.0	7.1	13.2	10.9	18.5	13.8	0.0	8.0	1.0	14.2	14.4	11.5	12.0	10.7	14.7	25.2	10.7	7.5	8.6	0.5	14.0	13.7	9.9	13.4	8.9	4.2	4.7	4.4	6.8	4.7	4.4	5.0	4.4	5.3	4.2	4.4	5.4	2.7	6.4	7.9	6.2	8.4	4.2	3.8	8.3	3.4	8.0	7.0	5.3	8.1	7.2	6.8	5.5	8.4	40.1	5.6	8.9	15.6	15.5	15.7	3.6	3.6	3.8	11.4	13.2	6.8	12.7	23.0	4.8	9.7	3.9	5.7	7.4	6.1	10.1	12.9	5.0	6.7	9.2	10.2	6.7	4.2	56.9	4.7	4.8	3.6	1.9	7.7	3.1	5.2	1.5	3.1	8.4	5.6	4.9	10.1	2.6	7.4	10.3	5.1	13.4	0.0	2.7	4.2	1.9	8.2	12.8	4.1	29.1	7.4	10.6	17.8	3.2
SCAMP1	SCAMP37	ENSG00000085365	"Secretory carrier membrane protein 1"	O15126	5	78360611-78480739	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044753, CAB079009"		Supported	Uncertain	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB079009: , HPA044753: "	"unprognostic (8.25e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.34e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (8.44e-3)"	"unprognostic (7.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.99e-2)"	17.9	22.4	18.4	12.7	20.5	8.5	28.2	24.5	29.1	23.9	23.9	19.6	16.0	25.0	23.2	24.7	29.6	20.2	24.7	20.4	22.4	28.6	17.8	17.8	12.1	18.4	21.5	22.8	25.2	47.1	15.7	23.4	21.4	34.3	22.3	40.2	31.5	29.8	10.6	17.7	15.6	26.6	20.0	13.6	27.9	14.1	23.3	14.6	39.8	16.3	13.4	25.0	11.4	19.0	32.7	23.9	23.4	76.1	35.5	45.5	40.8	30.0	46.1	26.5	56.1	9.3	61.1	48.1	31.4	45.5	65.7	26.2	34.9	57.0	45.9	17.4	32.5	20.5	17.8	20.1	22.7	13.6	16.5	28.6	54.5	27.3	41.2	62.5	41.3	25.0	8.4	33.6	50.9	39.2	25.2	26.7	19.9	14.3	26.0	29.5	38.3	55.3	43.5	38.6	70.9	40.6	27.6	38.5	26.7	24.9	52.5	26.1	36.6	26.3	19.3	30.0	24.2	20.9	29.4	27.6	50.1	50.4	22.6	20.3	11.4	13.2	7.5	12.7	9.3	7.6	8.7	9.2	14.8	6.5	7.1	6.3	6.8	10.3	16.6	4.5	9.1	8.0	18.4	20.5	24.5	29.1	20.4	22.4	18.4	21.5	21.4	20.0	23.3	19.0	59.5	25.6	22.4	45.7	20.3	39.1	31.5	33.6	38.7	72.1	33.4	22.7	36.1	21.5	30.4	40.5	70.9	13.8	21.7	19.1	13.7	24.2	42.2	34.9	30.2	31.4	35.4	12.0	80.0	30.5	24.8	34.3	36.7	34.1	12.0	41.7	27.1	15.7	19.2	32.0	100.1	34.2	20.3	33.7	33.1	15.3	20.2	25.1	30.2	45.0	19.1	47.4	19.6	76.4	60.3	29.8	14.9	28.6	23.9	44.6	14.2	24.7	65.4	68.2	13.1	33.5	25.4	25.6	23.1	30.8	45.3	10.5	21.2	30.8	18.8	33.7
SEMA4G	"FLJ20590, KIAA1619"	ENSG00000095539	"Semaphorin 4G"	Q9NTN9	10	100969518-100985871	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 84.6;liver: 102.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 66.4;Gastric mucus-secreting cells: 27.0;Hepatocytes: 60.5;Intestinal goblet cells: 34.6;Paneth cells: 38.5;Proximal enterocytes: 47.6;Undifferentiated cells: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 31.7;CACO-2: 30.5;Hep G2: 113.8;OE19: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038362, HPA077752"	Uncertain		Uncertain	"Vesicles,Lipid droplets"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 37: B-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Lipid droplets"		"HPA038362: AB_10669524, HPA077752: "	"unprognostic (3.90e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.05e-2)"	2.4	12.7	13.1	5.9	10.9	0.4	3.6	18.9	12.3	6.9	12.8	53.6	53.4	3.5	32.1	3.6	5.9	9.0	3.0	10.0	11.6	19.1	102.4	5.8	2.5	11.2	14.4	18.9	31.3	7.3	9.9	3.9	11.5	20.2	84.6	7.3	8.5	3.0	2.6	18.3	41.2	4.6	9.6	3.1	20.9	3.7	17.0	0.8	15.3	0.8	0.9	4.0	5.0	9.9	0.2	31.7	8.0	3.4	5.0	1.6	6.8	1.2	3.4	1.7	1.7	30.5	5.2	0.5	4.2	1.5	0.6	2.1	8.0	1.4	1.4	0.7	4.9	1.7	3.0	113.8	12.5	1.2	1.0	8.3	1.8	1.6	0.9	22.2	4.4	3.5	3.3	0.4	2.5	2.0	0.5	1.2	1.3	69.1	1.8	3.1	0.7	1.5	7.4	1.0	2.5	12.5	1.1	2.1	3.2	8.7	8.7	1.5	3.0	1.0	3.7	0.8	0.3	1.1	0.6	0.5	0.9	1.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	10.9	18.9	12.3	10.0	11.6	11.2	14.4	11.5	9.6	17.0	9.9	0.3	3.2	1.1	3.9	1.2	0.0	0.6	0.7	0.6	3.5	2.5	2.0	1.2	20.0	0.2	0.0	0.0	8.8	0.0	66.4	0.0	2.7	0.2	1.6	0.7	0.6	8.5	0.8	3.0	2.6	1.9	2.0	27.0	0.3	0.0	3.4	2.2	60.5	0.9	11.8	14.1	34.6	2.0	3.3	0.0	0.2	2.1	0.2	1.8	0.0	0.0	0.9	0.0	3.5	5.5	2.4	38.5	1.2	0.2	3.0	47.6	6.4	2.4	1.6	0.0	0.1	0.4	1.1	1.9	0.5	0.1	2.9	0.2	12.7	45.9	0.9
SEMA7A	"CD108, H-Sema-L, SEMAL"	ENSG00000138623	"Semaphorin 7A (John Milton Hagen blood group)"	O75326	15	74409289-74433958	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Differentiation, Inflammatory response, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 60.1;retina: 34.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 68.8;Extravillous trophoblasts: 58.8;Granulosa cells: 65.1;Pancreatic endocrine cells: 91.0;Rod photoreceptor cells: 58.3;Syncytiotrophoblasts: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 1.8;eosinophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 275.8;hTEC/SVTERT24-B: 108.7;U-251 MG: 166.3;U-87 MG: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008210, HPA042273"	Uncertain		Uncertain	Vesicles		NA	NA		38000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA008210: , HPA042273: AB_10806234"	"unprognostic (2.00e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.45e-11)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.57e-2)"	2.0	2.5	4.6	7.0	11.0	9.9	1.9	19.1	14.4	2.2	0.9	2.4	1.5	2.9	0.9	4.8	1.4	1.8	2.3	5.1	8.2	2.8	1.6	8.1	13.2	19.9	11.6	7.8	0.9	1.9	2.7	16.3	22.9	1.8	0.9	34.6	2.2	1.2	2.0	8.5	10.8	1.1	10.6	60.1	3.5	29.5	17.2	9.4	1.3	0.3	12.9	8.2	2.5	20.2	16.7	0.2	4.8	1.4	6.0	20.1	39.7	75.2	30.1	15.5	23.8	6.5	26.6	0.1	4.3	34.2	12.6	4.9	1.5	4.8	16.0	1.3	0.9	30.0	0.1	8.3	1.3	0.9	275.8	14.3	0.2	108.7	6.0	39.0	0.2	2.0	17.5	10.1	51.2	1.4	4.3	9.9	5.2	0.4	11.3	0.6	3.3	4.4	6.5	7.1	0.3	0.5	0.5	13.4	6.1	4.1	1.0	6.0	3.0	28.8	19.2	14.1	166.3	1.8	1.3	0.3	92.4	3.4	1.5	1.8	0.0	3.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	4.6	11.0	19.1	14.4	5.1	8.2	19.9	11.6	22.9	10.6	17.2	20.2	1.8	3.2	0.0	1.0	22.6	0.4	1.6	3.1	0.6	13.7	1.2	1.3	1.4	0.0	4.0	1.8	68.8	25.6	5.2	0.6	0.0	19.8	0.5	4.6	1.5	5.3	0.0	21.7	12.4	13.9	58.8	1.8	1.5	10.6	8.2	65.1	0.7	0.7	7.2	1.7	5.9	0.0	0.0	0.3	12.0	2.5	3.7	4.8	8.8	0.0	28.6	6.8	1.0	4.0	16.3	91.0	0.1	1.9	6.4	3.3	0.1	0.1	2.0	58.3	0.0	0.2	9.0	0.9	0.8	0.2	1.4	166.4	5.7	22.0	0.0	24.4
SERINC5	"C5orf12, TPO1"	ENSG00000164300	"Serine incorporator 5"	Q86VE9	5	80111651-80256048	"Predicted membrane proteins, Transporters"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 222.5;Urothelial cells: 254.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037898, HPA037899"	Supported		Supported	"Vesicles,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	"Vesicles, Centrosome"	"HPA037898: AB_10673649, HPA037899: AB_2675727"	"unprognostic (2.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.17e-2)"	12.9	34.8	19.2	9.8	31.0	6.3	11.8	27.2	20.7	16.4	17.4	28.3	9.2	9.2	21.1	17.6	16.2	14.2	5.3	18.0	22.7	6.2	45.4	14.1	8.2	26.5	27.6	15.1	7.6	7.1	4.1	16.5	26.8	33.7	29.4	16.3	13.3	7.0	2.7	19.1	9.7	7.6	22.2	4.8	16.6	29.2	28.0	7.9	5.8	2.9	11.4	17.8	11.3	44.4	11.3	19.7	6.6	4.2	8.9	9.5	19.6	9.0	6.0	3.9	4.0	40.0	56.7	1.7	9.0	11.7	9.2	31.7	8.9	23.9	5.6	1.6	4.8	1.4	2.2	21.7	3.3	1.3	4.1	10.8	13.1	10.2	26.0	11.0	7.3	54.0	3.6	9.4	10.4	19.4	22.8	5.5	9.3	15.8	6.8	26.9	5.8	3.0	11.5	54.4	0.4	6.3	8.0	18.5	35.4	33.5	8.2	6.9	8.0	11.3	3.2	11.6	11.3	7.1	3.5	28.1	21.0	3.9	46.9	10.4	9.1	6.7	2.1	4.9	1.6	0.8	18.7	5.7	5.8	1.1	23.3	14.1	5.2	0.6	1.5	1.4	6.6	7.5	19.2	31.0	27.2	20.7	18.0	22.7	26.5	27.6	26.8	22.2	28.0	44.4	48.5	60.9	30.2	46.0	10.5	6.4	56.8	5.6	19.9	3.6	27.7	14.1	8.2	31.5	18.3	16.5	0.0	16.1	12.9	127.4	9.8	26.5	1.7	82.0	29.6	24.5	60.1	24.8	20.9	19.5	25.7	24.9	40.2	157.0	8.2	27.6	35.3	82.7	21.8	3.3	78.3	60.0	4.1	29.2	27.8	7.6	18.3	38.4	5.4	66.5	44.8	65.1	1.0	223.2	222.5	35.4	56.4	39.9	8.7	148.2	27.7	5.1	4.3	5.3	32.9	7.5	17.4	3.1	12.8	44.4	9.8	129.2	37.7	15.2	85.9	254.2
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561442-94569913	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 550.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 245.9;Exocrine glandular cells: 93.8;Hepatocytes: 478.5;Pancreatic endocrine cells: 62.1"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 94.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 28.4"					"Not detected"	"Not detected"			"HPA003607, HPA068939"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA	14500000000	14000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA003607: AB_1079914, HPA068939: "	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favorable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.4	41.0	0.0	1.5	53.4	0.0	0.0	0.0	7.3	550.0	0.0	0.0	0.0	0.0	0.0	116.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	245.9	0.0	3.7	0.0	0.0	0.0	0.0	11.7	30.0	0.0	3.3	0.3	0.3	0.0	2.7	0.0	93.8	0.0	0.0	5.1	4.5	0.0	0.2	5.3	478.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SFXN4	SLC56A4	ENSG00000183605	"Sideroflexin 4"	Q6P4A7	10	119140767-119165714	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018028, HPA020872"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA018028: AB_1856792, HPA020872: AB_1856793"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.70e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.07e-3)"	13.3	35.9	9.9	10.1	12.5	16.4	14.1	12.8	13.6	14.2	17.0	21.9	20.4	11.1	13.5	19.1	14.3	8.6	33.1	10.2	12.4	24.5	36.4	8.5	14.4	11.3	12.5	16.0	33.7	23.1	21.5	8.8	11.6	18.8	22.7	5.7	27.8	13.2	51.4	11.5	17.3	12.2	10.6	20.9	17.3	11.9	11.3	11.0	24.7	59.3	17.8	16.4	13.8	12.5	26.2	27.6	8.7	41.8	10.4	19.7	33.0	16.3	19.8	21.0	21.8	45.9	43.2	62.6	15.6	14.9	22.4	48.2	57.5	36.3	24.3	33.1	65.7	28.7	18.4	47.3	37.1	49.7	28.8	21.1	34.4	22.0	63.8	19.5	25.0	46.5	45.2	17.5	13.6	29.6	53.8	60.4	11.8	50.2	32.5	51.7	27.1	49.0	24.3	17.3	25.2	13.9	10.8	42.2	61.9	11.1	26.0	28.4	11.5	10.6	21.9	19.8	37.6	42.6	53.0	56.3	16.2	72.6	7.2	2.5	18.1	1.9	6.5	19.5	10.8	12.5	7.9	7.1	21.2	7.0	12.1	9.8	2.2	7.3	15.9	10.6	6.0	11.1	9.9	12.5	12.8	13.6	10.2	12.4	11.3	12.5	11.6	10.6	11.3	12.5	8.0	6.4	5.6	29.0	16.9	12.0	25.8	39.9	23.3	7.9	17.8	18.2	36.2	12.8	19.1	14.7	2.1	37.6	6.2	13.2	58.7	28.4	27.4	7.6	8.9	8.4	18.0	33.6	22.3	23.8	25.8	12.4	14.3	7.9	5.7	28.5	7.1	31.5	29.2	6.7	29.1	24.7	30.5	17.6	5.0	69.3	8.7	13.1	12.4	8.4	11.3	7.7	10.3	22.1	19.5	17.6	12.1	13.5	31.9	28.0	29.8	65.6	13.5	11.3	6.6	22.3	10.6	27.7	15.2	26.9	9.1	21.9	9.2	44.5	45.8	20.5
SIGLEC14		ENSG00000254415	"Sialic acid binding Ig like lectin 14"	Q08ET2	19	51642553-51646801	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.3;lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 18.5;Kupffer cells: 41.5;Macrophages: 13.5;monocytes: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 109.1;intermediate monocyte: 125.1;myeloid DC: 65.4;neutrophil: 200.1;non-classical monocyte: 93.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 65.4;granulocytes: 200.1;monocytes: 125.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 98.7;U-937: 24.7"									"HPA014377, HPA014428"	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA		24000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane"	"HPA014377: AB_2189277, HPA014428: "	"unprognostic (3.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	3.4	2.4	1.4	25.2	1.5	28.3	1.0	1.6	3.2	1.8	1.3	1.8	0.7	0.9	0.3	1.1	2.3	2.6	1.3	1.4	2.4	0.7	3.5	7.3	13.3	4.7	3.0	0.4	1.1	0.4	0.5	2.5	3.9	0.9	1.6	0.1	1.1	0.9	0.4	0.3	6.1	2.5	2.7	40.3	1.6	2.4	3.9	1.9	0.6	0.0	14.2	4.1	0.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	1.6	98.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	16.6	109.1	1.8	0.3	125.1	0.1	19.3	0.2	0.3	65.4	18.2	0.1	0.1	200.1	0.7	93.3	12.0	0.2	40.3	1.4	1.5	1.6	3.2	1.4	2.4	4.7	3.0	3.9	2.7	3.9	4.1	0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	18.5	0.0	0.0	0.0	0.0	41.5	6.0	0.8	0.3	13.5	0.0	1.0	24.1	0.0	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1561385-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.2;lung: 19.4;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 10.9;Hofbauer cells: 14.7;Kupffer cells: 29.4;Macrophages: 30.9;monocytes: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1594.8"	"Group enriched"	"Detected in all"	6	"granulocytes: 1594.8;monocytes: 502.2"	"Group enriched"	"Detected in some"	4	"HMC-1: 54.0;NB-4: 76.2;THP-1: 58.9"									HPA047463	Uncertain		Uncertain	Vesicles,Centrosome		NA	NA		44000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	Centrosome	"HPA047463: AB_2680057"	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"	5.4	1.6	1.3	28.6	1.3	52.2	1.9	1.2	4.2	1.2	0.1	2.1	1.5	0.8	0.8	1.3	2.2	11.2	1.6	1.4	0.8	1.2	3.1	19.4	11.0	0.7	0.8	0.7	1.3	0.3	0.6	2.8	1.3	0.8	1.8	1.2	1.7	0.9	0.8	0.8	2.8	3.2	0.9	24.5	1.5	0.6	2.1	4.5	0.9	1.5	4.3	8.1	0.8	1.9	0.2	0.0	0.2	0.1	0.3	0.5	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.1	0.8	0.4	7.1	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	14.9	54.0	0.1	0.2	0.3	0.0	8.0	0.5	1.1	0.0	0.2	0.4	0.1	0.0	76.2	0.2	0.0	3.3	0.2	0.0	0.1	10.8	0.3	0.1	0.2	0.2	0.0	0.5	0.0	0.0	58.9	1.6	0.7	0.1	0.4	0.3	0.1	0.1	0.1	1.1	13.4	0.2	6.1	502.2	868.9	7.3	419.7	10.3	2.8	6.5	5.7	175.2	3.4	8.8	5.5	1594.8	8.2	357.6	165.7	11.8	287.0	1.3	1.3	1.2	4.2	1.4	0.8	0.7	0.8	1.3	0.9	2.1	1.9	0.6	3.2	5.2	0.3	1.2	0.0	0.1	0.2	0.6	0.2	0.1	0.0	0.5	0.0	1.6	0.0	0.0	0.2	10.9	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.1	0.7	0.0	0.2	7.0	0.0	1.8	0.2	14.7	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	30.9	0.0	0.0	26.7	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0
SIRT6		ENSG00000077463	"Sirtuin 6"	Q8N6T7	19	4174109-4182566	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Distal enterocytes: 199.2;Paneth cells: 129.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049729, HPA071776"	Supported		Supported	Nucleoplasm,Vesicles		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA049729: AB_2680865, HPA071776: AB_2686445"	"unprognostic (4.58e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.13e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.84e-2)"	"prognostic favorable (9.13e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.58e-4)"	8.2	12.0	10.4	7.8	10.6	10.4	8.6	10.3	15.1	10.5	8.7	23.6	10.0	10.6	2.4	12.3	9.2	3.5	10.0	10.7	10.2	13.7	11.0	8.9	7.1	11.2	10.3	7.5	14.1	5.2	13.3	4.3	10.5	12.7	7.5	1.9	9.3	5.0	8.0	11.8	14.2	2.6	9.8	15.3	9.8	6.0	12.1	4.9	10.1	2.7	3.9	9.9	9.7	10.6	25.7	16.8	8.3	10.4	6.5	6.2	12.9	12.0	8.9	10.1	8.8	11.2	9.5	16.0	12.9	8.1	9.1	15.9	4.6	12.9	1.6	30.8	10.0	6.8	9.7	10.3	14.3	17.4	25.2	7.9	10.4	10.3	6.4	7.7	8.7	15.0	15.2	35.3	5.4	19.2	23.9	18.3	14.5	9.3	15.2	18.9	7.7	18.8	9.7	11.4	11.0	18.1	11.0	10.2	24.1	3.2	10.2	23.0	12.2	10.4	10.5	36.9	17.4	45.6	25.7	18.4	20.8	28.1	12.7	5.3	13.1	12.2	10.8	16.3	6.4	9.6	7.5	8.7	14.3	10.1	6.4	6.1	11.8	5.6	13.5	11.9	12.6	8.5	10.4	10.6	10.3	15.1	10.7	10.2	11.2	10.3	10.5	9.8	12.1	10.6	9.2	12.8	7.3	5.9	13.8	10.3	10.3	32.3	9.6	12.6	6.6	6.3	3.2	7.2	18.4	5.5	18.8	24.1	7.1	199.2	13.7	32.2	1.9	6.2	7.9	11.8	26.4	9.5	8.9	26.7	24.2	9.3	19.9	9.2	5.7	5.6	13.6	6.8	24.0	13.5	10.4	29.1	18.3	11.7	10.1	2.6	11.5	15.0	5.4	1.9	27.0	15.2	14.4	3.5	6.3	32.5	129.7	8.2	10.3	9.7	28.2	14.3	11.0	13.8	0.0	7.2	11.3	7.4	9.6	13.3	12.6	25.6	10.6	7.9	30.9	11.9
SLC23A2	"KIAA0238, SLC23A1, SVCT2, YSPL2"	ENSG00000089057	"Solute carrier family 23 member 2"	Q9UGH3	20	4852356-5010293	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 99.3;choroid plexus: 88.4;retina: 107.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 236.8;Cone photoreceptor cells: 114.7;Excitatory neurons: 102.8;Inhibitory neurons: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052825, HPA059314"	Approved		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Golgi apparatus"	"HPA052825: AB_2681965, HPA059314: AB_2683975"	"unprognostic (3.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (6.22e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.36e-3)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.08e-5)"	10.2	99.3	26.3	8.2	27.2	7.8	9.4	24.1	26.0	13.5	88.4	9.4	6.4	12.9	8.7	6.1	15.9	10.1	8.3	28.5	26.7	13.0	57.0	12.1	10.2	28.1	32.0	38.5	10.0	17.7	23.3	8.1	29.5	12.5	6.1	107.2	5.9	10.3	3.3	11.4	12.5	10.0	25.6	20.9	9.4	11.4	34.6	8.2	25.0	4.5	9.9	18.9	8.9	33.1	21.2	24.5	32.2	12.2	22.2	12.4	40.9	8.9	12.1	10.3	9.6	12.7	23.6	9.6	9.4	12.4	29.1	20.1	9.1	24.2	19.2	6.0	16.2	13.3	4.3	48.0	12.5	18.9	7.6	10.6	13.8	25.8	15.4	21.5	15.2	15.5	9.3	7.9	13.7	7.9	20.7	10.5	11.4	16.9	14.9	19.0	21.2	14.3	5.6	34.2	10.7	12.0	17.0	17.7	63.3	11.4	9.8	10.9	13.1	23.0	10.7	27.8	17.4	11.2	22.2	25.5	8.1	11.2	36.8	0.0	1.1	0.1	1.1	0.7	1.0	1.8	0.8	0.8	1.5	1.0	0.8	0.8	1.2	0.3	0.9	2.4	0.5	0.9	26.3	27.2	24.1	26.0	28.5	26.7	28.1	32.0	29.5	25.6	34.6	33.1	9.3	6.4	7.2	50.3	14.5	7.4	4.5	7.0	12.5	236.8	8.3	7.4	7.9	15.7	9.4	14.7	114.7	4.9	12.6	0.8	0.0	5.0	4.6	2.8	10.1	13.0	7.2	8.6	102.8	5.5	6.6	14.2	3.6	1.9	8.2	13.5	17.5	71.3	10.6	85.8	117.4	1.9	0.0	30.2	7.5	9.3	20.2	16.3	16.0	60.0	8.8	24.8	7.2	77.4	78.3	3.4	6.7	29.3	11.9	8.2	0.6	1.3	7.8	71.5	13.1	12.6	12.2	0.6	8.0	5.5	6.1	4.0	8.2	65.6	2.8	14.7
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 51.3;salivary gland: 54.0;thyroid gland: 60.9"	"Cell type enhanced"	"Detected in many"		"Club cells: 25.5;Collecting duct cells: 112.2;Ionocytes: 79.3;Respiratory ciliated cells: 48.1;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 70.6;Hep G2: 43.0;RT4: 30.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	2.4	6.9	4.5	0.7	3.5	0.4	3.4	2.3	3.1	10.9	5.6	0.4	0.1	0.5	2.6	16.5	1.7	1.1	0.8	2.9	1.4	51.3	0.2	2.0	1.4	2.0	2.3	0.2	0.5	0.6	4.3	0.2	2.6	5.4	0.3	0.4	54.0	7.0	5.2	12.8	0.6	0.3	0.8	0.7	2.5	5.9	4.3	1.0	60.9	0.1	1.8	3.4	5.8	1.9	11.0	15.5	1.8	7.9	5.1	1.3	21.1	5.4	3.4	2.8	1.6	1.1	14.1	0.0	6.1	1.9	6.6	70.6	8.3	16.8	0.5	0.1	3.2	0.7	7.5	43.0	3.2	4.0	13.6	0.7	6.8	3.4	3.2	2.3	7.0	9.8	1.6	9.7	2.9	7.2	0.5	0.4	12.1	13.6	20.7	2.6	10.3	3.5	16.9	30.7	0.9	4.9	2.7	17.5	0.3	5.4	6.7	7.0	12.1	2.1	7.0	0.5	2.7	0.4	0.6	0.1	0.1	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.5	3.5	2.3	3.1	2.9	1.4	2.0	2.3	2.6	0.8	4.3	1.9	0.8	0.0	0.0	1.6	0.0	0.8	2.2	16.3	8.0	0.2	4.9	4.4	1.1	0.0	25.5	112.2	0.0	0.1	0.6	0.8	0.0	0.7	5.8	2.3	0.6	0.7	0.0	0.0	0.3	0.5	0.1	0.3	5.1	4.2	0.0	0.2	1.1	0.0	0.4	0.0	0.1	0.2	79.3	0.3	0.0	2.2	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.3	3.0	1.3	0.4	0.0	3.7	0.0	0.5	48.1	0.2	26.3	0.6	5.8	3.0	4.7	3.3	0.4	0.0	0.2	0.1	0.2	5.7
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816201-10940714	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 153.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 85.2;Excitatory neurons: 13.7;Inhibitory neurons: 25.8;Muller glia cells: 26.4;Oligodendrocyte precursor cells: 23.1"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HaCaT: 13.5;Hep G2: 16.0;hTCEpi: 11.9;NTERA-2: 6.7;T-47d: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.0	0.0	50.5	0.0	78.7	0.0	1.1	57.3	32.6	0.7	9.6	0.0	0.0	0.5	0.1	8.2	0.5	0.0	0.0	22.6	96.6	0.0	0.1	0.0	0.0	60.0	128.4	0.0	0.1	0.5	0.3	0.4	61.9	0.7	0.0	11.0	1.0	0.0	0.2	5.7	0.0	0.1	41.8	0.4	0.0	1.4	153.3	0.0	0.0	0.0	0.1	0.4	1.8	21.1	5.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.0	2.2	0.0	0.0	0.2	0.3	0.0	16.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.9	4.5	3.9	0.1	0.0	0.1	5.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	78.7	57.3	32.6	22.6	96.6	60.0	128.4	61.9	41.8	153.3	21.1	0.0	0.0	0.0	85.2	0.0	1.3	0.7	0.3	4.0	8.4	0.9	0.9	1.4	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	13.7	0.0	7.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.0	0.0	0.8	0.9	3.4	0.2	0.0	6.5	0.0	26.4	0.0	23.1	0.8	0.2	0.0	6.8	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.6	0.1	0.6	1.8	10.6	3.7	1.0	0.1	0.0	0.0	1.7
SLC7A6	"KIAA0245, LAT-2, LAT3, y+LAT-2"	ENSG00000103064	"Solute carrier family 7 member 6"	Q92536	16	68264516-68301823	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.0"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 55.3;Syncytiotrophoblasts: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050713	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Plasma membrane"	"HPA050713: AB_2681218"	"unprognostic (6.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.84e-4)"	35.3	8.8	1.7	15.5	1.9	8.4	26.9	6.5	3.3	5.5	17.3	8.3	3.9	5.8	11.5	4.5	8.6	4.4	18.5	3.3	2.2	5.9	2.0	10.9	18.6	1.0	1.3	2.7	3.8	2.5	9.6	18.6	1.5	6.2	11.1	5.0	7.3	5.2	75.0	10.2	12.0	7.7	1.0	10.7	6.6	5.1	2.2	37.6	16.7	26.9	21.5	6.8	4.8	1.1	22.6	22.1	16.3	16.8	46.9	27.6	42.9	24.9	18.7	36.9	30.6	97.9	16.2	43.7	19.8	33.4	10.9	33.1	32.0	32.2	39.7	9.5	22.9	23.8	47.3	31.0	7.7	28.2	20.3	19.3	26.1	27.5	13.5	11.4	25.3	21.0	35.1	7.3	20.5	11.7	36.4	19.3	12.4	14.6	8.1	45.0	10.2	36.0	12.0	19.6	23.7	13.5	75.7	20.8	6.8	13.4	30.9	13.3	38.4	24.6	19.0	20.5	32.8	16.7	33.5	50.3	15.6	20.1	17.2	3.4	3.2	2.8	4.3	1.7	5.4	6.8	6.6	4.3	3.6	6.3	11.7	6.7	6.1	7.1	1.4	16.8	3.1	1.5	1.7	1.9	6.5	3.3	3.3	2.2	1.0	1.3	1.5	1.0	2.2	1.1	8.5	41.7	18.8	12.4	18.4	19.6	9.3	8.5	13.6	6.1	5.9	4.8	19.9	2.8	4.9	18.4	37.5	25.1	23.3	7.3	0.0	3.3	5.5	10.7	16.8	12.0	2.4	2.1	39.3	4.0	2.5	12.8	4.1	3.3	4.5	1.8	6.8	1.4	14.6	10.1	40.3	10.5	4.1	8.5	12.1	18.3	5.9	9.9	10.6	55.3	10.0	1.8	14.4	13.0	10.7	5.6	5.9	3.8	16.0	8.0	2.5	0.6	10.4	2.7	0.0	10.8	7.2	17.3	10.9	6.7	21.9	47.9	23.5	4.3	7.8	2.6
SLF2	"C10orf6, FAM178A, FLJ10512, FLJ25012"	ENSG00000119906	"SMC5-SMC6 complex localization factor 2"	Q8IX21	10	100912963-100965134	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 108.1;Peritubular cells: 105.7;Theca cells: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 145.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038499, HPA057568"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA038499: AB_10672520, HPA057568: AB_2683471"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	9.1	17.2	17.3	10.9	29.2	11.8	8.8	20.4	23.1	14.0	9.3	12.6	7.9	20.8	48.6	8.9	17.6	8.0	10.8	17.0	24.9	11.3	11.6	10.8	14.7	24.5	24.7	25.1	13.1	7.9	23.8	15.4	25.7	15.2	10.1	11.7	9.4	12.9	17.8	13.4	12.7	10.7	19.1	23.1	10.4	25.8	25.3	12.2	11.3	13.3	11.5	11.3	11.2	46.2	25.7	20.6	29.6	31.4	16.1	20.9	11.3	26.3	18.5	24.1	29.0	15.2	17.5	24.1	15.8	11.3	17.9	25.3	20.4	8.8	29.1	26.6	16.6	21.7	14.2	31.0	11.7	28.0	24.9	10.0	13.2	18.6	19.9	25.1	15.7	14.7	15.6	22.5	37.3	17.7	19.1	16.0	13.7	9.9	15.2	18.5	145.7	8.3	10.1	12.8	6.6	12.9	16.5	4.6	30.6	14.1	26.3	10.7	20.6	28.2	23.4	18.0	31.1	18.1	28.5	19.1	20.0	32.9	15.1	6.1	6.6	7.0	9.8	6.7	8.9	8.6	7.8	8.5	5.2	11.0	8.5	7.8	3.6	9.1	7.5	7.5	8.0	4.6	17.3	29.2	20.4	23.1	17.0	24.9	24.5	24.7	25.7	19.1	25.3	46.2	18.4	25.6	18.9	0.0	18.2	0.0	8.4	0.0	12.5	33.8	13.8	12.6	0.0	5.7	8.6	25.8	25.0	17.4	29.4	9.0	13.7	11.0	8.4	22.7	64.8	20.8	12.2	11.3	0.0	8.0	7.1	20.2	10.7	25.0	24.0	32.3	26.7	12.8	17.9	38.7	0.0	10.5	0.0	18.2	0.0	10.4	108.1	18.6	0.0	0.0	19.2	19.7	46.4	0.0	0.0	7.0	8.4	105.7	12.3	9.4	9.3	8.9	13.8	31.4	19.7	44.5	12.8	33.5	43.0	10.4	0.0	5.1	19.7	77.6	8.2	6.0
SMARCA2	"BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2"	ENSG00000080503	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	P51531	9	1980290-2193624	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Hypotrichosis, Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 246.5;Inhibitory neurons: 263.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 1486.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029981, CAB037276"	Enhanced		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA		19000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB037276: AB_477083, HPA029981: AB_10602406"	"unprognostic (5.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.26e-6)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.50e-2)"	51.9	55.9	68.9	36.1	73.9	95.7	62.0	87.4	81.7	42.1	40.2	31.0	20.2	53.2	57.3	41.7	57.4	46.0	43.8	60.3	53.7	45.9	58.3	40.3	50.9	43.2	54.4	166.0	36.8	170.3	32.7	48.2	50.6	42.5	31.7	63.6	50.7	53.2	97.7	48.2	27.7	44.2	40.3	52.3	32.0	56.3	55.7	42.2	55.7	60.1	47.8	31.8	28.8	52.9	45.7	32.9	23.7	33.8	47.2	56.6	71.7	59.4	44.6	24.9	19.5	0.5	17.7	76.2	22.0	50.7	13.5	18.8	12.9	46.5	17.6	1486.7	20.2	208.3	88.2	16.2	18.7	88.3	118.1	37.6	17.5	24.9	46.4	44.9	40.3	35.4	7.3	255.1	43.0	19.1	22.2	72.3	23.4	26.4	12.6	97.6	30.5	69.4	57.6	40.9	15.3	14.0	36.2	8.3	14.9	34.1	16.3	55.8	49.1	40.6	19.8	25.8	27.3	22.9	31.8	33.6	43.5	32.5	11.4	26.1	5.2	15.8	10.8	7.2	10.4	12.3	10.5	11.2	6.4	9.4	13.1	10.3	14.6	9.9	10.3	12.5	12.6	5.0	68.9	73.9	87.4	81.7	60.3	53.7	43.2	54.4	50.6	40.3	55.7	52.9	83.9	73.7	70.6	246.5	57.2	58.6	18.3	55.0	82.6	57.6	103.7	74.3	95.2	31.5	54.1	106.7	37.5	99.3	102.8	32.0	31.3	30.6	38.0	44.1	61.6	69.0	37.2	41.2	216.2	22.4	24.5	65.7	19.4	45.2	48.0	27.9	36.8	62.0	31.5	35.3	263.2	31.2	48.8	54.9	34.7	22.6	76.7	57.5	49.8	142.4	45.2	53.4	43.3	120.6	100.8	18.7	15.1	86.9	71.4	13.9	26.9	18.5	88.3	37.4	13.1	58.7	40.3	42.9	14.6	66.2	52.7	88.7	74.8	56.1	28.2	12.7
SOHLH2	"bHLHe81, FLJ20449, SPATA28, TEB1"	ENSG00000120669	"Spermatogenesis and oogenesis specific basic helix-loop-helix 2"	Q9NX45	13	36168217-36214588	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 27.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 55.5;Extravillous trophoblasts: 19.5;Late spermatids: 77.0;Spermatocytes: 22.5;Spermatogonia: 33.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.3;HL-60: 11.2;Karpas-707: 12.1;NB-4: 16.1;U-266/84: 16.5"									HPA029182			Uncertain	Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Vesicles		"HPA029182: AB_10602409"	"unprognostic (1.00e-1)"	"unprognostic (1.65e-1)"		"unprognostic (1.99e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-2)"		"unprognostic (3.01e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.10e-1)"	"unprognostic (8.56e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.93e-2)"	0.5	0.4	0.9	0.1	0.9	0.8	0.5	0.5	1.1	0.3	0.2	2.0	0.3	0.4	2.1	0.4	0.3	0.3	1.0	0.9	1.9	0.7	0.0	0.1	0.3	0.8	0.7	0.3	0.0	1.4	0.3	1.1	0.7	1.8	0.1	1.2	0.2	1.3	0.6	0.3	0.2	0.5	0.8	0.1	0.3	27.5	1.1	0.3	0.5	5.3	0.0	0.9	0.1	1.1	8.3	0.2	0.8	0.0	0.7	1.3	4.8	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.5	0.2	0.2	0.0	0.1	0.0	0.1	1.9	0.1	0.0	0.1	11.2	0.0	2.2	0.6	0.0	0.0	0.4	1.0	0.3	0.4	12.1	2.5	0.1	0.0	16.1	0.2	0.0	0.0	0.2	0.2	0.9	1.2	0.8	0.2	1.5	0.0	0.0	0.0	2.9	0.1	0.7	0.0	0.0	0.9	0.6	0.5	1.6	16.5	0.2	0.9	5.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.5	1.1	0.9	1.9	0.8	0.7	0.7	0.8	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.7	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	55.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	19.5	0.1	0.0	0.3	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	77.0	0.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	2.1	0.0	0.3	0.0	0.0	0.1	22.5	33.5	0.0	0.1	3.4	0.0	0.1	0.0	0.1
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 111.3;stomach 1: 60.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 68.5;Distal tubular cells: 29.4;Gastric mucus-secreting cells: 76.5;Horizontal cells: 30.3;Ionocytes: 128.1;Melanocytes: 32.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;EFO-21: 12.7;HEL: 4.8;NTERA-2: 4.9;RPTEC TERT1: 23.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.2;hippocampal formation: 18.4;pons and medulla: 15.1;thalamus: 11.9"	"Low region specificity"	"Detected in many"			HPA042856			Uncertain	"Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	"Nucleoli, Nucleoli rim, Vesicles"	"HPA042856: "	"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (8.72e-4)"	0.2	0.5	1.3	0.9	2.7	0.1	17.9	1.7	3.4	2.6	111.3	10.9	11.6	4.7	0.3	3.7	5.0	0.3	3.1	3.7	0.3	22.3	0.0	39.2	0.1	0.7	0.9	1.1	0.6	0.6	2.4	0.0	0.1	1.8	15.0	3.0	15.6	3.5	0.1	16.8	8.6	1.1	0.2	0.1	60.4	1.9	2.2	0.1	8.6	0.9	3.9	1.4	3.5	1.8	0.0	0.0	7.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	12.7	0.0	0.0	0.3	0.4	0.0	0.0	0.1	2.6	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.3	0.1	0.0	0.1	0.7	0.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.7	1.7	3.4	3.7	0.3	0.7	0.9	0.1	0.2	2.2	1.8	0.4	0.0	0.0	0.0	0.2	5.6	4.3	2.1	9.1	0.6	68.5	17.8	3.8	0.0	2.0	14.7	0.0	0.0	0.4	1.2	29.4	0.0	19.7	1.0	0.1	2.9	2.4	0.0	0.0	0.0	0.0	3.9	76.5	1.5	0.0	0.0	0.4	0.1	0.0	30.3	0.0	0.2	128.1	0.0	1.2	13.0	7.2	0.4	32.0	0.0	0.0	14.2	0.0	0.0	0.0	0.4	2.2	2.6	0.4	1.1	0.0	21.8	0.0	0.7	0.0	0.1	0.3	3.4	1.2	14.1	7.2	0.0	0.9	0.0	2.3	1.5
SPTAN1		ENSG00000197694	"Spectrin alpha, non-erythrocytic 1"	Q13813	9	128552558-128633662	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 296.6;Cone photoreceptor cells: 310.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004581, HPA007927"	Enhanced		Approved	Vesicles,Microtubules		NA	NA		1600000	"Cluster 13: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Microtubules"		"CAB004581: AB_671135, HPA007927: AB_1857435"	"unprognostic (1.46e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.84e-12)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.19e-3)"	48.8	31.4	81.7	38.6	85.0	28.1	36.6	54.4	99.7	39.4	0.4	47.3	24.7	57.1	32.9	36.8	54.0	32.5	65.7	90.9	43.5	34.6	22.8	55.1	38.5	142.7	49.6	51.6	24.0	47.1	32.5	57.1	155.0	32.7	36.3	103.1	31.9	46.5	23.9	69.4	34.9	58.8	65.6	44.3	31.1	44.9	61.5	45.4	38.4	22.3	38.0	40.0	36.4	55.3	108.1	116.9	75.2	83.4	107.6	121.0	61.5	90.2	75.2	99.4	74.1	167.3	74.6	94.3	78.3	137.0	69.8	193.3	80.7	90.4	61.1	53.2	47.9	15.9	324.4	94.4	61.3	70.9	51.0	58.3	71.6	166.3	55.8	83.9	134.4	87.2	9.1	107.6	98.6	74.6	136.3	29.5	96.1	125.9	72.1	91.0	90.2	59.7	80.2	91.1	58.1	91.1	296.1	40.3	42.9	91.8	70.0	19.8	232.5	68.5	102.2	100.0	71.2	65.3	82.6	51.8	83.5	31.5	65.9	3.3	1.6	3.9	9.7	1.3	13.5	6.3	12.4	9.2	2.4	5.8	7.6	7.9	1.5	7.1	1.2	3.0	15.3	5.8	81.7	85.0	54.4	99.7	90.9	43.5	142.7	49.6	155.0	65.6	61.5	55.3	144.9	70.5	27.5	123.7	56.3	37.3	27.8	34.3	25.6	296.6	69.8	83.2	68.5	68.6	33.9	101.2	310.6	27.5	112.6	145.4	7.9	67.6	18.0	108.2	71.4	103.8	56.9	13.7	159.5	59.2	16.0	77.8	76.5	87.5	12.0	47.9	96.8	36.2	29.2	124.5	183.8	54.1	30.5	22.2	29.4	40.5	85.1	32.8	35.6	74.9	24.4	97.7	48.4	87.4	17.4	102.2	93.0	94.8	70.5	45.9	62.4	22.8	71.3	156.5	26.3	53.0	60.0	33.0	44.5	43.7	45.5	18.2	95.4	22.0	73.6	65.7
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66682497-66729226	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.6;skin 1: 85.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Cone photoreceptor cells: 104.3;Early spermatids: 30.9;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 45.6;NTERA-2: 49.1;SCLC-21H: 49.9;SK-BR-3: 52.3;T-47d: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Vesicles	"CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531"	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	1.3	14.4	26.8	1.0	32.6	2.3	7.7	29.7	73.6	14.3	0.0	0.9	0.9	1.7	1.2	39.8	3.7	1.7	1.4	38.8	0.3	37.5	23.3	1.1	0.2	4.8	0.9	0.9	16.7	13.1	16.4	0.4	3.2	12.4	0.7	14.7	29.6	4.7	0.5	85.5	1.0	1.1	0.0	0.9	2.9	52.8	4.6	1.0	0.3	0.1	6.7	1.6	16.5	24.2	20.5	7.4	3.4	0.3	0.1	0.0	0.6	0.3	0.1	0.1	0.0	4.8	28.2	0.2	3.7	0.0	0.7	16.9	25.2	2.4	0.0	0.1	10.4	0.1	45.6	3.0	0.8	7.3	0.6	0.2	11.5	0.0	7.4	4.2	6.3	5.2	7.3	0.1	0.1	35.2	6.3	3.5	49.1	28.7	21.1	23.8	2.8	14.7	9.6	4.8	49.9	29.4	14.0	52.3	3.2	2.7	67.2	2.4	1.4	0.1	8.6	1.3	11.5	0.7	3.0	14.7	0.1	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	26.8	32.6	29.7	73.6	38.8	0.3	4.8	0.9	3.2	0.0	4.6	24.2	0.7	3.2	1.1	4.9	0.3	3.7	2.7	3.2	2.8	11.0	4.7	4.6	1.8	1.5	4.6	86.5	104.3	0.9	0.0	0.6	0.0	2.6	30.9	3.6	1.8	1.1	3.0	7.2	29.3	10.0	0.3	0.8	1.5	3.6	0.0	1.4	1.4	24.7	0.1	0.0	20.7	1.6	0.0	0.3	0.7	77.6	1.8	0.1	0.0	2.8	0.6	1.6	0.0	7.5	4.6	7.5	0.2	1.5	0.8	3.2	0.2	1.3	3.5	21.3	0.0	0.2	0.5	8.5	9.4	14.6	12.5	0.3	0.2	0.1	0.8	1.7
SQLE		ENSG00000104549	"Squalene epoxidase"	Q14534	8	124998497-125022283	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018038, HPA020762"	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Cytosol"		"HPA018038: AB_2669753, HPA020762: AB_2670512"	"unprognostic (1.37e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.12e-2)"	"unprognostic (9.51e-3)"	"unprognostic (4.63e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (3.45e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (9.71e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.74e-3)"	8.6	31.1	17.5	19.6	27.0	23.0	22.1	26.8	24.0	30.7	25.4	21.6	31.0	16.4	9.1	78.7	18.6	10.7	7.2	18.6	24.4	17.1	72.3	30.9	17.7	47.3	27.7	14.3	10.7	22.7	16.5	47.5	35.1	25.0	18.6	17.8	19.1	7.6	1.4	49.4	14.0	12.3	27.6	9.7	21.8	59.4	21.8	14.2	10.5	1.6	29.4	14.7	46.2	34.6	135.5	51.5	301.6	87.2	91.7	154.1	30.5	34.9	106.3	46.5	84.7	70.6	192.3	92.7	49.2	43.2	186.0	101.0	127.3	192.4	53.6	77.1	268.3	265.2	32.6	181.1	134.6	31.5	74.6	106.1	201.4	138.8	113.3	29.8	51.5	64.2	153.8	174.8	38.1	223.7	109.6	39.3	125.2	92.6	35.2	47.5	55.4	126.6	329.3	153.3	93.9	47.6	71.6	226.3	74.1	96.5	60.7	81.3	50.8	19.2	66.0	22.9	31.6	31.6	69.6	126.6	32.0	93.7	33.8	1.5	6.3	0.7	10.6	10.8	5.0	16.6	6.0	9.5	15.2	17.1	8.2	8.6	0.2	12.6	12.7	10.8	7.1	7.7	17.5	27.0	26.8	24.0	18.6	24.4	47.3	27.7	35.1	27.6	21.8	34.6	13.2	60.9	97.9	21.5	34.7	22.9	64.0	199.9	16.5	41.8	35.6	27.3	6.1	31.5	129.6	53.3	50.1	99.7	20.6	81.6	7.9	60.3	21.0	95.9	23.3	39.7	31.7	22.3	14.3	83.6	133.7	35.3	51.0	80.5	41.3	77.1	9.7	127.9	61.1	148.0	18.8	58.0	126.1	10.9	30.1	13.2	23.9	22.2	21.4	13.1	91.0	24.3	8.2	20.1	77.9	98.6	38.4	10.9	30.6	118.0	17.3	3.7	123.0	61.1	26.3	12.5	42.0	179.5	128.6	69.5	89.1	217.1	21.1	171.8	35.0	114.8
SSTR1		ENSG00000139874	"Somatostatin receptor 1"	P30872	14	38207904-38213067	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0;intestine: 13.8;stomach 1: 21.7"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 18.1;Gastric mucus-secreting cells: 16.8;Hepatic stellate cells: 27.1;Oligodendrocyte precursor cells: 24.1;Paneth cells: 10.7;Proximal enterocytes: 11.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 118.9;BJ hTERT+: 32.5;BJ hTERT+ SV40 Large T+: 21.4;fHDF/TERT166: 70.7;HeLa: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003207, HPA031506"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA003207: , HPA031506: AB_2673913"	"unprognostic (1.40e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.34e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.19e-2)"	"prognostic favorable (4.28e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.28e-2)"	1.0	0.3	3.9	0.3	8.8	0.0	0.9	0.5	8.7	0.8	0.0	3.5	13.8	1.0	0.4	0.3	0.9	0.4	1.0	10.0	10.0	2.0	6.8	5.2	0.0	4.7	7.0	0.8	3.6	0.0	0.9	2.6	5.6	1.0	2.3	0.3	0.3	0.4	0.7	0.3	8.2	0.5	1.4	0.6	21.7	0.1	6.1	0.0	0.3	0.9	0.0	1.8	0.7	1.7	0.0	0.0	0.0	0.0	0.3	0.2	0.0	118.9	32.5	21.4	1.8	1.2	0.0	0.0	0.0	70.7	0.0	0.2	0.0	0.0	15.4	0.0	0.0	0.0	26.7	0.1	6.3	0.0	0.0	0.2	0.0	0.0	0.3	0.4	1.5	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.1	9.6	0.2	0.0	0.0	0.1	4.7	0.0	3.4	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	8.8	0.5	8.7	10.0	10.0	4.7	7.0	5.6	1.4	6.1	1.7	1.7	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.5	0.2	0.0	0.8	2.8	0.0	1.8	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	2.4	18.1	0.0	3.9	0.8	0.0	1.0	16.8	0.0	0.0	0.0	27.1	7.2	0.0	0.0	5.5	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	24.1	0.3	0.2	10.7	0.0	0.1	0.1	11.8	1.9	0.0	0.1	0.0	1.0	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.2	6.2	0.0
ST3GAL2	"SIAT4B, ST3GalA.2, ST3GALII"	ENSG00000157350	"ST3 beta-galactoside alpha-2,3-sialyltransferase 2"	Q16842	16	70375977-70439237	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017270	Approved		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA017270: AB_1857523"	"unprognostic (2.76e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (7.42e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.64e-2)"	"unprognostic (5.20e-2)"	8.6	8.3	4.7	6.4	5.8	7.4	7.2	8.4	6.5	9.3	1.6	9.2	3.5	12.5	1.1	2.6	8.2	2.5	10.5	7.1	2.9	8.2	10.3	9.0	6.3	3.1	2.6	7.2	3.6	2.6	6.4	3.2	2.6	7.1	1.6	1.7	3.2	2.8	15.8	4.2	7.1	4.1	1.9	13.2	4.7	6.7	3.3	3.6	6.0	3.1	3.4	8.4	5.6	2.9	1.7	8.6	7.7	11.2	3.9	5.4	2.3	6.1	6.0	6.2	3.0	5.5	4.0	4.6	9.8	6.3	5.8	1.9	3.2	2.5	3.3	9.9	5.0	18.0	4.5	8.7	4.7	6.7	29.4	4.1	1.5	6.7	1.3	8.2	8.6	7.6	25.1	4.2	3.7	1.5	7.5	19.8	10.1	2.9	4.5	13.9	2.9	5.9	5.1	1.5	3.7	9.4	15.8	0.6	7.1	8.1	2.4	7.3	9.9	9.0	10.0	4.0	4.7	8.6	3.9	9.7	10.0	5.9	12.5	4.2	1.9	5.2	2.0	1.8	1.7	2.0	2.3	2.0	1.0	2.9	3.8	3.0	10.1	2.8	1.3	14.3	2.6	1.1	4.7	5.8	8.4	6.5	7.1	2.9	3.1	2.6	2.6	1.9	3.3	2.9	15.4	9.6	5.2	13.4	12.6	3.3	4.2	2.1	2.2	15.7	2.8	3.0	6.8	10.0	1.9	9.2	14.6	4.7	56.1	4.5	0.0	5.7	16.9	1.7	6.5	15.0	13.2	24.8	21.3	4.4	2.5	11.0	2.6	2.2	17.7	19.7	18.2	13.1	13.7	18.5	15.2	4.5	2.0	15.4	35.1	33.2	11.8	11.9	1.8	17.8	24.9	5.6	23.7	16.6	7.4	1.8	1.5	8.2	13.5	3.0	6.8	5.7	1.3	11.1	6.6	8.5	8.8	9.3	8.9	1.1	2.4	1.8	11.5	4.7	5.6	2.3
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558727-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 51.0"	"Group enriched"	"Detected in some"	5	"B-cells: 60.8;granulocytes: 80.8;Ionocytes: 65.1;Plasma cells: 147.2"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 88.1;naive B-cell: 107.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 185.4;U-698: 83.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.3"	"Low region specificity"	"Detected in all"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.4	0.1	0.0	15.5	0.0	5.8	0.8	0.0	0.0	0.3	0.0	2.3	1.8	0.6	1.9	0.7	0.1	1.4	0.2	0.5	0.0	9.2	0.4	1.4	40.8	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.9	2.3	0.0	1.3	2.8	0.1	0.1	8.1	0.4	0.0	16.0	2.3	2.7	0.0	6.4	0.4	0.0	51.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	24.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	83.2	0.0	24.7	0.0	5.3	0.1	24.3	0.9	0.1	1.9	88.1	2.0	0.8	1.2	107.8	7.9	0.2	1.0	38.9	0.1	5.2	0.4	4.7	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.7	0.0	60.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	5.5	0.0	0.0	5.8	0.0	9.8	0.0	13.0	0.1	0.0	0.6	0.0	2.5	0.3	0.0	0.0	0.1	0.0	0.0	80.8	0.0	0.4	0.0	0.8	0.0	0.2	0.1	65.1	0.3	0.7	7.1	0.3	1.2	16.0	0.0	0.2	0.0	6.2	0.0	0.3	0.0	0.0	0.4	147.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.1	0.0	4.3	0.1	0.0	0.2
STMN4	RB3	ENSG00000015592	"Stathmin 4"	Q9H169	8	27235323-27258420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 333.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 45.6;Horizontal cells: 92.5;Oligodendrocyte precursor cells: 27.6;Oligodendrocytes: 217.4"	"Cancer enriched"	"Detected in some"	27	"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	26	"SCLC-21H: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027765			Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	Vesicles	"HPA027765: AB_1857607"	"unprognostic (1.52e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.19e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.31e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.37e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.63e-2)"	0.3	10.2	128.0	0.2	147.2	0.1	0.2	154.9	333.3	0.5	66.3	4.3	0.6	0.4	0.9	0.1	0.3	0.2	0.1	148.1	150.9	0.1	0.1	0.1	0.0	185.1	152.3	0.2	0.1	0.0	1.1	0.0	184.4	0.5	1.4	21.4	0.1	0.2	0.2	0.4	1.6	0.6	151.1	0.0	0.9	0.6	150.9	0.0	0.1	0.0	0.0	0.6	0.6	265.7	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	86.8	3.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.0	147.2	154.9	333.3	148.1	150.9	185.1	152.3	184.4	151.1	150.9	265.7	0.1	0.0	0.0	4.6	0.0	0.4	0.1	0.0	0.0	45.6	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	21.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	92.5	18.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.6	0.0	9.7	0.0	27.6	217.4	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.8	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5
STPG3	"C9orf173, FLJ40246"	ENSG00000197768	"Sperm-tail PG-rich repeat containing 3"	Q8N7X2	9	137251261-137253483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 42.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.3;RPMI-8226: 1.4;SK-BR-3: 1.2;T-47d: 2.0;U-266/70: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044352			Uncertain	Vesicles		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA044352: AB_10965328"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.72e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.59e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.95e-2)"	0.9	0.5	0.0	0.4	0.0	0.3	0.2	0.2	0.1	0.3	0.0	0.1	3.9	0.2	0.2	0.1	0.4	0.2	0.2	0.0	0.1	1.1	1.5	0.1	0.4	0.1	0.1	0.0	1.3	0.0	0.7	0.2	0.1	0.3	0.0	1.5	1.3	0.0	0.0	0.6	3.0	0.0	0.1	0.4	0.5	42.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.9	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.4	0.0	0.8	0.0	0.1	0.0	0.2	0.2	0.0	0.0	1.4	0.0	0.0	0.4	0.2	0.1	1.2	0.0	0.2	2.0	0.0	0.0	0.3	0.6	0.1	0.0	1.2	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0
SUMF2	DKFZp566I1024	ENSG00000129103	"Sulfatase modifying factor 2"	Q8NBJ7	7	56064002-56080670	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024040, CAB025743, HPA074892"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	Yes	No		750000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"		"CAB025743: , HPA024040: AB_1857651, HPA074892: "	"unprognostic (2.93e-1)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (3.87e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.71e-4)"	64.1	64.6	26.1	43.0	29.7	51.5	57.5	29.3	27.1	91.3	45.0	67.4	89.2	57.5	64.8	46.8	102.6	70.6	30.8	25.1	27.8	93.4	94.8	71.6	50.2	35.2	29.6	59.7	91.8	115.8	31.8	45.5	33.4	79.3	69.1	11.0	69.5	77.1	22.4	47.5	74.4	57.7	29.9	57.0	92.7	23.7	30.8	57.6	91.2	21.4	51.3	57.2	43.6	35.9	352.3	102.9	46.0	211.8	214.4	147.5	68.9	114.5	156.1	92.6	114.5	57.2	278.0	57.1	96.5	162.4	90.4	172.3	27.4	131.3	61.1	90.6	42.9	36.4	63.5	54.2	138.4	89.7	108.7	116.8	124.5	83.7	143.3	186.9	137.7	101.4	116.4	236.6	151.3	76.8	77.2	115.7	63.5	272.0	52.2	61.5	45.4	359.0	127.7	39.1	54.0	65.6	142.4	294.2	140.9	98.9	294.5	144.5	115.2	85.6	121.1	211.1	98.6	160.8	130.8	84.0	139.7	165.7	283.2	58.1	60.3	22.0	71.1	80.5	90.9	59.8	70.9	71.8	72.3	49.1	75.3	75.2	4.4	49.0	90.3	132.6	82.7	90.2	26.1	29.7	29.3	27.1	25.1	27.8	35.2	29.6	33.4	29.9	30.8	35.9	44.0	57.7	30.5	20.5	47.3	33.8	44.1	46.1	39.9	25.7	57.9	25.4	10.4	87.2	31.0	90.1	14.6	44.5	85.3	45.1	19.6	95.3	3.8	93.1	70.2	43.7	59.3	41.7	21.2	55.7	96.7	54.7	55.5	78.9	54.5	47.0	51.0	91.3	68.1	43.7	24.4	61.8	22.4	79.8	38.7	8.0	69.6	50.4	53.4	14.0	73.0	23.8	70.0	10.6	24.2	48.4	64.6	47.4	65.0	50.7	91.8	45.6	34.5	13.5	52.6	41.6	44.1	31.6	28.6	52.8	41.9	46.7	52.7	58.7	85.8	42.7
SUSD5	KIAA0527	ENSG00000173705	"Sushi domain containing 5"	O60279	3	33150043-33218810	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 15.4;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 61.3;Sertoli cells: 32.9;Smooth muscle cells: 29.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 31.1;HUVEC TERT2: 78.5;LHCN-M2: 30.4;TIME: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052788	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA		17000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus, Vesicles"		"HPA052788: AB_2681948"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.45e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.89e-2)"	4.6	1.4	2.9	0.9	3.0	0.1	1.9	2.2	4.6	6.3	4.4	1.7	0.8	4.6	2.2	1.3	5.2	5.5	1.5	3.1	4.4	1.5	0.5	1.7	2.3	3.4	3.4	3.8	0.6	1.0	0.8	0.2	3.4	1.3	1.2	0.6	0.7	6.3	1.6	1.9	1.9	4.8	3.8	2.5	1.8	2.1	4.7	0.1	3.2	3.3	5.3	1.5	2.4	3.5	0.0	1.1	1.2	0.7	1.7	0.2	0.1	9.6	3.4	31.1	10.5	0.1	0.0	0.0	8.8	2.5	9.5	0.1	13.7	4.5	12.9	0.3	15.3	0.0	2.0	0.0	0.2	0.1	0.1	1.3	2.4	19.9	3.9	15.2	78.5	0.0	0.0	0.1	30.4	0.0	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.0	1.0	0.1	0.1	2.5	0.7	1.8	1.9	31.3	0.0	14.4	1.2	4.7	0.0	0.7	0.0	0.3	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.9	3.0	2.2	4.6	3.1	4.4	3.4	3.4	3.4	3.8	4.7	3.5	0.1	0.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	2.2	0.5	0.0	0.0	15.4	0.0	0.1	1.4	0.0	0.9	0.0	0.2	0.4	0.0	0.0	3.3	10.5	0.0	0.0	2.1	2.0	0.3	0.0	0.1	1.8	0.0	0.0	0.5	0.0	61.3	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	32.9	3.6	29.0	0.1	2.6	0.1	1.0	0.0	0.2	0.1	0.0	0.1
TACC3	"ERIC-1, ERIC1, maskin, Tacc4"	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1712891-1745171	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.9;lymphoid tissue: 52.4;testis: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.4;Hofbauer cells: 43.9;Late spermatids: 69.9;Spermatocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	5.3	3.9	4.2	24.9	4.3	58.9	3.5	5.2	5.3	3.6	5.2	10.3	6.6	3.3	4.8	14.9	2.8	4.2	3.3	4.5	4.4	2.7	3.5	6.5	43.2	4.8	5.3	2.2	1.4	2.3	2.6	8.7	4.8	2.4	10.6	1.9	3.9	2.5	2.0	6.4	12.9	6.4	4.2	22.1	6.4	50.6	5.1	52.4	2.8	3.4	39.3	5.0	5.4	4.7	106.7	88.7	129.5	72.2	6.7	15.2	72.9	114.6	62.1	135.4	87.6	93.5	122.8	133.8	48.0	65.4	149.9	71.4	142.5	86.8	131.1	59.8	77.0	113.8	67.2	85.8	5.9	146.6	85.5	5.2	5.7	85.6	46.0	26.0	102.2	110.3	106.3	90.8	123.8	87.1	207.5	204.0	139.3	89.2	111.6	139.1	90.5	55.0	73.8	125.5	99.8	62.8	70.1	42.3	33.1	95.2	83.3	90.5	56.4	75.4	90.0	65.4	176.7	69.5	102.5	207.1	43.2	141.1	109.1	45.5	30.0	37.9	8.5	12.5	11.1	7.8	16.5	11.5	15.3	10.8	28.3	13.1	91.8	12.2	9.6	8.3	42.5	32.5	4.2	4.3	5.2	5.3	4.5	4.4	4.8	5.3	4.8	4.2	5.1	4.7	6.0	0.0	6.7	2.0	16.5	2.2	1.2	3.2	1.2	1.7	2.4	3.0	2.6	2.8	3.4	9.2	8.4	19.5	6.4	11.2	0.0	2.2	70.4	4.2	2.8	5.2	1.2	37.2	2.3	0.7	20.4	6.0	12.8	4.3	5.1	24.5	8.9	5.1	43.9	5.0	3.2	9.5	4.1	23.2	10.8	69.9	2.8	34.1	0.0	4.7	24.4	1.4	6.2	0.5	0.8	2.9	4.2	2.6	18.0	1.3	2.6	2.8	0.9	2.7	6.6	2.0	4.8	94.3	37.7	12.8	1.4	4.0	23.2	2.2	16.1	2.7
TAOK1	"FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1"	ENSG00000160551	"TAO kinase 1"	Q7L7X3	17	29390363-29551903	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 220.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007669	Approved		Uncertain	Vesicles		NA	NA		1600000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA007669: AB_1080201"	"unprognostic (1.46e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.62e-1)"	13.7	9.1	12.0	9.8	16.0	10.5	10.3	13.8	13.1	11.8	1.2	9.5	5.2	10.8	8.5	10.3	7.9	9.6	13.2	13.3	12.8	10.2	8.6	9.8	9.9	16.4	14.5	10.3	7.8	19.4	8.0	11.7	14.9	9.0	8.5	20.9	7.8	10.0	11.4	10.4	7.3	11.7	13.2	10.4	8.1	11.7	13.9	13.2	14.5	15.2	9.5	12.1	8.7	20.4	19.3	35.0	32.1	13.4	24.1	29.8	11.3	20.0	23.9	20.3	21.1	20.7	7.9	13.8	15.8	35.9	20.7	16.3	30.4	15.7	36.4	20.7	18.2	21.0	21.3	12.2	16.6	26.5	16.7	19.4	19.6	29.0	30.6	21.3	27.3	14.0	20.7	12.0	26.7	14.2	18.5	9.5	12.0	12.9	8.6	15.1	41.2	8.8	19.1	31.5	16.1	18.7	34.6	34.4	21.1	32.6	23.6	21.6	33.6	28.0	19.7	23.7	27.5	9.3	18.6	14.0	20.3	14.8	24.3	0.6	0.5	0.5	0.6	0.6	0.5	0.5	0.6	0.7	0.5	0.6	0.7	0.7	1.7	0.5	0.6	1.4	0.4	0.3	12.0	16.0	13.8	13.1	13.3	12.8	16.4	14.5	14.9	13.2	13.9	20.4	96.9	48.1	45.8	105.8	35.9	44.5	27.4	27.0	52.9	56.6	35.5	23.2	90.2	30.0	37.7	46.0	98.0	18.7	40.5	29.3	15.6	27.3	11.8	45.0	72.0	55.4	37.7	18.7	162.3	24.3	16.0	58.0	31.6	80.1	28.5	44.3	52.1	29.5	30.1	52.2	160.5	23.7	24.4	65.6	60.4	19.8	39.7	67.3	40.9	92.8	55.8	37.1	29.9	142.2	220.8	38.9	24.0	54.2	34.2	40.4	17.6	22.1	31.0	54.7	26.3	66.1	52.1	59.1	33.2	49.5	45.9	37.6	43.1	43.0	21.1	41.6
TBC1D3	"DKFZp434P2235, PRC17, TBC1D3A"	ENSG00000274611	"TBC1 domain family member 3"	Q8IZP1	17	38181659-38192541	"Predicted membrane proteins"		"GTPase activation"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 5.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.6;REH: 5.0;U-138 MG: 6.6;U-266/70: 10.3;U-266/84: 4.3;U-698: 5.4"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"		Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		0.9	1.9	0.8	0.0	0.9	0.2	0.7	0.8	5.2	1.7	0.8	1.1	0.0	2.3	0.0	2.3	0.7	1.0	0.8	0.9	0.6	1.6	2.0	1.1	1.3	0.9	0.8	1.5	1.2	1.0	2.1	0.0	0.9	2.0	1.4	2.9	1.4	0.1	0.9	2.3	4.1	0.0	0.6	1.5	1.1	3.7	0.8	0.0	1.3	0.0	2.1	1.7	1.8	0.7	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.6	0.0	0.0	0.0	10.3	4.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.8	5.2	0.9	0.6	0.9	0.8	0.9	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3B	"PRC17, TBC1D3I"	ENSG00000274808	"TBC1 domain family member 3B"	A6NDS4	17	36165681-36176636	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 13.8"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 20.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.6;HeLa: 8.7;T-47d: 5.9"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.15e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.34e-1)"	2.4	4.0	3.6	1.3	2.9	0.9	2.5	4.2	4.0	3.7	1.9	3.6	1.4	2.2	0.2	5.8	3.2	0.6	2.1	4.8	3.0	3.6	4.2	3.1	1.0	4.6	2.2	4.0	3.6	0.4	5.0	0.5	5.8	5.0	0.5	2.4	4.3	1.0	3.7	6.0	4.3	0.5	1.0	4.9	3.1	13.8	3.9	0.8	3.2	0.3	0.6	4.2	5.0	1.3	1.1	1.8	1.1	1.3	1.1	1.3	3.6	0.9	0.5	1.0	1.5	0.4	8.6	0.2	0.7	0.5	0.4	3.8	0.5	0.8	0.3	1.5	2.8	0.6	8.7	0.5	0.6	0.2	1.0	1.1	1.7	1.1	0.2	2.4	0.7	0.9	0.5	0.8	0.3	0.1	0.8	3.4	0.4	0.3	0.4	1.1	0.3	0.1	1.1	1.1	0.7	0.9	0.8	0.5	0.6	1.4	5.9	0.8	2.0	0.4	0.3	2.9	0.4	1.2	1.0	0.4	1.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	2.9	4.2	4.0	4.8	3.0	4.6	2.2	5.8	1.0	3.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TBC1D3C	MGC44903	ENSG00000278299	"TBC1 domain family member 3C"	Q6IPX1	17	38057693-38068592	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.0"	"Cell type enriched"	"Detected in single"	9	"Early spermatids: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"CAPAN-2: 34.4"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		1.1	1.5	1.5	0.4	1.7	1.8	1.2	1.9	2.7	1.1	1.7	1.3	0.5	2.1	0.0	2.2	2.3	0.7	0.9	1.6	1.6	4.0	2.1	1.3	0.7	2.0	1.4	1.8	1.6	0.0	1.9	0.2	2.0	2.5	0.0	1.5	1.7	0.1	1.3	2.2	2.1	0.2	0.8	2.3	1.3	7.0	1.5	1.5	1.2	0.0	0.6	1.6	2.1	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	7.7	0.1	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.3	0.0	1.2	0.0	0.0	3.3	6.9	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.9	2.7	1.6	1.6	2.0	1.4	2.0	0.8	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3D		ENSG00000274419	"TBC1 domain family member 3D"	A0A087WVF3	17	38003976-38014902	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.8;Cholangiocytes: 2.8;Cone photoreceptor cells: 6.2;Pancreatic endocrine cells: 4.1;Rod photoreceptor cells: 1.9;Syncytiotrophoblasts: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.7;HaCaT: 7.0;HeLa: 9.6;RPMI-8226: 4.2;RT4: 4.9"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		1.7	3.2	0.6	0.0	0.6	0.0	1.7	1.1	3.7	2.5	0.6	2.4	1.4	1.6	0.1	4.1	2.0	0.2	1.5	0.7	0.4	2.5	3.4	2.2	0.3	0.8	0.4	3.0	2.7	0.4	3.2	0.7	0.7	4.1	0.7	2.3	3.2	0.0	2.0	3.9	4.7	0.1	0.5	4.2	2.4	7.3	0.5	0.0	2.1	0.0	0.5	3.5	3.4	0.7	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.9	7.0	0.0	0.0	0.0	0.0	0.0	1.8	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	4.2	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.4	0.9	0.0	2.9	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	1.1	3.7	0.7	0.4	0.8	0.4	0.7	0.5	0.5	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.8	2.8	1.3	0.0	6.2	0.8	0.1	0.0	0.0	1.0	0.6	0.5	0.1	0.4	0.0	0.0	0.0	1.7	0.3	0.4	0.0	0.8	0.0	0.0	0.7	0.6	0.7	0.0	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0
TBC1D3E		ENSG00000278599	"TBC1 domain family member 3E"	A0A087X179	17	38127951-38138862	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HHSteC: 4.1;HL-60: 1.0"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"		Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"	"unprognostic (1.18e-1)"	"unprognostic (3.35e-1)"			"unprognostic (3.51e-1)"					"unprognostic (4.22e-2)"	"unprognostic (6.28e-2)"		"unprognostic (1.87e-2)"	"unprognostic (5.07e-3)"			"unprognostic (1.32e-3)"	0.4	0.8	0.0	0.0	0.0	1.6	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.0	1.1	0.3	1.2	0.4	0.0	0.0	2.8	0.9	0.6	0.7	0.2	0.0	0.6	1.7	0.0	0.7	0.0	0.3	1.3	0.0	0.3	0.5	0.0	0.4	1.0	0.8	0.0	0.0	1.1	0.5	3.3	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	4.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3F		ENSG00000275954	"TBC1 domain family member 3F"		17	36428618-36439566	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	13	"testis: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046969			Uncertain	Vesicles		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA046969: "																		0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.3	0.2	0.0	0.0	0.3	0.1	6.8	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3I		ENSG00000274933	"TBC1 domain family member 3I"	A0A087WXS9	17	36253456-36264553	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 7.0"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 38.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"CAPAN-2: 5.3"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		0.1	0.1	0.8	0.0	1.0	0.0	0.1	1.1	1.5	0.3	0.7	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.2	1.0	1.0	0.2	0.3	0.1	0.1	1.0	0.8	0.2	0.2	0.0	0.3	0.0	1.0	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.6	0.3	0.1	7.0	0.9	0.0	0.1	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.1	1.5	1.0	1.0	1.0	0.8	1.0	0.6	0.9	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3K		ENSG00000273513	"TBC1 domain family member 3K"	A0A087X1G2	17	37924415-37935365	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"T-47d: 1.4"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"		Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.3	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.3	0.2	0.0	0.0	0.2	0.1	2.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D3L		ENSG00000274512	"TBC1 domain family member 3L"	B9A6J9	17	37977972-37989048	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.0;Gastric mucus-secreting cells: 5.1;Glandular and luminal cells: 2.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.1;hTERT-RPE1: 42.8;NB-4: 38.0"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"	"unprognostic (5.14e-2)"	"unprognostic (8.71e-2)"	"unprognostic (8.44e-2)"		"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.63e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-3)"	12.9	26.7	9.5	9.7	8.8	5.7	12.3	12.6	25.1	23.0	10.8	18.2	10.9	9.8	11.4	33.8	19.1	6.1	12.6	9.3	7.6	22.9	29.8	17.8	10.1	8.8	7.5	17.4	17.6	3.5	29.0	4.7	9.2	31.0	6.6	46.9	19.8	7.2	17.5	36.3	20.3	4.4	6.4	30.3	17.0	26.1	8.5	9.8	16.4	7.6	4.8	20.6	28.0	11.8	12.8	16.7	6.6	10.0	12.3	11.1	39.1	5.7	3.8	5.1	5.9	9.3	0.2	4.3	0.2	7.3	4.5	20.5	6.1	5.4	3.4	12.6	15.5	0.0	31.9	4.0	8.6	1.7	15.4	9.4	13.0	6.6	3.7	42.8	7.0	8.0	3.4	14.6	8.4	6.8	7.6	38.0	6.3	9.6	3.7	5.0	7.7	0.0	16.1	17.2	9.0	12.5	0.0	6.6	7.7	15.3	9.6	2.7	15.7	0.0	8.6	6.7	8.0	10.2	4.8	0.0	10.2	5.3	5.8	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	1.0	0.2	0.2	0.0	0.1	0.1	9.5	8.8	12.6	25.1	9.3	7.6	8.8	7.5	9.2	6.4	8.5	11.8	0.2	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.2	0.0	0.6	0.9	0.1	0.0	0.0	1.8	0.0	0.1	0.3	0.2	0.0	0.4	5.0	1.1	0.9	0.2	0.0	0.0	1.1	0.0	0.1	0.3	5.1	2.2	0.0	0.9	0.0	0.3	0.1	0.0	1.0	0.3	0.0	0.3	0.0	0.6	0.3	0.4	0.0	1.9	0.0	0.0	0.0	0.5	0.1	0.5	1.3	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.7	0.0	0.3	0.6	0.4	0.5	0.0
TCTE1	"D6S46, DRC5, FAP155, MGC33600"	ENSG00000146221	"T-complex-associated-testis-expressed 1"	Q5JU00	6	44278734-44297698	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 14.4;testis: 30.0"	"Group enriched"	"Detected in some"	10	"Early spermatids: 161.8;Late spermatids: 359.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;U-266/84: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031739			Uncertain	Vesicles		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA031739: AB_10601269"	"unprognostic (3.27e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.23e-5)"	"unprognostic (7.68e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.68e-1)"	0.2	0.2	1.4	0.0	1.3	0.9	0.2	6.2	1.3	0.9	1.3	0.2	0.0	0.4	0.2	0.1	14.4	0.1	0.1	1.4	1.0	0.1	0.1	1.4	0.0	3.0	3.3	0.5	0.1	0.0	0.5	1.9	1.5	0.2	0.1	1.0	0.2	0.1	0.1	0.5	0.2	0.1	2.6	0.2	0.1	30.0	1.2	0.1	0.1	0.2	0.0	0.1	0.2	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.7	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	6.2	1.3	1.4	1.0	3.0	3.3	1.5	2.6	1.2	1.0	0.1	0.0	0.0	1.0	0.0	0.1	0.1	0.7	0.0	1.1	0.1	0.1	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	161.8	7.3	0.3	0.1	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	359.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	16.0	0.2	0.0	0.4	0.3	23.9	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TDGF1	"CR, CR-1, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582457	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.4;lymphoid tissue: 20.9"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 121.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 27.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;NTERA-2: 110.6;SuSa: 66.3"	"Group enriched"	"Detected in many"	5	"cerebellum: 11.2;pons and medulla: 8.7"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	Cytosol	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.4	3.4	2.4	0.5	1.9	0.3	0.3	2.1	4.8	0.7	1.4	2.6	0.7	1.0	2.0	0.1	0.1	0.6	0.6	1.8	1.7	23.4	1.3	0.4	0.4	2.1	1.8	7.7	0.4	0.1	0.1	0.2	2.2	0.4	4.6	0.4	1.0	0.3	1.5	0.3	0.5	1.2	1.7	20.9	2.7	0.5	3.1	15.1	0.8	1.5	0.1	0.2	0.1	1.9	0.1	0.2	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	1.8	0.0	0.2	0.0	0.0	25.7	0.2	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.2	110.6	4.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	66.3	0.1	0.1	1.8	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.9	0.3	0.1	0.1	0.0	0.0	2.4	1.9	2.1	4.8	1.8	1.7	2.1	1.8	2.2	1.7	3.1	1.9	0.9	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.5	0.0	0.0	0.0	0.9	121.3	0.2	5.0	0.3	0.1	8.2	2.4	0.0	0.0	0.0	0.0	0.3	8.2	0.2	0.0	14.3	0.4	1.4	0.1	0.0	0.0	5.5	0.0	0.0	0.0	1.0	0.3	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.1	17.7	6.1	0.0
TFAP2D	TFAP2BL1	ENSG00000008197	"Transcription factor AP-2 delta"	Q7Z6R9	6	50713526-50773033	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"brain: 6.3"	"Cell type enhanced"	"Detected in single"		"Horizontal cells: 1.7"	"Cancer enriched"	"Detected in single"	10	"lung cancer: 0.5"	"Region enriched"	"Detected in some"	5	"midbrain: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Region enriched"	"Detected in many"	4	"midbrain: 11.8"	"Region enriched"	"Detected in some"	6	"midbrain: 9.4"	HPA048962			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA048962: AB_2680573"																		0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.3	0.2	0.0	0.0	6.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
THAP7	MGC10963	ENSG00000184436	"THAP domain containing 7"	Q9BT49	22	20999104-21002196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 162.9;Spermatogonia: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 106.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003083	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane, Vesicles"	"HPA003083: AB_1080264"	"unprognostic (6.48e-2)"	"unprognostic (2.13e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-3)"	16.1	26.9	13.7	5.6	12.9	4.8	18.1	13.7	19.6	23.0	16.0	23.1	7.9	20.4	4.8	15.4	20.9	5.8	19.4	12.6	13.2	20.8	37.8	13.4	8.8	14.1	14.9	21.9	26.9	9.8	39.5	4.2	14.4	29.1	2.5	2.7	19.0	9.2	39.7	19.1	19.0	3.5	13.3	24.2	23.2	35.5	13.9	7.6	20.9	14.4	3.7	21.5	16.6	13.2	23.5	25.0	6.9	11.8	6.0	7.5	14.2	12.1	11.6	15.9	14.7	11.5	13.5	17.2	11.9	7.6	8.4	16.4	6.1	12.1	2.4	17.1	36.4	21.6	18.7	14.9	18.5	22.2	13.4	7.2	15.0	14.0	12.9	7.0	8.4	13.1	106.2	19.8	8.8	29.3	24.4	13.7	9.6	16.0	24.7	19.0	13.6	10.4	8.4	11.8	13.5	11.7	15.1	19.5	21.5	3.2	22.4	14.6	5.5	25.4	19.5	15.4	12.8	27.6	17.4	14.1	27.6	14.3	22.4	1.9	22.1	8.8	27.2	23.9	36.1	50.0	32.8	27.4	21.3	36.9	45.2	36.3	1.9	24.0	25.3	31.6	30.7	24.9	13.7	12.9	13.7	19.6	12.6	13.2	14.1	14.9	14.4	13.3	13.9	13.2	18.7	16.0	25.7	6.2	33.3	19.1	20.3	24.5	14.8	31.5	25.0	30.4	14.8	37.1	18.3	25.8	14.6	31.2	23.8	22.4	64.6	28.2	30.0	16.6	15.7	20.3	22.2	16.2	5.8	38.2	30.1	25.8	20.4	10.6	21.5	21.0	18.5	35.3	27.8	13.5	5.8	22.8	30.5	15.8	11.5	44.0	41.7	14.2	40.9	1.0	27.5	52.0	45.3	3.5	7.2	23.9	19.7	32.4	28.6	31.4	38.4	57.4	22.6	27.1	39.5	22.8	43.5	162.9	119.4	16.7	16.3	29.6	28.8	31.1	21.7	13.2
TMEM131	"CC28, KIAA0257, PRO1048, RW1, YR-23"	ENSG00000075568	"Transmembrane protein 131"	Q92545	2	97756333-97995948	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017678, HPA017682"	Approved		Uncertain	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	"Vesicles, Intermediate filaments"		"HPA017678: AB_1858086, HPA017682: AB_1858087"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.58e-2)"	"unprognostic (4.18e-2)"	"unprognostic (7.59e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.10e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.77e-1)"	12.1	12.2	7.2	20.7	7.5	17.5	10.6	7.2	7.6	18.8	9.3	25.8	18.5	16.3	8.5	14.3	15.3	15.8	13.0	7.4	5.5	12.1	13.5	12.4	25.4	6.1	7.5	16.3	19.0	27.5	11.1	18.3	6.1	16.6	23.2	11.4	13.4	11.5	24.4	24.1	19.4	16.5	6.6	18.4	26.2	14.7	10.3	18.4	12.8	22.3	23.1	14.1	10.4	8.6	26.1	15.7	28.8	21.0	29.6	35.8	31.4	37.8	36.5	18.9	22.7	20.3	36.8	41.3	20.4	39.3	32.2	18.4	30.5	50.5	28.0	29.4	19.8	30.0	10.6	29.3	33.4	28.2	38.6	34.4	20.2	33.7	34.7	32.0	23.5	19.8	18.1	42.8	58.2	15.7	20.6	17.9	15.8	20.2	33.4	29.7	18.3	18.3	19.3	30.7	32.3	15.7	24.4	16.7	23.2	30.7	14.0	25.8	28.1	49.1	22.4	23.9	14.7	18.1	26.8	20.6	38.5	24.3	33.9	3.7	1.3	3.6	1.7	1.6	1.9	2.1	1.5	1.7	1.7	1.9	1.7	2.3	0.9	2.5	1.6	2.4	1.0	1.0	7.2	7.5	7.2	7.6	7.4	5.5	6.1	7.5	6.1	6.6	10.3	8.6	29.4	16.0	27.9	90.1	41.2	19.8	17.7	16.3	24.5	28.3	17.3	16.0	34.7	15.7	23.4	20.2	22.9	15.4	33.1	62.2	3.9	9.7	14.4	88.9	33.9	19.3	30.1	23.5	113.1	24.0	12.7	23.5	60.1	86.8	23.5	21.3	22.9	26.0	24.5	25.2	99.7	45.6	10.2	29.2	18.5	20.1	20.8	35.8	12.4	87.1	47.0	14.1	9.2	92.5	129.8	18.1	40.1	19.2	36.3	17.9	27.4	7.0	38.2	19.3	13.1	31.9	24.9	21.2	26.0	25.0	25.6	13.5	22.4	28.0	36.6	16.0
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6;choroid plexus: 10.5;pituitary gland: 9.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.8;Spermatocytes: 2.6;Spermatogonia: 3.2"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.1;EFO-21: 2.7;JURKAT: 10.7;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	0.7	6.2	14.2	0.5	14.1	0.0	0.4	14.0	18.0	0.7	10.5	1.0	0.4	0.5	0.7	1.5	0.6	0.2	0.7	14.1	19.3	2.3	0.8	1.0	0.8	19.6	15.7	1.5	0.2	0.1	9.9	0.4	19.2	0.5	0.3	0.7	0.5	1.0	3.6	0.7	0.5	0.4	16.0	0.7	0.3	1.5	18.7	0.5	0.9	1.2	0.8	0.6	0.9	14.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	2.7	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.5	10.7	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.7	0.1	1.2	0.0	0.3	0.1	0.1	0.3	2.3	0.3	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.4	0.4	14.2	14.1	14.0	18.0	14.1	19.3	19.6	15.7	19.2	16.0	18.7	14.9	1.9	0.0	0.0	0.3	0.0	0.8	0.2	0.5	0.0	3.8	0.2	0.6	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.9	0.4	0.5	0.2	0.0	0.7	0.0	0.0	1.7	0.4	0.1	0.4	0.0	0.1	0.0	0.1	0.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.4	1.5	0.6	0.3	0.0	1.9	0.1	1.4	0.0	0.0	0.3	1.2	0.0	0.4	0.0	0.3	0.0	0.0	0.6	0.5	0.0	1.1	1.0	2.6	3.2	0.0	0.9	0.1	0.2	0.1	0.0	0.2
TP53BP1	"53BP1, p202, TDRD30"	ENSG00000067369	"Tumor protein p53 binding protein 1"	Q12888	15	43403061-43510728	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004083, HPA008788, HPA022133, CAB079980"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"CAB004083: AB_10694558, CAB079980: , HPA008788: AB_1078070, HPA022133: AB_1844382"	"unprognostic (2.12e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.07e-1)"	"unprognostic (8.06e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.99e-2)"	"unprognostic (3.38e-2)"	6.9	11.5	17.4	10.1	16.6	11.5	10.7	19.9	14.5	17.7	21.5	9.7	6.4	16.0	15.9	6.1	14.7	10.7	8.8	15.4	26.3	9.1	4.1	8.3	8.6	13.5	16.7	16.8	7.4	22.3	24.1	12.2	15.7	12.1	10.2	22.0	10.1	12.8	7.2	9.2	6.4	16.3	9.6	8.7	7.6	21.6	23.0	15.3	17.9	11.0	12.6	11.2	8.7	12.1	13.5	22.3	63.8	40.1	25.8	31.9	15.8	22.8	33.8	31.0	39.1	19.4	15.8	14.5	19.2	39.0	66.9	32.4	46.3	27.5	36.8	38.9	15.8	27.1	40.1	11.7	16.8	30.2	37.4	24.9	19.0	41.8	31.2	51.7	37.4	24.2	26.9	12.3	36.5	9.6	23.7	14.1	41.1	24.2	13.9	25.1	23.9	9.3	22.9	31.8	57.3	26.8	33.8	14.3	8.5	48.6	29.9	16.9	27.5	33.7	22.3	27.0	20.5	9.8	22.4	33.0	27.6	14.6	17.5	1.4	0.5	1.0	1.6	0.7	1.3	1.9	1.6	1.6	1.2	1.8	1.8	1.6	0.6	0.9	0.5	1.3	1.4	0.7	17.4	16.6	19.9	14.5	15.4	26.3	13.5	16.7	15.7	9.6	23.0	12.1	11.5	22.4	22.3	53.2	17.8	6.4	10.2	10.0	13.6	32.4	17.4	13.2	14.9	5.7	20.8	29.5	47.9	13.4	11.1	7.4	9.8	14.5	38.8	47.0	44.8	16.8	41.9	8.4	66.2	7.1	11.2	23.9	14.8	26.8	26.6	47.0	15.0	3.3	10.8	47.1	81.9	15.7	12.2	3.8	6.9	17.8	23.6	9.3	1.8	17.8	4.0	11.9	7.2	62.8	50.4	7.5	5.8	17.7	17.1	11.0	2.6	8.8	60.7	51.7	13.1	35.2	20.5	33.1	36.2	14.7	5.3	18.5	17.0	29.9	13.4	8.9
TSLP		ENSG00000145777	"Thymic stromal lymphopoietin"	Q969D9	5	111070062-111078026	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.5;urinary bladder: 12.0"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 108.1;Basal squamous epithelial cells: 338.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.0;HHSteC: 17.1;hTCEpi: 10.3;hTEC/SVTERT24-B: 18.9;hTERT-HME1: 12.5;hTERT-RPE1: 38.6;U-87 MG: 14.1"	"Not detected"	"Not detected"							HPA056350			Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	38400			"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Vesicles"		"HPA056350: "	"unprognostic (6.47e-4)"	"unprognostic (3.26e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.74e-3)"	1.6	0.7	0.3	1.3	0.3	0.0	1.5	0.3	0.5	1.4	0.2	1.1	0.7	0.8	0.3	3.8	0.6	8.8	4.3	0.3	0.3	1.2	11.5	1.9	0.4	0.4	0.3	0.3	0.3	0.4	0.4	0.1	0.4	6.2	0.9	0.0	1.2	4.0	1.4	0.8	1.0	0.6	0.3	0.4	1.2	4.8	1.1	0.2	2.7	1.4	0.5	12.0	1.9	0.4	0.0	0.0	0.0	1.8	2.3	15.0	0.0	0.0	2.3	0.4	2.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.5	0.8	0.0	2.4	2.8	0.1	0.0	17.1	0.5	0.0	0.3	10.3	18.9	12.5	38.6	0.0	6.6	0.3	0.0	3.2	0.0	2.5	0.0	0.4	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	1.2	0.0	1.1	0.0	0.0	0.9	0.0	0.0	4.1	0.0	0.0	14.1	0.3	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.3	0.4	0.3	0.4	0.3	1.1	0.4	6.2	0.0	3.1	0.3	0.1	55.8	26.6	108.1	338.6	0.0	6.5	8.0	7.4	0.0	35.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	38.5	0.1	0.9	10.5	0.0	0.0	0.0	0.0	0.1	10.0	0.0	0.1	0.0	0.9	7.9	9.4	0.2	0.0	0.0	0.0	24.4	1.2	5.0	26.3	0.6	0.8	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	24.7	0.2	1.6	3.5	0.0	0.0	6.9	3.8	0.4	0.9	38.0	25.1	0.0	0.8	1.9	0.1	3.1
TSPO	"BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS"	ENSG00000100300	"Translocator protein"	"B1AH88, P30536"	22	43151547-43163242	"Cancer-related genes, FDA approved drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 690.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1429.2;Pancreatic endocrine cells: 1442.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 516.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011232, HPA046260, HPA072304"	Uncertain		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria	"Vesicles, Cytosol"	"CAB011232: , HPA046260: , HPA072304: "	"unprognostic (5.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-3)"	249.3	164.5	42.3	65.3	46.3	488.7	204.3	50.9	61.1	217.3	45.8	189.7	73.6	91.8	8.7	690.1	108.5	39.4	174.7	39.9	51.0	120.5	81.9	181.5	44.3	61.9	48.8	72.3	93.4	22.4	50.8	30.5	57.4	126.6	33.9	4.2	244.9	28.9	84.0	388.0	116.9	26.6	58.0	206.9	216.9	21.4	59.5	22.2	77.4	27.5	39.9	135.7	355.5	69.0	300.0	143.3	10.2	134.4	54.7	175.3	10.8	216.6	107.0	109.4	115.7	28.8	222.4	0.3	147.8	175.7	52.2	242.2	27.9	171.7	13.9	49.5	111.4	28.9	150.4	10.1	193.4	66.4	145.0	137.5	276.4	65.9	58.2	125.8	262.9	0.2	24.0	53.6	114.2	244.5	1.1	188.5	11.6	154.0	355.7	67.0	0.0	516.2	139.3	173.8	14.0	65.4	103.9	200.4	263.5	0.1	76.3	256.6	269.7	132.6	96.9	135.5	92.9	21.7	4.1	2.7	170.0	218.3	171.4	656.8	1678.5	931.0	314.7	1051.6	247.7	199.2	429.9	309.2	1170.2	266.9	325.9	264.3	1052.3	365.0	713.1	209.0	539.5	1585.6	42.3	46.3	50.9	61.1	39.9	51.0	61.9	48.8	57.4	58.0	59.5	69.0	225.5	160.3	140.0	3.6	88.9	366.8	392.3	1429.2	554.3	2.8	269.3	360.2	92.1	323.1	555.7	206.0	2.1	10.0	140.3	680.7	369.8	578.5	2.4	170.8	143.6	220.4	194.9	239.9	0.3	586.4	284.9	205.1	440.9	309.5	268.6	124.3	187.1	110.5	758.5	3.3	0.8	636.8	478.1	644.7	524.7	11.7	82.6	611.6	723.9	10.3	776.9	180.5	207.0	6.0	20.1	1442.1	705.9	157.6	76.3	526.2	471.9	180.7	283.2	19.4	105.2	108.2	197.8	2.8	4.5	1067.4	536.0	20.0	180.0	30.5	664.1	786.1
TTC25	DKFZP434H0115	ENSG00000204815	"Tetratricopeptide repeat domain 25"	Q96NG3	17	41930617-41966503	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 17.0;testis: 44.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 227.2;Endometrial ciliated cells: 65.3;Late spermatids: 43.5;Respiratory ciliated cells: 79.4;Spermatocytes: 98.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.0;U-87 MG: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023908	Enhanced		Uncertain	Vesicles,Centrosome		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome	Vesicles	"HPA023908: AB_2241243"	"unprognostic (3.08e-3)"	"unprognostic (4.51e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.31e-4)"	"unprognostic (2.95e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.76e-1)"	"unprognostic (2.71e-1)"	0.6	0.6	1.8	0.0	1.8	2.7	0.8	1.6	1.8	2.6	6.8	1.1	0.1	1.5	1.3	0.1	17.0	0.5	0.7	1.8	2.4	2.0	0.4	2.8	0.1	3.1	3.3	1.3	0.7	1.9	5.6	0.3	2.4	0.9	0.1	1.7	0.3	0.4	0.5	0.4	0.3	0.5	2.2	0.2	0.5	44.9	2.6	0.3	2.0	0.2	0.0	0.8	0.5	1.7	0.1	1.2	1.4	1.4	0.3	0.3	0.2	0.0	0.6	0.2	0.3	0.2	1.0	0.1	0.5	0.2	0.4	0.3	0.2	0.1	0.3	0.2	0.3	0.3	0.3	0.0	0.4	0.0	0.7	0.2	0.2	0.6	0.0	0.8	0.0	0.7	0.1	0.8	0.2	0.8	0.8	0.1	0.4	0.0	0.1	0.0	0.1	1.0	1.3	0.1	3.0	2.0	0.1	0.4	1.1	0.4	0.5	0.3	0.0	0.1	0.6	0.5	0.3	1.0	0.9	0.1	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	1.8	1.6	1.8	1.8	2.4	3.1	3.3	2.4	2.2	2.6	1.7	0.4	3.2	4.8	2.9	0.0	0.0	0.5	0.0	0.0	2.7	0.5	1.1	1.6	1.5	14.9	3.7	8.4	0.5	0.0	0.3	1.9	2.3	227.2	65.3	2.6	0.9	0.0	18.7	5.2	0.8	0.7	3.0	0.5	3.1	3.8	0.6	0.7	0.2	0.4	3.3	4.6	0.2	0.0	0.0	0.0	43.5	3.4	0.4	0.0	1.0	0.2	2.8	0.0	1.0	0.7	0.4	0.1	1.9	0.0	0.2	0.0	3.4	79.4	5.2	13.1	4.1	0.6	98.4	3.5	0.0	0.0	0.1	0.2	1.5	0.2	0.3
UBA5	"FLJ23251, UBE1DC1"	ENSG00000081307	"Ubiquitin like modifier activating enzyme 5"	Q9GZZ9	3	132654446-132679794	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 418.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017235, HPA076042"	Supported		Enhanced	Vesicles,Cytosol		NA	NA		43000	"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA017235: AB_1858507, HPA076042: "	"unprognostic (4.34e-3)"	"unprognostic (6.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.40e-2)"	18.3	29.2	15.6	18.6	17.5	21.5	23.0	15.2	16.3	18.0	30.9	21.5	24.0	17.2	30.4	17.2	16.6	16.9	23.8	16.7	15.8	31.3	31.8	17.7	22.4	12.6	13.6	16.9	52.1	31.0	22.3	25.8	14.1	24.8	22.6	25.2	48.0	20.2	31.4	22.0	24.8	17.7	13.8	21.1	26.7	17.0	14.2	19.7	31.8	24.4	24.9	17.2	11.8	16.5	67.2	24.4	42.1	35.3	28.4	31.9	44.5	57.1	57.2	34.4	39.6	44.9	24.2	52.1	41.1	40.8	23.3	39.6	41.6	43.6	49.5	51.3	18.1	63.6	39.6	50.1	27.9	79.6	36.7	28.0	24.8	32.8	48.7	31.8	38.6	28.6	41.0	76.2	38.0	59.4	44.1	29.2	38.6	56.3	22.9	38.6	37.0	99.8	31.0	50.9	40.2	35.8	33.5	32.0	51.3	37.8	40.0	39.5	35.9	36.7	36.2	17.8	29.8	71.7	51.8	98.3	40.9	28.1	33.5	8.3	7.1	7.0	12.4	8.2	14.6	15.1	13.8	19.1	15.9	10.2	16.1	16.3	1.6	26.0	9.5	19.2	15.5	10.5	15.6	17.5	15.2	16.3	16.7	15.8	12.6	13.6	14.1	13.8	14.2	16.5	23.1	35.3	25.9	37.2	24.0	17.2	18.9	26.4	21.1	22.1	26.1	13.1	36.9	22.8	24.4	7.3	14.6	63.0	28.4	8.3	68.4	30.3	124.8	17.7	22.2	20.5	21.6	10.9	37.6	44.9	48.0	24.8	28.5	17.4	24.1	16.8	13.2	22.8	22.6	21.9	35.6	22.6	34.6	10.3	11.4	418.2	16.8	13.9	17.8	16.9	21.6	26.1	16.5	37.7	28.4	23.2	16.7	27.1	85.4	23.1	35.4	43.1	20.8	23.6	32.9	23.5	28.2	49.4	23.1	15.9	18.5	99.7	20.4	29.7	18.3	18.1
UHMK1	"KIS, Kist"	ENSG00000152332	"U2AF homology motif kinase 1"	Q8TAS1	1	162497251-162529631	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077624			Supported	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA077624: "	"unprognostic (6.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.81e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.08e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.66e-2)"	26.8	23.3	21.2	23.3	24.6	40.3	19.3	18.1	21.2	15.1	16.6	19.2	19.1	11.7	14.1	13.3	14.4	13.7	11.6	26.0	28.3	31.2	38.1	17.5	30.8	24.9	28.5	11.9	11.0	27.8	7.8	17.1	28.3	16.2	19.6	10.5	13.5	18.5	25.8	11.9	23.4	10.8	19.8	25.4	20.0	12.2	26.1	24.6	19.4	25.9	28.9	18.1	10.5	19.4	61.9	28.4	14.6	35.8	40.7	31.9	32.7	79.7	43.2	63.9	45.7	18.6	37.8	50.2	67.8	60.0	31.2	34.9	28.2	44.1	102.4	69.1	20.4	49.8	34.3	16.9	31.3	73.4	55.5	33.0	45.8	63.2	59.9	44.6	37.4	34.2	44.1	67.7	111.4	26.0	39.3	19.4	19.4	46.1	37.8	24.9	64.9	41.9	42.6	62.8	26.4	24.3	70.5	64.6	52.2	19.9	56.0	81.0	58.5	72.7	41.0	50.8	112.6	69.2	103.5	58.0	60.5	35.3	67.3	3.6	2.0	2.4	4.8	5.3	4.9	3.2	3.5	4.0	2.3	3.6	3.5	4.0	1.3	3.7	6.1	2.6	3.1	2.6	21.2	24.6	18.1	21.2	26.0	28.3	24.9	28.5	28.3	19.8	26.1	19.4	37.6	19.2	41.2	20.9	75.6	29.4	33.7	38.5	34.7	24.4	39.4	20.2	35.1	40.0	53.8	53.3	12.5	26.2	81.0	53.9	56.7	27.6	55.6	35.1	35.7	33.4	33.5	51.6	37.0	23.2	38.1	25.5	43.3	44.4	45.7	23.3	31.1	85.1	30.0	23.5	27.4	34.1	48.8	73.5	47.5	58.4	21.5	60.0	28.4	33.7	58.0	14.6	74.2	20.6	29.5	40.4	33.0	19.5	47.2	59.9	60.8	62.2	50.9	23.0	0.0	29.2	27.8	25.1	29.6	45.2	24.6	22.4	69.4	31.4	39.3	58.3
ULBP3	RAET1N	ENSG00000131019	"UL16 binding protein 3"	Q9BZM4	6	150061053-150069121	"Predicted intracellular proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 6.5;testis: 6.3"	"Cell type enhanced"	"Detected in single"		"Gastric mucus-secreting cells: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA056541, HPA063007"	Approved		Uncertain	"Vesicles,Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Centriolar satellite"	"HPA056541: , HPA063007: AB_2684920"	"unprognostic (4.87e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.16e-2)"	1.3	1.2	1.6	0.7	1.8	0.7	1.0	1.6	2.4	0.5	0.4	0.8	1.1	1.0	0.9	1.5	2.0	1.3	0.7	1.7	1.4	1.7	1.0	1.5	0.5	0.9	0.9	0.8	0.7	0.9	0.1	0.9	0.9	0.7	0.8	0.8	0.4	0.5	6.5	1.1	0.5	0.5	0.2	0.6	1.9	6.3	1.3	0.5	4.9	0.4	0.9	1.0	0.5	1.9	6.2	2.0	6.5	7.3	1.6	11.9	2.3	6.1	2.6	7.2	8.0	11.0	5.1	0.2	11.8	9.9	10.9	8.3	17.7	20.5	7.7	3.7	7.8	0.6	2.9	0.5	2.5	0.1	1.1	10.2	3.5	15.0	8.1	6.9	9.7	0.2	0.5	0.8	6.3	7.0	0.3	0.5	3.1	2.6	14.8	6.2	5.9	0.3	17.5	12.4	1.2	0.5	12.2	8.2	3.0	3.4	2.5	1.7	5.6	1.2	9.8	20.5	13.3	0.3	0.2	4.1	9.6	3.7	5.1	0.8	0.2	0.2	2.2	0.2	2.9	0.8	1.5	2.4	0.2	0.5	0.8	1.2	1.0	0.6	0.2	0.3	2.3	0.4	1.6	1.8	1.6	2.4	1.7	1.4	0.9	0.9	0.9	0.2	1.3	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0
USP6	"HRP1, Tre-2, TRE17, Tre2, TRESMCR"	ENSG00000129204	"Ubiquitin specific peptidase 6"	P35125	17	5116032-5175034	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Calmodulin-binding, Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 19.6;testis: 13.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.4;Spermatocytes: 26.9"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046969			Uncertain	Vesicles		NA	NA				"Cluster 23: Testis - Cell cycle regulation"		"Cluster 37: Myocytes - Muscle contraction"	Vesicles		"HPA046969: "	"unprognostic (3.89e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.91e-4)"	"unprognostic (6.28e-3)"	"unprognostic (3.24e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.09e-4)"	0.4	0.3	0.2	0.2	0.5	0.1	0.7	0.3	0.6	1.4	1.5	0.8	0.0	0.9	0.7	0.2	0.5	0.5	0.4	0.4	0.3	0.6	0.1	0.4	0.3	0.7	0.2	2.6	0.3	0.0	0.6	0.5	0.6	0.6	0.3	2.5	0.5	0.4	19.6	0.6	0.3	0.9	0.2	0.4	0.2	13.4	0.5	0.0	0.9	0.6	0.2	0.3	0.5	0.9	0.1	0.1	0.3	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.4	0.3	0.1	0.1	0.0	0.3	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.3	0.6	0.4	0.3	0.7	0.2	0.6	0.2	0.5	0.9	2.0	6.4	10.8	0.0	0.4	10.8	1.0	1.1	0.0	8.5	4.0	3.8	1.6	5.7	3.5	3.7	12.5	0.6	1.0	0.1	3.9	0.0	24.4	1.1	2.1	3.0	0.0	5.3	1.2	0.0	0.8	1.8	0.0	1.4	0.0	1.2	3.6	3.2	2.7	1.7	1.0	0.0	0.0	5.4	6.4	13.5	1.8	3.1	3.6	2.8	3.2	5.1	0.0	0.0	2.9	0.1	0.1	2.6	0.1	2.1	0.0	3.2	4.0	12.3	6.6	5.9	1.7	26.9	11.5	0.0	10.4	0.7	1.1	0.9	0.2	1.1
USP9X	"DFFRX, FAF, MRX99"	ENSG00000124486	"Ubiquitin specific peptidase 9 X-linked"	Q93008	X	41085445-41236579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011618, HPA047417, CAB070164"	Approved		Uncertain	Vesicles		NA	NA		24000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Vesicles		"CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: "	"unprognostic (5.42e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.33e-1)"	16.4	16.8	11.9	14.3	13.9	18.2	14.2	12.7	12.8	15.3	14.3	14.8	13.6	15.4	14.9	14.1	16.0	13.0	15.3	14.3	13.2	17.8	33.9	14.4	15.8	12.2	13.1	13.4	16.0	30.0	10.2	18.4	13.8	12.3	13.7	22.0	11.5	15.3	39.1	13.8	14.3	16.3	12.5	13.3	13.8	17.5	12.8	18.8	19.5	28.4	16.2	15.0	12.6	16.4	38.6	44.2	39.1	40.2	33.0	32.7	8.8	21.5	28.8	23.8	27.5	21.1	16.9	25.7	11.5	48.5	71.3	25.3	67.1	39.7	39.7	32.0	50.5	29.3	41.3	19.9	27.6	26.4	21.0	29.3	17.9	56.4	53.4	35.5	37.2	17.1	36.0	20.3	38.6	29.1	18.8	12.7	42.6	14.1	24.7	20.3	51.8	16.9	24.7	30.7	22.2	20.8	89.0	26.7	26.0	69.8	24.3	16.2	40.2	36.6	27.6	34.6	24.0	19.1	22.3	30.9	26.4	12.1	18.5	1.7	2.3	3.0	2.5	1.9	3.6	2.8	3.0	2.7	2.6	2.1	3.0	2.8	6.4	2.5	2.5	2.1	2.8	1.5	11.9	13.9	12.7	12.8	14.3	13.2	12.2	13.1	13.8	12.5	12.8	16.4	38.1	41.7	35.1	48.0	42.6	48.3	30.8	29.6	55.2	38.1	41.3	29.5	83.5	54.3	37.9	27.6	37.5	39.6	46.3	58.5	7.9	28.4	14.9	85.5	56.9	43.6	26.9	41.0	84.9	26.5	25.4	41.4	41.8	136.9	25.9	58.3	45.7	62.8	32.6	37.0	86.0	39.1	18.3	47.8	42.1	15.4	33.2	55.5	33.8	67.5	44.6	31.3	30.9	74.9	108.0	32.6	40.1	49.2	38.8	35.6	47.7	21.5	35.8	31.2	32.9	70.6	48.3	86.4	82.9	55.2	55.3	46.7	42.4	45.8	38.0	40.2
USP9Y	"AZFA, DFFRY"	ENSG00000114374	"Ubiquitin specific peptidase 9 Y-linked"	O00507	Y	12537650-12860839	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 89.5;Inhibitory neurons: 69.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 21.5;RT4: 17.4"	"Not detected"	"Not detected"							HPA057687			Uncertain	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA057687: "			"unprognostic (2.63e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.10e-5)"	"unprognostic (8.46e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.42e-1)"	3.6	5.2	1.3	1.7	1.4	2.6	3.3	2.8	5.2	0.0	2.5	4.5	1.7	0.0	7.2	5.2	0.0	4.6	5.5	1.3	1.4	7.1	3.0	5.2	2.2	1.2	1.1	0.0	6.0	3.5	8.8	2.3	1.3	9.7	4.9	12.9	4.9	7.0	5.2	3.2	4.4	0.0	1.0	5.1	3.9	4.2	1.4	0.0	5.7	9.7	5.6	4.5	0.0	2.4	0.0	4.7	0.0	0.0	0.0	0.0	5.3	14.2	14.6	7.2	8.5	0.0	0.0	7.7	0.0	12.2	0.0	0.0	0.0	0.0	8.6	8.1	0.0	7.3	0.0	9.5	5.8	0.0	0.0	9.7	8.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	12.2	0.0	9.8	0.0	4.6	0.0	0.0	0.0	3.5	2.1	21.5	17.4	7.2	0.0	0.0	0.0	4.4	12.5	0.0	0.2	10.6	9.5	0.0	0.0	7.0	0.0	9.7	15.1	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.4	0.7	0.5	0.1	0.7	0.8	0.5	0.0	0.1	0.0	0.6	0.6	0.0	1.3	1.4	2.8	5.2	1.3	1.4	1.2	1.1	1.3	1.0	1.4	2.4	0.0	25.6	23.5	29.4	11.0	11.7	8.5	9.5	18.2	23.6	0.0	0.0	26.5	7.2	12.6	20.2	64.6	6.3	5.3	0.3	1.9	6.9	0.5	0.0	0.0	5.8	0.0	5.9	89.5	0.0	1.7	8.1	6.6	0.0	2.5	0.0	6.1	2.3	3.1	26.9	69.5	1.1	8.2	5.6	9.3	1.1	12.5	3.6	3.6	31.9	3.6	8.8	14.4	28.6	17.4	2.3	0.0	15.4	4.1	13.2	0.7	6.3	19.9	23.1	0.0	5.2	4.4	2.8	2.6	20.6	11.6	3.4	14.7	0.0	1.5	11.9
VLDLR	"CARMQ1, CHRMQ1, VLDLRCH"	ENSG00000147852	"Very low density lipoprotein receptor"	P98155	9	2621182-2660056	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 77.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 78.1;Cone photoreceptor cells: 104.3;Oligodendrocytes: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 6.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.3;JURKAT: 20.5;THP-1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032462, HPA051312"	Uncertain		Uncertain	"Vesicles,Cytokinetic bridge,Centriolar satellite"		Yes	NA		330000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Cytokinetic bridge, Centriolar satellite"	"CAB032462: AB_2216805, HPA051312: "	"unprognostic (5.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.34e-2)"	15.7	16.3	2.7	2.2	6.4	0.8	8.5	5.3	4.2	10.3	6.4	6.6	0.5	9.6	3.2	19.2	13.8	2.9	43.7	3.2	5.3	10.6	3.1	10.7	0.7	7.7	5.6	77.5	27.4	19.5	6.5	5.9	5.9	6.6	2.0	12.3	11.6	2.0	26.2	5.3	1.9	6.8	4.0	5.5	9.0	6.0	4.9	0.8	11.6	11.7	1.7	12.5	10.4	9.8	0.1	0.8	14.3	0.4	1.5	0.5	22.3	7.0	2.2	1.7	4.3	3.6	0.3	0.0	6.4	2.8	0.6	0.3	3.4	5.6	4.5	9.7	2.4	0.1	1.6	1.8	1.9	9.2	1.7	1.5	3.3	0.7	0.1	7.6	0.7	20.5	0.0	17.4	1.1	0.9	1.1	1.1	9.9	1.5	0.9	0.1	0.4	0.0	6.4	0.4	2.5	2.4	0.6	0.6	10.4	7.5	0.3	33.3	0.3	2.8	4.5	0.1	3.3	14.1	6.1	2.6	14.7	8.2	0.6	0.0	0.0	6.3	0.2	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	2.7	6.4	5.3	4.2	3.2	5.3	7.7	5.6	5.9	4.0	4.9	9.8	4.2	16.0	8.8	1.0	0.1	2.7	1.2	18.7	4.6	23.8	4.3	3.9	78.1	1.5	9.7	5.5	104.3	13.2	1.6	9.8	1.9	11.3	5.7	8.6	6.1	3.6	10.9	0.0	8.3	10.3	29.0	17.2	3.1	19.3	0.0	5.7	2.2	2.8	2.3	11.8	10.9	1.4	24.4	1.0	1.1	2.8	7.8	0.6	10.6	2.8	1.0	3.9	0.0	8.0	39.1	8.6	4.3	10.9	0.5	5.1	0.0	8.0	11.9	32.5	0.0	2.7	9.4	8.2	6.4	5.0	2.0	3.4	1.7	15.9	1.3	6.0
VN1R1	"V1RL1, VNR19I1, ZVNH1, ZVNR1"	ENSG00000178201	"Vomeronasal 1 receptor 1"	Q9GZP7	19	57454790-57457142	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 8.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.5;Cone photoreceptor cells: 2.1;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 2.5;Rod photoreceptor cells: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.9;U-266/70: 2.5;U-266/84: 3.3"					"Not detected"	"Not detected"			HPA062209			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles	Nucleoplasm	"HPA062209: "	"unprognostic (7.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.59e-5)"	0.5	1.0	2.2	0.2	2.4	0.3	0.7	4.5	2.4	0.6	1.8	1.2	0.0	0.5	2.2	0.6	0.8	0.3	2.0	2.3	1.9	1.2	1.0	0.8	0.4	1.8	1.9	1.2	0.6	1.1	3.4	0.6	1.4	1.3	0.3	8.2	0.9	0.6	2.3	1.7	0.7	0.3	1.3	1.1	0.5	1.3	1.9	0.4	1.7	2.7	0.3	0.9	0.6	2.2	0.2	0.0	0.8	0.9	0.0	0.2	0.4	0.2	0.3	0.2	0.8	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.3	0.0	2.9	0.4	0.0	0.3	0.1	0.2	0.5	0.3	0.3	0.0	0.1	0.4	0.1	0.3	0.1	0.4	0.4	0.1	0.2	0.9	0.2	0.0	0.3	0.2	0.5	0.4	0.2	0.5	1.5	0.6	0.0	0.2	0.0	0.4	0.4	0.3	0.0	0.6	0.1	0.1	0.3	2.5	3.3	0.2	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	4.5	2.4	2.3	1.9	1.8	1.9	1.4	1.3	1.9	2.2	0.4	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	4.5	0.2	0.0	0.3	0.0	0.6	0.0	2.1	0.2	1.4	0.0	0.0	0.3	0.0	0.2	0.1	0.6	0.0	0.4	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.3	0.1	6.7	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.1	0.0	2.5	0.3	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	4.4	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.2
WBP4	"FBP21, MGC117310"	ENSG00000120688	"WW domain binding protein 4"	O75554	13	41061509-41084006	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038965, HPA058738"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA038965: AB_10672836, HPA058738: AB_2683803"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.65e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.52e-1)"	17.5	16.0	16.1	9.8	16.8	15.6	13.4	16.5	23.9	12.0	13.2	13.2	11.2	18.5	16.0	11.2	11.1	9.3	23.1	16.1	18.1	12.3	16.3	10.4	11.8	16.3	16.6	13.2	8.7	12.4	8.2	11.5	16.4	14.0	9.1	16.5	8.1	14.7	41.0	11.3	11.5	14.8	15.7	9.8	9.3	12.2	16.5	14.7	11.2	29.8	11.6	11.3	11.0	18.6	15.0	9.8	26.7	17.3	17.1	25.9	16.2	33.3	23.4	25.9	19.7	15.5	15.7	21.4	13.0	23.6	31.2	20.6	10.2	16.7	33.0	22.3	14.3	30.2	10.0	16.0	26.3	19.1	18.8	21.3	25.0	18.8	26.5	21.1	22.0	20.3	16.4	9.1	27.5	12.6	27.3	20.6	16.3	23.2	8.0	25.3	16.5	8.4	23.6	14.6	6.1	14.7	10.6	11.3	16.1	21.5	9.4	29.3	19.3	16.0	14.7	22.2	19.5	6.0	7.0	14.7	19.7	13.7	22.2	19.2	13.0	12.4	10.6	12.0	9.7	14.2	13.6	11.5	11.0	12.6	14.4	14.3	27.3	12.5	21.8	18.5	14.4	6.1	16.1	16.8	16.5	23.9	16.1	18.1	16.3	16.6	16.4	15.7	16.5	18.6	42.4	51.3	29.3	21.2	23.9	54.4	60.3	54.8	33.0	46.8	33.5	37.5	110.0	40.0	32.5	25.8	33.3	55.6	23.0	32.3	76.3	52.3	11.9	32.9	58.4	46.9	37.8	111.7	17.0	42.0	61.1	52.2	15.8	44.5	45.7	27.5	38.2	63.1	40.9	45.4	16.6	28.1	18.3	26.7	47.1	9.7	47.8	33.0	32.0	10.3	60.4	63.8	28.8	17.1	33.3	50.3	33.2	52.6	16.8	60.9	33.8	70.6	23.6	49.2	26.3	55.3	66.7	87.5	103.9	29.7	44.9	49.9	22.3	31.9	27.6	40.9
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type palmitoyltransferase 14"	Q8IZN3	6	157381133-157678157	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 161.7;Horizontal cells: 122.8;Inhibitory neurons: 108.1;Oligodendrocyte precursor cells: 315.2;Oligodendrocytes: 221.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013437, HPA063754"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA013437: , HPA063754: AB_2685113"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	2.9	1.6	7.3	1.8	7.6	2.5	1.6	9.7	6.8	5.3	1.1	2.4	2.8	12.4	0.4	1.7	2.0	2.3	5.2	7.5	5.1	4.6	4.4	3.0	2.4	12.5	9.1	1.4	2.5	5.6	1.6	2.2	10.9	3.5	1.7	1.3	2.1	1.4	2.3	1.4	4.1	6.1	13.5	3.1	3.8	3.3	10.8	0.9	1.7	3.9	2.4	2.4	1.9	22.7	2.6	2.7	0.8	3.8	2.0	1.5	8.7	4.1	3.7	2.8	2.5	3.3	1.9	6.4	1.4	3.3	5.4	1.3	2.2	2.2	2.5	50.9	3.2	12.7	1.0	1.5	2.7	1.7	2.8	1.1	2.3	2.9	1.2	2.4	4.3	2.8	10.4	4.7	1.6	1.7	1.1	4.2	1.6	5.1	3.2	0.2	0.4	3.9	5.8	1.1	6.3	1.9	4.8	3.1	3.5	1.6	0.4	2.0	6.0	4.2	3.1	8.3	5.2	1.1	1.3	0.9	1.5	4.5	4.7	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.1	7.3	7.6	9.7	6.8	7.5	5.1	12.5	9.1	10.9	13.5	10.8	22.7	23.4	3.2	0.0	45.4	9.8	12.9	2.1	3.0	4.0	25.3	5.8	8.0	18.3	12.8	1.4	7.3	6.2	12.5	11.2	7.4	11.7	7.5	10.7	5.0	16.6	15.1	2.4	4.2	161.7	3.1	2.2	11.4	6.1	9.4	0.0	7.7	22.5	23.1	11.4	122.8	108.1	9.8	6.1	15.5	6.7	5.9	8.1	8.8	10.6	65.6	3.8	5.4	7.2	315.2	221.0	2.7	8.5	10.1	4.5	14.2	6.0	3.8	0.4	6.0	0.0	6.2	8.4	7.2	10.0	1.5	8.4	21.1	6.6	4.6	11.5	2.7
ZIC5		ENSG00000139800	"Zic family member 5"	Q96T25	13	99962964-99971909	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.1;choroid plexus: 8.1"	"Group enriched"	"Detected in some"	7	"Astrocytes: 20.5;Microglial cells: 15.0;Spermatocytes: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 22.0;HEK 293: 12.7;NTERA-2: 15.1;SCLC-21H: 85.5"	"Group enriched"	"Detected in all"	5	"basal ganglia: 18.9;cerebellum: 18.4;thalamus: 5.3"	"Region enriched"	"Detected in all"	7	"cerebellum: 39.7"	HPA074045			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Vesicles"		"HPA074045: "	"unprognostic (2.78e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.38e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.87e-2)"		"unprognostic (1.13e-1)"	"unprognostic (3.12e-2)"		"unprognostic (4.94e-2)"	0.0	0.0	2.8	0.0	3.5	0.0	0.0	17.1	11.2	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	2.8	2.1	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	2.2	22.0	1.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.0	2.1	0.0	3.1	0.0	1.1	0.0	4.5	0.0	0.0	4.0	12.7	0.0	2.1	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.9	3.3	0.0	0.0	1.7	0.0	1.7	15.1	0.0	0.3	1.9	0.8	0.0	0.0	0.0	85.5	0.0	2.4	2.0	0.0	1.6	0.0	2.8	0.0	1.2	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.5	17.1	11.2	3.9	2.1	2.8	2.1	3.0	1.8	3.1	2.6	0.1	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.0	0.0	1.9	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF143	"pHZ-1, SBF, STAF"	ENSG00000166478	"Zinc finger protein 143"	P52747	11	9460319-9528524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003263, HPA003264, HPA074818"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Golgi apparatus, Vesicles"	"HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.72e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (4.87e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.55e-2)"	9.0	6.1	8.6	11.4	10.1	18.6	9.6	17.3	9.9	10.0	10.8	9.7	9.5	10.5	14.4	9.8	10.1	8.4	9.3	7.9	9.3	8.6	9.6	9.1	15.7	9.9	8.8	13.7	7.7	7.9	7.1	10.4	11.2	8.7	9.9	16.1	8.9	8.0	17.3	10.2	8.2	9.5	9.8	11.1	7.7	16.9	9.0	18.9	14.6	11.5	14.1	11.2	8.4	14.9	20.0	18.8	23.4	15.2	18.9	17.4	21.5	21.8	17.3	16.4	17.9	26.7	24.3	19.6	9.7	17.7	14.0	22.5	23.1	17.3	24.5	20.0	27.7	18.5	27.7	18.7	15.6	25.9	17.8	15.3	20.4	22.2	19.4	21.4	16.3	17.9	20.5	23.3	18.3	17.1	24.1	10.6	26.3	23.0	19.9	21.4	21.2	12.3	14.7	24.0	16.1	15.8	24.0	16.0	14.3	20.6	14.9	14.6	15.6	21.4	15.3	15.1	19.6	11.5	21.6	33.4	13.8	14.8	12.5	39.1	24.6	57.3	28.0	24.9	25.0	23.0	24.6	22.9	20.9	18.2	22.8	19.6	45.1	19.4	28.2	10.1	29.7	19.6	8.6	10.1	17.3	9.9	7.9	9.3	9.9	8.8	11.2	9.8	9.0	14.9	17.9	6.4	12.1	6.2	14.7	26.6	34.1	12.1	17.6	9.3	8.7	13.2	15.5	7.2	10.3	5.5	8.4	10.0	17.1	10.1	3.9	12.5	20.3	18.7	14.9	13.0	6.6	25.4	8.1	11.5	16.2	14.5	9.7	16.3	14.0	7.7	6.8	7.6	9.9	5.0	7.4	6.9	14.2	8.3	22.0	10.0	11.8	15.8	10.6	12.2	16.3	15.5	17.5	7.5	9.8	14.1	7.7	6.8	15.4	20.1	6.3	7.7	15.0	14.3	59.2	18.3	16.7	50.5	21.3	12.8	23.4	18.3	18.1	7.3	7.9	26.9
ZNF232	ZSCAN11	ENSG00000167840	"Zinc finger protein 232"	Q9UNY5	17	5105541-5123116	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 18.1;Spermatogonia: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027309, HPA028611"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA027309: AB_10603464, HPA028611: AB_2672700"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.69e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.12e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (6.55e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.49e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.61e-3)"	1.8	1.2	3.0	1.1	3.5	0.4	1.9	3.4	4.3	2.7	3.1	2.7	1.0	2.4	2.4	1.6	2.3	1.3	2.0	3.1	3.5	2.3	2.1	1.5	1.9	3.6	3.1	3.4	2.8	1.9	1.6	1.5	3.5	2.1	1.3	2.3	1.9	1.3	2.0	1.4	1.8	1.9	3.1	1.9	2.2	2.6	3.5	1.6	2.4	1.8	1.4	1.8	1.8	4.2	5.8	4.3	6.9	7.0	2.4	1.0	3.7	2.8	1.4	2.7	3.7	6.7	1.4	11.5	3.4	1.0	4.0	3.9	4.9	2.8	1.6	4.6	7.4	2.0	10.0	6.0	3.5	0.0	3.4	1.9	3.0	2.9	2.5	1.9	2.0	13.7	10.0	4.1	3.3	2.8	10.1	4.0	13.5	4.9	4.6	8.5	4.4	7.8	2.2	0.8	7.2	4.7	5.4	2.1	4.6	5.2	1.1	2.8	3.2	2.7	4.6	2.1	5.5	5.5	9.3	3.0	6.9	0.3	4.6	1.3	1.9	1.9	4.2	2.0	5.2	12.5	4.7	5.8	3.9	11.4	7.0	6.5	0.1	5.7	1.2	7.4	4.3	3.5	3.0	3.5	3.4	4.3	3.1	3.5	3.6	3.1	3.5	3.1	3.5	4.2	4.2	0.0	2.6	2.0	5.2	4.2	2.9	4.0	5.7	5.7	3.8	6.6	5.6	0.0	3.9	5.5	0.0	3.9	3.5	3.1	3.9	7.0	8.6	5.5	6.8	5.2	1.2	2.1	3.4	4.0	5.0	3.4	1.5	2.2	0.0	4.0	3.6	3.9	6.1	0.0	3.3	2.4	0.0	3.8	1.3	6.9	3.7	2.9	0.0	3.7	1.8	4.2	0.0	3.0	8.1	3.7	7.6	5.3	1.4	4.1	2.6	3.2	6.5	3.9	0.0	4.4	4.4	18.1	21.7	3.3	4.7	2.1	3.2	3.4	3.8	1.8
ZNF365	"KIAA0844, UAN"	ENSG00000138311	"Zinc finger protein 365"	Q70YC5	10	62374192-62480288	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;esophagus: 10.2"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 112.7;Oligodendrocyte precursor cells: 113.6;Oligodendrocytes: 195.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 22.7;hippocampal formation: 8.3;thalamus: 8.0;white matter: 16.6"	"Group enriched"	"Detected in many"	9	"gdT-cell: 2.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.7;naive CD8 T-cell: 2.7;NK-cell: 6.4;T-reg: 5.9"	"Group enriched"	"Detected in many"	62	"NK-cells: 6.4;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 22.3;PC-3: 13.9;U-251 MG: 18.6;U-87 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052446	Supported		Approved	Vesicles,Centrosome		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Centrosome"		"HPA052446: AB_2681836"	"unprognostic (7.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-6)"	"unprognostic (2.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.89e-2)"	0.1	1.3	1.0	0.1	2.8	0.0	0.3	1.5	22.7	0.9	0.0	0.0	0.1	0.1	0.2	10.2	0.1	0.3	1.0	8.3	0.0	0.1	0.0	0.7	0.0	0.0	3.2	0.0	0.4	5.6	1.6	0.1	0.0	1.8	0.1	5.1	1.1	2.0	0.0	0.8	0.1	0.1	0.0	0.3	0.0	0.5	8.0	0.5	0.6	0.1	1.4	0.8	1.1	16.6	6.3	0.6	0.1	0.0	0.1	0.0	0.0	5.5	5.8	2.6	2.1	0.0	1.0	0.0	0.2	3.1	8.4	22.3	0.0	0.4	3.5	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.9	6.6	0.9	0.0	0.0	0.0	5.5	2.1	0.7	0.0	0.9	0.0	13.9	0.0	0.2	0.0	0.3	2.8	0.1	1.2	1.1	0.2	0.6	0.0	0.0	0.0	0.0	1.1	6.1	0.0	18.6	0.0	0.0	0.0	12.9	0.0	1.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.1	2.7	0.0	0.0	0.4	2.7	0.0	6.4	0.0	0.0	5.9	0.8	1.0	2.8	1.5	22.7	8.3	0.0	0.0	3.2	0.0	0.0	8.0	16.6	0.0	0.0	0.0	15.3	0.2	0.5	3.7	0.6	0.0	13.5	0.3	0.3	2.6	1.5	0.1	3.7	2.1	0.0	2.8	0.0	0.0	0.2	0.5	0.3	0.2	0.2	0.0	0.0	112.7	0.0	0.0	0.9	0.0	0.6	0.0	0.1	0.0	0.0	0.1	18.5	23.4	0.0	0.0	0.3	1.1	0.3	0.0	0.4	0.0	6.5	0.0	2.7	0.0	113.6	195.5	0.9	0.0	0.0	1.9	1.2	0.0	0.7	0.1	5.3	0.0	0.8	0.8	0.1	0.7	0.0	0.4	0.0	3.9	0.2	0.0	6.0
ZNF511-PRAP1		ENSG00000283496	"ZNF511-PRAP1 readthrough"		10	133309410-133352529	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	13	"intestine: 9.2;kidney: 8.4;liver: 30.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.3;RPMI-8226: 1.0"									"HPA035360, HPA038713, HPA052451"	Supported		Uncertain	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839"																		0.2	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	6.2	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	30.4	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	9.2	0.0	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.3	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.1	0.1	1.0	0.0	0.1	0.0	0.7	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF644	"BM-005, KIAA1221, MGC60165, MGC70410"	ENSG00000122482	"Zinc finger protein 644"	Q9H582	1	90915298-91022272	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 262.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057795	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA057795: AB_2683529"	"unprognostic (8.20e-2)"	"unprognostic (5.86e-3)"	"prognostic favorable (4.27e-4)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (3.19e-3)"	"unprognostic (4.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-1)"	12.4	9.8	17.4	11.7	23.4	17.3	17.1	24.5	22.3	15.7	13.3	13.3	8.5	17.2	11.4	10.3	10.9	10.2	10.0	15.3	18.0	11.0	19.8	10.3	15.9	19.0	20.8	14.7	9.6	12.6	7.9	13.2	19.4	11.6	13.4	11.2	15.4	10.4	14.5	10.4	10.5	12.2	18.8	13.2	10.5	13.1	18.6	19.7	18.7	17.4	15.3	13.5	12.1	28.4	24.1	11.2	32.0	17.1	14.9	17.1	19.4	21.0	21.1	22.1	24.1	15.4	8.3	29.0	23.2	15.6	29.3	19.1	31.6	23.7	33.4	21.5	19.8	38.3	21.8	21.1	20.6	34.6	11.9	16.3	27.0	22.4	30.1	20.8	23.8	21.6	26.8	32.0	23.6	9.5	27.9	30.0	30.3	12.5	22.7	28.7	52.3	16.6	23.5	21.5	25.8	20.6	24.5	19.1	55.2	21.7	12.4	33.7	19.0	24.5	21.3	20.4	31.9	24.5	17.8	39.7	10.3	25.8	12.9	5.4	3.5	4.0	4.6	3.6	5.3	6.8	5.0	5.3	4.4	5.2	6.4	5.5	1.1	9.9	3.8	5.4	4.4	2.6	17.4	23.4	24.5	22.3	15.3	18.0	19.0	20.8	19.4	18.8	18.6	28.4	72.6	70.5	30.0	98.9	85.9	54.2	98.9	45.0	48.3	37.3	49.8	45.0	51.2	28.6	47.0	11.0	25.0	25.6	85.2	34.3	31.3	31.1	11.4	87.3	68.7	44.9	55.0	30.9	96.0	22.6	19.6	51.8	43.8	107.9	43.2	51.9	27.1	26.1	22.5	55.5	106.2	30.4	36.7	29.2	38.6	13.3	46.6	49.7	35.6	124.6	30.7	40.2	38.1	144.3	262.3	29.6	29.2	34.6	79.6	58.8	22.2	29.2	41.7	36.8	52.6	83.5	67.4	51.5	49.2	39.8	47.5	12.0	72.9	44.5	34.0	75.2